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Abstract 
The white, brown and scarlet genes of Drosophila melanogaster encode 
proteins (White, Brown and Scarlet) which transport precursors of the fly's red 
and brown eye -colour pigments. These proteins belong to the ABC transporter 
superfamily and current models envisage that the White protein interacts with 
the Brown or Scarlet proteins to form two heterodimeric transport complexes of 
different specificities - namely a White /Brown complex which transports a 
precursor of red pigments; and White /Scarlet complex which transports a 
precursor of brown pigments. In the study described in this thesis four different 
experimental approaches were used in order to investigate structure and 
functional issues regarding these ABC transporters. These approaches 
included: 1) immuno -localisation of White and Scarlet in the compound eye of 
D. melanogaster, 2) genetic and biochemical analyses of mutant white alleles 
which result in a partial decrease in eye pigmentation; 3) heterologous 
expression of white and scarlet cDNAs in insect cells using a Baculovirus- 
mediated approach; and 4) expression of the predicted soluble ATP binding 
domains of White and Scarlet in E. coli. 
Biochemical evidence prior to the commencement of this thesis implied that the 
White /Scarlet complex was located in the plasma membrane of pigment cells 
where they formed a transporter for tryptophan (Howells et al, 1977; Sullivan et 
al, 1980; Sullivan and Sullivan, 1975). To investigate this proposal, anti -White 
and anti -Scarlet specific antibodies were used in an immuno- electron 
microscopy localisation study using D. melanogaster eye tissue (Chapter 7). 
Secondary colloidal gold conjugated antibody labelling indicated that both White 
and Scarlet localise to the sub -cellular pigment granule membrane and not the 
plasma membrane as previously proposed. This finding provides fundamental 
insights into the role of White and Scarlet in the eye pigmentation pathway. This 
location indicates that White and Scarlet transports 3- hydroxykynurenine, the 
final pigment precursor found in the cytoplasm of the cell, which is converted to 
xanthommatin by enzymatic and chemical reactions within the pigment granule. 
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Genetic and biochemical analyses of mutant white and brown alleles from flies 
with partial decreases in red and /or brown eye pigments has previously 
identified residues within the transmembrane domain of white and brown 
encoded subunits which interact and are important for function (Ewart et al, 
1994). This thesis describes the analysis of a further five white alleles (Chapter 
3). The mutations identified fall into two categories: 1) those which occur within 
the transmembrane domain and which primarily decrease function of the 
White /Brown transporter (off: G589E and wsat: F590G); and 2) those which 
occur within the nucleotide binding domain and decrease function of both 
transporters equally (wcrr: H298N and w101: G243S). In addition, a mutation 
was identified within an intra- helical loop region (14,Et87: G509D) which caused 
the most severe reduction in eye pigments. Peptide- protein Interaction analysis 
using an lAsys biosensor indicated that the White nucleotide binding domain 
binds to the wild -type loop and that the substitution G509D causes a decrease 
in binding (Chapter 6, Section 6.2.5). 
Work towards the development of a heterologous Baculovirus- mediated 
expression system of white and scarlet cDNA is described in this thesis 
(Chapter 5). This system was tested as a model system for investigating: 1) 
sub -cellular location of the White and Scarlet proteins; and 2) the hypothesis, 
that White and Scarlet form a tryptophan transporter in the plasma membrane. 
White and Scarlet proteins were successfully expressed in insect cells and 
some of the protein was located in the plasma membrane. However no 
evidence for tryptophan uptake was obtained. This finding is in agreement with 
the immuno -EM localisation results indicating White and Scarlet are located in 
the pigment granule membrane where they function as an importer of 3- 
hydroxykynurenine into pigment granules, and not an importer of tryptophan at 
the plasma membrane. 
Heterologous expression in E. coli of the nucleotide binding domain of White as 
a fusion protein to glutathione- S- transferase allowed the over -expression of this 
domain and subsequent affinity purification by glutathione- agarose 
chromatography (Chapter 6). Although this domain was predicted to be soluble 
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by sequence analysis, most of the protein was found in the insoluble cell debris 
and membrane fractions. This domain was successfully solubilised using none 
denaturing detergents and it was subsequently partially purified, and shown to 
have ATP binding activity. 
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1. INTRODUCTION 
The biological significance of membranes and the proteins and reactions which 
are associated with membranes should never be under -estimated. Cell 
membranes enable order within an otherwise vast metabolic soup and are an 
integral part of the majority of cellular processes including: cellular respiration; 
intercellular communication; flux of metabolites in and out of the cell; the list 
goes on and on. The importance of passage of metabolites by specific 
membrane proteins becomes obvious in disease states where failure of a single 
membrane protein (e.g. a transporter, channel or receptor) can result in 
metabolic perturbation of the whole organism resulting in death or severe 
disability. A number of exmples of this can be found among the superfamily of 
membrane transporters known as the ATP binding cassette (ABC) transporters, 
including: 
Cystic fibrosis is the debilitating lung and pancreatic disease which 
results from mutation of the cystic fibrosis transmembrane regulator 
(CFTR) which controls chloride flux in specific tissues (Quinton, 1990; 
Rommens et al, 1989). 
i) Stargardt disease results from mutations within the ABCR gene (Allikmets 
et al, 1997) encoding a retinal rod photoreceptor protein which, when 
defective causes blindness. 
iii) Adrenoleukodystrophy results from mutations in the ALD gene which 
encodes a peroxisomal membrane protein and when dysfunctional results 
in impaired peroxisomal oxidation of very long chain fatty acids which 
results in neurodegeneration (Mosser et al, 1993). 
iv) P- glycoprotein is encoded by the MDR1 gene in humans (Fojo et al, 
1985; Roninson et al, 1986). It is the over -expression of this gene which 
contributes to a multi -drug resistance phenotype in cancer cells which is a 
serious clinical problem in the treatment of cancer patients (Gottesman and 
Pastan, 1993; Roepe, 1995; Roepe et al, 1996). Over -expression of P- 
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glycoprotein enhances the efflux of cytotoxic anti- cancer drugs from the 
cells. 
The work described in this thesis is focussed on the development of a model 
system for the study of the structure and function of ABC transporters. The 
genes white, scarlet and brown from Drosophila melanogaster encode 
membrane transporters involved in the biosynthesis and sub -cellular localisation 
of red and brown eye -colour pigments within pigment cells of the fly's compound 
eye. The products of these three genes belong to the ABC transporter 
superfamily, based on amino acid sequence similarity with members of the 
superfamily. This introductory chapter aims to review the current understanding 
regarding the structure and function of this very interesting superfamily of 
membrane transporters. The general protein topology of ABC transporters will 
be discussed, in addition to the different functional domains which make up an 
active ABC transporter. Evidence for inter -domain interactions and the 
significance of these interactions to the transport mechanism will be discussed. 
Particular reference will be made to two eucaryotic ABC transporters, P- 
glycoprotein and CFTR, which have been intensively studied for many years. 
Many of the insights gained from these systems may be applicable to the 
Drosophila proteins and other ABC transporters. An overview of the 
background literature regarding the white, scarlet and brown gene products will 
be given, concluding with the aims of the work described in the thesis. 
1.1 ABC transporters: an introduction 
The ABC transporter superfamily is made up of a large number (over 100 
identified) of membrane permeases which are energised by ATP for the 
transport of substrate against a concentration gradient. Members of this 
superfamily share a number of characteristic structural and functional features. 
Sequence similarity between members of the family, at first glance, is limited 
largely to a number of highly conserved sequence motifs which are diagnostic 
for ABC transporters. This conservation is most apparent for the ATP binding 
domains, suggesting that this domain is highly conserved both in structure and 
function. The transmembrane (TM) domains are less conserved, however all 
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members of the family share a similar predicted membrane topology. The 
highly conserved nature of the ATP binding domains and the membrane 
topology of the TM domains is indicative of a similar ATP powered transport 
mechanism which has adapted for the transport of a vast range of substrates by 
alterations in the transmembrane domains which provide specificity. These 
issues are discussed in more detail below. 
1.2 Overall Topology 
ABC transporters are composed of two hydrophobic domains each usually 
consisting of 6 putative transmembrane a helices. In addition, they possess two 
cytoplasmic ATP binding domains which harbour the ATP binding cassette. The 
four domains can be associated, in various combinations, on the same or 
different polypeptide chains (which are closely associated in the three 
dimensional structure), as indicated in Fig. 1. Bacterial ABC transporters 
usually possess an additional subunit known as the periplasmic substrate 
binding protein which presents substrate to the transporter. CFTR is the only 
known eucaryotic ABC transporter which possesses an extra domain, known as 
the regulatory domain, which is linked in the same polypeptide (Fig. 2). The 
different combinations of fused and unfused functional units gives an indication 
of possible gene fusion and duplication events which have occurred during 
evolution and suggest that the ABC transporters known today arose from a 
separate ancestral hydrophobic membrane spanning domain, combining with a 
separate nucleotide binding domain (Croop, 1998). 
Fig. 1 Topological categories of ABC transporters. 
ABC transporters can be grouped into a number of sub- 
groups based on whether or not the different functional 
domains are fused on the same polypeptide, or on separate 
polypeptides. This figure illustrates these sub -groups 
both diagramatically in A. and as a broad dendogram in B. 
which is suggestive of the evolutionary relatedness of the 
sub- groups. The diagram shown in B. was partly derived 
from Fath & Kolter (1993). 
A. 
His transport 
S. typhimurium 
W, St, Bw 
D. melanogaster 
P- glycoprotein 
Mouse, human 
Substrate binding domain (Bacteria) 
Membrane 
Membrane spanning domain (MSD) 
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Fig. 2 Predicted topology of CFTR and P- glycoprotein 
Shown here are simplified diagrammatic illustrations of the membrane topology 
of CFTR and P- glycoprotein. Both of these ABC transporters are made up from 
a single polypeptide chain. The putative membrane spanning a- helices are 
represented as grey filled cylinders and are numbered 1 to 12. Abbreviations: 
NBD, nucleotide binding domain; R domain, regulatory domain. This figure 
illustrates the relative positions of loops and transmembrane regions discussed 
in the text. 
A. The predicted transmembrane topology of CFTR (Riordan et al, 1989). 
CFTR is the only known eucaryotic ABC transporter which harbours the 
accessory domain known as the R (regulatory) domain. 
B. The predicted topology of P- glycoprotein (Gottesman and Pastan, 1988: 
Juranka et al, 1989). 
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1.3 Structure and function of the membrane spanning 
domains 
The TM regions of the integral membrane spanning domains of ABC 
transporters are assumed to have an a- helical secondary structure. This 
assumption is based on computer predictions and the theory that an a- helical 
conformation satisfies the hydrogen bonding requirements of the peptide 
backbone carbonyl and amide groups, thereby minimising the free energy cost 
of burying a polypeptide chain in the hydrophobic environment which exists 
within the membrane (Branden and Tooze, 1991). In addition, a- helical TM 
regions must be approximately 20 amino acids long in order to span the 
membrane. Experimental evidence for the a- helical secondary structure has 
been obtained for some ABC transporters. For CFTR, it has been shown that 
the binding of DPC to residues within TM 6 and TM 12 were separated by two 
turns of an a -helix (McDonough et al, 1994). Evidence for the a- helical nature 
of TM 1 has also been obtained. Cysteine- scanning mutagenesis and 
sulfhydryl- specific reagents were used to label transmembrane residues and 
these were shown to have an a- helical periodicity (Akabas et al, 1994). 
The existence of the 6 TM regions per transmembrane domain (i.e. 12 a- 
helices for the complete transporter) has been demonstrated experimentally for 
a number of ABC transporters e.g. the haemolysin transporter of E. coli 
(Gentschev and Goebel, 1992), OppB and OppC of the oligopeptide transporter 
of S. typhimurium (Pearce et al, 1992); P- glycoprotein (Kast et al, 1996; Loo 
and Clarke, 1995b); and the histidine transporter of S. typhimurium (Kerppola 
and Ames, 1992). 
The function of the membrane domains of CFTR and P- glycoprotein have been 
studied extensively using a combination of biochemical and genetic 
approaches, providing insights into regions important for channel activity (in 
DPC (diphenylamine -2- carboxylic acid) is thought to bind within the chloride permeation pore 
(McCarty et al, 1993) and mutations which influence DPC binding affinity change amino acid 
residues which line the chloride channel pore. 
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CFTR) and substrate binding and specificity. In particular, TM regions 1, 5, 6, 
11 and 12 of both P- glycoprotein and CFTR (see Fig. 2) have been extensively 
studied and shown to be important for the structure and function of these 
proteins. Some of these insights are reviewed below. 
Substrate specificity of transmembrane domains 
(a) P- glycoprotein 
It has been well established using photo- affinity drug labelling and energy 
transfer techniques that P- glycoprotein recognises its substrate within the 
context of the membrane bilayer2 (Bruggemann et al, 1989; Greenberger, 1993; 
Greenberger et al, 1991; Morris et al, 1994; Morris et al, 1991; Raviv et al, 
1990). It was reported that photolabelled sites were located symmetrically near 
TM 6 and 12 (Greenberger, 1993). The model illustrated in Fig. 3 was 
proposed, where TM 6 and 12 interact to form part of the channel that 
participate in drug efflux (Greenberger, 1993) and therefore may be a region 
important for substrate specificity. 
The specificity function of the TM domains was demonstrated by a number of 
studies using chimeric P- glycoprotein molecules (Buschman and Gros, 1991; 
Dhir and Gros, 1992). The conversion of MDR -3 (which does not have a drug 
efflux activity) into an active drug efflux pump, by substituting the extra -cellular 
loop between TM 11 and 12, as well as TM helix 12 from MDR1, was very 
strong evidence that these regions were of paramount importance for the 
transport activity of P- glycoprotein (Zhang et al, 1995a). In addition, it was 
observed that cross -resistance profiles altered (i.e. substrate specificity 
changed) depending on the replacements. 
Further investigations with respect to the issue of substrate specificity have 
identified a number of residues which alter P- glycoprotein's specificity to some 
2 i.e. P- glycoprotein substrates intercalate into the lipid bilayer prior to being recognised by the 
transporter, which pumps it out of the bilayer, 
Fig. 3 Model of the photoaffinity drug labelling site of P- glycoprotein. 
This model is based on photoaffinity drug labelling studies where the major sites of 
IMP labelling were proposed to be in contact with intracellular regions just beyond 
TM 6 and TM 11 and in close proximity to the ATP binding site. This figure 
illustrates TM 5 and 6, as well as TM 11 and 12 in close proximity and interacting in 
the formation of part of a channel that participates in drug eflux. This model also 
highlights a possible functional importance of intracellular loop regions in close 
proximity to the ATP binding domain. This figure was reproduced from 
Greenberger, (1993). 
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drugs, but not others. The serine residues Ser939of mdr13 and Ser941 of mdr3, 
both within TM 11, were shown to have marked modulatory effects on cross - 
resistance (Dhir et al, 1993). It was shown that the introduction of the bulky 
side chains of tyrosine and tryptophan at these sites caused loss of colchicine 
and adriomycin resistance, while increasing the actinomycin resistance of cells 
containing mdrl (3 fold) or mdr3 (4 -8 fold) (Dhir et al, 1993). 
This phenomenon was also observed for two adjacent residues in TM 6 of 
hamster P- glycoprotein. When GIy338Ala339 were mutated to AIa338Pro339, an 
altered cross -resistance phenotype was obtained with a marked increase in 
resistance to actinomycin D (Devine et al, 1992). The authors speculate that "if 
the site was altered to optimally recognise one type of compound, it might lose 
or be diminished in its ability to recognise others." (Devine et al, 1992). The 
authors note that this concept is consistent with reports of alterations of P- 
glycoprotein that convey increased resistance to one or more drugs, resulting in 
decreased resistance to others (Choi et al, 19881; Roninson et al, 1991; Safa et 
al, 1990). Residues within TM6 of human P- glycoprotein (for example Val338 
and GIy341) have also been shown to have an important role in substrate 
specificity (Loo and Clarke, 1994b). 
Alanine scanning mutagenesis was used to investigate residues in TM 11 
important for substrate specificity (Hanna et al, 1996). The two residues Phe9e3 
and Tyr949 when substituted individually to Ala, had the most dramatic effect on 
drug cross -resistance. It was noted that these two residues, along with other 
residues which affected specificity to some degree, occur on the hydrophilic 
face of the amphipathic predicted TM11 a- helix. In addition Phe9e3 
and Tyr' are highly conserved in both TM5 and TM11 of P- glycoproteins of 
other species, as well as other ABC transporters, including CFTR and its 
homologs in mouse, frog and dogfish (Hanna et al, 1996), also suggesting their 
functional importance. The residue Ile939 which reduced resistance to all four 
3 lower case "mdr" denotes mouse homologs of P- glycoprotein, while upper case denotes 
human homologs. 
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drugs tested, is also conserved in TM5 and 11 of P- glycoproteins in rodents, 
human and yeast. Isoleucine or leucine is also found in the analogous position 
in some prokaryotic ABC transporters (Hanna et al, 1996). 
(b) Cystic fibrosis transmembrane regulator 
It is very interesting to note that regions predicted to form TM 6 and 12 in CFTR, 
like P- glycoprotein, have also been found to be strongly associated with 
substrate binding and specificity functions (Anderson et al, 1991; Cheung and 
Akabas, 1996; McDonough et al, 1994; Tabcharani et al, 1993). 
TM 6 was first implicated in substrate specificity when it was demonstrated that 
mutation of Lysine335 of TM 6 to an acidic residue caused a change in halide 
specificity of the CFTR ion channel (Anderson et al, 1991). It was also shown 
that the mutation of S341 and K335 within TM 6 can alter the binding of a voltage - 
dependent open channel blocker (diphenylamine -2- carboxylic acid (DPC)) 
(McDonough et al, 1994). In both TM 6 and TM 12, residues involved in DPC 
binding were separated by two turns of an a helix (McCarty et al, 1993; 
McDonough et al, 1994). It was proposed that residues within TM 6 and TM 12 
line the chloride pore of CFTR. 
In addition to TMs 6 and 12, TM 1 in combination with TM 6 have been 
extensively studied by cysteine- scanning mutagenesis4 (Cheung and Akabas, 
1996; Cheung and Akabas, 1997). Fig. 4 A and B illustrates a helical maps of 
TMs 1 and 6 showing residues which were found to be water accessible 
(highlighted by black squares) when substituted for cysteine. The figure shows 
that most of the water accessible positions are on one face of the helix, with 
some notable exceptions (Q353 R352 and K335) which are proposed to loop up 
back into the water accessible channel. This is illustrated in the working model 
proposed for the CFTR channel represented in Fig. 4C (Akabas et al, 1997). It 
was proposed by these authors that the cytoplasmic end of TM 6 loops back 
The cysteíne- scanning- accessibility technique (Akabas et al, 1992) has been used to identify 
water- accessible residues of TM domains associated with channel activity by their reaction with 
sulfhydryl -specific methanethiosulfonate (MTS) reagents. 
Fig. 4 Model of the CFTR channel 
The helical -wheel plots of TM 1 and TM 6 shown in A and B show the relative 
positions of amino acid residues in the helices. Water -accessible residues 
(indicated by black squares) determined from MTS- accessibility studies 
(reviewed in (Akabas et al, 1997)). The model interpreting these data is shown 
in C where MTS- accessible residues line the channel lumen, while residues at 
the cytoplasmic end of TM 6 loop back into the channel lumen forming a 
selectivity filter. This figure was reproduced from (Akabas et al, 1997). 
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and may mediate resistance to current flow and form the anion -selectivity filter. 
In particular R352, when substituted by cysteine. causes a significant drop in 
charge selectivity. This result, in combination with data obtained with respect to 
electrical distances within the putative pore, provide evidence in support of this 
model (Akabas et al, 1997; Cheung and Akabas, 1996; Cheung and Akabas, 
1997). 
1.4 Intracellular loops: importance for subunit/subunit 
interactions 
It is clear from the work reviewed above that particular transmembrane helices 
are of functional importance for both substrate specificity and transport or 
channel activity in the case of CFTR. Also of functional significance with 
respect to transport function are certain intracellular loop regions which connect 
the TM helices. These intracellular loops are at the interface between the 
transmembrane (TM) domains and the cytoplasmic nucleotide binding domains 
(NBDs) and there is evidence (discussed below) that particular loop regions are 
important for the transduction of conformational changes between the 
membrane and cytoplasmic ATP binding domains. 
With respect to sequence homology, the membrane domains of ABC 
transporters have a lower sequence conservation in comparison to the 
homology of the NBDs. However significant amino acid homology has been 
noted in the loop regions connecting the TM regions in sequence alignments of 
CFTR, MDR, STE6, HLYB and HAM1 as shown in Fig. 5 (Manavalan et al, 
1993). In addition, the length of the loop regions are conserved. The 
sequence motifs LTLXXXXXXP (in loop 3) and GXXL (in loop 5) (Fig. 5) were 
noted in MDR, STE6, HLYB and HAM1 but not CFTR. This provides strong 
evidence for the evolutionary relatedness of these ABC transporters and that 
Fig. 5 Amino acid conservation of transmembrane domains of a number 
of ABC transporters 
This figure was reproduced from (Manavalan et al, 1993) and illustrates 
conservation of the putative transmembrane (indicated by the solid bars) and 
loop regions of ABC transporters with divergent functions from different 
organisms. Of particular interest is the homology between loop regions. 
There is also some degree of homology between some residues within the 
transmembrane regions. 
Abbreviations: 
Suffixes N and C after the identification code denote the N- terminal and C- 
terminal transmembrane domain, respectively; HMDR1 human MDR1; MMDR1, 
mouse MDR1; HCFTR, human CFTR; STE6, yeast a factor transporter; HlyB, 
E. coli haemolysin toxin exporter; RING4, human MHC- linked peptide 
transporter; HAM1, mouse MHC -linked peptide transporter 
Colour key: 
Yellow: Identical or very similar amino acid residues. 
Blue: Residues that are more specific for the first transmembrane domain. 
Pink: Residues that are more specific for the second transmembrane domain. 
Green: Sequence motifs that are observed only in MDR, STE6, HIyB, RING4 
and HAM1. 
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the folding topology of the membrane domain is probably similar (Manavalan et 
al, 1993). 
Of particular interest is whether a sequence analogous to the EAA motif found 
in procaryotic ABC transporters is found in the eucaryotic transporters. In the 
prokaryotic models this motif which is around 30 residues long, occurs within 
intracellular loop 4 (Kerppola and Ames, 1992; Saurin et al, 1994a). Certain 
residues in the motif have been shown to be important for function and it has 
been suggested that the EAA motif interacts with the nucleotide binding domain 
(Kerppola and Ames, 1992). Strong evidence for this proposal has been 
provided by mutagenesis studies whereby certain EAA mutants of the E. coli 
maltose permease caused the failure of MaIK to assemble with MaIF and MaIG 
(Mourez et al, 1997). In addition Mourez et al (1997) identified several 
mutations within the proposed helical- domain between Walker A and B motifs 
(Mimura et al, 1991) which restored activity in transport defective EAA motif 
mutants, providing strong evidence that these regions interact. It has also 
been noted that substrate specificity of procaryotic ABC transporters can be 
predicted by sequence variation in their EAA motif (Saurin et al, 1994b). 
Although a role in correct recognition between ATP binding domains (which are 
often separate polypeptide chains in procaryotes) and the membrane 
associated domain of procaryotic ABC transporters has been suggested 
(Saurin et al, 1994b) a role for this motif in substrate binding may also be 
possible. 
In eucaryotic ABC transporters, an EAA -like motif of around 15 amino acids has 
been noted in loop 4 (intracellular loop between TMs 4 and 5)(Shani et al, 
1995) (e.g. adrenoleukodystrophy protein (ALDp), Pxap, PMP70, TAP1, P- 
glycoprotein). It has been suggested that the ABC signature sequences 
interacts with the TM domain through this EAA -like motif in eucaryotes (Shani 
et al, 1996) (see Fig. 6). 
Fig. 6 The EAA -like motif of some eucaryotic ABC transporters 
A. A hypothetical model (Shani et al, 1996) of the topology of the peroxisomal 
ABC transporter Pxal p of S. cerevisiae. This ABC transporter is a 
member of a homologous family of eucaryotic peroxisomal ABC 
transporters implicated in the human genetic disorders of peroxisome 
biogenesis and function. A motif designated the "EAA -like motif has been 
identified in peroxisomal ABC transporters and other eucaryotic ABC 
transporters. The relative positions of the Walker A, and B, and signature 
sequence (motif C), are shown. Shani et al, 1996 proposed that motif C 
interacts with the EAA -like motif. 
B. Alignment of the EAA -like motifs of eucaryotic ABC transporters (from 
(Shani et al. 1996). 
Abbreviations are as follows: 
Pxalp, from S. cerevisiae 
Pxa2p, from S. cerevisiae 
PMP70, from human 
ALDP, from human 
(C. e C44B7.8), C. elegans open reading frame C44B7.8 
hTAP1, human TAP1 
mMDR2, murine MDR2 
dMDR4, Drosophila MDR 4 
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Evidence for the functional significance of intracellular loop regions has been 
presented for CFTR, P- glycoprotein and ALDp. In CFTR it has been reported 
that the intracellular loop between TMs 4 and 5 is involved in stabilising the full 
conductance state of the CFTR chloride channel (Xie et al, 1995). These 
authors suggested that the loop interacts with other domains in CFTR 
(nucleotide binding folds, R domain and /or other intracellular loops) or with 
other cellular proteins that may be involved in transition between conductance 
states. In addition, some mutations in the intracellular loop between TMs 4 and 
5 have a similar effect on CFTR activity as mutations within the nucleotide 
binding domains and so it was suggested that this loop couples the activity of 
the nucleotide binding domains to channel gating (Cotten et al, 1996). 
Similarly, mutations that cause CF disease map to the loops between TM 2 and 
3 and these have been reported to impede transition of CFTR to the open state 
(Seibert et al, 1997). In particular, mutations introducing a positive charge into 
this loop (G18R and E193K) have a severe effect on channel activity, which is 
consistent with the notion that electrostatic interactions between the 
cytoplasmic loops and other domains of the protein, are important (Seibert et al, 
1997). 
In the case of P- glycoprotein, a role of cytoplasmic loops in substrate specificity 
has been postulated (Loo and Clarke, 1994a), It has been demonstrated that 
mutating glycine residues in cytoplasmic loops between transmembrane helices 
2 and 3; 4 and 5; and 8 and 9 alters substrate specificity (Loo and Clarke, 
1994a). 
Although it is clear from the abovementioned reports that the loop regions 
between TM helices are functionally important, it is not yet clear what their 
specific functions are. 
5 The ABC signature sequence (also known as motif C), a highly conserved motif within the 
nucleotide binding domain, is diagnostic for ABC transporters and is not found in other ATP or 
GTP binding proteins. This motif is discussed in Section 1.5.2 c. 
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1.5 ATP binding domain 
The cytoplasmic ATP binding domains of the ABC transporter superfamily are 
thought to be the energy transducing machinery for powering the translocation 
of substrate, via the TM domains, from one side of the membrane to the other. 
As discussed below this domain is highly conserved in sequence, inferring 
conserved functional and structural elements common to all ABC transporters. 
The ATP binding domains of the ABC transporters share significant sequence 
homology of between 30 and 50% (Croop, 1998: Higgins, 1992) and sequence 
alignment of different ABC transporters reveal a number of highly conserved 
sequence motifs which occur within a region encompassing 200 amino acids 
(Croop, 1998; Higgins, 1992; Higgins et al, 1986; Hyde et al, 1990; Mimura et al, 
1991; Riordan et al, 1989). This is the region designated the "ATP binding 
cassette" from which the ABC transporter superfamily derives it's name. 
The structure of this domain was believed to be similar to other ATP and GTP 
binding proteins including adenylate kinase, p21' and EF -Tu. Crystallographic 
structures of these proteins have been solved and they harbour similar 
mononucleotide binding protein structural elements. The structure of p21'as 
which is a good example of the conserved folding pattern of this group of 
proteins is shown in Fig. 7. The core structure includes the P -loop motif 
(orange), followed by 2 0-strands and a domain composed of a helix- turn -strand 
motif which is a highly conserved structural element known as the Rossman fold 
(Rossman et al, 1974). The Rossman fold may be one of the most ancient 
protein motifs known and is conserved in many dinucleotide binding proteins 
(Bellamacina, 1996) as well as mononucleotide binding proteins. It is structures 
such as these that have provided the framework for a number of predicted 
models of the nucleotide binding domains of ABC transporters (Annereau et ai, 
1997; Bianchet et al, 1997; Hoedemaeker et al, 1998; Hyde et al, 1990; Mimura 
et al, 1991). However, the first solved crystal structure of an ATP binding 
Fig. 7 Structure of the GTP -bound form of p21ras 
This ribbon diagram illustrates the 3D structure of p2Iras determined by x -ray 
diffraction analysis and is taken from Bourne et al, 1991. This structure is a 
good example of the conserved nature of ATP and GTP binding proteins. The 
Rossman fold made up of a number of ß- strands is shown by grey arrows. The 
Walker A motif which forms part of the phosphate binding loop is coloured 
orange, and labelled G1. The Walker B harbouring a highly conserved Asp is 
coloured red and labelled G3. Other coloured regions labelled G2, G4 and G5 
highlight other regions which may be conserved and important for function in 
Ras or other members of the GTP binding protein family. 
Conformational 
change 
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domain of an ABC transporter (HisP) has recently been published (Hung et al, 
1998) and is markedly different from the predicted structures based on 
adenylate kinase, p21"s with only limited similarity to structures of recA (Story 
and Steitz, 1992) and the a- and ß- subunits of bovine F,ATPase (Abrahams et 
al, 1994). The uniqueness of the ABC transporter nucleotide binding domain, 
and its conserved nature among a large family, suggests an effective solution 
to a common metabolic problem i.e. the selective transport of molecules across 
membranes. The structure of HisP6 and possible functional significance is 
discussed below. 
1.5.1 Crystal structure of HisP 
The crystal structure of HisP shows that, in agreement with previous 
biochemical data, the subunits form a dimeric structure. Each monomer was 
described as having an overall "L" shape made up of two arms (arm I and arm 
II) illustrated in Fig. 8. The ATP binding pocket is near the end of arm I. The 
six stranded ¡3 sheet spans both arms of the L. On one side of arm I the 13- 
strand rich area forms an anti -parallel 13 sheet and it is through this structure 
that the two monomers contact each other, through hydrophobic interactions. 
Arm Il is a -helix rich and this region is less conserved in sequence among ABC 
transporters (except for the signature sequence). This region is appropriately 
placed for interactions with the TM domain. There is strong genetic evidence 
indicating that arm II is embedded in the membrane by interaction with the TM 
subunits HísQ and HisM. Mutations in arm Il of HisP have been shown to 
decrease the affinity of HisP for HisQ and HisM (Petronilli and Ames, 1991). It 
is assumed that the conformation of the TM domain has been appropriately 
changed (normally a role of the HisJ protein) to allow binding and transport of 
the substrate. The ABC signature sequence is located within the a helical rich 
part of arm II, well placed for its predicted role in transduction of conformational 
changes between the ATP binding site and the TM domain. However the exact 
role of this sequence is not obvious. This region is buried within arm II with only 
6 The crystal structure of HisP was unknown at the outset of this PhD project. 
Fig. 8 Crystal structure of the HisP dimer 
The view of the HisP dimer shown here is along an axis perpendicular to its two- 
fold axis. The top and bottom of the dimer are suggested to face towards the 
periplasmic and cytoplasmic sides respectively (Hung et al, 1998). ATP is 
illustrated by the ball and stick diagram at the nucleotide binding fold. 
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LSGGQQ (residues 154 -158) being partially exposed. A role for this sequence 
in structural stability has been proposed (Hung et al, 1998). However the 
sequence conservation and interesting and varied effects on function noted in 
other systems (described in Section 1.5.2c) indicate a possible role in 
protein /protein interaction, possibly with particular intra -helical loop regions of 
the TM domain. The positioning of the signature sequence suggests this role is 
carried out in an indirect way due to the distance of the sequence from the 
surface predicted to interact with the TM domain. 
1.5.2 The sequence and structural motifs of the ATP binding cassette 
1.5.2.a The Walker motif A 
This sequence motif, which was reported to be common to many distantly 
related ATP and GTP binding enzymes (Walker et al, 1982), and in ABC 
transporters, consists of the consensus sequence GXXXXGK[TS). Structural 
data obtained for a number of ATP or GTP binding proteins which harbour this 
motif reveal that this sequence encodes a conserved secondary structure 
known as the P -loop or phosphate binding loop (Saraste et al, 1990). A 
representative structure of the P -loop is shown in Fig. 9. The P -loop consists of 
a loop between a p- strand and an a -helix (Pai et at, 1990). Using the p21Hras P- 
loop structure as an example (Pai et al, 1990; Tong et al, 1989) the significance 
of this structure is partly due to the amide nitrogens of the glycine loop which 
provide a positively polarised electrostatic field for the binding of the 
mononucleotide. The inherent dipole of the a helix is also thought to be 
important for binding the y- phosphate (Saraste et al, 1990). The conserved 
lysine is thought to perform a dual role of binding to the 13 and y- phosphates of 
ATP or GTP, in addition to stabilising the transition state by neutralising both 
the charges at the y- phosphate and increasing the charge at the leaving 
phosphate group (Bossemeyer, 1994). The recently solved crystal structure of 
HisP is consistent with previously solved structures harbouring the conserved P- 
loop. 
Fig. 9 The phosphate binding loop 
This figure illustrates a stereo view of the mononucleotide -binding fold P -loop of 
p21'as. The GTP analogue GMP -PNP shown, and the Mgt+ is shown as a black 
dot. This figure was reproduced from (Bossemeyer, 1994). This loop contains 
the conserved Walker A motif. 
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1.5.2.b Walker motif B 
The sequence motif named motif B (Walker et al, 1982) was also identified in 
many ATP binding proteins. This motif is not as well characterised as the 
Walker A P -loop motif, however in ABC transporters it includes the consensus 
ILLLD. The function of the highly conserved aspartic acid has been assigned to 
the co- ordination of the Mg2'- phosphate interaction by analogy with the other 
GTP /ATP binding proteins which harbour typical Walker A and B motifs 
(Yoshida and Amano, 1995) and this was confirmed by the crystal structure 
obtained for HisP. The relative positions of the residues thought to be involved 
in ATP binding are illustrated in Fig. 10. Asp18 of the Walker B motif of His P 
interacts with they phosphate of ATP via a water molecule that occupies a 
position similar to that of the Mg 2+ ion in the crystal structures of Ras p21 (Pal et 
al, 1989), and the F1a,0- AMP.PNP -Mg complex (Abrahams et al, 1994). This 
HisP structure was crystallised without Mgt+ because its presence decreased 
the solubility of HisP. 
1.5.2.c Motif C (ABC transporter signature sequence) 
Motif C sequence includes the consensus "LSGGQXXXRHyXHyA" (Hy is any 
hydrophobic residue and X is any residue). This motif is found in all ABC 
transporters but not in other ATP or GTP binding proteins and is therefore likely 
to perform a function specific to this superfamily (Ames and Lecar, 1992; Ames 
et al, 1992). Mutation analyses of this motif indicates a mixed bag of possible 
functional roles depending on the system under study. These include: protein 
stability (Bakos et al, 1997); protein /protein interactions involved in transducing 
signals from the NBD to the membrane domain (Mimura et al, 1991; Shani et al, 
1996; Shyamala et al, 1991); the mechanism of ATP hydrolysis inferred by 
analogy with the GTPase reaction (Carson and Welsh, 1995); substrate 
specificity in P- glycoprotein (Hoof et al, 1994). 
Fig. 10 Residues of HisP involved with interactions with 
ATP 
This figure shows the atomic details of the interactions of HisP 
with ATP. Hydrogen bonding is shown by dashed lines, aromatic 
interactions are shown as vertical lines. Interactions between 
ATP and specific amino acid residues (boxed) are indicated; 
interactions to protein main chain atoms are shown as lines to 
the atoms. Fesidues included in the Walker A and walker B 
motifs are shown in green and red respectively. Water molecules 
are labelled Wat and are circled. This diagram was reproduced 
from (Hung et al, 1998). 
'Wat -538) Wad 
His -19 
Gin-158 
(Wat-4818 
Wat-445) 
N, N/ 
-N" 
Asp 178 
Gln-100 
i J 
Wat -4 
Glu -179 
(Wat-416) 
His -211 
Thr-47 
Ser -46 
(Lys-149') 
' :(Arg-145') 
% 
Ser -41 Wat-500 
(Wat-43 
15 
Although mutations at some positions of the motif have a detrimental effect on 
activity, there are some which rescue function in CFTR and Ste6. In CFTR 
R553Q (the 6th residue of the motif) partially corrects cystic fibrosis (Dörk et al, 
1991) in a patient carrying both AF508 (which causes severe cystic fibrosis) 
and R553Q. Similarly, R553Q restored alpha -peptide transport in a STE6- 
AF508 CFTR chimera in yeast thereby partially correcting the processing and 
channel defects caused by the AF508 mutation. These authors have 
suggested that the region containing the AF508 mutation (known as the center 
region) and the signature sequence interact. These reports make clear the 
importance of the signature region for the transport mechanism which is 
consistent with its high degree of conservation in ABC transporters. 
1.6 The white, brown and scarlet genes of D. melanogaster. 
Model system for studying ABC transporters 
1.6.1 Introduction: eye pigmentation in D. melanogaster 
Eye -colouration of D. melanogaster is due to two major types of pigments, 
namely, xanthommatin which belongs to the ommochrome class of pigment and 
results in brown pigmentation; and drosopterin, which belongs to the pteridíne 
class of pigments and results in red pigmentation. In flies with wild -type eye - 
colour, these pigments result in a brown -red eye -colour. The eye -colour 
pigments play an important role in vision in insects. They are deposited within 
granules of pigment cells of the compound eye (see Fig. 11) which surround the 
photoreceptor cells, thereby optically isolating each ommatidium from its 
neighbour. In so doing, the pigments enhance visual acuity, (Stark and 
Wasserman, 1972; Stark and Wasserman, 1974). Pigment granules also act 
as a moveable light screen and migrate radially towards or away from the 
retinula cells in response to light and dark, allowing either more or less light to 
reach the retina depending on the light availability (Bernard and Stavenga, 
1979; Lo and Pak, 1981). 
Fig. 11 Cartoon of the insect compound eye 
The top section of this figure illustrates the repetitive array of ommatidia which 
make up the compound eye. The bottom section illustrates longitudinally and in 
cross -section, the cells which make up a single ommatidium. Pigment cells 
surround both the cone region, as well as the photoreceptor cells, thereby 
forming a sheath of light screening cells between each ommatidium. This figure 
was reproduced from Keeton & Gould, 1986. 
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1.6.2 Role of white, scarlet and brown genes in the tryptophan - 
xanthommatin biosynthetic pathway 
The developmentally regulated process of the synthesis and deposition of eye 
pigments in D. melanogaster is a complex multi -step process involving a large 
number of genes (reviewed in (Phillips and Forrest, 1980)). Some of these 
genes are structural and encode enzymes involved in the biosynthesis of 
pigments from precursor molecules, others may play regulatory roles, while 
others are believed to be involved in transport of precursor molecules to 
appropriate sub -cellular locations. The white, brown and scarlet genes are 
believed to fall into the last mentioned category. These genes encode proteins 
bearing all the conserved motifs of the ABC transporter superfamily and their 
role in eye pigmentation is discussed below. 
The study of eye pigmentation in insects, particularly in D. melanogaster, has a 
very long history since the discovery of eye pigment mutants in about 1910 
(Morgan, 1910). These mutants have been used with great success for the 
study of the genetics', developmental biology and biochemistry of the 
pigmentation pathways (Summers et al, 1982). Of particular interest with 
respect to this thesis is the tryptophan -4 xanthommatin biosynthetic pathway 
(Fig. 12) which leads to the deposition of xanthommatin within pigment granules 
of the compound eye. To provide a perspective as to where the white and 
scarlet gene products might fit into this pathway, this introductory section will 
review the current understanding of this pathway with respect to its regulation 
during development through the larval, pupal and adult stages, and the roles of 
specific enzymes. 
' D. melanogaster eye- colour mutants provided fundamental demonstrations of Mendelian 
inheritance (reviewed in (Zeigler, 1961)). 
Fig. 12 The xanthommatin biosynthetic pathway in insects 
The biosynthesis of the major brown pigment, xanthommatin, involves a series of 
oxidation steps, each catalysed by a different enzyme (reviewed in Summers et al, 
1982). The enzymes of the pathway are highlighted in grey and the known 
structural genes are shown in brackets. 
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Tryptophan -* xanthommatin pathway 
Tryptophan is an essential amino acid in insects and comprises an indolyl 
moiety capable of donating electrons in chemical interactions with other 
compounds. The biological activity of this amino acid means that it can be toxic 
at high levels and therefore its metabolism requires strict regulation. The 
xanthommatin (or ommochrome) pathway is given in Fig. 12. One of the key 
functions of the pathway in insects is to regulate tryptophan levels at the larval 
stage of life, during which time an attenuated form of the pathway operates in 
the larval fat body (a single layer of about 800 cells) (Rizki, 1980) and the 
malpighian tubules (renal tubules). Later during development of the pupae the 
pathway operates to completion with the deposition of xanthommatin in the 
developing eye disc. 
The first enzyme in the pathway is tryptophan oxygenase (a soluble enzyme 
encoded by the vermilion locus of D. melanogaster (Tobler et al, 1971; Walker 
et al, 1986)) which converts tryptophan to formylkynurenine. The second 
enzyme in the pathway, kynurenine formidase, catalyses the conversion of 
formylkynurenine to kynurenine (Moore and Sullivan, 1978). No mutants of 
kynurenine formidase have so far been identified. This first stage of conversion 
of tryptophan - kynurenine is active early in larval life in the fat body tissue and 
is thought to be a mechanism for decreasing free tryptophan levels and for 
storage of kynurenine in this tissue or excretion (Rizki, 1961; Sullivan and Kitos, 
1976). The next step of the pathway requires the enzyme kynurenine 
hydroxylase (encoded by the cinnabar locus of D. melanogaster (Paton and 
Sullivan, 1978; Sullivan et al, 1973)) which is located in the mitochondrial outer 
membrane (Stratakis, 1981; Sullivan et al, 1974) and found mainly in 
malpighian tubules, and eyes of the developing adult (Sullivan et al, 1973; 
Sullivan and Sullivan, 1975). Kynurenine stored in the cells of the fat body, 
once released into the larval circulatory system or haemolymph, is transported 
to the malpighian tubules where it is converted to 3- hydroxykynurenine by 
kynurenine hydroxylase. The cells of the malpighian tubules store kynurenine 
and 3- hydroxykynurenine within vesicles (Bonse, 1969; Yagi and Ogawa, 
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1996). It is thought that these stores of xanthommatín precursors are released 
during tissue rearrangement which occurs during metamorphosis (Gilmour, 
1961; Wigglesworth, 1972) into the circulatory system (haemolymph) where 
they are transported to the pigment cells of the developing eye (Summers et al, 
1982). It has been shown by cell lineage experiments (Nissan', 1975) that eyes 
of wild -type D. melanogaster are capable of producing xanthommatin from 
tryptophan but depend on transported kynurenine and /or 3- hydroxykynurenine 
to produce normal quantities of xanthommatin. This finding indicates that the 
controlled production, storage and release of these precursors in the fat body of 
the larvae and malpighian tubules of the larvae and pupae is a very important 
process in the production of wild -type levels of xanthommatin. 
The gene- enzyme relationship of tryptophan oxygenase; (vermilion) and 
kynurenine hydroxylase; (cinnabar) have been extensively studied using the 
mutant forms of the genes and some of these studies are described below. 
Mutant vermilion larvae when fed or microinjected with kynurenine or 3- 
hydroxykynurenine, are subsequently able to produce xanthommatin (Beadle 
and Law, 1938; Ephrussi, 1942; Green, 1952). Transplantation experiments 
where developing vermilion mutant eye discs were transplanted into wild -type 
hosts resumed synthesis of xanthommatin (Beadle and Ephrussi, 1936). 
Similarly mutants of the cinnabar locus could resume xanthommatin synthesis 
when 3- hydroxykynurenine was provided by feeding, injection or transplantation 
into a wild -type host (Beadle and Ephrussi, 1936; Beadle and Law, 1938; 
Ephrussi, 1942). These genes are categorised as having a non -autonomous 
phenotype which contrasts with the autonomous phenotype of mutants of white 
and scarlet which cannot resume xanthommatin biosynthesis even when all of 
the precursors are artificially supplied as for vermilion and cinnabar (Beadle and 
Ephrussi, 1936). 
It has since been shown that tissues of both the malpighian tubules and the 
developing eye from w° and st° mutants, are defective in uptake of tryptophan 
and kynurenine (Sullivan et al, 1980; Sullivan and Sullivan, 1975) in comparison 
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to these tissues from wild -type flies. In addition, increased rates of excretion of 
exogenously supplied kynurenine and 3- hydroxykynurenine from w° and st° 
mutant larvae, also indicate a defect in uptake and storage of these compounds 
in the cells of malpighian tubules (Howells et al, 1977). This biochemical 
evidence, coupled with the transplantation data described above, provides 
strong evidence that the gene products of w and st are required for transport of 
precursors of xanthommatin. 
The DNA sequences of the three genes white, brown and scarlet are now 
known (Dreeson et al, 1988; O'Hare et al, 1984; Tearle et al, 1989) and the 
protein sequences derived from the translated cDNAs has revealed that all 
three proteins harbour all the amino acid sequence motifs typical of the ABC 
transporter superfamily (reviewed in (Ewart and Howells, 1998)). This is 
evident from sequence alignments of White, Scarlet and Brown with other ABC 
transporters (see Fig. 13). The hydropathy profiles of w, bw and st are also 
consistent with the ABC transporter superfamily in that each harbours a 
hydrophilic ATP binding domain and a hydrophobic domain predicted to consist 
of six hydrophobic membrane spanning a- helices (see Fig. 14). Thus w, bw 
and st each encode a half transporter and it has been proposed that interaction 
between White /Scarlet, or White /Brown result in two different ABC transporters 
each with two nucleotide binding domains and two transmembrane domains 
comprised of 12 hydrophobic a- helices. Since genetic and biochemical 
analysis shows that White is required for transport of precursors of both red and 
brown pigments, Scarlet is only required for transport of brown precursors, and 
Brown is only required for transport of precursors of red pigments, it was 
proposed that White and Brown interact to form a transporter for guanine 
(Dreeson et al, 1988), while White and Scarlet interact to form a transporter for 
tryptophan (Tearle et al, 1989) (see Fig. 15). 
The biochemical data with respect to pigment precursor transport defects of w °, 
bw° and st° mutants discussed above, implies that these proteins are located In 
the plasma membrane of specific cell types in order to allow the high level of 
Fig. 13 Amino acid sequence alignment of nucleotide binding domains of ABC 
transporters 
This sequence alignment illustrates sequence conservation of the ATP binding 
cassette. A comparison of the nucleotide binding domains of White, Brown and 
Scarlet, are compared with those from CFTR, MDR1 and HisP. Highlighted in 
colour are sequences included in the Walker motif A and B, as well as the highly 
conserved ABC signature sequence. CFTR and MDR1 (both from human) have 
two nucleotide binding domains and these are indicated as (1), the N- terminal 
NBD, and (2), the C- terminal NBD. The sequence alignment was performed as 
described in the experimental procedures. 
W 6 
S*_ 6 
Bw 61 
CFTR 2 16 
CFTR 1 16 
MDR1 2 17 
MDR1 1 16 
HisP 16 
W 65 
St 62 
Bw 115 
CFTR 2 72 
CFTR 1 60 
MERI 2 74 
MDR1 1 73 
HisP 73 
W 119 
St 116 
Bw 164 
CFTR 2 120 
CFTR 1 110S 
MDR1 2 125 
MDR1 1 122 
-HisP 133 
LLAV 
LMAL 
LIAI 
RVCLr 
LLAV 
TLAL 
TVAL 
VISI 
GSSGAGKTT 
GSSGSGKTT 
GGSGAGKTT 
GRTGSGKST 
GSTGAGKTS 
GSSGCGKST 
GNSGCGKSTI 
GSSGSGKST 
A 
LNALA-FRSPQGIQVSPSGMRLLdTGQPVDAKEMQARCAYVQQDDL 
MSTLA-FRQPAGTWQ--GDILINGRRIGP-FMHRNHGYVYQDDL 
LAAIS--QRLRGNLTG---DWLNGMAMERHQMTRISSFLPQFES 
LSAFLRLLNTEGEIQI----DDOVSWDSITLQQWRKAFGVIPQKVF 
LMMIMGELEPSEGKIK----H SGRISFCSQFSW 
QLLERFYDPLAGKVL---LDGKEIKRLNVQWLRAHLG WSQEPI 
VQLMQRLYDPTEGMVS---VDGQDIR.TINVRFLREIIGWSQEPV 
LRCINFLEKPSEGAII---VNGQNINLVRDKDGQLKVADKNQLRL 
FIG-SLTA.-=FLIFQAPIVRMPRHLTYRQRVAR-VDQVIQELSLSKCQHTI-IGV- -PGR 
FLG-SLTVLEHLNFMAHLRLDRRV"SKEERRLI-IKELLERTGLLSAAQTR-IGS---GDD 
NtiK-TFTAYEHL'YFMSHFKMHRRTTKAEKRQR-VADLLLAVGLRDAAHTR 
IF--SGTFRKNLDPYEQW SD-QEIWKV-ADEVGLRSVIEQFPGKLDFVL---VDG 
1M--PGTIKENIIFGVSY DE-YRYRSV-IKACQLEEDISKFAEKDNIVL---GEG 
LF--DCSIAENIAYGDNSRV VSQEEIVRA-AKEANIHAFIESLPNKYSTKV---GDK 
LP--ATTIAENIRYGREN VTMDEIEKA-VKEANAYDFIMKLPHXFDTLV---GER 
LRTRLTMVFQHFNLWSHMTVLENVMEAPIQVLGLSKHDARERALKYLAKVGIDERAQGKI' 
VKG 
KiLV 
IQQ 
GCV 
GIT 
GTQ 
GAQ 
PVH 
LSGGERKR 
LSGGERKRI 
LSGGERKRI 
LSHGHKQLi 
LSGGQRAR 
LSGGQKQR 
LSGGQKQR 
LSGGQQQR 
AFASEALTDPPL 
AFAVELLNNPVI 
SLAEELITDPIF 
CLARSVLSKAKI 
ISLARAVYKDADL 
IAIARALVRQPHI 
IAIAP.ALVRNPKI 
SIARALAMEPDV 
Signat ure 
ICDEPTSGL 
FCDEPTTGL 
FCDEPTTGL 
LLDEPSAHL 
LLDSPFGYL 
LLDEATSAL 
LLDEATSAL 
LFDEPTSAL 
SFTAHSVVQVLKKLSQKG 
SYSAQQLVATLYELAQKG 
SFSAYSVIKTLRHLCTRRRIAKHSL 
P-VTYQIIRRTLKQAFAD 
VLTEKEIFESCVCKLMAN 
T-ESEKVVQEALDKAREG 
T-ESEAWQVALDKARKG 
PELVGEVLRIMQQLAEEG 
Fig. 14 Hydropathy analysis of White, Scarlet and Brown proteins 
This figure illustrates a comparison of hydropathy profiles of White, Scarlet and 
Brown, with those from CFTR and MDR1 from human. Hydrophobic 
transmembrane domains are predicted at regions showing downward inflection, 
and are highlighted by the hatched bar. Upward inflections are indicative of 
hydrophilic regions associated with the nucleotide binding domains. White, 
Scarlet and Brown all show a single transmembrane domain, and single 
nucleotide binding domain, while MDR and CFTR both harbour two nucleotide 
binding domains and transmembrane domains on the same polypeptide chain. 
The hydropathy analysis was performed as described in the Section 2.6.10. 
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Fig. 15 Model of pigment precursor transporters encoded by the white, 
scarlet and brown genes of D. melanogaster 
This figure illustrates the currently accepted model of the interactions between 
the gene products of white and scarlet, or white and brown in the formation of 
heterodimeric transporters which transport tryptophan and guanine respectively, 
into the pigment cells of the compound eye (recently reviewed in (Ewart & 
Howells, 1998). 
Outs ide Cell 
Tryptop han Guanine 
CiII 
TMD 
11111 
White 
118 
r \ 
NBD \ 
ATP 
ADP +Pi 
Scar let 
o 
ATP 
ADP +Pi 
n() 
White' 
ATP /- \ 
ADP +P i 
1 Pigment Cell 
.1; Pigment 
Granules 
AIP 
ADP + Pi 
(Drosopt erins 
20 
. uptake required for the purposes of either storage (in larval malpighian tubules) 
and /or pigmentation in the pigment cells of the eye. 
9.7 Experimental aims 
The Drosophila pigment precursor transporters represent a novel and powerful 
i experimental system for the study of ABC transporters. Although there are 
amorphic alleles of the white gene (e.g. w1118 ), there are no known lethal 
mutations of white, scarlet or brown, so these genes are not essential for 
viability, however mutant animals are easily detected by a change in eye -colour. 
Many of these have been collected over the years and are available from mutant 
strain collections8. The P- element mediated transformation of embryos allows 
site- specific mutations to be introduced into transgenic flies thereby providing 
another vehicle for the production of flies with mutant eye -colour. 
The overall aim of this thesis is to develop a variety of systems, utilising 
genetics, biochemistry and recombinant DNA technology, as well as electron 
microscopy, to characterise the structure, function and sub -cellular localisation 
of the White and Scarlet proteins. Outlined below are the experimental 
approaches that were taken in order to achieve these aims. 
1.7.1 Genetic and biochemical analysis of partially pigmented white 
mutants 
Although w° mutations cause the complete loss of red and brown eye pigments 
giving a pure white eye phenotype, many white mutant alleles cause a partial 
loss of pigments. It has been an ongoing interest of this laboratory to identify 
alterations in amino acid sequence in the existing partially pigmented white 
mutants. The white alleles chosen for genetic and biochemical analysis are 
ones that have been previously reported to have gene structures undiscernible 
from the wild -type white gene (by Southern blotting), indicating that the gene is 
e Drosophila stock centres can be accessed through the internet site known as "Flybase ", 
http: / /flybase. bio. indiana. edu 
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intact and does not harbour any gross genetic lesions. These alleles are likely 
to harbour codon changes. In addition, the partial loss of eye -colour pigments 
shows that the White protein is at least partially functional, indicating that the 
altered protein is capable of assembling into a folded state capable of inserting 
into the membrane. This approach has been used very successfully by this 
laboratory to identify transmembrane regions of the White and Brown proteins 
which may interact and play a role in substrate specificity (Ewart et al, 1994; 
Ewart and Howells, 1998). The analysis of additional partially pigmented white 
alleles is presented in Chapter 3 and has led to the identification of amino acid 
replacements in the White protein which affect function. The consequences of 
these mutations on the levels of red and /or brown eye -colour pigments has been 
determined9. 
1.7.2 Expression of white and scarlet genes in insect cells 
Extensive genetic and biochemical studies have been performed, which have 
led to the current transporter model discussed above, however, direct 
biochemical evidence for the transport function and its characteristics are still 
lacking. One aim of this thesis is to express an active White /Scarlet transporter 
in an insect cell line using the Baculovirus -based expression of white and scarlet 
cDNA. Work towards the development of this system is described in Chapter 
5. The Baculovirus -based system has been used successfully for the 
characterisation of many membrane transport and channel proteins, including 
ABC transporters (Carter et al, 1992; Cope et al, 1994; Germann et al, 1990; 
Meyer et al, 1994; O'Riordan et al, 1995; Sarkadi et al, 1992; Tate and Blakely, 
1994), and was therefore considered a good starting point for the heterologous 
expression and characterisation of White and Scarlet proteins. The goals are to 
provide a convenient system for assaying transport activity, specifically, to test 
tryptophan uptake activity. In addition, it could provide a convenient system for 
analysing site -directed mutants, thereby providing a powerful model system for 
pursuing questions regarding structure -function relationships in these proteins. 
9 This work has been accepted for publication (Mackenzie et al. 1999). 
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1.7.3 Production of antibodies recognising White and Scarlet proteins 
As an adjunct to the aims described in Sections 1.7.2, 1JA and 1.7.5, 
antibodies specifically recognising White and Scarlet proteins were required in 
order to demonstrate protein expression and determine the localisation of 
expressed proteins by immuno- labelling techniques. 
This work (described in Chapter 4) involved raising antisera in rabbits against 
synthetic peptides representing protein epitopes of White and Scarlet 
respectively, followed by the demonstration of specificity. 
1.7.4 Immuno -localisation studies of White and Scarlet proteins in the 
compound eye 
The current model for the White /Scarlet transporter assumes that it is localised 
in the plasma membrane of pigment cells, where it functions as a tryptophan 
transporter (Swart et al, 1994; [wart and Howells, 1998), however there is no 
direct evidence for this hypothesis. In order to investigate this issue, an 
ímmuno- localisation study was performed on sections of adult eyes, using 
colloidal gold immuno -labelling at the electron- microscope level. The study was 
aimed at gaining a fundamental understanding of the sub -cellular localisation of 
White and Scarlet, and how this information relates to the tryptophan -* 
xanthommatin biosynthetic pathway. This work is presented in Chapter 7. 
1.7.5 Expression of the nucleotide binding domains of White and Scarlet 
in Escherichía coli 
Over -expression of heterologous proteins in E. coli has been shown to be a 
powerful technique for the production of high levels of proteins - difficult to 
obtain from the natural source - for subsequent purification and in vitro 
structure- function analysis. This technique has been applied successfully to the 
characterisation of nucleotide binding domains of a number of ABC transporters 
(Ko et al, 1997; Koronakis et al, 1993; Randak et al, 1995), and was therefore 
tested for the production of the nucleotide binding domains of White and Scarlet. 
The success of such a system would not only allow the characterisation of the 
ATP binding and hydrolysis activity of these domains, but also lead to the 
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possibility of obtaining enough pure material for crystallisation and x -ray 
crystallographic analysis. A crystal structure for the nucleotide binding domain 
of only one bacterial member of the superfamily has been reported, and 
therefore the solving of the structure for a eucaryotic nucleotide binding domain 
is a high priority in this field_ Work towards this goal is presented in Chapter 6. 
CHAPTER 2 
EXPERIMENTAL PROCEDURES 
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2. EXPERIMENTAL PROCEDURES 
2.1 Fly techniques 
2.1.1 Maintenance of D. melanogaster strains 
Standard methods were used for the maintenance of D. melanogaster stocks 
(Roberts, 1986). Flies were cultured in 250 mf milk bottles on a medium made 
up of the following components: For 100 ml of media - 10 g agar, 26.3 g 
sucrose, 52.7g dextrose, 90.9 g maize meal, 15.9 g dried yeast, 11 ml water. 
Flies were generally maintained at 25 °C and transferred to bottles containing 
fresh medium once a fortnight. When anaesthetised flies were required di -ethyl 
ether was used. The D. melanogaster strains used in this work are listed in 
Table 1. 
2.1.2 Extraction of drosopterin and xanthommatin eye pigments 
Modified small -scale methods described previously (Evans and Howells, 1978; 
Ryall and Howells, 1974) were used to extract xanthommatin and drosopterin 
pigments, respectively, from adult, 10 day old D. melanogaster. The ages of 
flies used for extraction of pigments were standardised to 10 days old since 
eye -colour changes as the fly matures. For extraction of xanthommatin 
pigments, 20 adult heads were homogenised in 0.3 ml of 2M HCI using a small 
homogeniser. The homogenate was transferred to an eppendorf tube and 
vortexed intermittently with 0.4 ml n- butanol and 1 mg sodium meta bisulphite 
for 10 min. The tube was then centrifuged in an Eppendorf bench top 
centrifuge for 2 mins and 200 µl of the upper (butanol) layer was removed and 
the absorbance measured at 492nm. n- butanol was used as a blank. For 
extraction of drosopterin pigments 10 adult heads were homogenised in a 1:1 
mixture (0.4 ml each) of 0.1% aqueous ammonia and chloroform using a small 
homogeniser. The homogenate was transferred to an eppendorf tube and 
Table 1 D. melanogaster strains 
white allele Flybase ID Discoverer 
w' 
.. ET87 
wsat 
w'oi 
FBgn0003996 (Morgan, 1910) 
FBa10018222 (Nicoletti, 1960) 
FBa10018230 (Judd, 1964) 
M.M. Green and A.J. 
Howells, unpublished 
FBa10018300 (Bridges, 1935) 
Source 
A J Howells 
Drosophila Stock 
Center, California 
Institute of 
Technology, 
Pasadena 
Drosophila Stock 
Center, California 
Institute of 
Technology, 
Pasadena 
A J Howells 
Drosophila Stock 
Center, California 
Institute of 
Technology, 
Pasadena 
FBa10018145 (Pastink et al, 1988b) DNA was obtained 
from A. Pastink 
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centrifuged for 2 minutes. 200 µl of the upper (aqueous) phase was removed 
and the absorbance measured at 485 nm. 0.1% aqueous ammonia was used 
as a blank. Duplicate xanthommatin and drosopterin extractions were 
performed. Duplicate readings were averaged and results were expressed as a 
percentage of the of absorbance readings obtained from extractions from 
heads of the D. melanogaster wild -type strain Canton -S. The heads of the D. 
melanogaster strain w11° which lacks pigmentation were used as a negative 
control. 
2.1.3 Solubilisation of proteins from fly heads for SDS PAGE analysis 
Fly head tissue was homogenised in a buffer containing 6 M urea and 5% SDS 
and incubated at 65 °C for 1 hr, followed by centrifugation for 2 mins in a bench 
top centrifuge, prior to adding 10 x SDS PAGE sample buffer and separation of 
proteins by SDS PAGE as described in Section 2.6.1. 
2.2 General Molecular Biology Techniques 
2.2.1 Synthesis and preparation of oligonucleotides 
Oligonucleotides were synthesised by the Biomolecular Resource Facility at the 
ANU. The oligonucleotides were subsequently precipitated from 1000 aliquots 
of the ammonia solution they were supplied in by addition of 1m1 of n- butanol 
followed by centrifugation for 1 min at room temperature in a benchtop 
eppendorf microcentrifuge. The pellet was dried under vacuum, resuspended 
in water and quantitated by absorbance at 260nm as described in Section 
2.2.2. 
2.2.2 Spectrophotometric analysis of DNA 
DNA in solution was diluted 1/200 and assayed at 260 and 280 nm using a 
Hitachi U -1100 Spectrophotometer. The DNA concentration was then 
determined, based on 1 optical density unit at 260 nm being equivalent to 
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50 ug /ml dsDNA or 20 µg /ml for oligonucleotides (Sambrook et al, 1989). DNA 
purity was assessed by dividing OD260 by OD2e0, which is between 1.8 and 2.0 
for DNA uncontaminated with RNA or protein (Sambrook et al, 1989). 
2.2.3 Polymerase chain reaction 
This technique was used to amplify DNA fragments from plasmids or genomic 
DNA. Polymerase chain reaction (PCR) (Mullis and Faloona, 1987; Saiki et al, 
1985) was performed in the Perkin Elmer Cetus Thermal Cycler, using sterile 
0.5ml thin walled polypropylene microcentrifuge tubes (Perkin Elmer Cetus). A 
typical reaction mix included Pfu DNA Polymerase buffer (supplied with the 
enzyme from Stratagene) (20mM Tris -Cl pH8.2, 10mM potassium chloride, 
6mM ammonia sulphate, 2mM magnesium chloride, 0.1% Triton X -100 10ng /ml 
nuclease free Bovine Serum Albumin), 20pmol of each of two opposite -facing 
primers (primers are detailed in Section 2.14), 200mM of each dNTP, 250ng of 
template DNA 2.5 units of Pfu DNA Polymerase (Stratagene)(from the 
hyperthermophilic marine archaebacterium, Pyroccocus furiosus), sterilised 
distilled water to a total volume of 50 µl . The PCR reaction mix was mixed 
gently and overlayed with mineral oil (Perkin Elmer Cetus). An estimate of the 
optimum annealing temperature for a primer was calculated by adding 2 °C for 
each A and T nucleotide present in the primer and 4 °C for each G and C 
nucleotide and subtracting 5 °C from the result. The tubes were pre- heated to 
the denaturing temperature for 1 minute then subjected to 25 to 30 cycles of the 
following typical temperature and time profile: 
Denaturation: 94 °C for 45 seconds 
Annealing: 55 °C for 1 minute 
Extension: 72 °C for 3 minutes 
Following 25 to 30 cycles, a final cycle with a 10 minute extension time was run. 
The PCR reactions were stored at 4 °C or -20 °C. 
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2.2.4 Chromosomal DNA extraction from D. melanogaster 
Chromosomal DNA was extracted from D. melanogaster strains using a 
modified method described previously (Bender et al, 1983). 100 µl of freshly 
made Lifton Solution (0.2M sucrose, 0.05M EDTA, 0.5% SDS, 100mM Tris pH 
9) was added to approximately 20 flies in an eppendorf tube. The flies were 
crushed with a small glass rod until most of the fly matter was broken up. A 
further 100 pl Lifton Solution was added and the flies were further crushed until 
the fly tissue was no longer aggregating. The fly homogenate was incubated at 
65 °C for 30 minutes. 50 pl of a solution containing 3 M potassium and 5 M in 
acetate was added to the fly homogenate, mixed gently and incubated on ice 
for 60 mins. The mixture was centrifuged at 10,000 rpm for 10 mins at 4 °C. 
The supernatant was carefully removed and transferred to a fresh eppendorf 
tube. The chromosomal DNA was purified by successive phenol, 
phenol /chloroform /isoamyl alcohol, and chloroform /isoamyl alcohol extractions 
by adding an equal volume of solvent, vortexing and then centrifuging in a 
benchtop Eppendorf microcentrifuge for 5 minutes at room temperature. The 
upper phase was removed and treated with RNAase A (2 µg) for 15 minutes at 
37 °C. The DNA was ethanol precipitated at room temperature by the addition 
of two volumes of ethanol, standing for 5 minutes, and centrifuging at 8000 rpm 
for 15 minutes. The pellet was washed with 70% ethanol, dried in a vacuum 
desiccator, and resuspended in 40 pl of TE buffer. 
2.2.5 Purification of PCR products, and products from restriction digests 
Products from PCR experiments and DNA digested by restriction enzymes for 
sub -cloning purposes, were purified using a BresaClean Kit (Bresatech). The 
PCR reaction is removed from the PCR tube and transferred to a clean 
Eppendorf tube being careful not to carry over any mineral oil. Three volumes 
of Nal solution was added to the reaction, followed by 5µ1 of well resuspended 
BresaClean silica resin. The solution was mixed and incubated for 5 mins to 
allow the DNA to bind to the silica resin. The solution was then centrifuged to 5 
secs at top speed in a bench top centrifuge and the supernatant removed. The 
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silica /DNA pellet was resuspended gently with 500µI of BresaClean wash 
solution followed by centrifugation at top speed in a bench top centrifuge. The 
wash solution was removed as completely as possible and the pellet was dried 
under vacuum in a SpeediVac Concentrator (Savant). The silica /DNA pellet 
was then resuspended in sterile distilled water and incubated for 5 mins at 
50 °C. The silica resin was pelleted by centrifugation at top speed for 1 min in a 
bench top centrifuge and the supernatant containing the PCR products were 
transferred immediately to a fresh tube. The DNA containing solution was 
centrifuged again for 30 sec and transferred to a new tube, in order to remove 
any residual silica resin. 
2.2.6 Agarose Gel Electrophoresis 
Agarose gel electrophoresis was used to separate DNA fragments by size. 
Generally 0.9g of agarose powder (Sigma) was dissolved in 100 ml TAE buffer 
(40mM Tris -HCI, 20mM sodium acetate, 1mM EDTA, pH 7.8) and was poured 
into a 15 x 18cm tray, with combs inserted to create sample wells. Samples 
were loaded in 20 µl volumes with loading dye (470mM sucrose, 0.75mM 
bromophenol blue, 48mM EDTA) and run at a constant current of approximately 
180mA, until the bromophenol blue dye front had migrated three -quarters of the 
length of the gel. After 20 min of staining the gel in a 1 ug /ml ethidium bromide 
solution, the DNA was visualised under UV light as fluorescent bands, and 
photographed. 
2.2.7 Growth of E. coli cultures for molecular biology work 
E. coli strains were grown in liquid culture in LB Broth (1.0% (w /v) Tryptone, 
0.5% (w /v) Yeast extract, 0.5% (w /v) sodium chloride, pH 7); or on agar plates 
(10% Bacto -agar dissolved in LB broth) with the addition glucose (1m1 of 2M 
glucose /100m1 of LB broth) and the appropriate antibiotic. The Table in 
Section 2.13 details the strains used in this work and their antibiotic resistance 
status in addition to the growth temperature. When a new E. coli strain was 
made by transformation with a recombinant plasmid a primary source of 
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inoculum was made by growing the strain on an agar plate overnight, and 
resuspending the cells with a sterile glass rod in 2 mis of a solution of 10% 
glycerol and LB broth. The resuspended cells were transferred to a sterile vial 
and stored at -20 °C or -70 °C. This primary source of inoculum was then used 
in future experiments where the cells would be thawed, a loop full of cells would 
be taken and streaked onto an LB agar plate, or used to inoculate LB broth, 
and the glycerol stock would be returned to the freezer. Small scale cultures 
for small scale purification of plasmids were grown in McCartney bottles, with a 
maximum of a 3ml culture volume. Liquid cultures were grown in baffled 
conical flasks with the culture volume not exceeding % the volume of the flask. 
Flasks without baffles were sometimes used and in this culture volume would 
not exceed 1/10 the volume of the flask to ensure good aeration. Liquid 
cultures were placed in a shaking air incubator. 
2.2.8 Small scale purification of plasmid DNA 
A commercially available kit from Qiagen was used to purify plasmid DNA from 
E. coli on a small scale. 3ml overnight E. coli cultures were harvested by 
centrifugation at 5000 rpm for 2 mins. The cells were resuspended in 3001_11 of 
Cell Resuspension Solution. 300µI of Cell Lysis Solution was added and mixed 
gently by inverting the tube several times. 350µI of Neutralisation Solution was 
then added and gently mixed by inverting the tube several times. A thick, White 
precipitate formed after addition of the neutralisation solution and this was 
pelleted by centrifugation at top speed in a microfuge for 15 mins. The 
supernatant containing the plasmid DNA was removed carefully, avoiding the 
White precipitate containing cell wall and chromosomal DNA, and transferred to 
a Qiagen column. The supernatant was passed through the column and 
discarded, the plasmid DNA remains bound to the membrane in the column. 
The column was washed with column wash solution by centrifugation. The 
wash solution was discarded and the column was centrifuged again for 1 min to 
remove as completely as possible any remaining column wash solution. 50411 of 
sterile distilled water was then added to column membrane and incubated for 5 
31 
mins at room temperature before centrifuging for 1 min collecting the 
supernatant containing the plasmid DNA in a fresh eppendorf tube. 
2.2.9 Large Scale purification of Plasmid DNA by CsCI Density Gradient 
When a large quantity of high purity plasmid DNA was required, for example, 
for sequencing of extensive regions of DNA, a CsCI density gradient purification 
was performed. The method described here was adapted from (Sambrook et 
al, 1989). An overnight 1 L E. Coli culture harbouring the desired plasmid was 
grown in the presence of the appropriate selective antibiotic(s) (see Section 
2.13. The bacteria were harvested by centrifugation at 5,000 rpm for 15 mins in 
an GSA Sorvall rotor. The bacterial pellet was resuspended in 20 ml of 
solution containing 50mM Tris, pH 8, 25% sucrose and left on ice for 5 mins. 
80 mg of lysozyme dissolved in 4mis of 0.25M Tris pH 8, was added to the 
cells, swirled gently and left on ice for 5 mins. 2 mis of 0.5M EDTA pH 8.0 was 
then added and mixed by swirling and incubated for 5 mins on ice. 16 mis of a 
buffer containing 0.3% TritonX -100, 50 mM Tris, pH 8.0, 62.5 mM EDTA was 
added, swirled to mix, and incubated for 15 mins on ice. The lysozyme treated 
cells were then centrifuged for 15 mins at 20,000 rpm in an SS34 Sorval rotor 
at 4 °C to pellet chromosomal DNA attached to E. Coli cell wall, and other 
insoluble material. The supernatant containing the plasmid DNA was decanted 
into a fresh tube, holding the pellet with a spatula to ensure it stayed in place. 
The volume of the supernatant was measured and 1/d this volume of 5 M NaCI 
was added, followed by'/ volume (including NaCI) of 50% w/v PEG 6,000 in 50 
mM Tris pH 8.0. This was gently mixed, intermittently for 15 mins on ice, then 
incubated on ice for between 2 and 18 hours. The solution was then 
centrifuged at 4,000 rpm for 5 mins in a GSA Sorvall rotor. The supernatant 
was removed and the plasmid DNA pellet resuspended in 7 ml of TE buffer (10 
mM Tris, 1 mM EDTA, pH 8.0). 7.2 g CsCI was added to the resuspended 
pellet and dissolved by mixing with a spatula in tubes for use in an SE12 rotor. 
This mixture was centrifuged for 20 mins at 15,000 rpm in an SE 12 rotor at 
15 °C. The protein layer at the surface of the solution was removed with a 
spatula as completely as possible. The supernatant was transferred to a Ti50 
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Beckman rotor tube and 0.3 ml of 10 mg /ml ethidium bromide was added. The 
solution was protected from light once the ethidium bromide was added. The 
solution was then centrifuged in an Beckman ultracentrifuge at 39,000 rpm at 
15 °C for 41 to 42 hrs. The centrifuge was slowed with the brake off to avoid 
disturbing the CsCI gradient. The plasmid band was extracted by inserting an 
18 gauge needle attached to a 5 ml syringe barrel, and transferred to a sterile 
tube. The ethidium bromide was removed from the DNA solution by adding 
isopropanol (stored over NaCI saturated TE buffer). The solution was vortexed 
to mix and the isopropanol phase containing ethidium bromide removed. This 
isopropanol extraction procedure was repeated until no further red colour could 
be seen in the isopropanol phase. CsCI was removed from the DNA solution 
by dialysis against one tenth the concentration of TE buffer, at 4 °C. To ensure 
complete removal of CsCI, the DNA solution was de- salted using a NAP25 de- 
salting column (Pharmacia). The concentration and purity were analysed by 
spectrophotometry as described in Section 2.2.2. The level of supercoiled 
plasmid DNA was analysed by agarose gel electrophoresis as described in 
Section 2.2.6. 
2.2.10 Site Directed Mutagenesis 
Two methods were used to alter specific DNA sequences in plasmid constructs. 
Both methods employ oligonucleotide directed mutagenesis. Whenever 
possible mutations were designed in order to introduce a restriction 
endonuclease site to allow identification of site -directed mutants by restriction 
analysis. 
2.2.10.a Site directed mutagenesis using Uracil -containing DNA 
This method described previously (Kunkel et al, 1991) is an oligonucleotide - 
directed mutagensis technique. A single stranded DNA template containing a 
small number of uracil residues in place of thymine (Kunkel, 1988) is prepared 
by passaging the appropriate plasmid through an E. colt dut- ung strain. This 
strain lacks the enzymes: dUTPase (dut) resulting in an elevated level of 
dUTP, which competes with TTP for incorporation into DNA; and uracil N- 
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glycosylase (ung) which normally removes uracil from DNA. The double duf 
ung mutant can be used to produce plasmid DNA or single stranded DNA 
containing uracil. The uracil- containing DNA was then used as a template for 
the synthesis of a complementary strand containing the oligonucleotide - 
directed mutant DNA sequence. The product of this reaction is then passaged 
through an ung` E. coli strain which inactivates the non -mutant template strand 
by the action of uracil N- glycosylase which removes uracil from DNA producing 
apyrimidinic sites in the template strand which reduces the biological activity of 
the template strand. This selection procedure results in the plasmids arising 
from the complementary strand containing the mutation. 
Infection of dut-, ung strain AN3828 with phagemid particles: The plasmid 
vector pBlueScriptSK' (a phagemid vector) harbouring the cDNA encoding the 
White nucleotide binding domain was used to produce ssDNA template in an 
E. coli dur, ung strain by first transforming CaClz competent cells with the 
plasmid vector (Section 2.3.9). Transformant colonies were then grown as an 
overnight culture and 1m1 of this culture was used to inoculate 50 ml of 2 x YT 
(1.6% (w /v) Bactotryptone, 1% Bacto yeast extract, 0.5% NaCI) and incubated 
with shaking at 37 °C until an OD600 of 0.3 was reached. The helper phage 
M13K07 (which contains a kanamycin resistance gene) was added to obtain a 
M.O.I. of around 20. After 1 hr of further incubation at 37 °C, 70 pi of 50 mg /ml 
kanamycin solution was added in order to select helper phage infected cells, 
and the incubation was continued for between 6 and 24 hrs. The cell culture 
was then centrifuged at 5,000 rpm in an SS34 rotor at 4 °C for 20 mins. The 
supernatant containing the phagemid particles was then transferred to a fresh 
tube. 
Comparison of phagemid titres in ung and ung E. Coli strains: The phagemid 
titre was compared in ung and ung E. Coli strains before extraction and 
purification of ssDNA, to check that the uracil content of the phagemid vector 
was high enough for use in the in vitro mutagenesis. This was done by first 
inoculating 50 ml 2 x YT with 1 ml of overnight culture. When the culture 
reached a cell density of 00600 of 0.3 the culture was infected with 10 pl of 
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U -DNA phagemid supernatant. The culture was grown for 2 hrs. Samples of 
the phagemid infected cultures were diluted 100 fold and 50 pi spread evenly 
onto Agar plates containing LB Glucose, ampicillin, tetracycline and glucose. 
The plates were incubated overnight at 37 °C. If the ung plate yielded 10,000 
fold more ampicillin resistant colonies than the ung` plate, the uracil content 
was considered sufficient for in vitro mutagenesis. 
Preparation of ssDNA for template for site directed mutagenesis: 30 ml of 
Phagemid supernatant prepared as described above was incubated on ice for 1 
hr with '/4 volume of 20% PEG, 2.5 M NaCI. This solution was then centrifuged 
at 5,000 g for 15 min at 4 °C to pellet phagemids. The pellet was drained well. 
The pellet was resuspended in 200 pi of high salt extraction buffer (100 mM 
Tris pH 8, 300 mM NaCI, 1 mM EDTA) by vortexing vigorously then left on ice 
for 1 hr. This solution was transferred to an eppendorf tube and centrifuged at 
5,000 g for 15 mins at 4 °C. The ssDNA was extracted twice with phenol and 
twice with chloroform /isoamyl alcohol (24:1). The ssDNA partitions to the 
aqueous phase while phagemid proteins partition to the organic phase. The 
ssDNA was precipitated by adding 0.1 volume of 3 M sodium acetate (pH 5.0) 
and 2 volumes of ethanol. The solution was incubated at -20 °C for at least 30 
mins. The ssDNA was pelleted by centrifugation at top speed in a bench top 
centrifuge at 4 °C. The ssDNA pellet was washed by slowly adding 0.5 ml of 
70% ethanol, then removing the ethanol of aspiration being careful not to 
disturb the ssDNA pellet. The pellet was dried under vacuum and resuspended 
in 50 l l of sterile distilled water and 5l 1 was used for analysis by agarose gel 
electrophoresis (Section 2.2.6). 
Annealing mutagenic oligonucleotide to ssDNA template: In a 25 pi reaction 
volume in an eppendorf tube,1 pg of template ssDNA template was mixed with 
10 ng of phosphorylated oligonucleotide and 1.25 µl of 20 x SSC (3 M NaCI, 
300 mM sodium citrate). The eppendorf tube was placed in a float in 500m1 of 
water at 70 °C and then cooled to room temperature or 26 °C. 
Synthesis of the complementary strand: In a reaction volume of 50 p1, 20 pl of 
the annealing reaction described above was added to 5 pl of 10 x T4 DNA 
polymerase buffer, 500 pM of each dNTP, 0.4 mM ATP, and 1 unit of T4 DNA 
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polymerase. The reaction mix was incubated for 30 min at room temperature 
then a further 1 unit of T4 DNA polymerase was added, and 2 units of T4 
ligase. This was incubated at 37 °C for 2 hrs. The reaction was terminated by 
adding EDTA to 15 mM. 
Transformation of E. coli dut° ung` strain XL1BIue with mutagenesis synthesis 
products: 10 pi of the mutagenesis synthesis reaction was used to transform 
CaCl2 competent E. Coli strain XL1 Blue (Section 2.3.9), including the following 
control transformations: 250ng of plasmid DNA, as a positive control; no DNA 
as a negative control; 0.5 pi of ssU -DNA. The transformed cells were plated 
out onto selective agar plates and incubated at 37 °C overnight. Well separated 
transformant colonies were single colony purified then single colonies were 
used to perform small scale plasmid purifications (Section 2.2.8). If the 
mutation was designed to introduce a new restriction site, plasmid DNA from 
several single colonies were screened by restriction analysis and agarose gel 
electrophoresis (Section 2.2.6) to confirm the introduction of the new site. 
Plasmids with the correct restriction pattern were then sequenced to confirm the 
correct sequence. 
2.2.10.b Site directed mutagenesis using PCR 
This method is based on a method described by Stratagene, and called 
QuikChangew Site- Directed Mutagenesis. An overview of the method is 
illustrated in the flow -chart in Fig. 1. A standard double stranded plasmid vector 
prepared by either small or large scale purification (Sections 2.2.8 and 2.2.9 
respectively) can be used as template DNA. The mutagenesis reaction mix in 
a volume of 50 µl contains the following: 50 ng of dsDNA template, 125 ng of 
each oligonucleotide (oligonucleotides were phosphorylated as described in 
Section 2.3.4), 5 pI of 10x Pfu reaction buffer, 1 pl of 10 mM dNTP mix (2.5 mM 
each NTP), distilled water to a final volume of 50 µl, 1 ul of native Pfu 
polymerase (2.5 U /µl). The Pfu polymerase was added last. The reaction mix 
was overlayed with a drop of mineral oil and the following temperature cycle 
was followed for 18 cycles, after heating the reaction to the denaturing 
temperature of 95 °C for 1 min: denaturation at 95 °C for 30 sec, primer 
Fig. 1 Overview of the QuikChangeTM site -directed 
mut agenisis met hod 
Template plasmid highlighting 
target site for SDM O 
Temperature cycling: 
Cycle of denaturing plasmid template, 
annealling oligonucletide primers Rau 
containing the desired mutation ( *), 
and synthesis of a mutant strand 
Removal of template DNA: 
Digest the methylated, nonmutated 
parental DNA template with Dpn I 
Transformation: 
Transform the circular, nicked 
dsDNA into XL1 -Blue competent 
cells 
After transformation, the XL1 -blue 
repair the nicks in the mutated 
plasmid 
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annealing at 55 °C 1 min, DNA polymerisation at 68 °C 2 mins /kb of plasmid 
length. The reaction was stored at 4 °C. The products of the PCR were 
analysed by agarose gel electrophoresis as described in Section 2.2.6. 
Generally 10 pl of the reaction mix was loaded onto the agarose gel. The 
presence of a DNA band the correct size was a good indication that the 
reaction was successful. Generally 20 pl of the reaction mix was used to 
transform 200 pl of CaCl2 competent E. Coll as described in Section 2.3.9. 
Transformant colonies were screened by small scale plasmid purification 
(Section 2.2.8). Reaction containing PCR products the correct size were then 
digested with 1 pl of Dpnl to digest the template DNA. Plasmids of the correct 
size were screened by restriction analysis if the mutation was designed to 
introduce a new restriction endonuclease site to allow quick identification of 
successful site -directed mutants. The gene containing the mutation was then 
sequenced to confirm that the altered sequence was correct, and to check that 
no errors were made by the Pfu polymerise. 
2.3 Sub -cloning DNA techniques 
The following techniques were used for the cloning of the D. melanogater white 
gene, and gene fragments into various plasmid vectors (plasmids used for this 
thesis are described in Section 2.4) for use for various uses, such as: 
* sequencing (pBSK'); 
protein expression and purification in E. coli (p2GEX and related plasmids) 
construction of Baculovirus transfer vectors (pAcUW31). 
2.3.1 Restriction endonuclease digestion of DNA 
The technique of digesting DNA at specific sites was used for the following 
purposes: 
to release a DNA fragment containing a gene or gene fragment of interest 
from a plasmid vector, for sub -cloning into a different plasmid vector; 
* to generate overhanging "sticky" ends, or "blunt ends ", suitable for ligation 
into a suitably digested plasmid vector; 
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" screening recombinant plasmids and site directed mutants by restriction 
analysis. 
Sizes of DNA fragments resulting from restriction digests were predicted using 
the MacVector program (Section 2.6.10). Restriction digests were usually 
performed in a 20 pl volume including plasmid DNA, 2 pl 10 x buffer 
(recommended by the supplier), distilled water and 1 unit of restriction enzyme. 
The reaction mix was incubated at 37 °C for 1 hr. 51,11 of the reaction was then 
analysed by agarose gel electrophoresis (Section 2.2.6). 
2.3.2 Production of "blunt ends" by DNA Polymerase Kienow fragment 
When convenient restriction sites flanking the DNA to be cloned were not 
available, a "blunt end" ligation technique was often used. Both the vector 
DNA and DNA to be inserted were digested with the appropriate enzymes, 
producing overhanging ends, which were then modified by end -filling by DNA 
Polymerase Klenow fragment to produce a "blunt end" for cloning. Following 
restriction enzyme digestion with the appropriate enzymes, the digested DNA 
was mixed in a reaction containing 25 pM dNTPs and 1 unit of Kienow, in a 
volume of 50 pl. The reaction was incubated at room temperature for 10 mins. 
The reaction was stopped with the addition of SDS to 1% and EDTA to 10 mM. 
The DNA was then purified as described in Section 2.3.6 
2.3.3 Removal of terminal phosphates from linearised vector DNA 
Removal of terminal phosphates from linearised DNA vectors was carried out in 
order to minimise re- ligation of the vector DNA. The vector DNA was digested 
with the appropriate enzyme, and on completion of the restriction reaction, 5 to 
10 units of Calf Intestinal Alkaline Phosphatase (CIP) was added directly to the 
digestion reaction and incubated for 15 min. If the buffer used for restriction 
digestion contained 100 mM NaCI or more, the reaction was diluted to medium 
salt level of 50 mM (King and Possee, 1992). The CIP reaction was stopped by 
adding EDTA to 25 mM and SDS to 1%. The linearised, phosphatased vector 
DNA was then purified using the BresaClean method (Section 2.2.4). 
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2.3.4 Phosphorylation of oligonucleotides 
25 -300 pmol of oligonucleotide primer was mixed with the following ingredients: 
10 mM ATP, 1 x One -Phor -Aff buffer PLUS (Pharmacia), and 5 units of T4 
polynucleotide kinase was added to the reaction mix. The reaction was 
incubated at 37 °C for 30 minutes prior to heat inactivation at 65 °C for 10 mins. 
2.3.5 Purification of DNA fragments 
Following enzymatic reactions performed in the process of preparing vector and 
insert DNA for ligation, such as restriction enzyme digestion, Klenow end -filling 
and phosphatasing, the resulting DNA was purified to remove enzymes and 
other reagents which could interfere with a ligation reaction. The BresaClean 
kit (Bresatech) was used. Three volumes of sodium iodide solution was added 
to the reaction followed by 5 pl of well resuspended BresaClean silica resin and 
incubated for 5 mins at room temperature. The silica resin /DNA was pelleted 
and washed as described in Section 2.2.4. 
2.3.6 Purification of DNA fragments from agarose gels 
This method involved digesting a plasmid vector containing a gene of interest to 
be sub -cloned into a different vector, with the appropriate restriction enzymes. 
The DNA fragments resulting from the digest were then separated by agarose 
gel electrophoresis and stained with ethidium bromide (Section 2.2.6). The 
DNA fragments were visualised using a UV light box and the correct band was 
removed using sterile scalpel and transferred to an eppendorf tube. The DNA 
fragment was purified from the agarose gel and ethidium bromide using the 
BresaClean Kit (BresaTech). 1 ml per gram of gel of sodium iodide solution 
was added to the DNA/gel slice and this was incubated at 55 °C with occasional 
gentle mixing until the gel had completely dissolved. 5 pl of well resuspended 
BresaClean silica resin was added and incubated for 5 mins at room 
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temperature. The silica resin /DNA was pelleted and washed as described in 
Section 2.2.4. 
2.3.7 Ligation of DNA 
For routine sub -cloning 50 pl ligation reactions were performed, using a total 
DNA concentration of 200 ng and a vector:insert molar ratio of approximately 
1:5. The reaction mix contained the following: 
31 pl distilled water, 2.5 pl 1M Tris, pH7.5, 5 pl 0.1M MgCl2, 5 pl 1 mg /ml BSA 
(nuclease free), 2.5 pl 0.1M DTT, 0.5 pi 0.1M spermidine, 0.5 pl 0.1 M ATP, 
20 ng linearised vector (usually 50 pg /ml) and 180 ng of prepared insert DNA 
followed by 1 T4 DNA ligase. For reactions where overhanging "sticky" ends 
were to be ligated the reaction was performed at room temperature for 30 mins. 
Blunt end ligations were usually more successful when incubated overnight at 
room temperature with the addition of PEG (to 15 %) in the reaction mix as 
recommended by Boehringer. 
2.3.8 Preparation of Competent E. coli using CaCl2 
1 L of LB broth was inoculated with 50 ml of overnight culture and incubated at 
37 °C with vigorous aeration until an OD, of 1 was obtained. The culture was 
then chilled on ice for 10 minutes and harvested by centrifugation at 7,000 rpm 
for 10 minutes. The supernatant was removed and the cells were resuspended 
gently (by pipetting up and down with a sterile pasteur pipette) in 10 ml of cold 
0.1 M CaC12 cells and then incubated on ice for 20 minutes. The cells were 
harvested again at 7,000 rpm for 10 minutes, the supernatant removed, and the 
cells were resuspended gently in 1m1 of a cold solution of 0.1 M CaCl2:glycerol 
(85:15). 501AI aliquots were then transferred to pre -chilled Eppendorf tubes, 
rapidly frozen in liquid nitrogen and stored at -70 °C. 
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2.3.9 Transformation of competent E. colí with plasmid DNA 
A 50m1 aliquot of frozen, competent cells (prepared as described in Section 
2.3.8) were thawed on ice for 5 minutes. 0.9ml of ice -cold CaCIZ was added 
and the cells mixed gently by pipetting up and down. 100 ELI aliquots of these 
cells were transferred to chilled eppendorf tubes and 5 of ligation mix was 
added and mixed gently, followed by a 30 minute incubation on ice. The tubes 
were transferred to a water bath warmed to 43.5 °C for 45 seconds then 
immediately returned to ice. This step is known heat -shock and facilitates the 
uptake of exogenous DNA by E. coli. 1 ml of LB broth (1.0% (w /v) Tryptone, 
0.5% (w /v) Yeast extract, 0.5% (w /v) sodium chloride, pH7) was added to each 
tube and the cells are incubated at 37 °C for an hour to allow recovery of 
expression of antibiotic resistance genes. The cells are harvested by 
centrifugation at 5,000 rpm for 2 minutes, the supernatant was removed and 
the cells were resuspended in 250 µl of fresh LB broth. The cells were then 
plated onto LB agar plates containing the appropriate antibiotic followed by an 
overnight incubation at 37 °C. 
2.3.10 Characterisation of plasmids from individual transformant E. coli 
colonies 
Inoculum from single transformant colonies was taken from the agar plate and 
mixed with a 50 µl aliquot of colony cracking solution (50mM sodium 
hydroxide, 10% SDS, 0.4M EDTA, 10% glycerol, 2% Bromocrescol green). 
After mixing, the reactions were incubated at 65 °C for 30 minutes. The size of 
plasmids in the lysed cells were analysed by agarose gel electrophoresis 
(Section 2.2.6) and compared to cells transformed with the parental vector 
without insert. Colonies containing larger sized plasmids were selected for 
further analysis by small scale plasmid purification (Section 2.2.8) restriction 
digest (Section 2.3.1) and further agarose gel electrophoresis of the DNA 
fragments from restriction analysis. 
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2.4 Plasmid vectors 
2.4.1 Plasmid vector pBluescript®SK +/- 
This plasmid vector (obtained from Stratagene, GenBank #52325 (SK +), 52324 
(SK -)) was used for general recombinant DNA sub -cloning and site directed 
mutagenesis using E. coll. The physical map of pBluescriptSK+ is shown in 
Fig. 2 The + or - suffix denotes the direction of the f1 filamentous phage origin 
of replication allowing recovery of either the sense ( +) or antisense ( -) strand. 
The plasmid is based on pUC19. The SK designation indicates the polylinker is 
orientated such that /acZ transcription proceeds from Sacl to Kpnl. 
2.4.2 Plasmid vector pGEX4T1 
This plasmid vector (obtained from Pharmacia) (see Fig. 3A) was used for 
expression of heterologous proteins in E. coli as C- terminal fusions to the 
enzyme glutathione -S- transferase from Schistosoma japonícum. This plasmid 
is based on pGEX -1 first described by (Smith and Johnson, 1988). 
2.4.3 p2GEX 
This plasmid was based on p2GEX -4T -1 (see Fig. 3B) and harbours a second 
GST coding region which was cloned into the Ssp1 /Smal site which is 5' of the 
ampicillin resistance gene and under control of the Ptac promoter element. 
This plasmid was constructed in Graeme Cox's laboratory, JCSMR, ANU. 
2.4.4 Plasmid vector pAcUW31 
The plasmid pAcUW31 (Clontech) (Weyer and Possee, 1991) is a baculovirus 
transfer vector for dual expression of two genes simultaneously. The physical 
map of pAcUW31 is illustrated in Fig. 4. The polyhedrin and p10 baculovirus 
promoter elements are arranged back -to -back transcribing in opposite 
directions. The polyhedrin promoter is followed by a unique BamHl cloning site 
for insertion of foreign genes and the polyhedrin polyadenylation signals. The 
Fig. 2 Plasmid vector pBluescript SK 
Illustrated in this figure is the physical map of pBluescriptSK'. Abbreviations 
and description of the features are listed below. 
f1 ( +) origin (6 -642 bp) f1 filamentous phage origin of replication allowing 
recovery of the sense strand of the IacZ gene when a host 
strain containing the Bluescript phagemid is co- infected with the 
helper phage. 
ColE1 origin (1032 -1912 bp) Plasmid origin of replication used in the 
absence of helper phage 
LacZ (lac promoter: 816 -938 bp) This portion of the IacZ gene 
provides a- complimentation for blue /white colour selection of 
recombinant phagemids. An inducible lac promoter upstream 
from the IacZ gene permits fusion protein expression with the 3- 
galactosidase gene product. 
MCS (657 -759 bp) Multiple cloning site flanked by T3 and T7 
promoters. 
Ampicillin (1975 -2832 bp) Ampicillin resistance gene for antibiotic 
selection of the phagemid vector. 
AmpR 
MCS 
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Fig. 3 Piasmid vectors pGEX4T1 and p2GEX 
This figure illustrates the physical maps of the plasmid vectors: 
A. pGEX4T1; and 
B. p2GEX 
Abbreviations and descriptions of the features are listed below: 
Tac promoter tac promoter : strong promoter element (hybrid of the tryp 
and lac promoters) induced by IPTG 
GST Glutathione -S- transferase gene region encoding 26 Kd GST 
protein 
MCS Multiple cloning site. 5' region harbours DNA sequence 
encoding site for thrombin cleavage to cleave GST and 
fusion partner 
AmpR Ampicillin resistance gene 
pBR322 ori E. coli origin of replication 
lac!' lac gene represser. Repression is inhibited by IPTG 
A 
B 
Tac promoter 
GST 
pBRi22 ori 
pRR322 ori 
4969 bp 
AmpR 
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Fig. 4 Plasmid vector pAcUW31 
This figure illustrates the physical map of the Baculovirus transfer plasmid 
vector pAcUW31. Abbreviations and descriptions of the features are listed 
below: 
AcMNPV 
AcNPV 
poly A+ 
M13 ori 
DNA sequences derived from the baculovirus Autographa 
californica multiple nuclear polyhedrosis virus. This 
sequence in conjunction with the sequence labelled 
AcNPV flank the region of the vector which harbours 
cloning sites for insertion of foreign genes and forms the 
region which undergoes homologous recombination with 
linear wild -type AcMNPV DNA. 
DNA sequence derived from the baculovirus Autographa 
californica multiple nuclear polyhedrosis virus. 
Polyadenylation signal for the polyadenylation modification 
of the 3' end of the transcribed insert DNA 
M13 origin of replication which can be use to package 
single stranded DNA of the coding strand of genes cloned 
behind the polyhedrin promoter and the non -coding strand 
of the genes cloned behind the p10 promoter (top strand in 
figure) 
p10 Prom p10 promoter element from Autographe californica nuclear 
polyhedrosis virus 
Polyhedrin Prom Polyhedrin promoter element from Autographa californica 
nuclear polyhedrosis virus 
pBR322 ori Origin of replication propagation in E. coli 
Ap -R Ampicillin resistance gene 
Ap-R 
M13 ori 
Polyhedrin prom. 
Cloning sites 
SV40 poly A+ 
signal GAATTCAGATCTGTGATTO 
Pp 1) 
Eco R Bgl II 
TCTAGA 
Xba l 
PPolyhednr 
> TAAATATCGGATCCGG poly A+ signal 
Barn HI 
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p10 promoter is followed by unique Bglll and EcoRl cloning sites and a 
polyadenylation signal from SV40. 
2.5 Insect Cell culture and Recombinant Baculovirus 
techniques 
2.5.1 General maintenance of insect cells in culture 
The insect cell line Sf9 (Invitrogen) derived from Spodoptera frugiperda ovarian 
cells (Sf21 cells) was maintained in Grace's insect media (Sigma) 
supplemented with 20 ml /L yeastolate (Gibco), 20 ml /L lactalbumin hydrolysate 
(Gibco) and 10% v/v foetal bovine serum (Commonwealth serum laboratories, 
Melbourne, Australia). The cells were grown either as an adherent monolayer 
culture or in suspension in spinner flasks at 27 °C. 
Grace's medía was prepared in 10 L lots from powdered stocks (Sigma) using 
double distilled water. Yeastolate (Gibco) and lactalbumin hydrolysate (Gibco) 
were added to 2% final volume. The pH was adjusted to 5.9 -6.0 with 10 M 
potassium hydroxide prior to filter -sterilisation through a 142 mm Millipore 
stainless steel sanitary filterholder (a tri -clamp sanitary inlet outlet system). A 
glass fibre pre -filter (Gelman Sciences, type A /E, 127 mm diameter) was used 
in conjunction with a 0.2 mm pore diameter membrane filter (Gelman Sciences, 
Supor 200, 142 mm diameter) to filter -sterilise the media by pressure filtration. 
At this point the osmolality of the solution was checked and adjusted, if 
necessary, by the addition of sterile water. Osmolality values of 300 -330 
mosmol I-1 were considered acceptable. When Sigma Grace's media was used 
osmolality values did not vary significantly and the addition of water was rarely 
required. Media was then dispensed into 500 ml sterile Schott bottles and 
incubated at 37 °C for two days to check for possible contamination. This stock 
media, referred to as incomplete TNM -FH, was stored at 4 °C. Complete media 
was prepared as required by the addition of heat inactivated foetal bovine 
serum (FBS) to 10 % v /v. Heat inactivation of FBS was performed at 56 °C for 
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30 min. This media, termed complete TNM -FH, had a final pH of 6.0 -6.2 and 
osmolality of 330 -360 mosmol.l' . Storage was at 4 °C in the dark. 
Sf9 cells were grown and maintained in spinner culture which allowed a more 
precise monitoring and control of their growth and provided sufficient numbers 
of cells for experimentation. Cells (1 x 10' ) were thawed at 27 °C from stocks 
frozen in liquid nitrogen and seeded into a 25 cm2 tissue culture flask (Corning) 
containing 5.0 ml complete TNM -FH. The cells were grown at 27 °C until a 
confluent monolayer had formed (5 -7 days); the media was generally replaced 
once during this time. In order to obtain enough cells to seed a 50 ml spinner 
(Belico) the cells were passaged into 75 cm2 flask and resuspended from the 
flask bottom by agitation achieved by pipetting fresh complete TNM -FH over the 
cells 4 -6 times. These cells were then seeded into a 75 cm2 flask and grown to 
confluence at 27 °C. The cells were passaged into three 75 cm2 flasks 
containing 10 ml complete TNM -FH. When a confluent monolayer of cells had 
grown (3 days), the cells were resuspended and seeded into a 50 ml spinner 
containing 10 ml complete TNM -FH. The cell density was adjusted to 0.5 x 106 
cells /ml with complete TNM -FH and incubated at 25 °C on a magnetic platform 
stirred at 50 rpm. The slightly lower temperature of the spinner cultures, 
compared to 27 °C used for flask cultures and viral incubations, meant cells took 
4 to 5 days to reach stationary phase and consequently decreased the handling 
time. Growth (cell density) was monitored by counting the cells using a 
haemocytometer and viability determined using trypan blue (4 %, sigma); 10 ml 
of trypan blue was added to 100 ml cells with viable cells excluding the blue 
dye. Cultures of 95 -98% viable cells were considered acceptable. The spinner 
culture was allowed to grow to stationary phase, 2 -3 x 106 cells /ml, before 
being diluted down to 1.0 -2.0 x 106 cells /ml. 
Every two weeks cells that had been grown in spinner culture were transferred 
to a sterile 50 ml tube (Falcon) and centrifuged at 1000 rpm for 10 min. The 
media was decanted and replaced with 30 ml fresh complete TNM -FH. The 
cells were resuspended gently and transferred to a clean, sterile spinner 
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containing 10 ml complete TNM -FH. The cell density was adjusted to 2.0 -5.0 x 
106 cells /ml in a volume of 50 ml. This procedure removed cell debris and the 
build up of cell components secreted by the growing cells into the media which 
may inhibit growth. A monolayer culture (25cm2 flask) was always maintained 
as a backup in case the spinner culture became contaminated or decreased 
viability. 
2.5.2 Production of recombinant Baculovirus 
A flow chart illustrating the steps involved in production of a recombinant 
Baculovirus is provided in Fig. 5. 
2.5.2.a Co- transfection method 
The cotransfection of Sf9 insect cells with linear viral AcNPV DNA (BacPAK6) 
(Clontech) and baculovirus transfer vector was carried out using the lipofectin 
method originally described by (Feigner et al, 1994) and specifically described 
for use with linear AcNPV DNA in the manufacturers protocol (Clontech). 
Sf9 cells were grown in spinner culture to a density of between 0.5 -0.7 x 106 
cells /ml were seeded into 35mm tissue culture places (Nunc) at 1.5 x 106. 
When the cells had formed a monolayer (approximately 20 mins), the media 
was replaced with 2.0 ml serum free TNM -FH. This washing step was repeated 
a second time to ensure that the component in serum which inhibits lipofectin- 
mediated transfection was removed. Plasmid DNA, prepared by either a mini - 
prep protocol or CsCI isopycnic (density gradient) centrifugation (Section 2.2.8) 
was filter sterilised and diluted in sterile TE buffer to a final concentration of 100 
ng /ml. The following reagents were mixed in sterile polystyrene tubes: 
Cotransfection Control 
Sterile water 40 pl 45 pl 
Plasmid DNA 5 pi 5 pl 
Linear viral DNA 5 pl 0 pi 
Lipofectin solution (0.1 mg /ml) 50 pl 50 pi 
ti 
Fig. 5 Construction of recombinant baculovrus 
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The lipofectin reagent (Clontech) was added last, then mixed gently and 
incubated at room temperature for 15 min to allow lipofectin -DNA complexes to 
form. Meanwhile, the media from the cell monolayers was replaced with 1.5 ml 
of serum free TNM -FH. The lipofectin -DNA complexes were added drop -wise 
to the media, which was swirled gently and incubated at 27 °C for 5 hr. After 
this time, 1.5 ml complete TNM -FH was added and the samples incubated at 
27 °C for a further 72 hr. The cotransfection media, containing recombinant 
viruses, was then harvested by centrifugation at 1000 rpm for 10 min in a bench 
top centrifuge and the supernatant stored at 4 °C. 
2.5.2.b Plaque assay: 
Individual recombinant viruses were isolated and purified from the 
cotransfection supernatant using a plaque assay essentially as described in 
(King and Possee, 1992). 
Sf9 cells growing in spinner culture at a density of between 0.5 -0.7 x 106 
cells /ml were seeded into 60mm tissue culture plates (Nunc) at 1.5 x 106 cells 
and allowed to form a monolayer. The cotransfection supernatant was diluted 
to 10 -1, 10-2 and 10 -3 in serum free media just prior to infection. Duplicate 
samples were prepared at each dilution. The media was removed from the cell 
monolayer and 1.0 ml of diluted cotransfection supernatant overlayed. The 
samples were incubated at room temperature with gentle agitation on a slowly 
rocking platform for 90 min. Approximately 15 min prior to the end of the 
infection sterile liquefied Sea Plaque agarose (3.0 %) (FMC) was allowed to cool 
slightly before adding complete media, diluting the agarose to 1%. At the end 
of the incubation period the diluted cotransfection supernatant was removed 
and 4 ml of the 1% Sea Plaque agarose which had cooled sufficiently but had 
not solidified, was added to each plate and then allowed to solidify. Finally the 
agarose was overlayed with 1 ml of complete TNM -FH to provide sufficient 
nutrients for cell growth. Each plate was then sealed with parafilm and 
incubated at 27 °C for 5 -8 days. The agarose overlays were then stained with 
Neutral Red (Sigma) (0.5% w/v in PBS). Live cells take up the dye while cells 
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killed by viral infection would not, thus viral plaques appear clear in a 
background of red cells. 
At least 10 well separated plaques for each sample were picked from the 
highest dilution on which plaques could be visualised. Each agarose plug was 
taken up in a pasteur pipette and expelled into 1 ml serum free TNM -FH media. 
Plugs were left overnight at 4 °C to allow diffusion of the virus particles into the 
media before being used for further rounds of plaque purification and 
subsequent P1 viral supernatant production. 
2.5.2.c Identification of Recombinant Viruses 
Individual plaques were used to prepare a seed stock (P1) from which 
recombinant isolates were identified by Western blotting. Infected cells were 
harvested at least 30 hpi, cell proteins separated by SDS PAGE and Western 
blotting 2.6.1, using anti -White and anti -Scarlet antibodies 2.11 as described 
below. 
2.5.2.d Preparation of P1 seed stock: 
Sf9 cells growing in spinner culture at a density of 0.5 -0.7 x 106 cells /ml were 
seeded at 1.5 x 106 cells into 25 cm2 flasks containing 2.0 ml complete TNM - 
FH. When the cells had formed a monolayer the media was removed and 1.0 
ml of virus suspension from a single plaque pick used to infect the cell 
monolayer. The flasks were incubated for 90 min at room temperature on a 
slowly rocking platform. The inoculum was removed, the cells overlayed with 5 
ml complete TNM -FH, and then incubated at 27 °C for 6 days. Medium, 
containing viral particles, was harvested by centrifugation at 1000 rpm for 10 
min in a bench top centrifuge and stored at 4 °C. 
2.5.2.e Screening of Recombinant Viral Isolates by Western blot 
Detection of the White and Scarlet protein 
Sf9 cells growing in log phase in spinner culture, 0.5 -1.2 x 106 cells /ml, were 
seeded to form a confluent monolayer in wells of a 96 well plate (Nunc) which 
contained 100 pl of complete TNM -FH. This volume varied between 
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approximately 120 -200 µl of cells depending on cell density. The media was 
removed and 40 µl of each of each P1 supernatant added to individual wells 
and incubated at room temperature for 90 min. The virus was removed prior to 
adding 200 pi of complete TNM -FH and the cells incubated at 27 °C for 24 -72 
hr. 
The infected cells were resuspended in the incubation media and transferred to 
1.5 ml eppendorf tubes. The samples were centrifuged in a microfuge at 14000 
rpm for 2 min. The liquid was aspirated off and 0.5 ml PBS added to wash the 
cells. Following a second centrifugation the liquid was removed and 50 µl of 
reducing electrophoresis sample buffer added. The samples were then boiled 
for 5 min and the proteins separated on a 12% SDS polyacrylamide gel 
(Section 2.6.1). The proteins were transferred to a PVDF membrane (Novex) 
and the White and Scarlet proteins were detected by Western blotting using 
anti -White or anti -Scarlet polyclonal antibodies (Chapter 4). 
2.5.2.f Amplification of Recombinant Viral Stocks: 
To produce a large volume of high titre viral supernatant (P3) a positively 
identified recombinant P1 viral supernatant was propagated according to the 
protocol described in King & Possee. The procedure involves the passaging of 
a P1 viral stock (5ml) through an intermediate passage (P2) to provide a 
suitable volume (10m1) of ideally similar or lower titre virus for subsequent 
production of a large volume of amplified viral progeny. Continued passaging 
and amplification of recombinant virus is reported to result in viral instability and 
accumulation of defective interfering virus particles (King and Possee, 1992); 
hence amplification of the virus was performed from a small viral population to 
produce progeny of similar derivation. 
2.5.2.g Production of P2 Recombinant Viral Supernatant: 
Sf9 cells growing in spinner culture at a density of 0.5 -0.7 x 106 cells /ml were 
seeded at 5 x 106 cells into 75 cm2 flasks (Corning) containing 10 ml complete 
TNM -FH and allowed to form a monolayer. The P1 supernatant was diluted 
eight fold with incomplete TNM -FH (2.0 ml per infection). The media was 
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removed from the monolayer and the cells overlayed with the 2.0 ml of diluted 
P1 supernatant. Infection was performed at room temperature for 90 min with 
the flasks on a slowly rocking platform. The virus was then removed and the 
cells overlayed with 10 ml of complete TNM -FH and incubated at 27 °C for 4 -6 
days. The propagation time was monitored by the degree of cell lysis, i.e. cells 
floating, indicative of viral infection. When approximately 60 -80% of the cells 
had lysed the P2 viral stock was harvested by centrifugation of the supernatant 
at 1000 rpm for 10 min in a bench top centrifuge and stored at 4 °C. Typical 
incubation times were 5 to 6 days. 
2.5.2,h Production of P3 Recombinant Viral Supernatant: 
A spinner flask was seeded (0.5 x 106 cells /ml) and the cells grown to 
confluency (approximately 2 -3 x 106 cells /ml, at which time it was diluted down 
to 0.1 -0.2 x 106 cells /ml (approx. 2 days) the cells were infected at a MOI of 0.1- 
0.2 pfu /cell according to the following calculation: 
Volume of P2 viral supernatant added = IMOI (pfu /cell) x number of cells] 
titre of virus (pfu /ml) 
Volume of cell culture 
cell count 
total cell number 
Virus titre (P2) 
multiplicity of infection (MOI) 
50 ml 
0.5 x 106 cells /ml 
2.5 x 10' cells /ml 
x pfu /ml 
0.2 -0.2 pfu /cell 
The spinner was then placed on a magnetic stirrer and incubated at 27 °C for 6 
days. To harvest the supernatant the spinner was placed at 4 °C overnight and 
the next day the supernatant spun at 1000 rpm for 10 min in a bench top 
centrifuge. This P3 supernatant was stored at 4 °C and its titre determined by 
plaque assay. 
49 
2.5.2.i Infection of Sf9 cells with recombinant Baculovirus 
All assays included uninfected and an infected negative control cells. The virus 
used for the negative infected control was a recombinant Baculovirus 
constructed by Brett Cromer containing the cDNA encoding the human Gaba 1 
subunits al and 81. Cells expressing a heterologous gene product unrelated to 
the White or Scarlet protein was considered to be a better control than the wild - 
type AcNPV infected cells which produce large amounts of polyhedrin making 
them optically very different to cells expressing recombinant virus which does 
not express the polyhedron gene. Sf9 or Hi5 cells growing at a density of 0.5- 
0.9 x 106 cells /ml were seeded in 30cm2 tissue culture plates (Nunc) at 1.5 x 106 
cells and allowed to form a monolayer. Duplicates of each sample were 
prepared as follows. Recombinant viral supernatants were diluted in 
incomplete TNM -FH for infection at MOls of 50 Pfu /cell. Typically P3 (1 x 108 
Pfu /ml or better) were diluted 4 fold and P2 stocks (1 x 10' Pfu /ml) were diluted 
1 fold. The media was removed and 1.0 ml of diluted recombinant viral 
supernatant added to the cell monolayer and incubated for 90 min at room 
temperature on a slowly rocking platform. The virus was then removed and the 
cells overlayed with 3.0 ml of complete TNM -FH and incubated at 27 °C for 
times ranging from 24 -48 hours post infection (hpi). 
2.5.3 Inhibition of glycosylation in Sf9 cells 
In experiments examining the effect of inhibition of N- glycosylation by 
tunicamycin (Sigma), the inhibitor was dissolved in DMSO at a concentration of 
1 mg /ml and added 3 hpi to the media overlay at a final concentration of 1 
mg /ml. The delay in tunicamycin addition was to ensure that the cells had 
recovered sufficiently following infection in serum free media. The time of 
addition was well before promoter activation of the foreign proteins (12 hpi). 
Cell proteins from tunacamycin treated cells and those not treated with 
tunacamycin were analysed by SDS PAGE and Western blotting to detect 
changes in apparent molecular weight due to the presence or absence of 
glucose residues. 
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2.5.4 Flow cytometry analysis of recombinant Baculovirus infected cells 
2.5.4.a Labelling of infected Sf9 cells for FACS analysis and confocal 
microscopy 
The viral supernatant was removed and the cells were resuspended in PBS 
and transferred to polystyrene tubes. The cells were harvested by 
centrifugation at low speed in a bench top MSE centrifuge at 1,000 rpm for 5 
min. Duplicate samples were prepared for analysis of (1) plasma membrane 
protein targeting, and (2) cytoplasmic protein targeting which required 
solubilisation of the membrane with SDS. The main difference between the 
preparation of these duplicate samples was that for plasma membrane 
targeting analysis, the primary and secondary antibodies were incubated with 
the cells prior to fixation in order to minimise protein damage due to the fixation 
procedure which may alter epitopes recognised by the antibodies. The 
samples prepared for cytoplasmic targeting analysis required fixing prior to SDS 
treatment to preserve the cell's structure during membrane permeabilisation. 
The SDS treatment precedes antibody incubation to allow the antibody access 
to the inside of the cell. 
1. Plasma membrane protein targeting 
The liquid was aspirated off and samples for analysis of plasma membrane 
targeting were resuspended in a solution containing PBS, 1% BSA and typically 
a 1:10 dilution of purified polyclonal primary antibody, or a 1:100 dilution of 
serum containing polyclonal primary antibodies. The cells were incubated for a 
minimum of 30 mins at room temperature, or at 4 °C over -night. At this stage 
the cells were transferred to small tubes pelleted by centrifugation at 1,000 rpm 
for 5 min in a benchtop centrifuge, the antibody solution removed and replaced 
with 0.4ml of PBS to wash the cells. The small tubes allowed smaller volumes 
to be used in order to decrease the loss of cells due to the cells sticking to a 
larger surface area. The cells were then incubated for 30 min at room 
temperature with 10011l of a solution containing PBS, 1% BSA and a 1 :50 
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dilution of a goat anti rabbit antibody conjugated to FITC. The samples were 
protected from light after addition of the FITC conjugated secondary antibody to 
prevent photobleaching of FITC fluorescence. The cells were then washed 
with PBS and resuspended in 100u1 of Zamboni's Fixative (2% formaldehyde, 
15% saturated picric acid in 0.1M phosphate buffer, pH 7.4) for 90 mins at 
room temperature. The cells were washed twice with PBS. 
2. Cytoplasmic membrane targeting 
The cells were harvested in the same way as above, and resuspended in 0.4 
ml of PBS and transferred to small tubes. The PBS was removed and replaced 
by 1001.1I of Zamboni's fixative (as in 1 above) and the cells were incubated for 
90 mins at room temperature. The cells were washed twice with PBS, then 
incubated for 30 mins at room temperature with 1001.1I of a solution containing 
PBS, 1% BSA and 0.1% SDS. The cells were washed twice with PBS then 
incubated with primary and secondary antibodies as described in 1. above. 
2.6 Protein Biochemistry Techniques 
2.6.1 Electrophoresis of proteins 
Proteins were separated by electrophoresis essentially as described previously 
by (Laemmli, 1970) using either a Novex XCell II apparatus and pre -cast 
polyacrylamide gels (Novex), or polyacrylamide gels were manually poured and 
a Biorad Mini -PROTEAN II Cell (10 x 7cm) as follows: 
Non- denaturing conditions (native PAGE) 
Stacking gel: 12mM Tris, pH 6.8, 1.95% (29:1) acrylamide /Bis, 0.1% TX -100 
Resolving gel: 38mM Tris, pH 8.8, 7.5% (29:1) acrylamide /Bis, 0.1% TX -100 
Denaturing conditions (SDS PAGE) 
Stacking gel: 1.95% (29:1) acrylamide /Bis, 12mM Tris, pH 6.8, 0.1% (w /v) SDS 
Resolving gel: 12% (29:1) acrylamide /Bis, 38mM Tris, pH 8.8, 0.1% (w /v) SDS 
APS and TEMED were added last to initiate polymerisation. The resolving gel 
was poured first and was set under a thin layer of water -saturated butanol 
which straightened the surface and excluded oxygen. After the resolving gel 
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had set the stacking gel was poured and a 10 well comb was inserted to form 
sample wells. Once the stacking gel was set, the plates were transferred from 
the casting try to the BioRad Mini Protean buffer tank, and covered with SDS 
Running Buffer. 
Samples were prepared for SDS PAGE by adding 2x SDS sample buffer (0.5M 
Tris -HCI, pH 6.8, 10% SDS, 0.1% Bromophenol blue, 20% glycerol, 2% DTT) to 
an equal volume of sample (usually 501_1,I ). Or alternatively, a one tenth 
volume of SDS -Z buffer (40mM Tris -HCI pH 8, 10% (w /v) glycerol, 16% (w /v) 
SDS, 4% DTT) to dilute protein solutions. Samples were then incubated for 2 
minutes at 100 °C, then centrifuged for 1 minute in a benchtop microfuge. 
Samples were prepared for native PAGE by adding an equal volume of 2x 
native sample buffer (1.5M Trís -HCI, pH 8.8, 0.1% bromophenol blue, 20% 
glycerol, 0.2% TX -100) 20m1 samples were loaded into the wells. Gels were 
run at 35mA per gel in SDS running buffer (25mM Tris -HCI, 190mM glycine, 
3.5mM (w /v) SDS) for denaturing conditions and native running buffer (5mM 
Tris -HCI, 38.4mM glycine) for non -denaturing conditions until the dye front was 
at the bottom of the gel (denaturing conditions) or run off the bottom of the gel 
(non- denaturing conditions). Low range molecular weight markers and 
prestained molecular weight markers were from Biorad and Novex (SeeBlueTM) 
Gels were stained either with Coomassie R -250 (PhastGelTM Blue R, 
Pharmacia Biotech)(1.25% (w /v), Coomassie R -250 dye, 10% (v /v) acetic acid, 
50% (v /v) methanol, 25% (v /v) ethanol) and destained overnight in destain 
solution (25% (v /v) ethanol, 8% (v /v) acetic acid), or silver stained. After 
staining and destaining, gels were desalted in water and incubated in gel drying 
solution (5% (w /v) glycerol, 30% (v /v) methanol), then dried between sheets of 
cellophane (pre- soaked in gel drying solution) (Novex) using a Novex gel 
drying frame. 
2.6.2 Silver staining of polyacrylamide gels 
This method relies on differential reduction of silver ions that are bound to the 
side chains of amino acids. The method was carried out as described 
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(Sambrook et al, 1989). Proteins were fixed after electrophoresis in a solution 
of ethanol:glacial acetic acid:water (30:10:60) for 4 to 12 hours. If Coomassie 
Blue staining was used initially, the gel was destained overnight. The fixing 
solution was discarded and the gel was incubated with shaking at room 
temperature with 30% ethanol 30 minutes. This step was repeated. The 
ethanol was discarded and deionized water was added and the gel was 
incubated for 10 minutes at room temperature. This step was repeated twice. 
The last of the water washes was discarded and a solution of 0.1% silver nitrate 
was added and the gel was incubated with shaking for 30 minutes at room 
temperature. The silver nitrate was discarded and the gel was washed on both 
sides with a gentle stream of deionized water for 20 seconds each side. 
Freshly made aqueous solution of 2.5% sodium carbonate and 0.02% 
formaldehyde was then added. The gel was incubated at room temperature 
with gentle agitation until the stained bands of protein appeared. When the 
desired contrast was obtained the reaction was quenched by the addition of a 
solution of 1% acetic acid and the gel was incubated for 2 to 3 minutes. The 
gel was then washed in deionized water several times. 
2.6.3 Detection of Protein by Western blot 
For Western blot detection proteins were transferred to nitrocellulose essentially 
as described by (Towbin et al, 1979). The semi -dry transfer technique, using a 
MultiphorRll electrophoresis system (Pharmacia), was used to electrophorese 
proteins from the polyacrylamide gel onto the nitrocellulose membrane 
(Schleicher and Schuell) or PVDF membrane (Novex), following the 
manufacturer's assembly instructions as follows. Two layers of 3 MM filter 
paper, cut to the exact same dimensions as the resolving gel (9 x 6 cm), were 
soaked in semi -dry transfer buffer (39 mM glycine, 48 mM Tris, 0.0375% w/v 
SDS, 20% v/v methanol). Six sheets were stacked onto the graphite anode 
followed by a piece of nitrocellulose the same size. The gel was then mounted 
followed by the final six sheets presoaked filter paper. Efectrophoretic transfer 
proceeded at 0.8 mA per cm' (e.g. 0.8 x (9 x 6) = 43.2 mA for 50 min. 
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At the completion of the transfer step the nitrocellulose was incubated in 
blocking buffer (10 mM Tris pH 7.5, 10% milk powder, 0.9% NaCI, 0.05% 
Tween 20 (Biorad)) for 40 -60 min on a rocking platform. The blot was washed 
in Tris buffered saline with Tween 20 (TTBS) solution (10 mM Tris -HCI pH 7.5, 
0.9% NaCI, 0.05% Tween) three times, each for 5 mins. The primary polyclonal 
antibody (either anti -White or anti -Scarlet (Section 2.11) specific for either the 
White or Scarlet proteins was diluted 500 fold in blocking buffer to a final 
volume of 10 ml and the blot immersed in the solution. The blot was incubated 
at either 4 °C overnight, or 2 hours at room temperature. The blot was washed 
in TTBS solution three times, each for 5 min, prior to immersing in secondary 
antibody (goat -anti- rabbit immunoglobulins conjugated with alkaline 
phosphatase) (DAKO) diluted 1 in 1000 in TTBS for two hours at room 
temperature. The blot washed with TBS (omitting Tween 20) three times, each 
for 5 min, prior to detection of immunoreactive bands by incubation with a 
solution containing alkaline phosphatase substrate (Western Blue® Stabilised 
Substrate for Alkaline Phosphatase (Promega)). Once the immunoreative 
bands reached the desired intensity the membrane was washed with distilled 
water thee times, each for 5 mins and dried. 
2.6.4 Tryptophan uptake assay of whole insect cells 
Tryptophan transport activity of insect cells was performed using L -[5- 
3H]Tryptophan (Amersham International plc). 16 wells of 3 x 24 well plates 
were seeded with 150 µl of 100 x 10' cells /ml and left for between 30 mins to 
overnight to form a cell monolayer. This allowed for four wells or quadruplicate 
samples, of four different times. The media was removed from each well 
followed by the addition of either BV -w,st P3 stock; or control virus (expressing 
the human Gaba 1 subunits a1 and (31 obtained from Brett Cromer, JCSMR, 
ANU); or media containing no virus for an uninfected control. The cell 
monolayers were incubated for 90 min at room temperature with gentle rocking 
on a rocking platform. The viral supernatant was removed and fresh media (0.5 
55 
ml) containing approximately 1 µCí /ml of L- [5- 3H]Tryptophan, was added to the 
monolayers. The cells were incubated at 25 °C. Cells were harvested over a 
time course of 6 hpi, 24 hpi, 31 hpi and 48 hpi. The cell monolayers were 
resuspended by pipetting up and down gently then were transferred to separate 
eppendorf tubes for harvesting by centrifugation. The cells were washed twice 
with PBS, then resuspended in 0.5 ml PBS and stored at -20 °C until counting. 
Cells were then added to 3 ml of scintillation fluid and counted in a scintillation 
counter. 
2.6.5 Separation of cell fractions by differential centrifugation 
2.6.5.a Fractionation of E. coli cells 
Harvested cells were resuspended in 50mM Tris -HCI pH 7.4 and 20% glycerol, 
in a volume of 2ml /g wet weight of cells for large cell cultures (20 -40L) or in a 
minimum volume of 50m1 for 1L cultures. Cells were then lysed using a RF -1 
Ribi Cell Fractionator (Sorvall) at a pressure of 20,000 p.s.i. 0.05g DNAase 
was added to the lysate to degrade the DNA released from the lysed cells to 
reduce the viscosity of the suspension. The lysate was centrifuged at 15,000 
rpm in a Sorvall SS34 rotor for 30 minutes to pellet the cell debris (cell wall, and 
insoluble aggregates such as inclusion bodies), and the supernatant was 
centrifuged for a further hour at 60,000 rpm in a Beckman Ti70 rotor (approx. 
100,000 g) to separate the membrane fraction (pellet; lipids and integral 
membrane proteins) from the cytosol (supernatant; this fraction contains soluble 
proteins). 
2.6.5.b Fractionation of Sf9 insect cells 
Sf9 cells growing as suspension culture or cell monolayer were harvested by 
centrifugation at 1,000 rpm and washed in PBS. Cells were resuspended in 
10mM Tris, pH 7.4, 200 mM Sucrose and then lysed using a dounce tissue 
homogeniser (Wheaton) by 15 strokes with the loose- fitting pestle followed by 5 
strokes with the tight- fitting pestle. The cell lysate was centrifuged at low speed 
(1,000 rpm or 121 g) in an SS34 rotor for 5 minutes to separate insoluble 
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material. The supernatant from the low speed centrifugation was centrifuged at 
60,000 rpm (around 100,000 g) in a Ti 60 (Beckman) rotor for 1 hr to separate 
crude membranes from soluble cytoplasmic fraction of the cell. 
2.6.6 Separation of cell fractions by percoll density gradient 
Sf9 cells harvested by centrifugation at 1,000 rpm and washed in PBS. Cells 
were resuspended in 10mM Tris, pH 7.4, 200 mM Sucrose and then lysed 
using a dounce tissue homogeniser (Wheaton) by 15 strokes with the loose - 
fitting pestle followed by 5 strokes with the tight- fitting pestle. Percoll 
(Pharmacia) was added to the cell lysate to a final concentration of 11.9 %. The 
solution was centrifuged at 20,000 rpm in a Ti 50 Sorvall rotor for 30 minutes. 
Fractions were removed by gentle aspiration with a pasteur pipette. 
2.6.7 ATP binding assays of protein immobilised to glutathione -agarose 
This method was developed in this laboratory. 10 4Ci of [a -32P] -ATP 
(Amersham International, plc) was added to 100 µl sample volume of protein 
immobilised to glutathione -beads (50% bead slurry), (described in Section 
2.9.1). Samples were gently mixed and incubated at room temperature for 
between 30 sec to 2 mins. The beads were then washed by filtration three 
times with 150u1 of sample buffer prior to resuspension in 100 µl of sample 
buffer which was then transferred to a scintillation vial containing 3 ml of 
scintillation liquid. The radiation was then counted by a scintillation counter 
(Packard Tri Carb 300) for 5 minutes. 
2.6.8 [-32P]-8-Azido-ATP photocrosslinking 
This method was modified from previously described methodology (Czarnecki 
et al, 1979) and utilizes the photoreactive ATP analog 8 -azido -ATP. Exposure 
of 8 -azido -ATP to UV irradiation converts the azido group into a highly reactive 
nitrene which can form a covalent bond with amino acids at the nucleotide - 
binding site of the protein being studied. [a- 32P] -8 -Azido -ATP (ICN 
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Pharmaceuticals) was added to 50 µl sample volume on ice, to a final 
concentration of 10.3 pM. The sample was mixed gently incubated for 
approximately 30 seconds, then irradiated with UV radiation at 254 nm for 
between 30 sec and 1 min on ice. Samples were then TCA precipitated and 
proteins were separated by SDS PAGE on a 12% Tris -Glycine polyacrylamide 
gel. The gel was then stained with Coomassie blue, destained, then 
incubated in a solution of 5% glycerol and 30% methanol twice for 10 minutes 
with two changes of solution. The gel was then dried onto chromatography 
paper using a Biorad slab drier and autoradiographed at -70 °C for periods 
ranging from overnight to two weeks. 
2.6,9 Detection of ATPase activity in non -denaturing polyacrylamide gels 
Detection of phosphate release due to ATP hydrolysis activity in polyacrylamide 
gels under non -denaturing condition was performed as described previously by 
(Weinbaum and Markman, 1966) and modified by (Fayle, 1978). Protein were 
separated by non -denaturing PAGE prior to incubating the gel with an ATP /lead 
staining buffer (35 mM Tris -HCI, 270 mM glycine, 14 mM magnesium sulphate, 
0.2% (w /v) lead nitrate, 8 mM ATP, pH 7.4). The gel was incubated at 37 °C 
overnight to allow the white precipitate to form. 
2.6.10 Precipitation of proteins with trichloro acetic acid 
Proteins samples to be concentrated prior to SDS PAGE analysis were 
precipitated by adding trichloro acetic acid (TCA) to a final concentration of 10% 
(w /v). Samples were then chilled for 10 minutes at 4 °C, then centrifuged in a 
benchtop microcentrifuge for 5 minutes at 4 °C. The supernatant was removed 
and the pellet was washed with ethanol. The sample was resuspended in 1 x 
SDS PAGE loading buffer (40 mM Tris -HCI, pH 8.0, 10% glycerol, 1.6% SDS, 
10 mM DTT) and prepared for SDS PAGE. 
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2.7 Computer analysis of protein and DNA sequences 
Protein analyses including hydrophilicity analysis, antigenic index, sequence 
alignments, calculation of isoelectric points were performed using the computer 
program MacVector version 6.0.1. 
Sequence comparisons were performed using CLUSTAL W alignment program 
(Higgins et al, 1996) using the Macvector computer program. The settings 
used were as follows: pairwise alignment mode: slow; pairwise alignment 
parameters: open gap penalty 10; delay divergent 40 %; extend gap penalty 0.1; 
gap distance 2; similarity matrix used was blossom; multiple alignment 
parameters: open gap penalty, 10; extend gap penalty, 0.1; delay divergent, 
40 %; gap distance 2; similarity matrix, blossom. 
2.8 Over -expression of heterologous GST- fusion proteins in 
E. coliand solubilisation of membrane and cell debris 
fractions 
This method describes the over -expression of GST -wNBD fusion proteins for 
subsequent affinity purification first described by (Smith and Johnson, 1988). 
Recombinant GST fusion proteins were over -expressed in protease deficient E. 
coli strains (AN3700 or AN3701) by induction with 0.1 mM IPTG during late log 
phase and grown at 30 °C for between 2 and 3 hours. Cells were harvested by 
low speed centrifugation at 4 °C and resuspended in 2 ml /g of fresh weight of 
cell pellet of a buffer containing 50 mM Tris -HCI, 10% glycerol, pH 7.4, and a 
protease inhibitor cocktail (CompleteTM (Boehringer)). The resuspended cells 
were lysed by a ribi French pressure cell. The cell lysate was subjected to 
differential centrifugation to separate membrane, cytoplasm and insoluble 
material (Section a). Membrane and cell debris fractions were resuspended in 
buffers containing non -denaturing detergents at concentrations above the 
critical micellar concentration (CMC) i.e. the minimal concentration at which 
detergents begin to form micelles . such as TX -100 (0.1%) (Sigma), CHAPS 
(1.0 %)(Boehringer), deoxycholic acid (0.25 %)(Sigma), and NaCI (0.1M). 
59 
Solubilisation buffers also contained 50 mM Tris -HCI, 20% glycerol and 
protease inhibitors (Complete TM (Boehringer)) and were pH 7.4. After 
resuspending membrane and cell debris pellets in solubilisation buffer they 
were incubated overnight at 4 °C with constant stirring. 
2.9 Protein purification techniques 
2.9.1 Glutathione -agarose chromatography 
This method of affinity purification was performed essentially as described by 
(Smith and Johnson, 1988). GST -wNBD fusion proteins were partially purified 
from non -denaturing detergent solubilised membrane and cell debris E. coli 
fractions by the addition of pre -swollen glutathione-agarose beads (Sigma). In 
general 0.2 ml of beads were added to solubilised fraction obtained from a 1 L 
cell culture. The glutathione-agarose beads were incubated with the solubilised 
cell fraction containing GST -wNBD fusion protein at 4 °C with gentle rocking for 
periods ranging from between 2 hrs to overnight. The solution was then 
passed through a column containing a sintered glass filter at its base, thereby 
collecting the glutathione -agarose beads with bound fusion protein at the base 
of the column and unbound proteins and impurities were removed by filtration. 
The glutathione -agarose beads with bound fusion protein were then washed 
with 20 volumes of solubilisation buffer (omitting protease inhibitors which could 
interfered with thrombin digestion) used to solubilise the cell fraction. Samples 
of the beads were removed for analysis by SDS PAGE and Western blotting. 
Fusion protein was eluted from the glutathione -agarose beads by incubation 
with 100 mM reduced glutathione. Typically 0.5 ml of beads were incubated 
with 1 ml of 100 mM reduced glutathione (reduced glutathione was always 
prepared fresh in a strongly buffered solution containing the same detergent 
and NaCI concentration used for solubilisation, 20% glycerol, and 1 M Tris pH 9 
was added until the pH rose to pH 7.4). The beads were incubated with 100 
mM reduced glutathione for 10 minutes with gentle rocking prior to collecting 
the supernatant by filtration. This was repeated two or three times resulting in 
several 1 ml fractions containing partially purified fusion protein samples of 
60 
which were then analysed by SDS PAGE and Western Blotting. Samples of 
fusion protein were then digested with human thrombin (10 units /ml) (Sigma) 
overnight at 4 °C. The extent of digestion was analysed by SDS PAGE and 
Western blot detection of a change in molecular weight of the fusion protein 
(- 75.5 Kd) to a molecular weight of - 47.5 Kd representative of the wNBD 
released from the fusion protein. Protease inhibitors were then added to the 
digested sample in order to prevent further non -specific thrombin digestion. 
Samples were then buffer exchanged into the original buffer used for 
solubilisation of the fusion protein (excepting that the glycerol concentration 
was decreased to 10 %) using a PD -10 buffer exchange column following the 
instructions of the supplier (Pharmacia), in order to remove glutathione. 
2.9.2 Purification of hexa -histidine tagged proteins 
This method of protein purification utilising immobilised metal chelate affinity 
chromatography was. based on the method described by (Janknecht et al, 
1991) and was used as a secondary purification step subsequent to partial 
purification of the White nucleotide binding domain (wNBD) by glutathione- 
agarose chromatography. The metal chelating absorbent resin (Ni -NTA resin) 
(Quiagin) was added to samples containing wNBD6h,S (0.2 ml of resin was 
added per 5 ml protein sample) and incubated at 4 °C for 1 hr prior to eluting 
unbound proteins. Proteins bound to the resin were eluted by incubation with 
imidazole. The resin was incubated with rocking for 10 mins with generally 1 ml 
of sample buffer with imidazole. This eluting step was repeated, each time 
increasing the concentration of imidazole (between 10 mM and 1M). Samples 
of each eluent were then analysed for the presence of wNBD and other 
contaminants by SDS PAGE and Western blotting. 
2.9.3 Dye -ligand chromatography 
This technique was performed essentially as described above for metal -chelate 
chromatography however resins with immobilised dye molecules were used as 
the affinity chromatography resin, namely Cibacron Blue 3GA (Sigma) and 
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Reactive Red 120 -agarose (Sigma). The technique is based on one 
previously described for purifying proteins with a nucleotide binding fold 
(Thompson et al, 1975). Increasing concentrations of MgCl2 and ATP (1 mM to 
50 mM) buffered to pH 7.4 in an appropriate solubilisation buffer (i.e. the buffer 
used for initial solubilisation and partial purification of GST -wNBD from cell 
debris or membrane cell fractions) was used to attempt to elute proteins from 
the resin. 
2.9.4 Cation exchange high -performance liquid chromatography 
HPLC was carried out on a dual -pump Bio -Rad gradient module fitted with 
titanium 1/16" tubing. Detection was carried out using a Linear Instruments 
Uvis -204 ultraviolet/visible absorbance detector. Operation was under the 
control of a Bio -Rad model 700 Chromatography Data Station. Ion exchange 
chromatography was performed using a strong cation exchange column, Bio- 
GeITM MA7S Cation Exchange Column (Bio -Rad). The column and pumps were 
pre -equilibrated with buffer to be used for chromatography (10% glycerol, 50 
mM Trís -HCI, 1% CHAPS, pH 7.4) prior to loading the sample. Buffers to be 
used for cation exchange HPLC were filtered prior to use, through 0.5 µM filter 
paper (Millipore). A linearly increasing NaCI concentration over time was used 
to elute proteins from the cation exchange column. The elution profile was 
obtained using absorbance readings at 280 nm and a flow rate of 1 ml /minute. 
Fractions were collected every minute and samples from each fraction analysed 
by SDS PAGE and Western Blotting. 
2.10 lAsys Biosensor techniques 
The protein -peptide interaction analysis experiments were performed using an 
lAsys auto plus biosensor machine (Fisons Applied Sensor Technology, 
Cambridge, UK). The cuvettes designed for use in this machine had two wells 
allowing experiments to be performed in each well to be performed 
simultaneously. 
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2.10.1 Immobilisation of peptides to CMD matrix surface of cuvette 
This technique involves immobilisation of synthetic biotinylated peptides 
(synthesised by the Biomolecular Resource Facility, ANU) via interaction with 
avidin which was immobilised to the carboxy methyl dextran (CMD) matrix 
surface of the lAsys auto plus cuvette. Coupling of avidin occurs through 
primary amino groups reacting with N- Hydroxysuccinimide (NHS) in a reaction 
mediate by 1- ethyl -3 -(3- dimethylaminopropyl) carbodiimide (EDC) (see Fig. 6). 
The instructions supplied by lAsys were followed exactly, as follows. The CMD 
matrix was first activated by addition of NHS (0.013 g /ml) and EDC (.076 g /ml) 
to the cuvette which was pre -equilibrated at room temperature with phosphate 
buffered saline (0.01 M phosphate buffer, 0.0027 M KCI, 0.137 M NaCI, 0.05% 
Tween 20) (PBS /T). The CMD matrix was activated for 7 mins at room 
temperature and the unreacted activation mixture was removed and the cuvette 
washed with PBS /T buffer for 2 minutes. Avidin (50 µg /ml in 10 mM acetate 
buffer, pH 4.5) was added to the activated cuvette and incubated for 10 mins. 
The non -coupled avidin was removed and the cuvette washed with PBS/T for 2 
mins. 1 M ethanolamine, pH 8.5 was added to the cuvette and incubated for 2 
mins. The ethanolamine was removed and the cuvette washed with PBS /T for 
5 mins. The synthetic biotinylated peptides were dissolved at a concentration 
of 50 µg /ml in 10 mM Acetate buffer pH 4.45 (both peptides were soluble in this 
buffer) and were added to the cuvette whereupon the biotin group binds 
irreversibly to the avidin immobilised on the CMD matrix surface. Fig. 7 
illustrates the lAsys responses recorded during the immobilisation procedure 
which are indicative of the level of protein immobilised to the CMD surface. 
This figure shows that the levels of avidin, and subsequently, wild -type or 
mutant biotinylated peptide immobilised to the cuvette CMD surfaces to an 
approximately equal degree. 
Fig. 6 Chemistry of immobilisation of biomolecules to carboxy methyl 
dextran 
The standard coupling chemistry available for immobilization of biomolecules 
on carboxy methyl dextran (CMD) coated lAsys sample cells by reaction via N- 
hydroxysuccinimide (NHS) in a reaction mediated by (1- ethyl -3 -(3- 
dimethylaminopropyl (EDC) as shown in this figure. 
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Fig. 7 Immobilisation of synthetic peptides to the avidin -CMD matrix of an 
lAsys cuvette 
This figure shows the profiles obtained from the lAsys biosensor during 
immobilisation of biotinylated synthetic peptides to avidin which was previously 
immobilised to the CMD matrix of the cuvette surface. Immobilisations were 
carried out at the same time, using an lAsys two well cuvette. The same 
concentrations of avidin, and synthetic peptide (wild type peptide is shown in 
blue, while the peptide containing a single amino acid alteration is shown in red) 
were added to each well respectively. Events are numbered as follows: 
1. Baseline obtained after immobilisation of avidin. The profiles prior to 
immobilisation of avidin are not shown here. 
2. Buffer wash. 
3. 1 M ethanolamine to block unreacted succinimide esters. 
4. Buffer wash. 
5. Addition of biotinylated peptide. 
6. Buffer wash. 
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Table 2 Peptides used for lAsys biosensor interaction analysis 
The peptides listed in this table were synthesised and biotinylated at the amino - 
terminus by the Biomolecular Resource Facility (ANU). The biotinylated 
peptides were immobilised to the lAsys cuvette surface by way of avidin which 
was immobilised to the CMD surface of the cuvette. 
Peptide Sequence Description 
name 
WL2 -3 W CMREARSRLYRCDTYFLGKTIAE Representative of a loop 
between TM helices 2 and 
3 of the predicted White 
structure 
WL2 -3 mut CMREARSRLYRCDTYFLDKTIAE As above however contains 
substitution identified in the 
eye -colour mutant wETB' 
(G509D) 
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2.10.2 Peptide -protein interaction experiments 
Interaction analysis between peptides immobilised to the lAsys auto plus 
cuvette were carried out as follows. The buffer used for all experiments i.e. 
equilibration, sample and wash buffer, was phosphate buffered saline (PBS) 
(0.01 M phosphate buffer (0.01 M Na2HPO4, 1.76 mM KH2PO4), 0.137 M NaCI, 
0.0027 M KCI, pH 7.4), 0.1% TX -100, 10% glycerol, pH 7.4. All experiments 
were carried out at 25 °C with constant stirring set at 80% of the maximum 
stirring. The cuvette was pre -equilibrated with buffer and a baseline was 
obtained prior to addition of experimental samples. Protein samples for 
interaction analysis containing White nucleotide binding domain (wNBD) were 
partially purified by over -expression in E.coli, solubilised from membrane the E. 
coli fraction using TX -100 and partially purified using glutathione -agarose 
chromatography (as described in Section 2.8), however PBS was the buffer of 
choice. Generally a number of consecutive experiments were performed to 
obtain binding curves at a number of different concentrations. A binding curve 
was recorded over a period of 5 mins, after which time the cuvette was washed 
three times with buffer, followed by regeneration with 6 M guanidine HCI, pH 
4.4 for 2 mins. This washing and regeneration step was performed subsequent 
to each experiment. 
2.10.3 Analysis of binding data 
The interaction between immobilised peptides and wNBD was analysed in real - 
time by a resonant mirror optical biosensor device (Buckle et al, 1993; Cush et 
al, 1993) using the lAsys auto plus biosensor machine. The lAsys biosensor 
was provided with a digital DECpc 450D2LP computer. Data obtained with the 
biosensor were transferred directly to the Fast Fit computer program (Fison 
Applied Sensor Technology). This program uses an iterative curve- fitting to 
derive the observed rate constant and the maximum response at equilibrium 
due to ligand binding at the particular ligand concentration. The association of 
a soluble ligand with an immobilised macromolecule when only one binding site 
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is available for the ligand can be described by the pseudo- first -order equation: 
R = R0 + E(1 - e -kob5t) (Cush et al, 1993) 
Where: 
R, = the lAsys response at time t in units of arc -seconds 
Ro = the lAsys response at time t = 0 in units of arc -seconds induced by the 
addition of the ligand solution to the buffer in the cuvette (this 
represents a net displacement of the biosensor signal, and its value is 
determined by the Fast Fit program for each binding curve analysed 
t = O in units of arc -seconds induced by the addition of the ligand solution to 
the buffer in the cuvette (this represents a net displacement of the 
biosensor signal, and its value is determined by the Fast Fit program for 
each binding curve analysed 
E = the maximum lAsys response in units of arc -seconds due to bound 
ligand at equilibrium 
the observed rate constant (termed kon in Fast Fit, i.e. kon = kobs) given 
by: 
kobs = koff + koo[ligand] (George et al, 1995) 
2.11 Production of antibodies in rabbits recognising white 
and scarlet protein epitopes 
2.11.1 Peptides used for raising antibodies 
Polyclonal antibodies were raised in New Zealand White rabbits against 
peptides synthesised by the Biomolecular Resource Facility at the Australian 
National University, Peptides for injection into rabbits were coupled via a C- 
terminal cysteine to a lysine core matrix, also called multiple antigen peptide 
(MAP) system. This system is based on a small immunogenically inert core 
molecule of radially branched lysine dendrites onto which a number of peptide 
antigens are anchored (Lu et al, 1991). The sequences of the synthetic 
peptides are shown in Table. 3. 
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Table 3 Peptides used for raising anti -White and anti -Scarlet antibodies 
in rabbits 
Epitope Epitope Peptide sequence 
Code 
Predicted extracellular loop wECL RYANEGLLINQWADVEPGEC 
region between TMs 5 and 6 of 
the White protein 
N- terminus of the White protein. wNT MGQEDQELLIRGGSKHPSAC 
This is also at the N- terminus of 
the intracellular ATP binding 
domain 
N- terminus of the scarlet protein. stNT MSDSDSKRIDVEAPERVEQC 
This is also at the N- terminus of 
the intracellular ATP binding 
domain 
2.11.2 Immunisation of rabbits with Multi -Antigenic Peptides 
Blood was collected before injection of peptide as a negative pre- immune 
serum control. For the first or primary injection, MAP coupled peptide was 
dissolved in MTPBS (150 mM NaCI, 16 mM Na2HPO4, 4 mM NaH2PO4, pH 7.4) 
to 50 .tg /ml and was emulsified with an equal volume of Freund's Complete 
Adjuvant (Freund and McDermott, 1942) (Sigma) by vigorous vortexing for 
several minutes. The peptide /adjuvant mix was considered thoroughly 
emulsified when a 20 pl drop of the mix did not disperse when placed onto 
water. 3 ml of peptide /adjuvant mix was injected sub -cutaneously at several 
sites along the back of the rabbit. Not less than four weeks after the primary 
injection the rabbit was injected again in the same way as described for the 
primary injection, however using Freund's incomplete adjuvant instead of 
Freund's complete adjuvant. A third injection or boost was given not less than 
four weeks after the previous boost. Seven days after the respective 2nd and 3rd 
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boosts, blood was collected from the anaesthetised rabbit, through the marginal 
ear vein. Serum was separated from whole blood by first allowing a clot to 
form at 37 °C for 1 hr then incubating at 4 °C overnight. Serum was transferred 
to a centrifuge tube and centrifuged for 20 minutes at 4 °C to pellet any 
remaining insoluble material. The serum was stored in aliquots at -20 °C. 
2.11.3 Detection of anti -peptide polyclonal antibodies in rabbit serum 
The appearance of polyclonal antibodies in rabbit serum specific to the MAP - 
peptides used in immunisation was monitored enzyme -linked immunosorbent 
assay (ELISA) (Engvall and Perlmann, 1971). ELISAs were performed in 96 
well micro -titre plates. Wells were coated with the appropriate peptide by 
incubating with 50 µl of 504/ml peptide in PBS overnight at 4 °C or 2 hours at 
room temperature. A set of control wells were included which were not 
exposed to MAP -peptide. The wells were washed twice with PBS. Serial 
dilutions in blocking solution (10% skim milk in PBS) of pre- immune and post - 
immune serum to be tested were prepared over a range of between 1:10 to 
1:1000. 50Etl of each dilution was added to the MAP -peptide coated wells or 
control wells (with no peptide) and incubated for 1 hour at room temperature. 
Wells were washed twice with PBS. 50µI of secondary anti -rabbit alkaline 
phosphatase conjugated antibody was then added to each well and incubated 
for 1 hr at room temperature. Wells were washed twice with PBS then once 
with pH 9.5 buffer (10mM Diethanolamine, 0.5mM MgC12, pH 9.5). 50 µl of 
alkaline phosphatase substrate (1 mg /ml p- nitrophenylphoshate in pH 9.5 
buffer) was then added per well. The yellow colour was then allowed to 
develop and the optical density between 405 nm and 630 nm was recorded in a 
micro -titre plate reader. 
2.11.4 Purification of polyclonal anti -peptide antibodies from serum by 
immunoaffinity purification 
Polyclonal antibodies against synthetic MAP -peptides in rabbits were purified 
by immunoaffinity purification using a SulfoLink® Kit from Pierce. Synthetic 
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peptides equivalent to those used to produce antibodies (without the coupled 
MAP) possessing a C- terminal cysteine were covalently immobilised via an 
iodoacetyl group on a crosslinked agarose support. The preparation of the 
SulfoLink® immunoaffinity column was carried out as described in detail in the 
instructions provided with the kit by Pierce. The appropriate serum containing 
polyclonal antibodies against the respective peptide was diluted 1:10 in PBS. 
10 ml of diluted serum was passed through the column 3 times. 
2.12 Transmission electron microscopy techniques 
2.12.1 Preparation of Drosophila eye tissue 
The fly eyes were carefully dissected away from the head tissue and primary 
fixation was performed in 2%/1% paraformaldehyde /glutaraldehyde in 0.1 M 
sodium cacodylate buffer (pH 7.4) for 1.5 hrs. The tissue was washed for 15 
mins three times in 0.1 M sodium cacodylate buffer (pH 7.4). Secondary 
fixation was performed using 1% osmium tetroxide in 0.1 M sodium cacodylate 
buffer (pH 7.4) for 30 mins followed by three 15 minute washes in 0.1 M sodium 
cacodylate buffer (pH 7.4). The tissue was dehydrated through a graded series 
of ethanol:water (30% to 70 %) for 15 mins, three times, followed by two 15 min 
washes in 70% ethanol prior to infiltration of LR White resin for 1 hr in 50:50 
alcohol:resin, followed by overnight incubation with 100% resin, and a further 2 
hrs in 100% fresh resin, and for a further 24 hrs in 100% resin at 55 °C. 
2.12.2 Immuno -gold labelling of Drosophila eye tissue and Sf9 cell 
sections 
Thin sections (80 nm) were collected on Formva coated and carbon coated 
nickel grids (slot grids were used for Drosophila eye sections) (ProSciTech) and 
incubated with primary affinity- purified antibody (either anti -White at 1:10 
dilution, or anti -Scarlet at 1:40 dilution) diluted in 0.05 M Tris buffered saline 
(TBS) pH 7.6 overnight at 4 °C. The sections were washed twice for 10 mins in 
0.05M TBS pH 7.6. The sections were then washed in TBS containing 1% 
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bovine serum albumin (BSA) (Fraction V, Boehringer) for 10 mins, followed by 
incubation with EM -grade goat- anti -rabbit gold conjugated antibody (EM 
Sciences) (diluted 1 :20) in 0.02 M TBS (pH 8.2) containing 1% BSA for 1 hr at 
room temperature. The sections were washed in TBS containing 1% BSA, then 
washed a further two times in TBS for 10 mins each wash, prior to washing in 
distilled water for 10 mins, two times. The sections were post- stained with 2% 
uranyl acetate for 15 mins and lead citrate for 10 mins and allowed to dry prior 
to visualisation using a Hitachi H -7000 electron microscope. 
2.12.3 Preparation of insoluble material obtained from percoll gradient 
A drop of the protein sample was placed on Formva coated and carbon coated 
grids (ProSciTech) supported on lenspaper, and incubated for 1 minute to 
adhearto the Formvar coating. The grid was gently swirled in 2% uranyl 
acetate followed by brief swirling in water to wash excess material off the grid, 
then placed briefly in 90% ethanol. The grids were then visualised using a 
Phillips CM10 microscope. 
2.12.4 Preparation of Sf9 insect cells for immuno -electron microscopy 
Sf9 cells were harvested by centrifugation washed with PBS buffer prior to 
primary fixation with 1%/3% paraformaldehyde /glutaraldehyde in 0.1 M sodium 
cacodylate buffer (pH 7.4) for 1.5 hours. The cells were then washed three 
times for 15 mins each wash with 0.1 M sodium cacodylate buffer (pH 7.4). A 
secondary fixation was performed as follows: the cells were incubated with 1% 
osmium tetroxide in 0.1 M sodium cacodylate buffer (pH 7.4) for 45 mins. The 
cells were then washed 3 times for 15 minutes each wash with 0.1 M sodium 
cacodylate buffer (pH 7.4). The cells were then dehydrated through a graded 
series of ethanol:water (30% to 100 %) for 15 mins, three times, followed by two 
15 min washes in 70% ethanol prior to infiltration of LR White resin for 1 hr in 
50:50 alcohol:resin, followed by overnight incubation with 100% resin, and a 
further 2 hrs in 100% fresh resin, and for a further 24 hrs in 100% resin at 55 °C. 
2.13 E. coli strains 
Strain Genotype 
XL1BIue recA1, endA1, gyrA96, 
thi-1, hsdR17, 
supE44, relA1, lac, [F' 
proAB, IacIQZAMIS, 
Tn10(tetR) 
AN3700 lac(am), pho(am), 
mal(am), trp(am), 
supC(ts), rpsL(StrepR), 
rpoH 165-Tn 10(TetR) 
AN3701 pESL(CapR)/IacZ(am,fr 
p(am), pho(am), 
mal(am), trp(am), 
supC(ts), rpsL(StrepR), 
rpoH 165-Tn 10(TetR) 
AN3828 HfrKL16 P0/45 
[IysA(61-62)], dut1, 
ung1, thi1, relAl, Zbd- 
279: : Tn10(TetR, 
supE44 
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Antibiotic Resistance Source 
and growth temp 
Tetracyline 37°C 
Streptamycin 30°C 
Tetracyline 
Streptamycin 30°C 
Tetracyclin 
Chloram- 
phenicol 
Stratagene 
Laboratory 
strain 
Laboratory 
strain 
Tetracyline 37 °C Previously 
called RZ1032 
(Kunkel, 1985) 
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2.14 Sequence of oligonucleotides 
'Recognition sequences for restriction by EcoRl, Hindlll, BamHl and Pstl 
endonucleases and underlined. 
'Binding sites are numbered with +1 as the A of the translation start codon in 
the published white genomic or cDNA as indicated (O'Hare et al, 1984; Pepling 
and Mount, 1990). 
+ indicates the coding strand; - indicates the complementary strand. 
Primer Sequence (5' to 3')a Site of 3' base Use 
binding' 
Strand` 
91 -136 AACCGAATTCGTAGGATACTTCG 3102 PCR Exon 2 -6 + 
white 
91 -135 GCAGAGAATTCGATGTTGCAATCGC 123 PCR Exon 1 
white 
91 -134 TTGAAGCTTGAGTGATTGGGGTG -81 PCR Exon 1 + 
white 
91 -73 GATGAAGCTTATCTTGTTTTTATTGGCAC 5714 PCR Exon 2 -6 
white 
91 -72 GATGTGCAGCTAATTTCGCC 5431 Sequencing - 
white 
91 -71 CTTTTACGAGGAGTGGTTCC 4537 Sequencing - 
white 
91 -70 GATCGTGTGCTGACATTTGC 3872 Sequencing - 
white 
91 -69 ACACCTACAAGGCCACCTGG 4467 Sequencing + 
white 
96 -74 CAATGAATTCCGTTTTAACTGAAACAAAC PCR, st NBD + 
TGG 
96 -74 CATAGCGGCCGCCCGCAACCATTGAATC PCR, st NBD - 
GTGG 
91 -68 CCACGACATCTGACCTATCG 3824 Sequencing 
white 
91 -22 GTTCCGGTGCCCTGCAGACGACCCTG + 392 cDNA SMD white + 
96 -71 CCTGATCCTCTTGGCCCATTCAGATCTG + 16 SDM white - 
96 -70 CAGATCTGAATGGGCCAAGAGGATCAGG -9 of start SDM white + 
96 -62 GATCCGTGATGGTGATGGTGATGT 6 his DNA - 
insert 
96 -61 GATCACATCACCATCACCATCACG 6 his DNA + 
insert 
94 -6 TATAGGATCCATGGGCCAAGAGGATCAG 1 (cDNA) PCR, w NBD + 
G 
94 -5 TAAGGAATTCTTATAGGAGGAGTGGTTC 1296 (cDNA) PCR, w NBD - 
C 
CHAPTER 3 
GENETIC AND BIOCHEMICAL ANALYSIS 
OF white MUTANTS 
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3. GENETIC AND BIOCHEMICAL ANALYSIS OF white 
MUTANTS 
3.1 Introduction 
The white gene has a very long history, dating back to early this century when 
white eye -colour was among the first mutant traits of D. melanogaster to be 
observed (Morgan, 1910). Since that time the white, gene and mutants of this 
gene, have played a vital role in the development of the field of genetics and this 
gene has been extensively characterised at the genetic, molecular, and 
biochemical levels (Hazelrigg, 1987; O'Hare et al, 1984; Sullivan et al, 1979; 
Sullivan et al, 1980; Sullivan and Sullivan, 1975; Summers et al, 1982; Zachar 
and Bingham, 1982). Due to the ease of identification of mutant white alleles by 
the change in eye -colour, the gene has provided an important phenotypic 
marker and has been a useful model system for the study of many phenomena 
in classical Drosophila genetics as well as a number of genetic regulatory 
mechanisms occurring in higher eucaryotes (Hazelrigg, 1987). The D. 
melanogaster experimental system also provides a powerful tool for producing 
transgenic flies (via P- element transformation (Rubin and Spradling, 1983)), 
which can be used to investigate the correlation between mutant eye -colour 
phenotype and mutations in the white gene. 
The white gene has been used to study the nature of mutations caused by a 
number of mutagens, including chemicals and x -rays (Pastink et al, 1987; 
Pastink et al, 1988a; Pastink et al, 1988b). For example, the alkylating agent 
methyl methanesulfonate (MMS) has been shown to introduce genetic 
translocations and deletions which significantly alter the structure of the gene. 
On the other hand N- ethyl -N- nitrosourea (ENU) and ethyl methane sulfonate 
(EMS), which are also alkylating agents, as well as X -ray induced mutagenesis 
under the appropriate conditions, have been shown to introduce small 
alterations and single base changes in the white gene, which do not alter the 
overall structure of the gene (Pastink et al, 1987; Pastink et al, 1988a; Pastink 
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et al, 1988b). A very large collection of mutant white alleles has been built up 
using these techniques, in addition to many white alleles which have arisen 
spontaneously in laboratory populations. Many of the flies carrying these mutant 
white genes can be obtained from various Drosophila stock centres. 
Zachar and Bingham, (1982) selected a sample of white mutants for molecular 
characterisation using the Southern blotting technique and comparing restriction 
fragment maps to the wild -type counterpart gene from Oregon -R or Canton -S 
(Zachar and Bingham, 1982). These mutants are shown in Table 1 and can be 
grouped into two categories. Those in one category have major genetic 
aberrations, such as large insertions of non -white DNA or deletions either within 
the gene or in upstream regulatory elements. These mutations would be 
assumed to disrupt the coding sequence in a major way or may prevent 
expression. 
The other category of mutant alleles (highlighted with asterisks) were identified 
as having the same gene structure as their wild -type counterpart strain (Canton - 
S or Oregon R), and do not harbour any major molecular alterations. An 
interesting characteristic of this category of white alleles is that homozygous flies 
express an abnormal eye -colour distinguishable from the others in the category 
where either red and /or brown pigment deposition has been partially reduced to 
different extents in each of the mutants. This gives an indication that the 
mutation has not ablated protein assembly and that the level of function of the 
pigment precursor transporters are different in each of the mutants. Fig. 1 
shows a comparison of the eye -colour of some of these mutants which will be 
further characterised in this chapter. 
It has been a major focus of our group to further characterise this category of 
partially pigmented white mutants, which potentially carry point mutations, with a 
view to gaining insights into regions of the White protein which are important 
Table 1. Molecular structure of a sub -set of mutant white alleles. 
The mutant white alleles listed were analysed by Southern Blotting and 
restriction mapping to determine the cause of the mutant phenotype. All of 
these mutants were characterised by Zachar and Bingham, 1982, with the 
exceptions of the w101 allele which was produced and characterised by Pastink, 
1988, and wETB' which was induced by EMS mutagenesis and identified by our 
group, (M.M. Green and A.J. Howells, unpublished). Mutants which have 
retained some level of eye pigmentation and have a normal genetic structure 
compared to the wild -type counterpart strain (Oregon -R, or Canton -S), are 
highlighted with an asterisk. 
white mutant Cause of 
mutation 
Genetic structure change 
wcol 
* wcf 
* 
W 
.. b5a25 
* w3wx 
wc« 
* wsat 
* w1o1 
* wET87 
wbfl 
wai 
* wa2 
* wa3 
wa4 
w1 
W 
Sei» 
iNch 
wzm 
wsp55 
wsp1 
wsp2 
wDZL 
w11E4 
wsp3 
wsp4 
X -ray No change (Canton -S) 
X -ray No change (Oregon -R) 
X -ray No change (Oregon -R) 
Spontaneous No change (Canton -S) 
Spontaneous No change (Oregon -R) 
Spontaneous No change (Canton -S /Oregon -R) 
ENU No change (M56í Amherst) 
EMS No change (Canton -S) 
Spontaneous 9.5 kb insertion 
Spontaneous Copia insertion 
Spontaneous No change 
Spontaneous No change 
Spontaneous 10 kb insertion 
Spontaneous 5.7 kb insertion 
Spontaneous Additional insertions into the w1 
element 
Spontaneous Additional insertions into the w1 
element 
Spontaneous Identical to we 
Spontaneous 7.5 kb insertion 
Spontaneous 5.8 kb insertion 
Spontaneous 8.6 kb insertion 
Spontaneous 0.2 kb deletion 
Spontaneous 13 -14 kb insertion 
X -ray Deletion 
X -ray 15 kb deletion 
X -ray 1.2 kb deletion 
Fig. 1 Eye -colour phenotypes of D. melanogaster mutant white alleles 
The top photograph displays eye -colour phenotypes of wild -type flies in 
comparison to phenotypes generated by null mutations in the scarlet, brown 
and white genes: clockwise from left, wild -type eye -colour (w`), eye -colour 
when no brown pigment is present (st), eye -colour when no red or brown 
pigments are present (w), and when no red pigment is present (bw). The four 
photographs at the bottom of the page represent four of the D. melanogaster 
strains displaying partially pigmented mutant eye -colour phenotypes due to a 
mutant white allele. 
ion^ 
JJOM 
74 
for structure and function. This approach has been used very successfully by 
our group, in the characterisation of the white allele wCO2, which was shown to 
affect transport of drosopterin (i.e. red pigment) precursors, only when in 
combination with either of the brown alleles bw6 or bwT50 (Ewart et al, 1994). 
When a wild -type w+ or bw+ encoded subunit is present function is restored and 
the phenotype is normal. The positions of the mutations identified in these 
mutants all occur at the extracellular end of predicted transmembrane (TM) 
a helices of the White and Brown proteins in locations appropriate for possible 
interactions. The w °°2 change is within TM 5, and bwT5o or bw6 within the 
predicted TM helices 5 and 6 respectively. Since these mutations result in 
reduced red pigments, leaving brown pigments unchanged, coupled with the 
predicted role of White /Brown in transport of guanine, it is postulated that TM 
helix 5 of the White protein and TM helix 5 and 6 of the Brown protein interact in 
the formation of a guanine specific transporter (Ewart et al, 1994). The 
putative model resulting from this work is illustrated in Fig. 2. Since brown 
pigment deposition is not affected in these mutants, the region in White 
responsible for the substrate (tryptophan) specificity resides in a different and as 
yet unidentified location. In addition, the mutant w8 which is due to a deletion 
of an isoleucine residue within TM 5 (see Fig. 2) completely knocks out red 
pigment synthesis without affecting the deposition of brown pigments. This 
further strengthens the proposal that helix 5 of White is part of the lining of a 
pore specific for guanine. 
The characterisation of the amino acid changes in wcoz wBWx bw150 bw6 as 
described above gave a very strong indication of the potential of this approach 
to provide information with respect to the structure and function of the pigment 
precursor ABC transporters of D. melanogaster. Honours and Graduate 
Diploma students T. Gill and M. Brooker, respectively, have continued this 
approach and have identified point mutations in the alleles wET87 and w101. 
Work undertaken to characterise the alleles w°'r, w °f and wsat and their effects on 
pigmentation will be described in this chapter. 
Fig. 2. Proposed interaction between transmembrane helices 5 of White and 
transmembrane helices 5 and 6 of Brown. 
This figure is taken from Ewart & Howells, 1998 and represents a model of the 
physical interactions which occur between the transmembrane helix 5 of White 
and 5 and 6 of Brown, interpreted from mutant data discussed in the text. 
Brown TM 5 
NA, 
Outside of cell 
G (T in Bw L(â(S in wW2) 
(D in bWT50) 
(Del in wan 
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Cytopl asmic side 
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This chapter firstly describes the measurement of the levels of red and brown 
eye pigments present in flies carrying v r, w °f, w°° and wETgr in comparison to 
wild -type eye pigment levels. Secondly, amplification by PCR and sub -cloning 
of each of the white alleles will be described, and the identification of the 
mutations by sequence analysis will be presented. The significance of the effect 
of each mutation on pigment levels will be discussed in the context of the 
current model of the White protein and ABC transporters in general. 
3.2 Results 
3.2.1 Comparison of levels of xanthommatin and drosopterin pigments in 
mutant and wild -type eye -colour strains 
In order to define the eye -colour levels of each of the mutants chosen for this 
study, pigments were extracted from adult fly heads of the same age, optical 
density measurements recorded and compared to the optical density obtained 
from extracts from the D. melanogaster wild -type strain Canton -S (described in 
Section 2.1.2). Eye -colour of D. melanogaster changes over time and in order 
to standardise this source of variability, the ages of the flies used for extractions 
were synchronised (described In Section 2.1.2) to 10 days old, at which time 
pigment deposition has been completed and is representative of adult flies 
(Summers et al, 1982). 
The results of the pigment extractions are illustrated in the histogram in Fig. 3 
and expressed as a percentage of the wild -type pigment levels. In all four 
mutants drosopterin pigments are reduced to less than 30% of wild -type. 
Xanthommatin levels however are reduced to very low levels in w °" and vFT87 
mutant flies, while w°f and wsat retain levels of around 60% and 80 %, 
respectively. On the basis of levels of red and brown eye pigments the four 
mutants can be separated into two groups: 
1. both pigments reduced to low levels (w°"- and vtEr87)i 
2. only red has been reduced to low levels, while brown is reduced only 
marginally (w °f and wsat) 
Fig. 3. Comparison of levels of eye colour pigments 
xanthommatins (brown pigments) and drosopterins (red 
pigments) extracted from the compound eyes of flies 
carrying mutant white alleles. 
Eye colour pigments were extracted from adult 10 
day old flies as described in Chapter 2. Pigment levels are 
expressed as a percentage of the optical densities obtained 
for pigment extractions from wild type D. melanogaster strain 
Canton -S. Duplicate values from duplicate extractions were 
obtained and the mean value plotted in the histogram. The 
error bars represent the standard error of the mean. 
Photographs of representative flies containing these alleles 
are shown in Fig. 1. 
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3.2.2 PCR amplification of Exon 1 of w° ", w°` wsaf 1,° °1 Wm', and w101 
mutant alleles 
The coding regions of the white gene were amplified as two PCR fragments: a 
220 bp fragment encompassing Exon 1, and a 2.6 Kb fragment encompassing 
Exons 2 -6. This was done to omit the large 3 Kb intron 1 and allow more 
efficient amplification of the coding regions of the gene (see Fig. 4). 
Genomic DNA prepared from mutant D. melanogaster strains (as described in 
Section 2.2.4) was used as template for PCR reactions amplifying Exon 1 of the 
white gene (described in Section 2.2.3). Positive controls were included in 
which a plasmid harbouring the full white gene was used as the DNA template. 
The strategy for PCR amplification of Exon 1 (and Exon 2 -6) of white is shown 
in Fig. 4. The oligonucleotide primers used were 91 -134 and 91 -135 (the 
sequence of these oligonucleotides are provided in Section 2.14) which anneal 
to DNA sequences flanking Exon 1 of white, resulting in a predicted PCR 
product of 220 bp. Fig. 5A is a representative example of the PCR products 
obtained for each of the PCR reactions using genomic DNA as template, and 
control template. The PCR products were the predicted size of 200 bp and 
were free from other contaminating non -specific PCR products and were 
purified from the PCR reaction mix before sub -cloning into the plasmid vector 
pBlueScriptSK' for sequencing. Exon 1 from strains wE'B' and wt01 were 
amplified by PCR in the same way as described above. 
3.2.3 PCR amplification of Exons 2 -6 of wW", w``, wsat w° °7 wErB', and w101 
mutant alleles 
Exons 2 -6 of the white gene from the alleles wf", w wsa` w °' and wETB'were 
amplified by PCR, using genomic DNA extracted from the mutant 
D. melanogaster strains as described above for Exon 1. For WnW" and Ws' two 
sets of oligonucleotide primers were tested, (91 -73, 91 -136) and (95 -51, 91- 
136). Occasionally the PCR reactions performed were unsuccessful when the 
Fig. 4 Strategy for PCR amplification and sequencing of the coding regions 
of mutant white alleles. 
Primers for PCR: H 
white gene structure: 
PCR Products: H E 
220 bp 
Sequencing Strategy: 
- E E I kb i 
II ni iv v vi 
H 
E H 
2624 bp 
Coding regions of the white gene were amplified by PCR as two DNA 
fragments using genomic DNA prepared from mutant fly strains as template 
DNA as described in Chapter 2, This PCR strategy omits the large 3 Kb intron 
1 of the white gene which occurs between Exons 1 and 2 and allowed more 
efficient amplification of the coding regions of the gene. Exon 1, a 220 bp 
fragment was amplified using primers 91 -134 and 91 -135. Exons 2 -6, a 2624 
bp fragment was amplified using primers 91 -136 and 91 -73, or 95 -51 and 91- 
136 (the sequences of these oligonucleotides are given in Section 2.12). Two 
primer sets were used to increase the success rate of amplifying the desired 2.6 
Kb fragment in the event that one primer set was not as efficient as the other 
set (see text). Each primer had a recognition sequence for restriction by either 
EcoRl(E) or Híndlll (H) incorporated at their 5' ends to allow subsequent cloning 
of the PCR -generated fragments to pBluescriptSK+ for sequencing. 
Fig. 5 PCR Amplification of coding sequences of mutant 
white alleles 
A. 0.9% agarose gel analysis of the 220 bp PCR products (highlighted 
with an arrow) representing Exon 1 of a mutant white allele (lane 1) 
and wild type white gene as a positive control (lane 2). A representative 
PCR product is shown. This result was the same for all of the white 
mutants. 
B. 0.9% agarose gel analysis of PCR products from reactions using 
two different primer sets and either genomic won', wsator w+(plasmid) 
template as indicated. Each lane represents a separate PCR reaction 
(5 ul of the reaction mix loaded per well). The 2.6 Kb DNA product 
representing Exons 2 -6 are indicated with an arrow. PCR reactions 
resulting in successful amplification of Exons 2 -6 of wcrrandwsat are 
indicated with an asterisk. 
2.6 Kb -0- 
A. Exon 1 
1 2 
12,216 - 
3,054- 
2,036 - 
1,636- 
1,018 - 
506- 
201- -4-220 bp 
B. Exons 2-6 of wcrr and wsat 
91 -73, 91 -136 95 -51, 91 -136 ] Primer pair 
Gi 
,g)" st< "0 4> 4> ]Template 
- 12,216 
-3,054 
2,036 
1,636 
1,018 
506 
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primer pair 91 -73 and 91 -136 was used. Consequently a second pair of primers 
was designed (95 -51, 91 -136). Both of these sets of primers anneal to 
sequences at the 5' end and 3' ends flanking Exons 2 -6 of the white gene. The 
strategy for PCR amplification of Exons 2 -6 of the white gene is illustrated in Fig. 
4. The sequences of these primers are detailed in Section 2.14. Fig. 5B shows 
the amplified PCR products from duplícate PCR reactions using the different 
primer sets. The 2.6 Kb amplified DNA fragment is indicated with an arrow, 
This is the correct size for the Exons 2 -6 gene fragment. Lanes highlighted 
with an asterisk represent successful duplicate PCR amplifications for each of 
w °r` and wsat derived Exons 2- 6,whìch were used for sub -cloning into the plasmid 
vector pBlueScríptSK'. Independent sub -clones from two separate PCR 
reactions were sequenced, to ensure that mutations identified were not due to 
an error introduced by the Pfu DNA polymerase. Exons 2 -6 of the strains wET87 
and w101 were amplified by PCR and sub -cloned in the same way as described 
above. 
The w°' Exons 2 -6 were amplified as a single DNA fragment as described for 
wsat 
and WIT. However due to competing amplification of non -specific products, 
a second nested PCR reaction was required in order to generate a sufficient 
quantity of amplified product for sub -cloning. Fig. 6A shows PCR products from 
the first PCR reaction using primers 91 -73 and 91 -136 (the sequences of these 
oligonucleotides is given in Section 2.14) where a low yield of the correct size 
DNA can be seen and is indicated with an arrow. A large quantity of non- 
specific products are also seen in Fig. 6A. The 2.6 Kb fragment was gel purified 
(Section 2.3.6) and used as template in a second PCR reaction using the nested 
primers 96 -96 and 95 -51 (Section 2.14). Fig. 6B lanes 1 and 2 show the 2.6 Kb 
products amplified from duplicate PCR reactions which is the correct size of the 
Exon 2 -6 gene fragment. 
PCR amplification of Exon 2 -6 of the w ° °/ allele from genomic DNA template 
proved to be problematic. Several attempts to amplify this gene fragment, using 
different quantities of template DNA, different genomic DNA extractions, 
Fig. 6 PCR amplification of Exons 2 -6 of the wcf allele. 
A. Lane 1 represents the products of a primary PCR reaction 
which amplified a low yield of the 2.6 Kb Ex 2 -6 white fragment 
and a large quantity of non -specific products. 
B. The 2.6 Kb product obtained from A. lane 1 was purified and used in a 
secondary PCR reaction using a nested set of primers (as described in 
the text), which resulted in a higher yield of the desired product. 
PCR products from duplicate PCR reactions are shown in lanes 1 and 2. 
2.6Kb -S 
-12,216 
- 3,054 
-2.036 
1,636 
1,018 
-506 
201 
A Primary PCR reaction 
12216- 
2.036- 
1,018- 
506- 
-46-2.6 Kb 
B Secondary PCR reaction 
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and different annealing temperatures in the PCR reaction were carried out, 
however no 2.6 Kb product was obtained. To further investigate the possible 
cause of this problem, a number of separate PCR reactions were carried out 
using different sets of primers (designed for sequencing the Exon 2 -6 region of 
the white gene). These anneal internal to the primers normally used (which 
anneal to sequences outside the coding regions of Exons 2 -6), in an attempt to 
identify which region of the wC' was causing the problem. A variety of results 
were obtained from this PCR analysis (data not shown). Some of the PCR 
reactions resulted in amplification of a DNA product of approximately the 
correct size, but were difficult to subclone because they lacked restriction 
enzyme sites at their ends (most of the primers were designed for sequencing 
reactions and did not harbour appropriate restriction enzymes sites for cloning). 
Most of them were formed in low yield and required further amplification. In 
view of these difficulties, it was decided to discontinue analysis of this mutant in 
order to devote time to other parts of the thesis project. This mutant white 
allele has been previously analysed by Southern blotting and was deemed to 
have a normal restriction map compared to the wild -type counter -part strain 
(Zachar and Bingham, 1982), The sensitivity of this technique is such that 
deletions or insertions down to approximately 50 bp can be detected. It is 
possible that this mutant harbours a small deletion, insertion or rearrangement 
which was not detected using restriction analysis but which affects the primer 
binding sites. 
3.2.4 Sub -cloning white allele PCR products into pBluescríptSK' plasmid 
vector 
The PCR products were cloned (described in Chapter 2, Section 2.3) by "sticky - 
end" ligation into the multiple cloning site of the plasmid vector pBluescriptSK` 
(described in Chapter 2, Section 2.4.1). The PCR products were purified, 
digested with EcoRl and Hindlll followed by ligation into the EcoRl /Hindlll site 
of the multiple cloning site of pBlueScriptSK`. Following transformation, 
plasmid DNA was isolated from transformed colonies. 
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Fig. 7A is a representative restriction analysis of the pBSK' constructs 
harbouring Exon 1 of white. It can be seen that EcoRl and Hindlll digests result 
in the release of the 200 bp Exon 1 white gene fragment. Fig. 7B is a 
restriction analysis of the pBSK' constructs harbouring Exon 2 to 6 derived from 
w" and ws' flies. In this case, an EcoRI and HindlIl digest results in the release 
of a 2.6 Kb fragment which is the predicted size of Exons 2 -6 of the white gene. 
Similar results were obtained for wET87 and w101 (data not shown). 
The DNA fragments separated by agarose gel electrophoresis resulting from 
EcoRl and Hindlll double digest of two Exon 2 -6 w`' sub- clones are shown in 
Fig. 8A. The digest products are different compared to the other white exons 
2 -6 sub -cloned in that the fragment representing Exon 2 -6 is about 2 Kb instead 
of 2.6 Kb which is the predicted size. The EcoRl and Hindlll digest shown in the 
set of lanes labelled 1 in Fig. 8A, shows three products of around: 300 bp, 
2900 bp, 2300 bp. This restriction pattern suggests that the 2.6 Kb Exon 2 -6 
DNA fragment has been cleaved into two fragments, of about 300 bp and 
2.3 Kb. The Hindlll digest resulted in a single fragment of around 5.5 Kb, the 
predicted size of the construct. This suggests that there is a second EcoRl site 
around 300 bp from either the 5' or 3' end of the gene fragment. This is 
confirmed by the EcoRl digestion which yields two products about 2100 and 
3200 bp. As will be described in Section 3.2.5, the introduced EcoRl site is due 
to one of the W` mutations and the restriction map of pBSK'Exon 2 -6 is as 
illustrated in Fig. 8B. The set of lanes labelled 2 in Fig. 8A does not show the 
300 bp fragment. In this case the cloning of the entire Exon 2 -6 must have 
occurred due to a partial digestion by EcoRl prior to ligation into the plasmid 
vector since the EcoRl site is actually present in the sequenced plasmid 
(Section 3.2.5). 
Fig. 7 Restriction analysis of purified plasmid DNA from 
transformed E. coli. 
A. A representative pBSK +Exon1 subclone digested with EcoRl and 
Hindi' resulting in release of the 200bp Exon 1 and 2.9 Kb vector 
DNA. 
B. pBSK +Exon 2 -6 subclones of canal and w°" digested with EcoRl and 
Hindlll resulting in release of the 2.6 Kb Exon 2 -6 DNA fragment and 
2.9 Kb vector DNA. 
A 
B 
12,216 - 
3,054- 
2,036- 
1,636- 
1,018- 
606- 
201- 
0;1/4.. ct 
.14 
pBSK+ (2.9 Kb) 
- Exon 1 (200 bp) 
/pBSK+ (2.9 Kb) 
Exon 2-6 (2.6 Kb) 
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3.2.5 Amino acid substitutions and eye -colour pigment levels in the white 
alleles W and ws't: mutations affecting transmembrane spanning 
helix 5 of the white protein 
The sequences obtained from the cloned PCR products were compared to the 
published wild -type Canton -S strain white genomic (O'Hare et al, 1984) and 
cDNA (Pepfing and Mount, 1990) sequences. Two nucleotide changes 
affecting the amino acid sequence were identified in the w`f allele: G589E, 
and L49R. The mutation G589E introduces an EcoRl site (underlined in the 
sequence shown below) due to the nucleotide charge: 
wd sequence: TTT GGC GAA TTC TTC 
Phe587 Gly588 GIu589 Phe590 Phe590 
Wild -type 
sequence TTT GGC GGC T T C CTG 
Phe Gly Gly Phe Phe 
The G589E substitution is predicted to occur at the C- terminal end of putative 
transmembrane spanning alpha helix 5 of the protein structure previously 
modelled (Ewalt et al, 1994). This is a major change in amino acid 
chemistry, with the introduction of a larger acidic residue which would be 
predicted to substantially alter the physical and chemical environment around 
this site. The other mutation identified in w`', L49R occurs in the cytoplasmic 
domain of the protein near the amino terminus in a region which is not 
conserved in amino acid sequence among other ABC transporters, nor in 
homologs of white in other species (Zwiebel et al, 1995). However it is not a 
conservative change with a hydrophobic residue being replaced with the 
positively charged arginine. 
In Section 3.2.1 it was shown that this mutant has low levels of drosopterin 
(red pigments) (30% of wild -type levels), while xanthommatin (brown pigments) 
are closer to wild -type levels (65 %). This result indicates that the mutation /s 
identified in w reduces the uptake of precursors for drosopterins (red 
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pigments) while having a lesser effect on the uptake of precursors of 
xanthommatins (brown pigments). 
In the wsat allele, only one nucleotide change was identified which altered the 
amino acid sequence and this resulted in the substitution F590G. This 
substitution represents a major change in residue chemistry, with a large 
hydrophobic residue being replaced by glycine. This residue is adjacent to 
G589 which has been substituted in the w,fallele. F590 is located on the 
extracellular, C- terminal end of transmembrane helix 5 in the White protein 
model (Ewart et al, 1994). 
It was shown in Section 3.2.1 that flies carrying this mutation have very low 
levels of drosopterin pigments (5 %) while the xanthommatin levels were almost 
at wild -type levels (80 %). This result suggests that the F590G substitution has 
caused a significant loss of function of the transporter for precursors of 
drosopterins, while the transporter function for precursors of xanthommatin are 
near wild -type levels. 
3.2.6 Amino acid substitutions of the white alleles w "' and w101: mutations 
identified within the cytoplasmic region of the white protein 
The coding regions of the white allele w"; and w101 were cloned and sequenced 
as described for W1 and wsa`. The only alteration to amino acid sequence found 
in the w`" allele was the substitution H298N. Although this represents a 
substantial change in residue chemistry with the histidine residue being 
replaced with uncharged, polar asparagine, it is a relatively conservative 
substitution with respect to size and hydrogen bonding potential. H298 is 
located within the region encompassing the ATP binding cassette and the 
possible significance of this residue will be discussed in Section 3.3. It was 
shown in Section 3.2.1 that both xanthommatin and drosopterin pigment levels 
in flies carrying this allele are significantly reduced (10% and 20% respectively). 
This result suggests that the H298N substitution has caused a significant loss 
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of function of both transporters for precursors of drosopterins, and 
xanthommatins. 
In the w101 allele two nucleotide changes were identified which altered the 
amino acid sequence: G243S and í_49R. Both of these residues are located 
within the ATP binding domain. G243S alters a highly conserved residue within 
the ABC transporter "signature sequence" (described in Section 1.5.2 c) and 
represents a major change with the replacement of the small uncharged glycine 
residue with a larger residue, (serine) with hydrogen bonding potential. The 
L49R substitution resides near the amino terminus within the cytoplasmic 
domain of the protein and is the same change identified in the w°r allele. This 
suggests that this substitution might be a polymorphism present in the strains 
from which these mutants were derived. The pigment levels of flies carrying 
the wi01 allele could not be assayed because flies were not available (DNA for 
analyses was obtained from Dr A Pastink). However, the eye phenotype is 
reported to be partially pigmented ( Pastink et al, 1988a) suggesting that there 
are detectable levels of both eye -colour pigments. 
3.2.7 Amino acid substitutions of the white allele wET87: a mutation 
identified within an intracellular loop region connecting TM helices 
2 and 3 
In the wEt87 allele the only nucleotide change identified resulting in a change in 
amino acid sequence was the substitution G509D. This is a major alteration in 
residue chemistry with a small glycine residue substituted with a larger charged 
aspartic acid residue. G509 is located in the transmembrane domain in a 
predicted intracellular loop between transmembrane helices 2 and 3 of the 
proposed White protein structure. It was shown in Section 3.2.1 that both 
pigment levels of flies carrying this allele are dramatically reduced. 
Drosopterins were 0.2% and xanthommatin was undetectable. This result 
suggests that the G509D substitution has effectively eliminated the activity of 
both transporters. 
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3.3 Discussion 
The White protein of D. melanogaster is an unusual member of the ABC 
transporter family in that it is a subunit of two different transporters: the 
combination of White and Brown subunits makes a drosopterin precursor 
transporter, while the combination of White and Scarlet subunits forms an 
xanthommatin precursor transporter. The fact that each of these transporters 
is required for normal deposition of red or brown pigments, respectively, in 
Drosophila eyes, makes eye -colour phenotype a convenient way to assess the 
function of white alleles (Ewart and Howells, 1998). The five mutant white 
alleles analysed in this work were selected from amongst many of the known 
white alleles on the criterion of partial eye pigmentation. Our expectation was 
that such non -knockout phenotypes would be caused by mutations changing 
single base pairs in the gene and so reveal individual amino acids in the White 
protein with functional roles. 
In the work presented here, DNA sequence analysis of the w , wsa` w`` w701 
and wcT87. alleles has identified point mutations which alter amino acids in the 
encoded White protein (see Table 2). The relative positions of these 
mutations, and other previously reported mutations in relation to the predicted 
structure of White are shown in Fig. 9. As will be discussed below, five of these 
changes affect residues in regions or motifs conserved among members of the 
ABC transporter superfamily. The mutations G243S in wf01 and H298N, in w", 
affect motifs within the nucleotide binding domain and correlate with reduced 
function in both of the White- containing transporters. Similarly, the mutation 
G509D in w'', located in the cytoplasmic loop between helices 2 and 3, 
severely reduces function of both transporters. In contrast however, the 
mutations G589E and F590G in w°` and Wa` respectively, affect function of the 
White /Brown guanine transporter more than the White /Scarlet tryptophan 
transporter. 
Sequence analysis of these alleles performed by earlier students in this laboratory, 
Table 2. Point mutations identified in the white genes of white alleles of 
D. melanogaster 
Mutation sites are numbered with +1 as the A of the translation start codon in 
the published white genomic DNA sequence (O'Hare et al, 1984). 
b Mutations previously reported In the white and brown genes (Ewart et af, 
1994). 
white 
allele 
Mutation in 
DNA' 
Amino Acid 
Change 
Leu 49 to Arg 
Gly 243 to Ser 
His 298 to Asn 
Gly 589 to Glu 
Leu 49 to Arg 
Phe 590 to Gly 
Gly 509 to Asp 
Ile 581 deleted 
Gly 588 to Ser 
Asn 638 to Thr 
Gly 578 to Asp 
Predicted location in 
protein 
N- terminal region of the 
nucleotide binding domain 
Nucleotide binding domain 
Nucleotide binding domain 
Transmembrane helix 5 
N- terminal region of the 
Nucleotide binding domain 
Transmembrane helix 5 
Intracellular loop between 
transmembrane helices 2 
&3 
Transmembrane helix 5 
Transmembrane helix 5 
Transmembrane helix 6 
Transmembrane helix 6 
wrai 
wcrr 
V 1fr 
wsat 
wEta7 
wan, b 
wCO2 b 
bw6 b 
bwT50 b 
T to G (3270) 
G to A (3925) 
C to A (4090) 
GC to AA (5315) 
T to G (3270) 
TT to GG (5317) 
G to A (5075) 
A (5290 ) ATC 
GtoA(5311) 
AtoC(1913) 
G to A (1733) 
Fig. 9. Model of the topology of the protein products encoded by the 
white and brown genes of D. melanogaster. 
This figure is a simplified representation of the model of Ewart et al, 1994, 
based on hydropathy analysis, and illustrates the relative positions of the amino 
acids which are altered due to mutations in the white gene described in this 
work and highlighted in red. These include F590G and L49R (wsat), G589E 
(wet) and H298N (wcrr). In addition, the previously reported mutations in the 
brown gene (referred to in the text), bw7-50 (G578D), bw6 (N638T), and white 
gene wco2 (G588S) are also shown. The mutations w107 (L49R and G243S) 
and wEt87 (G509D) identified by Michael Brooker and Tim Gill respectively are 
also shown. The black vertical rods represent putative membrane spanning 
alpha -helices; circles represent the ATP binding domains; lines connecting the 
transmembrane helices represent intra or extra -cellular loop regions. 
White subunit 
G588 
I581 
G509 
COON 
Brown subunit 
NH3 
0 Outside 
G578N6= 
X..J Inside Cell 
COON 
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From these and previous (Ewart et al, 1994) results, we conclude: (1) that 
proper functioning of the nucleotide binding domain of the White subunit is 
essential to activity of both transporters; and (2) that the transmembrane helix 5 
of the White subunit has different roles in the mechanisms of the two different 
transporters. These mutations are discussed further below in relation to the 
effects of identical or similar mutations in other ABC transporters. 
3.3.1 Mutations identified in the transmembrane domain of the White and 
Brown proteins 
There is a clustering of mutations at the extracellular end of TM a helix 5 of 
White and these correlate with decreased red pigmentation in all the mutants 
identified to date (Ewart et al, 1994). The mutation G589E in w`` is located at 
the extra- cellular end of transmembrane helix 5 of the predicted structure (see 
Fig. 9). This alteration is a major change with the small uncharged glycine 
being replaced with a larger, acidic side chain which would substantially alter 
the physical and chemical environment around this site. In addition, the 
introduction of a charged residue into the hydrophobic environment of the 
membrane domain would be expected to be energetically unfavourable. 
Pigmentation levels in the G589E mutant flies indicate that the mutation has a 
greater effect on transport of precursors of drosopterin (30% of wild -type) 
compared to transport of precursors for xanthommatin (65% of wild- type). 
The mutation F590G identified in wsa` also results in a major change in 
chemistry, and like the mutation at position 589, the F590G mutation 
preferentially affects transport of drosopterin precursors with the red pigment at 
about 5% of wild -type level and the brown pigment at 80% of wild -type level. 
An adjacent mutation (G588S) in the white allele W O2 ( Ewart et al, 1994) (see 
Fig. 9) was also shown to decrease transport of drosopterin precursors, but 
only when combined with either of the brown alleles bw6 or bWT50 which also 
have amino acid substitutions in the extracellular ends of TM 5 and TM 6 (see 
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Fig. 9). The w°°2 mutation is silent when a wild -type brown allele is present as 
are the two brown alleles when w` is present. This suggests a functional 
interaction between the TM 5 of White and TM 5 and 6 of the Brown subunit 
(Ewart et al, 1994). It is interesting to note the gradation of effect on the 
presence of red pigments, with wCO2(588) having the least effect, w°` (589) 
having an intermediate effect while wsa( (590) has the greatest effect. 
The functional significance of transmembrane helix 5 for transport of precursors 
of drosopterins was also highlighted by the white allele ..Ewx (Alle581) (Ewart et 
al, 1994) which completely abolished the presence of red pigments, while 
brown pigment synthesis was unaffected. It has been proposed that this 
region is associated with the function of the mouth of a pore specific for 
guanine and that helix 5 of the white encoded subunit interacts with helices 5 
and 6 of the brown encoded subunit in formation of a guanine specific 
transporter (Ewart et al, 1994). 
Studies on CFTR suggest that the pore through which substrate passes is 
funnel shaped, and that the narrow end of the funnel is the region associated 
with specificity and rate of flow of solute (Akabas et al, 1997). It would be 
interesting to investigate whether this structural feature also applies in the 
White /Brown transport complex if an appropriate model system was available. 
The mutant data collected so far suggests that the predicted extracellular ends 
of TM 5 of White and TM 5 and 6 of Brown may form the gate region of the 
transport route (Ewart et al, 1994), which would account for the sensitivity of 
this region to mutations. It is possible that residues in this region interact in a 
way which imparts a selectivity filter, and in combination with subtle 
conformational changes propagated by ATP binding /hydrolysis at the ATP 
binding domains, side groups manoeuvre in a way which opens and closes the 
transport route, possibly by a slight rotation of one or more of the helices. 
The White, Brown and Scarlet systems of D. melanogaster appear to be 
analogous to other ABC transporters. It has been reported in the P- glycoprotein 
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system, and CFTR that substrate specificity resides in the transmembrane 
domain. There is biochemical evidence to suggest that transmembrane 
helices 5, 6, 11 and 12 are involved in drug binding and specificity in P- 
glycoprotein (Devine et al, 1992; Greenberger, 1993; Hanna et al, 1996; Loo 
and Clarke, 1994a). In CFTR, residues within and flanking transmembrane 
helix 6 have been proposed to line the ion conducting channel (Cheung and 
Akabas, 1996; McDonough et al, 1994; Tabcharani et al, 1993) and influence 
halide ion specificity (Anderson et al, 1991; Cheung and Akabas, 1997). In 
particular, the cytoplasmic end of TM 6 is postulated to loop back into the 
channel thereby affecting electrical resistance and anion selectivity (Cheung 
and Akabas, 1997). This model is described in more detail in Chapter 1, 
Section 1.3. 
It was recently reported that the White, Scarlet and Brown proteins` closest 
relatives based on sequence homology of the nucleotide binding domains are 
the human and mouse homologs of White, and the yeast drug resistance 
proteins Snq2, Bfr1 and Pdr5 (Croop, 1998). In order to investigate possible 
homology between the transmembrane domains of these proteins a sequence 
alignment was performed and the relevant regions of this alignment are shown 
in Fig. 10. A number of conserved residues were noted, in particular, TM 5 of 
homologs of White, Scarlet and Brown show marked homology to Pdr5, Bfr1 
and Snq2 which is highlighted in Fig. 10A. Of particular interest is the almost 
100% conserved Gly which corresponds to the G589E mutation. This 
observation is suggestive of a conserved structural /functional element. It is 
noteworthy that guanine and tryptophan are similar to substrates of the MDR 
family of ABC transporters which generally consist of a series of indole and 
alkaloid compounds which are mostly cationic yet relatively lipophilic (Beck and 
Qian, 1992). It has been noted that the transmembrane domains of the P- 
glycoprotein family and related proteins with similar substrate specificity profiles 
contain a much higher percentage of aromatic amino acids (Pawagi et al, 
1994). Computer modelling of transmembrane a- helices of P- glycoprotein 
indicate that many of the transmembrane helices can interact in a way which 
Fig. 10 Protein sequence alignments of White, Scarlet and Brown 
proteins with other ABC transporters 
The multiple alignments were performed using the CLUSTAL W alignment 
program (described in Chapter 2, Section 2.6.10). Numbers on the left and 
right hand side of the protein sub -sequences indicates the amino acid residue 
number as published in the SwissProt database. Residues boxed in black are 
present in all (or most) sequences. Boxed residues occur more than once in 
that position. 
A. Alignment of transmembrane helices (TM) 5 of White, Brown and Scarlet 
from D. melanogaster and homologs of White from mouse and humans' , 
and transmembrane regions of yeast multiple drug resistance proteins. 
The number of the TM region is indicated on the far right hand side of the 
respective sequence. The residue altered in the w' mutant (G589E) is 
circled. 
B. A region of the nucleotide binding domain of White, Scarlet and Brown 
harbouring a highly conserved histidine residue. The residue altered in 
the w`r mutant (H298N) is circled. The same histidine is also present in 
HisP. 
C. Alignment of loop regions between transmembrane helices 2 and 3 of 
White, Brown and Scarlet from D. melanogaster and White from mouse 
and human. The residue altered in the wET87 mutant (G509D) is circled. 
Loop regions from yeast multiple drug resistance proteins are also shown 
(the position of the loop is indicated in brackets on the right). 
D. Alignment of the ABC transporter "signature sequence" of White, Scarlet, 
Brown from D. melanogaster, human MDR1, human CFTR and HisP. The 
residue altered in the wi01 mutant (G243S) is highlighted with a circle. 
Abbreviations: 
dWhite, dBrown, dScarlet - protein sequences from D. melanogaster 
mWhite - protein sequence from mouse White 
hWhite - protein sequence from human White 
Homologs of the Drosophila White protein have been identified in mouse and humans (Chen et 
al, 1996; Croop et al, 1997; Savary et al, 1996), however homologs of Brown and Scarlet have 
not been identified in mammals. The function of mammalian homologs of White has not yet 
been determined. 
A dBrown 562 S 
dScarlet553 M 
E C A A P F D© I F L 
A Y © V P © D Y I F M 
Î 
I 
QF G 
T S 
578 TM5 
569 TM5 
dWhíte 573 L S V G P P V I I P F L L F G 589 TM5 
mWhite 553 T F V G P V T A I P V L L F S 569 TM5 
hWhite 561 T F V G P V T A I P V L L F S 577 TM5 
Snq2 661 N S I S G I N I M M S I S M Y S T 677 TM2 
Snq2 1333 N V I©G L C L S F M LQ SF C 1349 TM7 
Bfrl+ 682 A L G G I G V© A I A]Y T 698 TM5 
Bfrl+ 1367 ' V V N S L L F T F© I T QF N 1383 TM11 
PdrS 666 © V P A S M L L© A L S M Y T 682 TM5 
Pdr5 1355 A N L A S L L F T M S© S QF C 1371 TM10 
B dScarlet 266 T T I L C T I Q P S S Q L F D N F 283 dBrown 284 K A A I C S I Q P T S D I F E L F 301 
dWhite 291 K T V I L T I Q P S S E L F E L F 308 
HisP 204 K T M V V V T E M G - F A R H V S 220 
G . dBrown 483 V G E G T Y S L © ®Y Y V P. 498 (2-3) 
dScarlet474 T R G L Y T G Q Y Y AL 489 (2-3) 
dWhite 494 A R ® L Y R C D T Y F L0509 (2-3) 
mWhite 474 H L N Y W Y S L K 4 Y Y L A 489 (2-3) 
hWhite 482 H L N Y W Y S LKAYYLA 497 (2-3) 
Snq2 1253 Q S N M F H W©L V L I T 1268 (5-6) 
Pdr5 1269 S R P S® T F W I S F I F® 1284 (7-8) Bfrl+ 1284 K P S N I E W V I E I F V F S 1299 (8-9) 
D dWhite 241 L S ERKRLAF ` 252 
dScarlet 216 L S ERKRLAF ` 227 
dBrown 167 L S ERKRLS 178 
MDR1 NBD2 1196 L S QKQR IAI ` 1207 
MDR1 NBD1 531 L S Q K Q R I A I 442 
CFTR NBD2 1366 L S H O H K Q L M C L 1377 
CFTR NBD1 548 L S G QRAR I S L 599 
HisP 154 L S Q Q Q R V S I ` 165 
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facilitates the formation of a pore lined by aromatic side groups and that a 
typical P- glycoprotein substrate (rhodamine 123) can intercalate between these 
side groups (Pawagi et al, 1994). Also of relevance is the proposed "tunnelling" 
mechanism of tryptophan synthase, where free indole diffuses through a 
"tunnel" which is lined by aromatic residues from one active site to another 
(Dunn et al, 1990; Hyde et al, 1988). In support of this concept, it has been 
shown that Phe residues in TM 6 and TM 12 of human P- glycoprotein play an 
important role in recognition and transport of specific substrates (Loo and 
Clarke, 1993). 
Taking the above into consideration, it is possible that the White /Scarlet 
tryptophan transporter, and the White /Brown guanine transporter are 
functionally related to the P- glycoprotein and related proteins in yeast. An 
interesting feature of the pigment precursor transporters is the altered substrate 
specificity conferred by the subunit interactions between either White /Scarlet or 
White /Brown. To date no mutations have been reported in White which affect 
substrate specificity for tryptophan only. Since the mutations in White TM 5 
affecting guanine transport have little effect on tryptophan transport it is 
reasonable to assume that TM 5 of White is not involved in tryptophan 
transport. It is possible that the transport route for tryptophan is less stringent, 
and has a broader substrate specificity for other xanthommatín precursors (i.e. 
kynurenine and 3- hydroxykynurenine), analogous to the broad substrate 
specificity of P- glycoprotein, which would account for the lack of partially 
pigmented eye -colour mutants deficient in brown pigments only. 
3.3.2 Mutations identified in the ATP binding domain and intracellular 
loop regions of the White protein 
The mutation identified in w"', H298N changes a histidine residue in the ATP 
binding domain which is highly conserved in ABC transporters, but not other 
nucleotide binding proteins. In the sequence alignment in Fig. 10B, H298 of 
White aligns with H211 of HisP which according to the crystal structure of HisP, 
is involved in hydrogen bonding to 6-phosphate of ATP via a water molecule 
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(wat -415) which is adjacent to the water molecule proposed to be the attacking 
water during ATP hydrolysis (wat -437) (Hung et al, 1998) as illustrated in 
Fig. 11A. H211 of HisP is positioned near the carboxy -terminal end of [3-strand 
10 forming part of a [3-sheet which is involved in the ATP binding site, as well as 
an interface between the ATP binding site and the a- helical rich arm Il which 
interacts with the membrane domain (Hung et al, 1998). ß -10 is joined to a -6 of 
arm I l via a loop, and the carboxy -terminal end of this helix protrudes from the 
structure thereby being appropriately placed for interaction with the membrane 
domain (Hung et al, 1998} (illustrated in Fig. 11B). Significantly, the residue 
K204 located on a loop arising from the carboxy -terminal end of a -6 has been 
shown to be accessible from the periplasm and therefore involved in formation 
of a hydrophilic pore, or a substrate binding site (Baichwal et al, 1993). Taking 
the above into consideration, it can be imagined that the consequences of the 
mutation of H298 of White could have a far reaching consequence on the 
transport function, both with respect to ATP binding and /or hydrolysis and 
subsequent propagation of conformational changes. It is interesting to note that 
when the homologous residue in the ATP binding domain of the histidine 
permease of S. typhimurium is mutated to either D, R or Y, transport function is 
abolished, while ATP binding is not affected ( Shyamala et al, 1991). This 
suggests that this residue is not crucial for ATP binding, however may affect 
ATP hydrolysis activity (which was not tested in this report) or be involved in 
conformational changes subsequent to ATP binding (Shyamala et al, 1991) 
which is consistent with the above interpretation of the crystal structure of HisP. 
The presence of only very low levels of both eye pigments in flies carrying the 
we" allele suggests that the transporters for both drosopterin and xanthommatin 
pigment precursors have been severely affected despite the presence of either 
the normal brown or scarlet encoded subunits. The presence of some pigment 
however, indicates that replacement of H298 with a residue containing an 
amine may be tolerated while another residue may not be tolerated. 
The H298N mutant results in a more or less equal decrease in transport of both 
precursors for red and brown pigments indicating that the White nucleotide 
Fig. 11 Position of H211 in the crystal structure of HisP 
The diagrams shown in this figure have been reproduced from (Hung et al, 
1998). 
A. Residues of the nucleotide binding fold of His P which interact with ATP. 
Hydrogen bonds are represented by dashed lines, and aromatic stacking is 
indicated by vertical lines. The residue H211 which is analogous to H298 of 
White is highlighted and interacts with the y phosphate of ATP via a water 
molecular. 
B. Illustration of the secondary structure of HisP derived from the x -ray crystal 
structure of the HisP dimer (the monomer only is shown). Cylinders and 
arrows represent a helices and p strands, respectively. ATP is shown in 
yellow (A, adenine; R, ribose; P, phosphate group). The approximate 
position of H211 in 0 strand labelled 010 is indicated by a circle. The 
connection between 010 and a6 (shown in blue) is also highlighted as a 
grey line. 
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binding domain is required for function of both transporters. This observation is 
consistent with studies of P- glycoprotein which show that blocking either of its 
nucleotide binding sites by either chemical modification10 or mutation, resulted 
in elimination of ATPase activity or drug transport (Azzaria et al, 1989; Loo and 
Clarke, 1995a). These observations led to the proposal that both nucleotide 
binding sites in P- glycoproteín are catalytically active and that there is a strong 
cooperative interaction between them (Urbatsch et al, 1995b). Evidence 
supporting this proposal has come from the use of a vanadate- trapping 
technique where orthovanadate (Vi) traps nucleotide within the nucleotide 
binding site thereby inhibiting P- glycoprotein ATPase activity (Urbatsch et al, 
1995b). It was demonstrated that vanadate- trapped ADP at one nucleotide 
binding site was sufficient to block all ATPase activity (Urbatsch et al, 1995a). 
Assuming that trapped Mg- ADP -Vi complex is representative of the transition 
state conformation, the site is locked into this conformation which prevents the 
other site from functioning (Senior et al, 1995; Urbatsch et al, 1995a). It was 
proposed that the two nucleotide binding sites undergo sequential or alternating 
cycles of ATP hydrolysis (Senior et al, 1995; Urbatsch et al, 1995a). This 
proposal is consistent with the effect of the H298N mutation since if ATPase 
activity at the White nucleotide binding site is reduced, this would consequently 
reduce the ATPase activity of both the Brown and Scarlet nucleotide binding 
sites to the same degree. 
The mutation G509D identified in w'87 occurs within the cytoplasmic loop 
between transmembrane helices 2 and 3 of the predicted structure of the 
white -encoded subunit (see Fig. 9). This is a major change with glycine being 
replaced by a charged aspartic acid residue. The loop region containing the 
G509D mutation may be analogous to loops of the other ABC transporters 
which have been shown to be important for function. Intracellular loop regions 
of CFTR (Cotten et al, 1996; Xie et al, 1995) as well as ALDp (Shani et al, 
1996) and P- glycoprotein (Loo and Clarke, 1994a; Zhang et al, 1995b) have 
10 P -gp harbouring a single Cys residue in the Walker A motif of either NBD 1 or NBD 2 were 
used, where ATP binding was blocked at one or the other NBD by reaction with NEM -CI (Loo 
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been reported to be functionally important. In CFTR it has been reported that 
the intracellular loop between transmembrane spanning helix 4 and 5 is 
involved in stabilising the full conductance state of the CFTR chloride ion 
channel (Xie et al, 1995). These authors suggested that the loop interacts with 
other domains (nucleotide binding folds, R domain and/or other intracellular 
loops) in CFTR or with other cellular proteins that may be involved in the 
transition between conductance states. In addition, mutations in intra- cellular 
loop 4 having a similar effect on CFTR activity as mutations within the 
nucleotide binding domains have been reported (Cotten et al, 1996) and it was 
suggested that this loop couples the activity of the nucleotide binding domains 
to channel gating. In the case of P- giycoprotein It has been demonstrated that 
mutating glycine residues in cytoplasmic loops between transmembrane helices 
2 and 3; 3 and 4; and 5 and 6 alters substrate specificity (Loo and Clarke, 
1994a). 
In order to investigate possible homology between intrahelical loop regions of 
White, Scarlet and Brown and the yeast MDR proteins Pdr5, Bfrl and Snq2 a 
sequence alignment was performed. The loop between helices 2 and 3 of 
White, Scarlet and Brown showed marked homology with loop regions of the 
yeast MDR proteins, in particular a 100% conserved Arg -Glu pair. These 
aligned sequences are illustrated in Fig. 10C. According to the predicted 
topology of these proteins, the Bfr1 aligned sequence is analogous to the 
intracellular loop of White, Brown and Scarlet. However, this region is within 
predicted extracellular loops of Pdr5 and Snq2. It is speculated that this 
conserved glutamic acid is inherited from the EAA motif of procaryotes. The 
observation that the conserved RE motif is found on the extracellular side of the 
membrane in Pdr5 and Snq2, may be indicative of topological rearrangements 
which have occurred during evolution. 
Certain eucaryotic ABC transporters possess, within an intracellular loop 
region, a 15 amino acid motif resembling the EAA motif of procaryotic ABC 
and Clarke, 1995a) 
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transporters (Shani et al, 1995). Although the loop between transmembrane 
helices 2 and 3 of the white encoded subunit has low similarity to this EAA -like 
motif, it nevertheless is an important region for function for both the guanine 
and tryptophan transporter since the wEC87 G509D substitution causes almost 
complete knock -out of pigment levels compared to wild -type. This intracellular 
loop region of the white- encoded subunit may perform a similar functional role 
to loops of other ABC transporters containing the EAA -like motif. In the case of 
procaryotes, it has been suggested that the EAA motif interacts with the 
nucleotide binding domain (Kerppola and Ames, 1992; Mourez et al, 1997). It 
has also been observed that the EAA motif has a higher degree of conservation 
among procaryotic ABC transporters which transport similar substrates (Saurin 
et al, 1994b). A role of this motif in correct recognition between ATP binding 
domains (which are often separate polypeptide chains in procaryotes) and the 
membrane associated domain of procaryotic ABC transporters has been 
suggested (Saurin et al, 1994b). It was recently demonstrated (Mourez et al, 
1997) that the EAA motifs of the E. coli maltose permease forms an important 
site of interaction between the ATP binding domain of MalK and the 
transmembrane domains MalF and MaIG. In addition Mourez et al, (1997) 
(Mourez et al, 1997) identified several mutations in the region between the 
Walker A and B motifs (Mimura et al, 1991) which restored activity in transport 
deficient EAA motif mutants, providing strong evidence that these regions 
interact. Particularly interesting are the mutations at positions Val149 and Val154 
which are positioned between the LSGGQ signature sequence and the Walker 
B motif (Mourez et al, 1997). These observations strongly suggest a 
structural /functional link between the LSGGQ region and the loop harbouring 
the EAA motif and this concept is discussed further below with respect to the 
recently solved structure of the ATP binding domain of the histidine permease 
of Salmonella typhímurium (Hung et al, 1998). 
In w101, two mutations were found, G243S and L49R. The w101 mutation G243S 
(underlined in the sequence below) is located within the highly conserved 
signature sequence which has the consensus sequence 
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"LSGGQXXXRHyXHyA ", (Hy is any hydrophobic residue, and X is any residue) 
and is illustrated in the sequence alignment in Fig. 10D. The replacement of 
the single hydrogen atom of the side chain of glycine with the polar hydroxyl 
moiety of serine with hydrogen bonding potential represents a significant 
alteration in residue size and chemistry. Possible consequences of this 
change may include a loss of flexibility and /or an alteration of the intramolecular 
interactions which may occur between this residue and others in the 
cytoplasmic domain. Mutations in the signature motif have been shown to 
adversely influence function in several systems. In the histidine permease of 
Salmonella typhimurium the mutation S155F (the 2nd residue of the motif) 
decreased histidine transport to 6% of wild -type, while ATP binding function 
was unchanged (Shyamala et al, 1991). In the STE6 alpha- factor transporter 
the mutations S507R, S5071, and S507N (the 2nd residue of the motif) as well 
as G509D and G509S (the 4th residue of the motif) were reported to cause 
severe defects in alpha- factor transport without affecting the level of expression 
or localisation of the protein (Browne et al, 1996). However, the analogous 
residues in human P- glycoprotein (S532R and G534D) result in very low 
expression levels, while K536Q altered the substrate specificity increasing 
resistance to colchicine of CHO cells containing the mutant gene (Hoof et al, 
1994). On the other hand, it has been reported that mutations in this region of 
human P- glycoprotein eliminate expression (L531 R, G534V) or eliminate the 
ATPase activity (G534D, 1541 R, R538M) and it was concluded that the ABC - 
signature region is essential for MDR1 protein stability and function, but 
alterations in this motif do not modulate P- glycoprotein -drug interactions directly 
(Bakos et al, 1997). In human CFTR S549R (Kerem et al, 1990) (the 2nd 
residue of the motif) and G551D (Cutting et al, 1990) (the 4th residue of the 
motif) drastically reduces function causing severe cystic fibrosis. On the other 
hand the mutation R553Q (the 6th residue of the motif) partially corrects cystic 
fibrosis (Dörk et al, 1991) in a patient carrying both ÁF508 (which causes 
severe cystic fibrosis) and R553Q. Similarly, restoration of a- peptide transport 
in a STE6 -ÁF508 CFTR chimera in yeast was achieved by the mutation R553Q 
and showed that the R553Q mutation partially corrected the processing and 
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channel defects caused by the AF508 mutation (Teem et al, 1993). It was 
suggested that the region containing the AF508 mutation and the signature 
sequence interact (Teem et al, 1993). An involvement of the Q in the LSGGQ 
motif in the mechanism of ATP hydrolysis was proposed" when it was reported 
that mutation of the Q in CFTR NBD1 and the analogous residue in NBD 2 
altered the closed and open states of the CFTR chloride channel (controlled by 
ATP hydrolysis) in a way which correlated with the hypothesis that the Q in the 
LSGGQ motif plays a role in the mechanism of ATP hydrolysis at the NBDs. 
The crystal structure of HisP rules out a direct mechanistic role of this residue in 
the ATPase reaction, nevertheless this and other mutant data discussed above 
highlights an important structural and functional connection between ATP 
binding /hydrolysis, the signature sequence and transport or channel function. 
The signature motif in the crystal structure of the ATP binding subunit of the 
histidine permease of Salmonella typhimurium forms the first half of an alpha 
helix (a5) within a region of the protein designated arm Il and which interacts 
with the membrane domains HisQ and HisM (Hung et al, 1998). According to 
this structure only the residues LSGGQ (residues 154 to 158 in HisP) are 
partially exposed to the cytoplasmic side of the protein (Hung et al, 1998). A 
role in the structural integrity of the folded HisP molecule was suggested (Hung 
et al, 1998). It is interesting to note that the a5 helix of the HisP crystal 
structure is mostly buried between the a helices of arm Il of the protein, 
however it is physically connected via a loop to the ß strand harbouring the 
highly conserved aspartic acid believed to be involved in the co- ordination of 
Mg' during ATP binding and hydrolysis (Hung et al, 1998). Conformational 
changes which occur upon ATP binding and /or hydrolysis may well be 
propagated via this connection to arm lI proposed to interact with the 
membrane domains HisQ and HisM (Hung et al, 1998). 
" This proposal was based on possible homology between LSGGQ motif and the DX[G /A]GQ 
motif of GTPases. The Qin this motif is involved in the mechanism of GTP hydrolysis (Bourne 
et al, 1991). 
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3.4 Conclusion 
Analysis of mutant white and brown alleles from D. melanogaster flies with 
partial eye pigmentation has revealed a number of amino acid residues with 
signficant roles in the structure and function of this ABC transporter. A 
mutational hot spot has been identified at the extracellular end of TM helices 5 
of White, and 5 & 6 of Brown which is involved in substrate specificity as well as 
function. Mutations identified within the nucleotide binding domain and 
intracellular loop region of White have been shown to decrease transport of 
both eye -colour pigments consistent with the concept that these regions of the 
White protein are essential for transport by both pigment precursor transporters. 
An interpretation of the accumulated mutant data previously published and the 
data presented in this chapter, has been presented and is consistent with the 
previous model (Ewart et al, 1994). A more detailed model for the involvement 
of particular residues in the gating mechanism for the transport of guanine will 
be described in Chapter 7. 
It has not been shown definitively in this work that the mutant proteins 
assemble correctly in the membrane. However, since: 
I) each mutation has a different effect on pigmentation; 
ii) there is a consistency of the effects (residues in close proximity have 
similar effects); and 
iii) the regions identified are also critical in other transporter systems; 
it is reasonable to conclude that any decrease in function is unlikely to be a 
result of decreased protein assembly efficiency. This is particular evident in 
the transmembrane mutants which affect drosopterin levels only. If the 
mutations at any of these sites caused reduced assembly, this presumably 
would alter assembly of both transporters and pigment levels would be reduced 
to an equal extent. Nevertheless, direct evidence on assembly would 
strengthen these arguments. Analysis of eye tissue by immuno -electron 
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microscopy, described in Chapter 7 would be a useful technique for 
investigating this issue further. 
The mutations identified in this work provide an excellent starting point for 
further investigation of the mechanism of transport, substrate specificity, and 
the ATP binding /hydrolysis function, once the model systems In Chapters 5 
and 6 are developed to their full potential. In addition, the transposable 
element (P- element) transformation system available in Drosophila, provides a 
powerful technique for production of transgenic flies conaining site- directed 
mutations, and could be used to confirm the phenotypic effects of these 
mutations in the intact fly. 
CHAPTER 4 
PRODUCTION OF POLYCLONAL ANTIBODIES 
TO THE WHITE AND SCARLET PROTEINS OF 
Drosophila melanogaster 
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4. PRODUCTION OF POLYCLONAL ANTIBODIES TO 
THE WHITE AND SCARLET PROTEINS OF 
D. melanogaster 
4.1 Introduction 
This chapter describes the production of polyclonal antibodies that recognise 
specific epitopes of the White and Scarlet proteins of D. melanogaster. These 
antibodies provide a means of detecting White and Scarlet, not only in the 
heterologous expression systems described in Chapters 5 and 6, but also for 
the sub -cellular localisation of White and Scarlet in Drosophila eye tissue 
described in Chapter 7. Polyclonal antibodies were raised in rabbits against 
synthetic peptides corresponding to amino acid sub -sequences of White and 
Scarlet (described below). An overview of the method used to effectively 
induce production of antibodies against the synthetic peptides is also 
described. 
4.2 Methods 
4.2.1 Selection of antigenic sites 
Synthetic peptides representing sub -sequences of White and Scarlet protein 
(shown in Table 1) were synthesised by the Biomolecular Resource Facility 
(ANU). The amino terminal region of White and Scarlet were considered to be 
feasible first choices since these regions are predicted to be accessible in the 
native folded state of the proteins, are relatively hydrophilic and have a degree 
of antigenicity as predicted by computer analysis (see Fig. 1). It was 
envisaged that antibodies raised against this region of both White and Scarlet 
would be useful both for SDS PAGE analysis of the denatured protein, in 
addition to labelling the protein in the native folded state. For the White protein, 
a second antigenic peptide was chosen, corresponding to a region predicted to 
comprise an extracellular loop between transmembrane spanning regions 5 and 
6 (see Fig. 2), in order to obtain antigenic determinants at both extracellular and 
Table 1 Peptides used for polyclonal antibody production 
Location Name Peptide sequence 
Predicted extracellular loop region 
between TMs 5 and 6 of the White protein 
Amino terminus of the White protein. 
Amino terminus of the Scarlet protein. 
wECL RYANEGLLINQWADVEPGEC 
wNT MGQEDQELLIRGGSKHPSAC 
stNT MSDSDSKRIDVEAPERVEQC 
Fig. 1 Analysis of hydrophilicity and antigenicity of peptides chosen for 
the raising of antibodies 
The hydrophilic nature of the peptides representing protein sub -sequences of 
White and Scarlet was analysed using the MacVector protein analysis software 
as described in Chapter 2, Section 2.6.10. 
The hydrophilicity plots are based on the Kyte -Doolittle scale (Kyte and 
Doolittle, 1982), originally used for hydrophobicity profiles. This figure 
illustrates hydrophilicity by the reversal of the sign. The values are assigned 
using a combination of the water- vapour transfer free energies for amino acid 
side chains and the preference of amino acid side chains for the interior or 
exterior environments. The window size of 7 is useful in locating small 
hydrophilic regions that may protrude from the protein surface and thus provide 
a potential antigenic site. Values above the axis denote hydrophilic regions 
which may be exposed on the outside of the molecule; values below the axis 
indicate hydrophobic regions which tend to be buried inside the molecular or 
inside other hydrophobic environments such as membranes. 
The antigenic index profile is designed to locate possible exposed surface 
peaks of a protein which are potential antigenic sites (Jameson and Wolf, 
1988). This analysis combines information from hydrophilicity, surface 
probability, backbone flexibility predictions along with secondary structure 
predictions of Chou -Fasman (Chou and Fasman, 1978) and Robson -Garnier 
(Garnier et al, 1978; Robson and Suzuki, 1976) in order to produce a 
composite prediction of the surface contour of a protein. Regions that plot 
above the graph axis are predicted to be exposed at the protein's surface. 
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Fig. 2 Sites of White and Scarlet protein targeted for antibody production 
Antibodies were raised against synthetic MAP -peptides representing amino acid 
regions at the amino terminus of both White (shown in green) and Scarlet (shown 
in purple). Both these sites were predicted to be located at an intracellular location 
as indicated in the illustration. Antibodies were also raised against a peptide 
corresponding to an amino acid sequence within a predicted extracellular loop 
between transmembrane helices 5 and 6 of White, which is shown in blue. 
White subunit Scarlet subunit 
ATP 
Binding ATP 
Domain ! Binding 
Dnain 
NH3 NH3 
tJ wNT stNT 
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intracellular sides of the membrane. It was considered necessary to obtain 
such an antibody, recognising an extracellular epitope, to enable plasma 
membrane localisation of White to be assessed after heterologous expression 
in insect cells. This predicted loop region harbours two potential glycosylation 
motifs. The peptide sequence chosen for antibody production does not 
encompass either of these motifs in order to avoid the potential inhibition of 
antibody binding to the antigenic site by sugar residues. 
4.2.2 Multiple antigen peptide system 
The peptides for injection into rabbits were synthesised as multiple antigen 
peptides (MAPS) (Lu et al, 1991; Tam, 1988) by the Biomolecular Resource 
Facility (ANU). This system is proposed to be a more reliable and efficient 
means of inducing an immunological response to the synthetic peptide, 
compared to previously described and commonly used protein- carrier methods 
which utilise proteins such as serum albumin, or keyhole limpet hemocyanine 
as a protein carrier (Tam, 1988). The MAP system is based on a small 
immunogenically inert core of radially branched lysine dendrites onto which the 
synthetic peptide antigens are coupled via carboxy- terminal cysteine residues 
to chloroacetyl groups on the lysine matrix (see Fig. 3) (Lu et al, 1991; Tam, 
1988). The resulting macromolecule has a unique three -dimensional 
configuration which has a high molar ratio of peptide antigen to core molecule 
and does not require the use of a carrier protein to elicit an antibody response 
(Lu et al, 1991; Tam, 1988). 
4.3 Results 
4.3.1 Detection of anti- peptide antibodies in rabbit serum by ELISA 
Two rabbits were injected with each synthetic MAP -peptide (wNT, stNT, wECL) 
as described in Chapter 2, Section 2.11. Blood was taken from each rabbit 
prior to the first injection to provide a pre -immune negative control. Blood was 
collected seven days post- injection which corresponds to the approximate time 
Fig. 3 Multiple antigen peptide 
Diagrammatic representation of synthetic peptides anchored to a poly -lysine core 
matrix forming a multiple antigen peptide (MAP). The C- terminal cysteine of the 
antigenic peptide were conjugated to the lysine core matrix by reaction with 
chloroacetyl groups as described previously (Lu, 1991). 
MAP polylysine 
core 
Peptide antigen 
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the antibody titre would be at its highest. Serum was separated from whole 
blood and serially diluted. The presence of anti -peptide antibodies were 
detected by ELISA as described in Chapter 2, Section 2.11.3. 
A summary of the ELISA results for antibodies raised against wNT, stNT and 
wECL MAP -peptides is provided In Table 2. With respect to antibodies raised 
against wNT peptide, only rabbit B showed successful production of anti - 
peptide antibodies. Antibodies were detected after the first injection and 
increased in level after the 2' injection and maintained a good titre after the 3`d 
injection. With respect to antibodies raised against stNT MAP- peptide, rabbit C 
showed a low level of antibodies from all 3 injections, while rabbit D showed a 
much higher level. With respect to antibodies raised against wECL MAP - 
peptide, rabbit E showed a low level after the 15` and 2°d injections and a higher 
level after the 3rd injection. Rabbit F showed a high titre after all three 
injections. 
The variation in immune responses of the rabbits illustrates the need for the use 
of more than one rabbit to maximise the chances of success in raising 
antibodies to the respective MAP -peptides. 
4.3.2 Purification of serum anti -peptide antibodies 
Antibodies raised in this work were purified using an antigen column as 
described in detail In Chapter 2, Section 2.11.4. Briefly, the peptide antigen 
was coupled via a carboxy terminal cysteine residue to an immobilised 
íodoacetyl group on a crosslinked agarose support. Serum containing the 
highest levels of anti -peptide antibodies were diluted 1:10 in PBS and applied 
to the antigen column during which time the anti -peptide antibodies bind to the 
antigen column. The column was washed with buffer prior to eluting the anti - 
peptide antibody at high pH and also at low pH. 1 ml fractions were collected 
and screened by dot blot for the presence of antibody and to determine which 
fractions contained the highest concentration of antibodies. Antibody 
containing fractions were pooled and dialysed against PBS. The purified 
Table 2 Detection of serum antibodies raised against synthetic peptides 
Antibodies were raised against synthetic MAP conjugated peptides in rabbits as 
described in Chapter 2, Section 2.11. Two rabbits were injected with the same 
MAP- peptide and blood was collected seven days post injection and the serum 
was serially diluted and screened by ELISA assay against the respective 
synthetic peptide used for injection. The presence of antibodies was detected 
by way of a colour reaction with the use of a secondary anti -rabbit alkaline 
phosphatase conjugated antibody. The table represents the relative level of 
antibodies in pre- immune serum (PI) which was taken prior to injection and 
after the first, second and third boosts. The strength of the colour reaction of 
alkaline phosphatase is indicated using several ticks for a strong reaction, one 
tick for a weak colour reaction and a dash for no colour reaction. 
Peptide Rabbit Boost 
10' 
Serum Dilution 
10.2 10-3 10-4 
wNT A PI 
1 
2 - - 
3 - 
B PI - 
1 
2 VV 
3 
stNT C PI - - - 
1 - - 
2 - - 
3 - 
D PI - - 
1 VV 
2 VVV - 
3 VV - 
wECL E PI - - 
1 - 
2 - 
3 
F PI - 
1 VV 
2 VV VVV 
3 
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antibodies were then tested for specificity by dot blot against peptide antigen, 
and by Western blot analysis using Sf9 cells expressing White and Scarlet 
protein, uninfected cells, and cells infected with a control recombinant 
baculovirus which does not harbour white or scarlet cDNA (data not shown). 
The Western blot analysis of Sf9 cell lysates (Fig. 4) shows that the major 
immunoreactive bands correspond to the predicted molecular weight of the 
White protein (75.6 kDa) where wNT or wECL antibody was used, and the 
Scarlet protein (74.5 kDa) where the stNT was used. lmmuno-reactive bands 
were not observed in either the uninfected or control virus infected cells. This 
indicates that all three purified antibodies are highly specific for White and 
Scarlet proteins. 
Specificity of wNT and stNT antibodies was also tested using an E. coli 
expression system (described in Chapter 6). Three groups of cells were 
prepared for SDS PAGE, and Western blot analysis: 
A Cells which do not express White or Scarlet (the background E. coli strain) 
B Cells which express the White nucleotide binding domain 
C Cells which express the Scarlet nucleotide binding domain 
Proteins from these three groups of cells were separated by SDS PAGE 
followed by Western blot analysis testing both crude antiserum and purified 
antibody (Fig. 5). It can be seen from Fig. 5 that prior to purification of the 
antibodies, a large amount of non -specific binding was observed. However, 
where anti -wNT was used (Fig. 5A, lane 2), a distinctive and unique 
immunoreactive band is seen at approximately 72 kDa, in the lane representing 
cells expressing the GST -White nucleotide binding domain fusion protein (GST- 
wNBD) but not in the control lanes. This corresponds very well to the predicted 
molecular weight of the fusion protein (72 kDa). Bands corresponding to low 
molecular weight proteins were also observed, presumably indicative of 
proteolysis of the GST -wNBD fusion protein. Similarly, a distinctive and unique 
immunoreactive band is seen in the lane representing cells expressing the GST- 
Scarlet nucleotide binding domain (GST- StNBD), where anti -stNT antibody was 
used (Fig. 50, lane 3). This immunoreactive band is smaller (in the vicinity of 55 
Fig. 4 Western blot analysis of specificity of anti - 
White and anti -Scarlet antibodies in a heterologous 
Sf9 expression system 
A Baculovirus based expression system (described in Chapter 5) 
was used to analyse the specificity of antibodies raised 
against synthetic peptides. Sf9 cells were infected with 
recombinant Baculovirus harbouring both white and scarlet 
cDNAs, harvested 30 hours post infection and cell proteins 
were separated by SDS PAGE and analysed by Western blot 
(indicated on the blots by W /S) using the purified antibody as 
indicated. Immunoreactive protein bands were detected by 
secondary antibody conjugated with alkaline phosphatase. 
Control cells included uninfected cells, as well as a control 
Baculovirus infected cells (indicated by Control Inf) which do 
not harbour white or scarlet cDNA. 
98 - 
64 - 
50 - 
36 - 
30 - 
wNT anti -White 
98 
98 - 64 
64 - 50 
50 - 
36 
36 - 
30 
30 - 
c 
wECL anti -White stNT anti -Scarlet 
Fig. 5 Western blot analysis of specificity of anti -peptide antibodies using 
an E. coli heterologous expression system 
An E. coli heterologous expression system (Chapter 6) was used to test the 
specificity of anti -peptide antibodies obtained from rabbit serum, both before 
and after purification using an antigen column (described in Chapter 2, Section 
2.11.4). Three strains of E. coli were used in this experiment as follows: 
Lane 
1. Cells not expressing White or Scarlet protein 
2. Cells harbouring p2GEXwNDB, which express the White nucleotide binding 
domain as a GST fusion protein 
3. Cells harbouring p2GEXstNBD, which express the Scarlet nucleotide 
binding domain as a GST fusion protein 
The E. coli strains were grown on Luria plates supplemented with glucose, 
Ampicillin (50 .tg/ml) and 0.01 mM IPTG. The control background strains was 
grown without addition of Ampicillin. Samples of cells were resuspended from 
the plate and prepared for SDS PAGE by boiling in SDS PAGE sample buffer 
followed by vortexing for 30 secs to shear chromosomal DNA. Proteins were 
separated by SDS PAGE on a 12% Tris -glycine polyacrylamide gel prior to 
Western transfer and blotting. The anti -peptide antibody used for each blot is 
indicated. Antibody binding was detected by way of a secondary anti -rabbit 
alkaline phosphatase conjugated antibody. 
GST: glutathione S- transferase. 
A 
250 - 
98 - 
64 - 
50 - 
36 - 
30 - 
16 - 
Serum 
1 2 3 
ant i -wNT 
Purified 
g antibody 
1 2 3 
250 - 
98 - 
64 - 
50 - 
36 - 
30 - 
16 - 
Serum 
1 2 3 
250 - 250 - 
98 - 
64 - 
50 - 
36 - 
30 - 
98 
64 
50 
36 
30 
16 - 16 - 
ant i -st NT 
E 
250 - 
98 
64 
50 
36 
30 
16 
ant i-wNT 
Purified 
antibody 
1 2 3 
ant i -stNT 
Purified 
antibody 
1 2 3 
ant i -wECL 
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Kd) than the predicted molecular weight for the GST -StNBD fusion protein (70 
kDa), indicating the protein maybe being cleaved by an E. coli protease. 
After purification of the antibodies (Fig. 5B and D), a much higher specificity of 
labelling was observed for both the White nucleotide binding domain (wNT 
antibodies) or the Scarlet nucleotide binding domain (anit -stNT), and very little 
background or non -specific labelling of other E. coli proteins was observed in the 
control lanes. In the case of the anti -wECL purified antibodies, no labelling was 
detected which is consistent with the absence of the transmembrane loop region 
in the cytoplasmic nucleotide binding domain. 
Summary 
This chapter has described the production of antibodies in rabbits, which after 
purification using an immobilised -antigen column, were shown by Western 
blotting, to label White and Scarlet epitopes specifically in crude extracts from 
both Sf9 and E. coli cells. This shows that the anti -peptide antibodies described 
in this chapter, specifically recognise antigenic sites of the denatured SDS 
solubilised protein. The issue of whether the antibodies recognise these sites in 
the native non -denatured form of the protein - as White and Scarlet exists in 
Drosophila eye tissue - will be examined in Chapter 7. These antibodies will 
also be used to characterise expression and localisation of White and Scarlet 
using a baculovirus based expression system in insect cells, described in 
Chapter 5. 
CHAPTER 5 
EXPRESSION OF WHITE AND SCARLET 
PROTEINS FROM D. melanogaster 
IN INSECT CELLS 
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5. EXPRESSION OF WHITE & SCARLET PROTEINS 
FROM D. melanogaster IN INSECT CELLS 
5.1 Introduction 
The aim of the work described in this Chapter was to develop a heterologous 
eucaryotic expression system for the structural and functional characterisation of 
the white and scarlet gene products. The baculovirus expression system was 
chosen because it is a well established technique for expression of eucaryotic 
membrane proteins (Grisshammer and Tate, 1995; King and Possee, 1992) (an 
overview is provided below) and has been used successfully to study a number 
of ABC transporters (Germann et al, 1990; Meyer et al, 1994; O'Riordan et al, 
1995; Sarkadi et al, 1992) and many transport and channel forming proteins 
(Carter et al, 1992; Cope et al, 1994; Tate and Blakely, 1994). Furthermore, 
insect derived cell lines were considered an appropriate choice for expression of 
D. melanogaster proteins. The advantages of this system include: the high 
expression levels which may be achieved; the eucaryotic background has been 
shown to perform post -translational modifications such as glycosylation, 
palmitoylation, myristoylation, addition of glycosylphosphatidylinositol (GPI) 
anchors and site -specific proteolytic cleavage (Grisshammer and Tate, 1995); 
and proteins are targeted in a similar way as they would be in the proteins' 
native cell background (King and Possee, 1992). 
The baculovirus used in this expression system is derived from Autographa 
californíca and is a double- stranded DNA -containing virus, surrounded by a lipid 
membrane (reviewed in (Fraser, 1992)). New viruses bud from the infected cell 
from about 8 hours post infection (hpi) and the cells die about 4 -5 days post - 
infection. Baculovirus genes are classified into four groups depending on the 
time post -infection they are expressed: immediate early genes (0 - 4 hpi); 
delayed early genes (4 -8 hpi); late genes (8 -24 hpi) and the very late genes 
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(12 -18 hpi, until cell death). The very late genes which include genes encoding 
polyhedrin protein and p10 protein are driven by promoter elements which 
result in very high expression and for this reason have been largely the 
promoters of choice for the over -expression of foreign genes (King and Possee, 
1992). The function of polyhedrin in the native virus is to provide a protective 
capsule in which virus particles are protected from the external environment 
once released from the host cell. The function of the p10 protein is not clear, 
however, it is thought to play some role in polyhedra formation (Williams et al, 
1989). Both the p10 and polyhedrin genes are not essential when the virus is 
used under laboratory cell culture conditions, so these genes can be deleted 
and a gene of interest can be inserted downstream of the polyhedrin or p10 
promoter elements. The baculovirus genome is large in size (128 Kb) and is 
therefore difficult to manipulate for the purpose of inserting foreign genes. 
However, specialised plasmid vectors (known as baculovirus transfer vectors) 
have been developed which enable the insertion of foreign genes with relative 
ease. The baculovirus transfer vector is based on a bacterial plasmid allowing 
propagation in E. coli and manipulation using standard molecular biology 
techniques. The transfer vector used in the work described here, harbours both 
the p10 and polyhedrin promoters (Chapter 2, Section 2.4). The promoters are 
oriented back to back and are flanked by sequences from the wild -type virus. 
Co- transfection of cells by both finearised viral DNA and transfer vector DNA 
results in homologous recombination resulting in insertion of the foreign genes 
and promoter elements into the wild -type viral genome and production of 
recombinant viral particles. The linearised viral DNA used in these 
constructions has been digested at three positions with the restriction 
endonuclease Bsu361 (Clontech) which deletes the polyhedrin gene and part of 
a downstream gene that is essential for viral replication. The transfer plasmid 
contains flanking regions that include the essential gene, ensuring that greater 
than 90% of the viable progeny virus are recombinants (Kitts and Possee, 
1993). An outline of the steps involved in production of a recombinant 
baculovirus is illustrated in Fig. 1. 
Fig. 1 Construction of recombinant bacubv'rus for 
heterobgous expression of t he white and scarlet cDNA from 
D. melanogaster 
Baculovirus transfer vector 
pAcUw3l -w -st 
+ 
Construct transfer 
vector harbouring white 
and scarlet cDNA 
white cDNA 
P1 Oorom. 
ólyhedn rm. m. 
scarlet cIXJA 
Linear Viral 
DNA Transfer 
Vecto r 
Recombinant baculovirus 
ev- 
Co-transfect ion of linear viral 
DNA and t ransfer vecto r 
resulting in recombinat ion 
bet weerhomologoussequences 
shown in blue 
Amplification of recombinant 
viral progeny 
Carry out analysis of infected cells for protein 
expression, localisation and functional 
characte risation of expressed White and Scarlet 
proteins 
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Once the recombinant baculovirus harbouring White and Scarlet cDNA was 
constructed, and successful expression had been achieved, the following 
objectives were envisaged: 
1. Determination of the cellular localisation of the expressed proteins. White 
and Scarlet were predicted to be targeted to the plasma membrane where 
functional White /Scarlet complex would form a biologically active 
transporter. 
2. Test uptake of tryptophan relative to control cells not expressing White or 
Scarlet protein. 
3. If a functional transporter was expressed, then the system should provide a 
powerful system for construction, expression and characterisation of site 
directed mutants. 
5.2 Results 
5.2.1 Construction of baculovirus transfer vector harbouring White and 
Scarlet cDNA 
The cDNA encoding the full length white and scarlet genes were cloned into the 
baculovirus transfer vector pAcUW31 (Chapter 2, Section 2.4.4) by a two step 
process. The white cDNA was sub -cloned first, followed by cloning of the 
scarlet cDNA into pAcUW31 w resulting in the plasmid pAcUW31 w,st. 
5.2.1.a Construction of pAcUW31w 
The white cDNA was cloned into the EcoRl site downstream from the p10 
baculovirus promoter element by blunt end ligation (described in Chapter 2, 
Section 2.3). The white cDNA was removed from its previous plasmid vector by 
restriction digestion with EcoRl and Kpnl. The white cDNA fragment was 
separated from the vector fragment by agarose gel electrophoresis and 
subsequently purified from the agarose gel (described in Chapter 2, Section 
2.3.6) followed by treatment with Klenow fragment to produce blunt ends 
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(Chapter 2, Section 2.3.2). The pAcUW31 plasmid DNA was digested with 
EcoRl followed by treatment with Klenow fragment (to produce blunt ends) and 
alkaline phosphatase (Sections 2.3.2 and 2.3.3) to prevent re- ligation of vector 
DNA. The white cDNA fragment and digested pAcUW31 plasmid DNA were 
then ligated and transformed into E. coli strain XL1 Blue. Transformant colonies 
were screened by colony cracking assay (Chapter 2, Section 2.3.10) and 
colonies harbouring plasmid DNA larger than the circular vector plasmid were 
used to prepare small scale plasmid preparations which were analysed by 
restriction mapping. Fig. 2A is a plasmid map detailing the predicted DNA 
fragment sizes resulting from digestion with BgII restriction enzyme. Fig. 2B is 
an agarose gel analysis of plasmids digested with BgII. Plasmids showing the 
correct restriction map are highlighted with an asterisk. The resulting construct 
was named pAcUW31 w. 
5.2.1.b Construction of pAcUW3lw,st 
The scarlet cDNA was cloned into the BamHl site downstream of the polyhedrin 
promoter element in the pAcUW31 w vector. The scarlet cDNA fragment was 
released from its previous plasmid vector by restriction digestion with Pstl and 
Hindlll and separated from the vector DNA by agarose gel electrophoresis. 
The scarlet cDNA fragment was purified from the gel and treated with Klenow 
fragment to produce a blunt ended fragment as described above for the white 
cDNA fragment. The pAcUW31 w plasmid was digested with Bgll , treated with 
Klenow to produce blunt ends, treated with alkaline phosphatase, and purified 
(as described in Chapter 2, Sections 2.3.2, 2.3.3 and 2.3.5). The prepared 
pAcUW31 w vector and blunt ended scarlet cDNA were ligated and transformed 
into the E. coli strain XL1 Blue. Colonies harbouring plasmid DNA larger than 
the pAcUW31 w circular plasmid were used to prepare small scale purified 
plasmid DNA which was then analysed by restriction mapping which is 
illustrated in Fig. 3. Fig. 3A illustrates the plasmid map and predicted fragments 
resulting from a digest with Bgll, where both white and scarlet are in the correct 
orientation with respect to their respective promoter elements. Fig. 3B is the 
agarose gel analysis of plasmids digested with Bgll. The plasmids showing 
Fig. 2. Restriction analysis of putative recombinant transfer 
vector plasmid pACUW31w. 
A. Diagrammatic representation of the predicted sizes of fragments after a 
Bgl1 digest when the white cDNA is in the correct orientation. Full details of 
the pAcUw31 plasmid are provided in Chapter 2. 
B. Restriction analysis of purified plasmid DNA of transformant colonies 
diagnosed to contain white cDNA from cracking assay. The plasmids showing 
the correct restriction pattern are signified with an asterisk. 
A 
B 
Bgl1 
Bgl1 
12,216 - 
2,036 - 
1,016 
- 
506 - 
1.6 Kb 
5.2 Kb 
pAcUw31w 
10597 bp 
3.7 Kb \ white cDNA 
` Bgli 
P10 prom. 
nil ONO e 71r ONO wNr. MINI ü,r 
5.2 Kb 
IK3.7 Kb 
~ 1 .6 Kb 
Fig. 3 Restriction analysis of putative recombinant transfer 
vector plasm ids pACUW31 w,st. 
A. Diagrammatic representation of the predicted sizes of fragments after a 
í3g11 digest when both white and scarlet cDNA are in the correct 
orientation. 
B. Restriction analysis of purified plasmid DNA of transformant 
colonies diagnosed to contain white cDNA from cracking assay. The 
plasmids showing the correct restriction pattern are signified with an 
asterisk. 
Bglt 
Bgh 
12,216 - 
3,054- 
1,636- 
506- 
5.2 Kb 
1.5Kb 
pAcUw31 w,st 
12598 bp 
2.8 Kb T 
Bgl1 
scarlet cDNA 
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Bg11 
P10 prom. 
Polyhedrin prom. 
..4_5 Kb 
-4-3 Kb 
f1.5 Kb 
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DNA fragment sizes consistent with the predicted BgII restriction map are 
highlighted with an asterisk. The resulting construct was named pAcUW31 w,st. 
52.1.c Site directed mutagenesis of pAcUW3lw,st to correct the white 
start codon 
Sequence analysis of pAcUW31 w, st revealed that the start codon for the white 
cDNA was incorrect, possibly due to degradation of the 5' end of the white 
cDNA prior to ligation into pAcUW31. Apart from the start codon, no other 
errors were detected in the rest of the white or scarlet DNA sequences. The 
start codon was corrected by site directed mutagenesis using the PCR based 
approach described in Section 2.2.10 b using oligonucleotides 96 -70 and 96 -71 
(for sequence see Section 2.14). Fig. 4A is an agarose gel analysis of PCR 
products from the site directed mutagenesis reactions. PCR products were 
digested with Dpnl to inactivate the plasmid template DNA and transformed into 
E. coli XL1 Blue. Transformant colonies were used to prepare small scale 
plasmid DNA which was analysed by agarose gel electrophoresis to select those 
of the correct size (data not shown). Plasmid DNA from selected transformants 
was then sequenced over the region of the white start codon. Fig. 4B is an 
autoradiograph of a sequencing gel showing the corrected sequence. 
5.2.2 Production of recombinant baculovirus and expression of White 
and Scarlet protein 
The baculovirus transfer vector pAcUW31 w, st DNA was co- transfected with 
linear (Bsu36 I digested) viral DNA (BacPAK8) as described in Chapter 2, 
Section 2.5.2a. The principle of the production of recombinant baculovirus is 
summarised in Fig. 1, The co- transfection supernatant was harvested after 5 to 
6 days of incubation and then used to perform plaque assays in order to isolate 
recombinant baculovirus particles derived from a single recombinant baculovirus 
particle. P1 viral stocks were produced from several single plaque picks 
(described in Chapter 2, Section 2.5.2b). The cells used in the production 
Fig. 4 Correction of start codon of white cDNA in pAcUW31 w,st by site 
directed mutagenesis 
A. Seven mutagenesis reactions were performed (as described in Chapter 2, 
Section 2.2.10) each containing the basic reaction mix (lx Pfu polymerase 
reaction buffer, 20 mM of each dNTP, 100 ng /µl DNA template, 100 ng /µl 
of each forward and reverse primer, 2.5 units /µl of native Pfu polymerase). 
The following additives were trialed as follows: 
Lane Additive 
Molecular weight marker 
1. 10µg /m1 BSA 
2. 5% (v /v) formamide 
3. 5% (v /v) DMSO 
4. 5% (v /v) glycerol 
5. 15 mM ammonium sulfate 
6. No additives 
7. Template DNA 
In lane 6 can be seen a DNA product of similar molecular weight as the 
template DNA. The DNA from this reaction was digested with Dpnl then 
transformed by electroporation into E. coli strain XL1 Blue. Plasmid DNA was 
purified from transformant colonies and sequenced over the region of the start 
codon. 
B. Autoradiograph of sequencing gel showing the corrected start codon of 
white cDNA in pAcUW31 w,st. 
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Fig. 5. Expression of White and Scarlet protein by Sf9 cells 
infected with putative recombinant baculoviruses. 
Virus particles derived from single viral plaque picks were used to infect Sf9 
cells in 25 cm2 flasks. After 5 days the supernatant was harvested and the 
cells were washed and prepared for SDS PAGE followed by western transfer 
and immune- detection. Antibodies specific for White and Scarlet proteins 
were used (described in Chapter 4). Detection of primary antibody was by 
way of a secondary alkaline phosphatase conjugated antibody. Each lane 
represents cells infected from different plaque picks. 
A. Western blot screening for White protein expression. Lanes 4 and 6 are 
positive for White protein. Lane 5 shows a very low level of White protein. 
B. Western blot screening for Scarlet protein. Lanes 4 and 6 are positive for 
Scarlet protein (the identical lanes are also positive for White protein 
expression). Lane 5 shows a very low level of scarlet protein. Lane 7 shows 
scarlet expression but no White expression. 
98 - 
64 - 
50 - 
36 - 
16 - 
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1 2 3 4 5 6 7 
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50 - 
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16 - 
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-40--White 
Scarlet 
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of P1 supernatant were harvested and analysed by Western blotting to test for 
White and Scarlet protein expression. Fig. 5 is a Western blot of cells used in 
the production of P1 recombinant baculovirus. Lanes 4 and 6 are positive for 
both White and Scarlet proteins and the molecular weights are approximately 
that predicted for White (75.6 Kd) and Scarlet (74.5 Kd). The recombinant 
baculovirus was named BV -w,st and the P1 supernatant was used to produce 
high titre P2 and P3 viral stocks for use in further experimental work. 
5.2.2.a Western blot analysis of the expression of White and Scarlet 
protein in BV -w,st infected cells over time 
Confirmation of successful production of a recombinant baculovirus expressing 
the white and scarlet cDNA was obtained by immuno- detection of expressed 
White and Scarlet protein as described above. Expression of White and Scarlet 
protein were analysed over a time course. Fig. 6 is a Western blot of BV -w,st 
infected cells harvested over a period of between 0 to 64 hours post infection 
(hpi). White and Scarlet protein expression was first detected at 16 hours and 
increases to a maximum at 48 hpi. This is consistent with the time post 
infection that the p10 and polyhedrin genes are activated (King and Possee, 
1992). Both the White and Scarlet proteins migrated at their predicted 
molecular weights representing the major immuno- reactive product. Some 
lower molecular weight species are also detected indicating a minor degree of 
degradation. 
5.2.2.b Analysis of glycosylation of White and Scarlet protein expressed 
in Sf9 cells 
The Sf9 insect cell line has the cellular machinery to glycosylate heterologously 
expressed proteins by way of the well documented N- linked process that occurs 
in the endoplasmic reticulum (King and Possee, 1992). The consensus 
recognition site, Asn- X- Ser /Thr occurs at two locations of the White protein and 
once for the Scarlet protein, within a loop region between transmembrane 
helices 5 and 6, which has been postulated to be extracellularly accessible 
Fig. 6 Expression of White and Scarlet protein in Sf9 insect cells 
infected with recombinant baculovirus. 
Sf9 cells (30 x 104 cells) were infected with BV -w,st. were harvested over a 
time course. The cellular proteins were separated by SDS PAGE, transferred 
onto PVDF membranes and incubated with polyclonal antibodies raised 
against the White protein (wNT) A, or the Scarlet protein (stNT) B. Detection 
was by way of a secondary antibody conjugated to alkaline phosphatase. The 
White (75,667 kDa) and Scarlet (74,546 kDa) proteins are labelled and run at 
their predicted molecular weights. 
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(Ewart et al, 1994). For proteins targeted to the plasma membrane, 
glycosylation is a good indicator for plasma membrane insertion due to the 
asymmetric orientation of oligosaccharide chains which are added on the luminal 
side of the ER and Golgi apparatus. This means that glycosylated regions of 
plasma membrane proteins face the outside of the cell membrane (Alberts et al, 
1989). Glycosylated proteins migrate more slowly, appearing as a higher 
molecular weight protein on polyacrylamide gels, in comparison to the 
nonglycosylated counterpart (King and Possee, 1992). In order to investigate 
whether White or Scarlet undergo glycosylation processing, infected cells were 
treated with tunicamycin, which is an inhibitor of N- linked glycosylation. 
Glycosylation has a significant effect on the apparent molecular weight of 
proteins analysed by SDS PAGE so a comparison between protein from 
tunicamycin treated cells and cells without tunicamycin treatment is a good test 
for whether or not the proteins are glycosylated. Fig. 7A is a Western blot 
analysis of both the White and Scarlet protein comparing tunicamycin treated 
cells and cells not treated. It can be seen that tunicamycin treatment has had a 
marked effect on the yield of expressed White and Scarlet protein, however the 
apparent molecular weights between treated and untreated are not visibly 
different. In order to compare the heterologously expressed White and Scarlet 
protein molecular weight, with that from D. melanogaster tissue, proteins from fly 
heads were subjected to SDS PAGE and analysed by Western blot. Fig. 7B 
shows that the molecular weight of the proteins cross -reacting with the White or 
Scarlet antibodies are significantly higher than the predicted molecular weight for 
the nonglycosylated form of the proteins. This provides evidence that the White 
and Scarlet proteins may be glycosylated in vivo, however are not glycosylated 
in Sf9 cells. 
5.2.3 Localisation of White and Scarlet protein expressed in Sf9 cells 
Western blot analysis confirmed that both white and scarlet genes were being 
expressed under the control of the baculovirus p10 and polyhedrin promoters. 
Fig. 7 Analysis of molecular weights of White and Scarlet protein 
expressed in Sf9 cells and extracted from Drosophila tissue 
A. Analysis of the effect of tunicamycin on the apparent molecular weight of 
White and Scarlet protein expressed by Sf9 cells was performed as 
described in Chapter 2, Section 2.5.3. Cells were infected with BV -w,st. 
Tunicamycin was added 5 hpi to 11.1g /ml. Cells were incubated for 42 hours 
prior to harvesting and preparing the cells for SDS PAGE on a 12% Tris- 
glycine gel. The gel was analysed by Western blotting using anti -wNT and 
anti -stNT antibodies respectively, as indicated below each Western blot. 
B. Western blot analysis of White and Scarlet protein extracted from 
D. melanogaster heads. Fly heads were homogenised in solubilisation 
buffer as described in Chapter 2, Section 2.1,3 and solubilised proteins 
were separated by SDS PAGE on a 12% Tris -glycine gel. The gel was 
then analysed by Western blotting using anti -wNT and anti -stNT antibodies 
respectively and visualisation using an alkaline phosphatase conjugated 
secondary antibody. 
Lanes: 
1 Solubilised extract from fly heads 
2 Cell lysate from Sf9 cells expressing White and Scarlet protein 
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The next step was to establish whether the White/ Scarlet complex was being 
assembled in the plasma membrane, or into some other intra- cellular membrane 
or site. 
Flow cytometry was used to assess the following parameters: 
relative fluorescence of populations of cells immuno -fluorescently labelled 
with antibodies specific for White or Scarlet protein epitopes in comparison 
with control populations; 
changes in light scattering properties of populations of cells, indicative of 
baculovirus infection. 
Three groups of differently treated Sf9 cells were used in the experiments 
described in this section: 
1. BV -w,st infected Sf9 cells: the experimental group expressing White and 
Scarlet protein when infected with BV- w,st. 
2. BV -gaba infected Sf9 cells: the control baculovirus infected group which 
does not express the White or Scarlet protein, but does express the human 
Gaba 1 subunits al and 131. This virus was constructed by Brett Cromer, 
Membrane Biochemistry Group, JCSMR, ANU. 
3. Uninfected Sf9 cells: the negative control group which does not express 
White or Scarlet protein and has the cellular characteristics of uninfected 
cells. 
The BV -gaba infected cells were used as a control group as they would have the 
same cellular characteristics as the experimental By- w,st infected cells, minus 
the White and Scarlet protein. The uninfected cells gave a good indication of 
the changes in fluorescence during normal growth. In addition, the 
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change in light scattering properties before and after infection gives an 
indication of the percentage of cells infected in the infected groups. 
5.2.3.a Flow cytometry analysis of non -permeabilised Sf9 cells: plasma 
membrane labelling using wECL antibody 
The distribution plots in Fig. 8A illustrates the comparison of relative 
fluorescence of Sf9 cells labelled with anti -wECL antibody followed by the 
secondary FITC- conjugated anti -rabbit antibody. The BV -w,st infected cells 
have a geometric mean relative fluorescence of 174 which is 1.6 fold higher 
than BV -gaba infected cells (which have a geometric mean of 107) and three 
fold higher than uninfected cells (which have a geometric mean of 54). The 
distribution plots for the two infected groups do overlap, however approximately 
50% of the cells (indicated under the marker line M1) in the BV -w,st infected 
cells have a higher fluorescence value than the brightest cells of the BV -gaba 
control group. 
The three density plots shown in Fig. 8B, C and D give an indication of the 
correlation between BV -w,st infection and increased fluorescence due to 
immuno -fluorescence. The side -scatter parameter on the x axis, is plotted 
against relative fluorescence on the y axis. Each plot is divided into four 
quadrants. In the plot for the uninfected group, around 60% of the cells show a 
side scatter in the lower, left quadrant. This side scatter distribution is indicative 
of uninfected Sf9 cells. For both the infected groups the side scatter has 
increased substantially shifting the majority of the cells to the right hand 
quadrants. This change in distribution is indicative of baculovirus infected Sf9 
cells. For BV -w,st infected cells around 80% of the cells lie in the two right 
hand quadrants (compared to 36% in the uninfected group). In comparison 
with the BV -gaba density plot, although the 76% of cells have increased side 
scatter, the fluorescence intensity has not increased to the extent of the BV- 
Fig. 8 Flow cytometry and immuno -fluorescence labelling of Sf9 cells 
using anti -wECL antibody 
A. The three overlayed distrubution plots provides a comparison of relative 
immuno -fluorescence of cells infected with BV -w,st virus, BV -gaba virus, and 
uninfected cells. Cells were harvested 30 hpi and were incubated with the 
primary antibody, wECL (1:100) prior to fixation followed by labelling with 
secondary FITC- conjugated anti- rabbit antibody as described in Chapter 2, 
Section 2.5.4. The marker line labelled M1 indicates the number of cells with 
fluorescence that fall in this range. The distribution plots are normalised with 
respect to cell number. 
B., C. and D. Density plots showing side scatter against relative fluorescence 
as frequency distribution. The colour coding represents an increase in 
frequency or density where blue is least frequent, green is intermediate and red 
is the highest frequency. Each plot is separated into four quadrants and the 
percentage shown in each corner represents the percentage of cells which 
occur in that quadrant. This allows a direct comparison of the population shift 
which occurs when side scatter increases due to Baculovirus infection, in 
addition to the increase in relative fluorescence due to immuno -labelling 
between cells expressing White and Scarlet protein, and those which do not. 
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w,st population of cells. This flow cytometry data provides evidence that at 
least some of the White protein is being assembled in the plasma membrane 
and that the White protein epitope is exposed extracellularly in agreement with 
the proposed model for the White protein (Ewart et al, 1994). 
5.2.3.b Flow cytometry of permeabilised Sf9 cells: intracellular labelling 
with wECL antibody 
In order to investigate the intracellular location of the White and Scarlet protein, 
cells were permeabilised with 0.01% SDS after fixation as described in Chapter 
2, Section 2.5.4. Cells were then incubated with anti -wECL antibody, washed, 
then incubated with FITC- conjugated anti -rabbit secondary antibody. The 
distribution plots in Fig. 9A plot relative fluorescence against number of cells. 
The BV -w,st group has a geometric mean relative fluorescence of 30 which is 
six fold higher than both the control groups BV -gaba infected (which has a 
geometric mean of 5), and uninfected cells (which have a geometric mean of 7). 
This indicates that the White protein is produced in the BV -w,st infected cells 
and that there is a more noticeable difference between the test and control cells 
than was indicated in the cells not permeabilised described in Section 5.2.3a. 
The density plots in Fig. 9B illustrate the correlation between BV -w,st infection 
and increased relative fluorescence. In the uninfected density plot, around 80% 
of cells lie in the lower left-hand quadrant, which is the region associated with 
uninfected Sf9 cells. For both BV -w,st and BV -gaba infected groups, the 
populations have shifted towards the high side scatter values in the right hand 
quadrants which is associated with Sf9 cells infected with baculovirus. For both 
infected groups, -70% of cells are within the region associated with higher side 
scatter. Relative fluorescence however has remained constant for the BV -gaba 
infected control group, and increased for the BV -w,st group. 
This ímmuno- fluorescence data provides evidence that a significant amount of 
expressed White protein is intracellular. Taking into consideration the results 
from Section 5.2.3a which show the White protein is targeting the plasma 
membrane, it can be said that although some White protein reaches the plasma 
Fig. 9 Flow cytometry and immuno -fluorescence labelling of 
permeabilised Sf9 cells using anti -wECL antibody 
A. The three overlayed density plots provides a comparison of relative 
immuno- fluorescence of cells infected with BV -w,st virus, BV -gaba virus, and 
uninfected cells. Cells were harvested 30 hpi prior to fixation and 
permeabilisation with 0.01% SDS before incubation with the primary antibody, 
wECL (1:100) and then labelled with a secondary FITC- conjugated anti -rabbit 
antibody as described in Chapter 2, Section 2.5.4. The marker line labelled M1 
indicates the number of cells which fall under the horizontal line. The 
distribution plots are normalised with respect to cell number. 
B., C. and D. Density plots showing side scatter against relative fluorescence 
as frequency distributions. The colour coding represents an increase in 
frequency or density where blue is least frequent, green is intermediate and red 
is the highest frequency. Each plot is separated into four quadrants and the 
percentage shown in each corner represents the percentage of "cells which 
occur in that quadrant. This allows a direct comparison of the population shift 
which occurs when side scatter increases due to Baculovirus infection, in 
addition to the increase in relative fluorescence due to immuno -labelling 
between cells expressing White or Scarlet protein, and those which do not. 
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membrane, most is found at intracellular sites. This issue will be further 
investigated by confocal microscopy in the Sections 5.2.3d and 5.2.3e. 
5.2.3.c Flow cytometry analysis of Sf9 cells using Scarlet specific 
antibody 
The anti -stNT antibody was used to detect Scarlet protein in BV -w,st insects 
cells in the same way as described above for the White protein. The protein 
epitope the stNT antibody recognises is at the amino -terminus of the ATP 
binding domain which is predicted to have an intracellular localisation (see 
Chapter 4). 
The distribution plot in Fig. 10 illustrates a comparison of relative fluorescence 
between three populations of Sf9 cells. All three groups of cells were treated 
with stNT antibody, followed by FITC- conjugated secondary anti- rabbit 
antibody. The histogram in red represents BV -w,st cells which have been 
permeabilised after fixation to allow the stNT antibody to enter the cell. This 
population which is normally distributed has a geometric mean of 6 which is 2 
fold higher than the cells not permeabilised but infected with the same virus, 
BV -w,st (which had a geometric mean of 3). The permeabilised BV -gaba 
infected control group has a geometric mean relative fluorescence of 2 which is 
3 fold tower than BV -w,st infected cells. This comparison provides evidence 
that the Scarlet epitope is accessible only inside the cell. 
The density plots of these same populations of cells illustrates the correlation 
between relative fluorescence of permeabilised cells and BV -w,st infection. 
Comparing the three infected groups, BV -w,st non -permeabilised, BV -w,st 
permeabilised and BV -gaba permeabilised, with the density plot of the 
uninfected group, it can be seen that the 80 -90% of cells in populations in the 
infected groups shifted to the region of high side scatter associated with 
baculovirus infected Sf9 cells, compared to -20% in the uninfected control 
group. However the relative fluorescence has increased substantially only in 
the permeabilised BV -w,st infected population and not in the other groups. 
Fig. 10 Flow cytometry and immuno -fluorescence analysis of Sf9 cells 
using anti -stNT antibody 
A. The three overlayed distribution plots provide a comparison of relative 
immuno -fluorescence of cells infected with BV -w,st virus and BV -gaba virus. 
Cells were harvested 30 hpi. Permeabilised cells were fixed prior to 
permeabilisation with 0.01% SDS, incubated with the primary antibody, anti - 
stNT (1:100) and then labelled with a secondary FITC- conjugated anti -rabbit 
antibody as described in Chapter 2, Section 2.5.4. Cells which were not 
permeabilised were treated with primary and secondary antibody prior to 
fixation. The marker line labelled M1 indicates the number of cells which fall 
under the horizontal line. The distribution plots are normalised with respect to 
cell number. 
B., C., D. and E. Density plots showing side scatter against relative 
fluorescence as frequency distributions. The colour coding represents an 
increase in frequency or density where blue is least frequent, green is 
intermediate and red is the highest frequency. Each plot is separated into four 
quadrants and the percentage shown in each corner represents the percentage 
of cells which occur in that quadrant. This allows a direct comparison of the 
population shift which occurs when side scatter increases due to Baculovirus 
infection, in addition to the increase in relative fluorescence due to immuno- 
labelling between cells expressing White or Scarlet protein, and those which do 
not. 
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These results provide further evidence that the Scarlet epitope is at an 
intracellular location. Plasma membrane localisation was investigated by 
immuno- fluorescence confocal microscopy, as well as cell fractionation, which 
is described in the next Section. Although differences in test and control cells 
were detected by flow cytometry, unfortunately due to the low level of 
fluorescence, stNT antibody was found to be unsuitable for fluorescence 
microscopy analysis. 
5.2.34 Confocal microscopy analysis of extracellular plasma membrane 
localisation of White protein expressed by BV -w,st infected Sf9 
cells 
Laser Scanning confocal microscopy was used to investigate the cellular 
localisation of the White protein expressed in Sf9 cells infected with BV -w,st 
recombinant baculovirus. Fig. 11A is a micrograph of Sf9 cells, 30 hpi, infected 
with BV -w,st and immuno -fluorescently labelled with affinity purified anti -wECL 
antibody. The anti -wECL antibody recognises an epitope within a loop region 
between transmembrane helices 5 and 6 of the White protein and has been 
predicted to be extracellularly accessible (see Chapter 4). Strong fluorescent 
immuno -labelling was observed at the surface of the cell and this is represented 
in Fig. 11A. In comparison, the control BV -gaba (Fig. 11B) infected cells and 
uninfected cells (11C), show some amount of background fluorescence, 
however do not show specific plasma membrane targeting which is observed 
for the White /Scarlet expressing cells. 
5.2.3.e Confocal microscopy analysis of intracellular localisation of White 
protein expressed by BV -w,st infected Sf9 cells 
Flow cytometry analysis using anti -wECL antibody provided evidence that the 
White protein was found in both the plasma membrane (Section 5.2.3a), and 
intracellularly (Section 5.2.3b). Confocal laser scanning microscopy was used 
to investigate this further. Fig. 12A is a micrograph of Sf9 cells 30hpì, infected 
with BV -w,st permeabilised with SDS and immuno -fluorescently labelled with 
Fig. 11 Confocal microscopy analysis of extracellular plasma membrane 
localisation of White expressed in Sf9 cells 
Cells were infected with either BV -w,st or BV -gaba as indicated and harvested 
30 hpi and were incubated with the primary antibody, anti -wECL (1:100) prior to 
fixation followed by labelling with secondary FITC- conjugated anti -rabbit 
antibody as described in Chapter 2, Section 2.5.4. The gain is the same for 
each group. 
A. Cells infected with BV -w,st. 
B. Cells infected with BV -gaba. 
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Fig. 12 Confocal microscopy analysis of intracellular localisation of 
White protein expressed by Sf9 cells 
Cells were harvested 30 hpi prior to fixation and permeabilisation with 0.01 
SDS before incubation with the primary antibody, anti -wECL (1 :100) followed by 
a secondary FITC- conjugated anti- rabbit antibody as described in Chapter 2, 
Section 2.5.4. 
A. Cells infected with BV -w,st. 
B. Cells infected with BV -gaba. 
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wECL antibody (see Chapter 4). Strong immuno -fluorescent labelling can be 
seen, appearing as a dense concentration of fluorescent labelling appearing as 
bright spots. Extensive intracellular labelling was also observed in 
permeabilised cells immuno -fluorescently stained using the anti -wNT antibody 
(Fig. 13A). Although there is some cross -reaction in the control infected cells 
(Fig. 13B), the level of labelling is much greater in the White /Scarlet expressing 
cells and the punctate labelling observed in Fig. 13A is suggestive of 
localisation to an intracellular compartment. These results suggest that a large 
percentage of expressed White protein is not being assembled in the plasma 
membrane and may be locating to the membrane of an intracellular 
compartment. 
5.2.4 Separation of Sf9 cell fractions by differential centrifugation 
In order to investigate further the cellular localisation of the White and Scarlet 
proteins expressed in insect cells, the crude membranes, cytoplasm and 
insoluble cell material were separated by differential centrifugation, as 
described in Section 2.6.5 and analysed by SDS PAGE and Western blotting. 
Fig. 14 shows the levels of White and Scarlet detected in the different cell 
fractions. It is clear from Fig. 14B, lane 3 that approximately 95% of the White 
protein is detected in the insoluble cell material which is separated from the 
cytoplasm and membrane fractions by low speed centrifugation. A low level of 
White protein was detected in the crude membrane fraction (Fig. 14B lane 4). 
On the other hand, 100% of the Scarlet protein was detected in the insoluble 
cell fraction (Fig. 14C lane 3) and none in the crude membrane fraction (Fig. 
14C lane 4). No White or Scarlet protein was detected in the cytoplasmic 
fraction (Fig. 14B & C lane 5). 
The method of percoll gradient centrifugation was also used to separate 
membrane and other cell fractions (described in Chapter 2, Section 2.6.6). The 
initial purpose of the percoll gradient was to attempt to isolate White and 
Scarlet enriched membrane vesicles with a view to functional characterisation 
of the White /Scarlet transporter complex. This method resulted in the 
Fig. 13 Confocal microscopy analysis of intracellular immuno- 
fluorescent labelling White protein expressed by Sf9 cells 
Cells were harvested 30 hpi prior to fixation and permeabilisation with 0.01% 
SDS before incubation with the primary antibody, anti -wNT (1:10) followed by a 
secondary FITC- conjugated anti -rabbit antibody as described in Chapter 2, 
Section 2.5.4. 
A. Cells infected with BV -w,st. 
B. Cells infected with BV -gaba. 
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Fig. 14 SDS PAGE and Western blot analysis of cell fractions from Sf9 
cells expressing White and Scarlet protein 
Cells were infected with either BV -gaba control virus or BV -w,st virus and were 
harvested 48 hpi and lysed using a dounce homogeniser. Fractions were 
separated by differential centrifugation as described in Chapter 2, Section 
2.6.5b. The gain is the same for each group. 
A. SDS PAGE analysis of proteins. 
B. Western blot using wNT primary antibody. 
C. Western blot using stNT primary antibody 
The labelled wells are representative of samples taken from the following cell 
fractions: 
Lane Cell fraction 
1 Lysed cells, prior to differential centrifugation. 
2 Supernatant obtained from low speed centrifugation (121 g). 
3 Pellet obtained from low speed centrifugation (121 g). Representative of 
insoluble proteins. 
4 Pellet obtained from high speed centrifugation (100,000 g). 
Representative of crude cell membranes. 
5 Supernatant obtained from high speed centrifugation (100,000 g). 
Representative of soluble cell cytoplasm. 
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separation of a very distinct band which is shown in Fig. 15A, which is present 
in both the White /Scarlet expressing cells and Gaba control cells (only the 
White /Scarlet derived gradient is shown in Fig. 15). An SDS PAGE /Western 
blot analysis of this band and other fractions separated by the percoll gradient 
is shown in Fig. 15. The Western blot indicates that a very large percentage of 
White and Scarlet protein is found within the distinct band highlighted by the 
arrow in Fig. 15C and D. It was assumed that this fraction separated by the 
percoll gradient is the same fraction separated by low speed centrifugation as 
described above. 
The material contained in the cell fraction containing a large amount of White 
and Scarlet protein, was analysed by transmission electron microscopy (TEM) 
and revealed a large quantity of 14 nm spherical particles as shown in Fig. 16. 
The experimental procedure for preparing this material for TEM is described in 
Chapter 2, Section 2.12.3. Membrane vesicles were not observed in this 
fraction. These results indicate that a large percentage of expressed White and 
Scarlet protein was not being targeted to the plasma membrane or intracellular 
membrane, but was forming insoluble misfolded protein particles which can be 
separated by low -speed centrifugation. 
5.2.5 Electron microscopy analysis of infected cells 
The confocal microscopy immuno- localisation studies indicated that a large 
proportion of White /Scarlet was located intracellularly and possibly localising to 
an intracellular compartment. This was further investigated by immuno -electron 
microscopy. Sf9 cells were prepared for transmission electron microscopy by 
Cathy Gillespie (Electron Microscopy Unit, John Curtin School of Medical 
Research) as described in Chapter 2, Section 2.12.4 and were immuno -labelled 
as described in Section 2.12.2. 
No specific gold labelling by either anti -wNT, anti -wECL or anti -stNT was 
observed at the plasma membrane or any other intracellular site, possibly due 
to the destruction of the antigenic sites by the preparative process required for 
Fig. 15 Analysis of cell fractions separated by percoll density gradient 
A cell monolayer in a 25cm2 flask was infected with BV -w,st virus, harvested 48 
hpi and lysed using a dounce homogeniser. The cell lysate was added to 
percoll solution to a final percoll concentration of 11.9% prior to centrifugation 
as described in Chapter 2, Section 2.6.6. 
A. Photograph of the tube after percoll gradient was generated by 
centrifugation. Fractions labelled 1 to 4 were extracted by aspiration with 
a pasteur pipette and analysed by SDS PAGE and Western blotting 
shown in B and C. 
B. SDS PAGE analysis (12% Tris -glycine gel). Wells labelled 1 to 4 
represent samples from fractions 1 to 4 shown in A. 
C. Detection of White protein by Western blot analysis of fractions 1 to 4 
shown in A. 
D. Detection of Scarlet protein by Western blot analysis of fractions 1 to 4 
shown in A. 
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Fig. 16 Transmission electron microscopy analysis of the cell fraction 
containing White and Scarlet protein 
Samples taken from the fraction 3 of the percoll gradient shown in Fig. 15 
were placed on carbon coated grids supported on plastic and negatively 
stained with uranyl acetate as described in Chapter 2, Section 2.15.3. 
A. 38,000 x magnification, bar = 0.26 µm 
B. 71,000 x magnification, bar = 70 nm 
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transmission electron microscopy_ The internal organisation of BV -gaba, 
BV -w,st, and uninfected cells were compared and the following observations 
were made. 
BV-w,st infected cells showed typical signs of baculovirus infection (see Fig. 
17). The baculovirus genome is associated with a highly basic (arginine -rich) 
protein of 6.5kDa (Tweeten et al, 1980), within a rod -shaped nucleocapsid which 
contains a 39 kDa capsid protein (Thiem and Miller, 1989). Several 
nucleocapsids are packaged within a lipoprotein envelope forming a virus 
particle or virion and these are easily seen in Fig. 17B and 17C. This type of 
virion, i.e. harbouring one or more nucleocapsids, are typical of this sub -group of 
the Baculoviridae family, known as nuclear polyhedrosis viruses (NPV) which 
have been developed as expression vectors in this system. In a wild -type 
AcNPV infection virions are encapsulated within an electron dense polyhedrin 
envelope made up of polyhedrin protein, collectively called polyhedra. The 
polyhedrin gene has been removed in this recombinant expression vector and 
hence the absence of polyhedra. The nucleus of the infected cells were 
enlarged compared to uninfected cells which is typical in a baculovirus infection 
(King and Possee, 1992). 
Investigation of the cytoplasm of infected cells (Fig. 17D) revealed a large 
number of spherical particles, very similar to the particles observed in the percoll 
fraction containing high levels of White and Scarlet protein (see Fig. 16). 
5.2.6 Analysis of tryptophan transport activity of White and Scarlet 
expressing insect cells 
As described in the introductory Chapter 1, the White and Scarlet proteins are 
postulated to form an ABC transporter specific for tryptophan which is a 
precursor of the brown pigment, xanthommatin. It was established in the 
previous sections that the White and Scarlet proteins were being expressed in 
Fig. 17 Transmission electron microscopy analysis of Sf9 cells infected 
with BV -w,st 
Sf9 cells were harvested 30 hpi from monolayer cultures and prepared for 
transmission electron microscopy as described in Chapter 2, Section 2.12. 
Immuno -labelling was attempted using anti -wNT, anti -wECL and anti -stNT as 
described in Chapter 2, Section 2.12.2 however specific labelling was not 
observed. 
A. Uninfected Sf9 cell, magnification 3,750 x (bar = 5.3 µm) 
B. BV -w,st infected cell, magnification 2,500 x (bar = 5.3 µm) 
C. Higher magnification of cell nucleus of a BV -w,st infected cell. 
Magnification 10,500 x (bar = 2 µm). 
N = nucleus, NS = nucleolus, NE = nuclear envelope C = cytoplasm, 
V = virion 
D. Higher magnification of a cytoplasmic region of a BV -w,st infected cell. 
Magnification 255,000 x (bar = 0.08 µm). N = nucleus, NE = nuclear 
envelope, V = virion, C = cytoplasm. 
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insect cells after recombinant baculovirus infection and that some of the White 
protein was reaching the plasma membrane. The confocal and flow cytometry 
analysis of the localisation of Scarlet protein indicated Scarlet protein was 
located intracellularly, however it could not be determined whether Scarlet 
protein was also assembling in the plasma membrane. Consequently, it 
seemed appropriate to test White /Scarlet expressing cells for an increase in 
tryptophan uptake in comparison with uninfected and control virus infected 
cells. This was carried out by incubating the cells with radiolabelled tryptophan 
and subsequently harvesting the cells at different times after infection and then 
quantifying the level of radiolabel uptake of the cell samples by liquid 
scintillation counting (as described in Section 2.6.4). 
Fig. 18 illustrates graphically the counts /min versus the hours post infection of 
the three experimental groups: A. BV -w /s infected, B. BV- control virus infected, 
C. uninfected cells. The graphs illustrate that there is no significant difference 
in level of uptake of radiolabelled tryptophan between uninfected cells, 
White /Scarlet expressing cells, or control virus infected cells. This experiment 
was performed on two separate occasions with similar results on each 
occasion. 
5.3 Discussion 
The results presented in this chapter describe work directed towards the 
development of a heterologous insect cell expression system for characterising 
the structure and function of the White and Scarlet proteins of 
D. melanogaster. As an adjunct to this work, antibodies were raised against 
synthetic peptides representing protein epitopes of White and Scarlet 
(described in Chapter 4). The cDNA of both genes were sub -cloned into the 
baculovirus transfer vector pAcUW31 for the dual expression of both the White 
and Scarlet proteins under the control of the p10 and polyhedrin baculovirus 
promoter elements respectively. Recombinant baculovirus BV -w,st was 
produced by co- transfection and homologous recombination between 
Fig. 18 Analysis of L45 3H]Tryptophan uptake activity of White and 
Scarlet expressing cells 
Sf9 cells growing as a cell monolayer in a mìcrotitre plate were infected with the 
respective virus as indicated on each graph and L -[5 3H]Tryptophan was added 
to the cells in growth medium at a concentration of 1 µCi /ml, as described in 
Chapter 2, Section 2.6.4. Cells were harvested at 6 hpi, 24 hpi, 31 hpi and 48 
hpi and counted for radioactivity. Each time course was performed in 
quadruplicate and the mean plotted on the graph. The error bars represent the 
standard deviation of the mean. 
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pAcUW31 w,st and linear AcMNPV baculovirus DNA. Cells infected with the 
resulting recombinant baculovirus were shown to express both the White and 
Scarlet proteins by Western blot detection using antibodies specific for the 
White and Scarlet proteins. The appearance of White and Scarlet protein 
coincided with the time post infection when both promoter elements were 
activated (around 18 hpi). The molecular weights of both White and Scarlet 
observed by SDS PAGE and Western blotting indicated that the proteins were 
not being glycosylated which was confirmed by addition of tunicamycin (an 
inhibitor of glycosylation) which did not alter the apparent molecular weight of 
White or Scarlet. 
The immuno -localisation studies of the White and Scarlet protein in BV -w,st 
infected cells and differential centrifugation indicated that some of the White 
protein was reaching the plasma membrane, however most of the protein 
remained intracellular and was insoluble. Immune- localisation of Scarlet using 
anti -stNT antibody provided evidence that most of the protein was intracellular 
and insoluble, however it could not be ruled out that a low level - which could 
not be detected by Western blotting - might be reaching the plasma membrane 
and assembling with the White protein. A further antibody recognising an 
extracellular epitope of Scarlet would have been useful to clarify this point. 
However, despite the presence of White, and possibly a low level of Scarlet, no 
evidence for an increased level of tryptophan uptake in Sf9 cells was observed. 
It is not clear whether this was due to the presence of a native tryptophan 
transport activity causing any activity conferred by a low level of White /Scarlet 
transporter to be undetectable. Alternatively, it may be that the White /Scarlet 
transporter is not assembling correctly or requires some form of post - 
translational modification for function. The Western blot analysis of White and 
Scarlet protein from Drosophila heads suggests that White and Scarlet are 
glycosylated or post -translationally modified in some way, in vivo. 
The observation that most of the protein was sedimented by low speed 
centrifugation, as well as the presence of 14 nm particles in this cell fraction 
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(observed by transmission electron microscopy) strongly suggests that a large 
proportion of the expressed White and Scarlet protein was failing to enter the 
correct folding and targeting pathway resulting in misfolding and precipitation. 
The presence of some White at the plasma membrane however, suggests that 
at least some White protein (and possibly also Scarlet) leaks into an 
appropriate pathway for plasma membrane localisation. The observation that 
insoluble 14 nm particles were also present in Gaba infected cells suggests 
that a large proportion of the Gaba protein was also misfolded and forms very 
similar protein particles. It is possible that this is a common problem with over - 
expression of membrane proteins late in the Baculovirus infection and this is 
discussed below. 
The possible reasons for the misfolding could be due to a combination of the 
following: 
a) late over -expression of the heterologous proteins, at a time when the 
cells are under severe metabolic stress; 
b) the protein sorting signals of White and Scarlet may not be recognised 
by the Sf9 protein sorting machinery; 
c) and the absence of glycosylated White and Scarlet may contribute to 
protein instability and misfolding of these proteins. 
Each of these factors are discussed below. 
Heterologous protein expression during the late stages of baculovirus 
infection 
It has been recently noted that a major disadvantage of the baculovirus based 
expression system is that the viral infection causes dramatic perturbations of 
the cellular environment (Lenhard and Reiländer, 1997). As a result, the insect 
cells may not be able to fulfil the post -translational modification and folding 
pathways required for the over -expressed foreign protein (Lenhard and 
Reiländer, 1997). This was thought to be particularly evident for polytopic 
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membrane proteins where correct folding of the recombinant protein is often the 
rate limiting step in production of the active protein (Grisshammer and Tate, 
1995; Lenhard and Reiländer, 1997). The polyhedron and p10 promoters are 
designated "very late" promoters and therefore the over -expression of a foreign 
polytopic membrane protein at this late stage of viral infection - at a time when 
the cell is under severe metabolic stress - can often result in misfolding 
(Lenhard and Reiländer, 1997). This problem has been recently addressed by a 
combination of the use of an earlier promoter, in addition to a modified Sf9 cell 
line, stably transformed with the ninaA gene from Drosophila (Lenhard and 
Reiländer, 1997). The product of the ninaA'3 gene has been demonstrated to 
ensure the correct folding of the membrane protein rhodopsin 1 in the 
photoreceptor cells of Drosophila, as well as playing a role in protein trafficking 
(Schneuwly et al, 1989; Shieh et al, 1989; Stamnes et al, 1991). The 
combination of an early promoter element (immediate early 1 (iel)) and the 
modified Sf9 cell line (Sfn) was used to express the human dopamine 
transporter with a five fold increase in activity of the transporter, compared to 
expression in standard Sf9 cells (Lenhard and Reiländer, 1997). 
Protein sorting and trafficking 
A possible contributing factor to the misfolding of White and Scarlet may be due 
to the absence of appropriate protein sorting signal sequences which are 
recognised by the sorting machinery of Sf9 cells. Protein sorting motifs are 
generally found at specific regions of the carboxy -terminal or amino -terminal 
cytoplasmic tails of membrane proteins and a number of examples of membrane 
protein sorting signals are shown in Table 1. The protein localisation prediction 
program PSort (Nakai and Horton, 1999) was applied to White, Scarlet and 
Brown and did not detect any relevant signal sequences. Close inspection of 
the amino acid sequences of White and Scarlet reveals no obvious sorting 
signals, however a possible di- leucine motif is evident in the White protein 
"The NinaA protein is a cyclophilin homolog which are peptidyl- prolyl cis -trans isomerases 
and has been implicated in catalyzing protein folding (Lang et ai, 1987). 
Table 1 Consensus sequence motifs for membrane protein localisation 
Consensus sequence Protein Reference 
& type 
Tyrosine based (NPXY -type) 
FDNPVY LDL receptor (Chen et al, 1990) 
YENPTY ß- amyloid precursor (Kang et al, 1987) 
protein 
FENTLY mannose receptor (Taylor et al, 1990) 
Tyrosine based (YXX0 -type) 
YKYSKV CD- Mannose -6- (Canfield et al, 
phosphate receptor 1991) 
YTRF transferrin receptor (Collawn et al, 
1990) 
YQPL T -cell receptor (CD3) (Letourneur and 
Klausner, 1992) 
GYQTI Igp -A /lamp -1 (Williams and 
Fukuda, 1990) 
GYRHV lysosomal acid (Trowbridge and 
phosphatase Collawn, 1993) 
Di- leucine -based 
DKQTLL CD3 -y (Letourneur and 
Klausner, 1992) 
ENTITYSLL IgG Fc receptor (Hunziker and 
Fumey, 1994) 
MHC class II invariant (Salamero et al, 
chain 1996) 
LIMP -II (Höning et al, 1998) 
Tyrosinase (Höning et al, 1998) 
LI 
DEXXXLI 
EEXXXLL 
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sequence, at the N- terminal domain close to the first predicted transmembrane 
domain (Fig. 19). This sequence does not appear to be conserved in the 
Scarlet or Brown protein sequences, although it is conserved in homologs of 
White in other species (see Fig. 19). This sequence is similar to a di- leucine 
motif important for protein sorting of membrane proteins to the eucaryotic 
lysosome and melanosome", as well as the yeast vacuole (see Fig. 19). This 
issue is taken up again in more depth in Chapter 7 which describes the 
localisation of White and Scarlet in Drosophila eye tissue, providing new 
insights into the specialised nature of targeting of the White and Scarlet 
proteins. 
Role of glycosylation in protein folding 
The absence of glycosylated product is another possible contributing factor to 
the misfolding of White and Scarlet in Sf9 cells. Western blot analysis of White 
and Scarlet extracted from eye tissue indicated that the protein is glycosylated 
(or post -translationally modified in some other way) due to the higher molecular 
weight observed in comparison to the predicted molecular weight. In this study 
it was clear that White and Scarlet were not glycosylated in Sf9 cells (see 
Section 5.2.2b). It has been previously observed that membrane proteins 
containing 10 to 12 transmembrane domains are poorly glycosylated in Sf9 
cells when over -expressed (e.g. P- glycoprotein, CFTR and serotonin receptor), 
particularly during the later stages of Baculovirus infection (Germann et al, 
1990; Kartner et al, 1991; Tate and Blakely, 1994). This is in contrast to 
recombinant membrane proteins with only one or relatively few transmembrane 
spanning regions which are glycosylated efficiently (Grisshammer and Tate, 
1995; Tordo et al, 1993). This indicates that the machinery required for 
glycosylation is not deficient in insect cells, but is less likely to function 
efficiently when faced with more complex membrane proteins harbouring 
multiple transmembrane regions. 
Melanosomes and pigmented organelles containing melanin and are found in eucaryotic 
melanocytes. 
Fig. 19 Comparison of signal sequences of membrane proteins targeted 
to lysosomes and melanosomes with a possible signal sequence of White 
Illustrated here are similarities between a possible sorting signal identified in the 
White amino- terminal domain, and dileucine -based sorting signals in a number 
of membrane proteins targeted to the melanosome and to the lysosome of 
eucaryotes and vacuole of yeast (the yeast vacuole is considered to be 
equivalent to the eucaryotic lysosome). This diagram was reproduced in part 
from a review by (Odorizzi et al, 1998). The dileucine -based sequences are 
boxed, and the surrounding residues are shown, including conserved glutamic 
acid residues (bold -face) located upstream of the dileucine. The number of 
additional residues either side of the motif sequence is indicated over a solid 
line. The positions of the N- or C- termini and transmembrane domains (TMDs) 
are also shown. 
Abbreviations are as follows: dWhite, Drosophila melanogaster White; Lc, 
Lucilia Cuprina (Australian sheep blowfly); Cc, Ceratitis capitata (Mediterranean 
fruit fly); Ag, Anopheles gambiae (African malaria mosquito); hWhite, human 
White homolog*; mWhite, mouse White homolog" . 
Homologs of the Drosophila White protein have been identified in mouse and humans (Chen et 
al, 1996; Croop et al, 1997; Savary et al, 1996), however homologs of Brown and Scarlet have 
not been identified in mammals. The function of mammalian homologs of White has not yet 
been determined. 
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Although glycosylation may not always be required for function, it is often 
required during the folding pathway and for stabilisation of the protein (reviewed 
in (Lis and Sharon, 1993)). Glycosylated proteins bind specifically to the 
membrane bound protein calnexin, which is proposed to perform a role as a 
molecular chaperone (Bergeron et al, 1994). It has been shown that the folding 
pathway of P- glycoprotein involves calnexin and Hsc70 in HEK cells (Loo and 
Clarke, 1995c). In addition, glucosyltransferase in the ER recognises unfolded 
proteins and re- glucosylates them so that they are retained in the ER for folding 
(Hartle et al, 1994). Misfolded proteins precipitate or aggregate at the ER and 
are often degraded (Hartle et al, 1994). However degradation does not appear 
to be a significant problem with the baculovirus -based expression of White and 
Scarlet due to the low level of visible degradation products. 
Future prospects 
The future prospects for this work as a heterologous expression system for 
structure and function analysis of White and Scarlet depends on whether the 
misfolding problem can be overcome. The approach described above (Lenhard 
and Reiländer, 1997) which combines a modified Sf9 strain (Sfn), harbouring 
the Drosophila ninaA gene, in addition to the use of an earlier promoter 
element, to drive expression, would be a feasible course of action_ In addition 
to this, the introduction of an appropriate plasma membrane signal sequence, 
could also have a significant impact on targeting to the plasma membrane. 
Alternatively, a solubilisation and reconstitution system could be developed. 
This technique has been used successfully for a number of ABC transporters, 
including both human P- glycoprotein (Dong et al, 1996; Shapiro and Ling, 
1995; Urbatsch et al, 1994), and CFTR, (Bear et al, 1997; Li et al, 1996a; Li et 
al, 1996b). Chaotropic agents such as urea, guanidine HCI, or SDS are often 
used to completely denature and solubilise the proteins from protein 
aggregates or inclusion bodies obtained through E. coli based or eucaryotic 
based expression systems, followed by removal of the denaturant and addition 
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of membrane phospholipids, resulting in reconstitution of the membrane protein 
into proteoliposomes. In some cases e.g. P- glycoprotein, the use of 
denaturants is not required and solubilisation can be achieved using non - 
denaturing detergents such as octyl -glucoside (Urbatsch et al, 1994). The 
protein particles observed in this work - believed to be White and Scarlet 
protein - are not typical of previously described inclusion bodies in Sf9 cells, 
which form very large, electron dense inclusions within the cytoplasm (Barber et 
al, 1990; Matsuura et al, 1987). The small size of the White and Scarlet protein 
particles may allow their solubilisation with non -denaturing detergents. 
CHAPTER 6 
EXPRESSION OF THE WHITE ATP BINDING 
DOMAIN IN E. coli 
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6. EXPRESSION OF THE WHITE ATP BINDING 
DOMAIN IN E. coli 
6.1 Introduction 
The aim of the work described in this chapter was to develop a system for 
studying the structure and function of the ATP binding domains of the White, 
Scarlet and Brown proteins of D. melanogaster. As a first step towards this 
goal, attention was focused on the expression and partial purification of the 
White nucleotide binding domain (NBD), in order to develop a system which 
could then be applied to the NBDs of Scarlet and Brown. Expression of the full 
length white encoded subunit has been previously attempted in this laboratory, 
however was unsuccessful largely due to low expression levels and to the 
insolubility of the protein. For this reason, the expression of the NBD on its 
own, was thought to provide a much better chance for high expression levels 
and solubility. The NBD of the White protein, as well as those of other ABC 
transporters, have a high degree of hydrophilicity as predicted from sequence 
and hydropathy analysis. In addition, the strategy of expressing and purifying 
the NBD on its own, has been used successfully in the functional 
characterisation of both NBD 1 and 2 of CFTR (Gruis and Price, 1997; Ko et al, 
1997; Randak et al, 1995), and P- glycoprotein (Dayan et al, 1996), as well as 
for procaryotic ABC transporters (Koronakis et al, 1993). 
The power of the technique of heterologous expression and purification of the 
NBD alone - for gaining insights into the structure and function - has been 
elegantly shown in studies of the NBDs of CFTR. It has been shown that 
NBF 1, in the absence of any CFTR transmembrane domain, was able to 
conduct anions across a planar lipid bilayer and that the channel activity was 
modulated by ATP (Arispe et al, 1992). This finding challenged the earlier 
predicted structural models based on sequence and hydropathy analysis that 
the NBDs of CFTR and other ABC transporters are intracellular and do not 
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span the membrane (Higgins et al, 1986). It has also been shown that the 
CFTR NBDs, by themselves, are capable of spanning the eukaryotic cell 
plasma membrane and are accessible from the outside of the cell (Gruis and 
Price, 1997). These findings were in agreement with earlier reports that the 
bacterial histidine transporter NBD, namely HísP protein, was also surface - 
accessible (Baichwal et al, 1993). These studies suggest that the NBDs of 
ABC transporters may form an integral part of the channel or transport lumen. 
Although the structure of HisP is now known (Hung et al, 1998), the 
extracellular accessibility could not have been predicted from the structure 
alone. It is only biochemical and biophysical studies such as those mentioned 
above, that can provide such insights, particularly in the absence of a crystal 
structure of the complete transporter in its various conformational states 
between open and closed. 
This work represents the first steps towards the development of a new model 
system for studying not only ATP binding and hydrolysis activity of this domain 
of the Drosophila transporters, but also for protein -protein interactions. The 
proposed importance of intracellular loops as an interface between the NBD 
and TM domains was introduced in Chapter 1, Section 1.4. Work towards the 
development of an experimental approach to investigate interactions between 
the predicted intracellular loop between TM 2 and TM 3 (see Fig. 1), and the 
White NBD, and the effect of the mutation identified in the wEr87 allele (Chapter 
3), is investigated. 
The experimental strategy used in this work, utilises fusion protein technology 
which is a well established technique used for the over -expression of 
heterologous proteins in E. coli (Uhlen and Moks, 1990). Recombinant DNA 
technology allows relatively easy construction of gene fusions. There are 
many specialised plasmid vectors available commercially with convenient 
multiple cloning sites allowing insertion of the gene of interest, in frame with the 
fusion partner, for expression in E. coli. A number of different proteins have 
been utilised as fusion partners, and advantage is taken of particular 
Fig. 1 Model of the White /Scarlet transport complex 
This cartoon illustrates the possible interactions which may occur 
between the nucleotide binding domains (NBDs) and intra- helical 
loop regions. Evidence of such interactions in other ABC 
transporters was discussed in Chapter 1. The position of the 
mutation identified in the eye colour mutant WET87 (G509D) is 
highlighted and the sequence representing the wild type and mutant 
loops is provided. The interaction between the White NBD and the 
wild type and mutant forms of this loop is investigated in this 
chapter. 
ADP + Pi 
Loop 2 -3 peptides: 
C I EAF SRLYRCDTYFLGK +TIAÉ wild type 
D WET87 G509D mutant 
Scarlet NBD 
/ ATP 
ADP + Pi 
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characteristics or properties of the protein (e.g. substrate binding affinity can be 
used as an affinity tag ). Another advantage of expressing heterologous 
proteins in E. coli as fusion proteins, is the increased solubility and decreased 
proteolytic degradation often observed compared to expression of the foreign 
protein alone (Uhlen and Moks, 1990). 
Glutathione -S- transferase (GST) was chosen as the fusion partner for the 
White NBD. GST fusion protein technology (Smith and Johnson, 1988) has 
been used successfully in this laboratory to express and partially purify a 
number of heterologous membrane proteins in E. coli (Ewart et al, 1996; Piller 
et al, 1999). GST is a soluble procaryotic enzyme and thereby can help reduce 
insolubility problems of a heterologously expressed protein. GST binds with 
high affinity to its substrate, glutathione, and therefore, GST fusion proteins can 
be affinity purified using glutathione- immobilised agarose beads (see Fig. 2). 
The aim of this technique was to over -express the GST -White NBD fusion 
protein for subsequent purification under non -denaturing conditions which 
would allow functional characterisation of the biologically active protein. In 
addition, development of a successful system for purification of high levels of 
the White NBD (e.g.10 mg /ml) would present the possibility of protein 
crystallisation and x -ray crystallographic analysis. To date the crystal structure 
of the nucleotide binding domain from only one procaryotic member of the ABC 
transporter superfamily has been determined (Hung et al, 1998). The 
determination of the structure of other members of the family would add 
significantly to the understanding of the function of the nucleotide binding 
domain and the superfamily as a whole. 
The results section of this chapter is divided into a number of sub- sections as 
follows: 
Construction of expression vectors. This part describes the E. coli 
plasmid expression vectors used for expression of the white NBD. In addition, 
the site directed mutagenesis of the Walker motif A for subsequent functional 
studies is described. 
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Purification trials. A number of difficulties were encountered with the 
attempted purification of the White NBD and this section summarises the 
different conditions which were trialed in an attempt to optimise the purity and 
yield of the White NBD. 
Functional studies. ATP binding and hydrolysis studies were performed 
using partially purified wild -type and mutant White NBD to determine whether 
the protein was biologically active. 
Protein -peptide interaction studies. Interactions between the White 
NBD and a predicted intracellular loop between TM 2 and 3 of the White 
transmembrane domain were investigated. 
6.2 Results 
6.2.1 Construction of E. coli plasmid vectors for expression of the 
White NBD as a GST fusion protein 
A number of E. coli plasmid expression vectors were constructed in this work 
and these are described in the first part of the results section. They are based 
on the plasmid p2GEX (see Chapter 2 Section 2.4 for a full description of this 
and related plasmids). This vector in turn was based on the commercially 
available vector pGEX -4T -1 (Pharmacia) which was modified by our laboratory 
to incorporate an additional GST gene; one which will act as the 5' fusion 
partner to the white NBD; and the other which is expressed as unfused GST. 
This construct was found in some cases to aid solubility of heterologously over - 
expressed proteins, as well as decrease degradation of the fusion protein and 
was the original concept of our Group Leader G Cox. The reasoning for this is 
due to the high propensity of GST monomers to dimerize (Reinemer et al, 1991), 
and when a GST fusion protein is expressed without free GST present, some 
GST fusion proteins may aggregate and become unstable due to the steric 
hindrance to the dimerization caused by the heterologous protein fused to the 
GST. The effect of the presence of unfused GST is tested here and was 
consistent with the above interpretation. The theory behind the purification of 
GST- fusion protein is shown in Fig. 2. 
Fig. 2 Affinity purification by glutathione- agarose 
chromatography and Ni -NTA affinity chromat ography 
Glut at híone- 
Agarose bead 
glutath ione 
GST 
GST - .:::wNBD: 
GST 
GST ,`wNBD`` 
Thrombin cleavage site 
GST 
GST 
'w 
GST fusion protein over - 
expressed in E coil is 
parti ally purified from 
fractions containing fusion 
protein by binding to 
glutathi one -agarose beads. 
Fusion proteins are elute d 
from glutathione -agarose by 
incubation with reduced 
glut athione. 
Parti ally purified fusion prote in 
The wNBD is released from 
its GST fusion partner by 
digestion with thrombin. 
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6.2.1.a Plasmid construct pGEX4T1,wNBD 
A DNA fragment encoding the White nucleotide binding domain (NBD) 
(nucleotides 1 to 1293 of the white cDNA; amino acids 1 to 431 of White 
protein) (see Appendix 1) was amplified by PCR using oligonucleotides 94 -6 
and 94 -5 (the sequences of these oligonucleotides are listed in Section 2.14). 
The oligonucleotides were designed to incorporate BamHl and EcoRI restriction 
sites at the 5' and 3' ends respectively of the amplified DNA fragment. The 
1.3 Kb amplified PCR product (shown in Fig. 3A) was purified and then ligated 
(described in Chapter 2, Section 2.3) into the multiple cloning site of the 
plasmid vector pGEX41T, resulting in the final construct which was named 
pGEX41T,wNBD. The plasmid map of this construct is illustrated in Fig. 3B. 
Fig, 3C shows restriction analysis of a sub -clone, where a BamHl and EcoRI 
restriction digest of pGEX41T,wNBD resulted in the predicted fragment sizes 
representing the vector DNA (4.9 Kb) and the wNBD DNA (1.3 Kb). 
6.2.1.b Plasmid construct p2GEX,wNBD 
The plasmid p2GEX,wNBD was constructed in the same way as described for 
pGEX4T1,wNDB (Section 6.2.1a), except that the plasmid p2GEX was used as 
the vector for the wNBD cDNA PCR fragment. The plasmid map of this 
construct is illustrated in Fig. 3D. Fig. 3E shows restriction analysis of a 
successful sub -clone where a BamHl and EcoRI restriction digest of 
p2GEX,wNBD resulted in the predicted fragment sizes representing the vector 
DNA (6.1 Kb) and the wNBD DNA (1.3 Kb). 
6.2.1.c Introduction of a hexa -histidine motif into p2GEX,wNBD 
A DNA fragment encoding a six -histidine repeat motif was introduced into the 
plasmid vector p2GEX,wNBD at the 5' of the white NBD in order to provide a 
second affinity tag and enhance purification. Two complimentary 
oligonucleotides (96 -61 and 96 -62) (sequences provided in Section 2.14) were 
Fig. 3 Plasmid maps and restriction analysis of p2GEX,wNBD and 
pGEX4T1,wNBD. 
A. The 1.3 Kb PCR product of a reaction amplifying the white cDNA 
encoding the nucleotide binding domain (NBD). This product was 
subcloned into the plasmid vectors shown in B and D. 
B. Plasmid map of pGEX4T1,wNBD. A full description of the plasmid vector 
is provided in Chapter 2, Section 2.4. The 1.3 Kb PCR product encoding 
the White NBD was sub -cloned into the BamHl and EcoRl restriction site 
as a C- terminal fusion to GST, 
C. Agarose gel electrophoresis analysis of DNA fragments resulting from a 
BamHl and EcoRl restriction digest of pGEX4T1,wNBD. The 4.9 Kb 
vector, and 1.3 Kb wNBD DNA can be seen. 
D. Plasmid map of p2GEX,wNBD. A full description of the plasmid vector 
p2GEX is provided in Chapter 2, Section 2.4. This construct harbours an 
addition, unfused GST gene. The 1,3 Kb PCR product encoding the 
White NBD was sub -cloned into the BamHl and EcoRl restriction site as a 
C- terminal fusion to GST. 
E. Agarose gel electrophoresis analysis of DNA fragments resulting from a 
BamHl and EcoRl restriction digest of p2GEX,wNBD. The 6.1 Kb vector, 
and 1.3 Kb wNBD DNA can be seen. 
pGEX4T1,wNBD 
6269 bp 
EcoR1 
A 12216- 
3,054- 
2,036- 
1,636- 
1,018- 
506- 
C 
12216 
3,054- 
2,036- 
1,536- 
1,018- 
506- 
Thrombin Multiple cloning site 
I 
Leu Val Pro Arg Gly Ser Pro Glu Phe Pro Gly Arg Leu Glu Arg Pro His Arg Asp 
CTG GTT CCG CGT rGA TCC CCG GAA TTC CCG GG CGA CT GAG CGG CCG CAT CGT GAC TGA 
Stop codons 
BamHI EcoPi Smal Sall Xhol Noll 
D PTac 
GS 
p2GEX,wNBD 
7424 bp 
AmpR 
oR1 
E 
12,216- 
a 
,p 3,054- 
d 2,036- 
á 1,636- 
< 1,018- 
Z 
o 
506- 
4- 1.3 Kb 
F 4.9 Kb 
F 1.3 Kb 
F6.1 Kb 
F1.3 Kb 
131 
designed to encode a six histidine repeat, with overhanging BamHl 'sticky ends'. 
Equal quantities of each oligonucleotide (0.3 }.tg /µl) were mixed in water and 
heated to 100 °C, then cooled slowly to room temperature to allow the 
oligonucleotides to anneal. The annealed oligonucleotides were then ligated 
into the BamHI digested, and phosphatased vector as described in Chapter 2, 
Section 2.3. The resulting plasmid (named p2GEX,wNBDsh;swas sequenced 
over the region of the inserted hexa histidine to ensure the insert was correctly 
oriented and that it was in frame with the GST gene and white NBD (data not 
shown). 
6.2.1.d Plasmid construct p2GEX,wNBD, stNBD 
This construct was based on p2GEX,wNBD however the cDNA encoding the 
scarlet NBD was sub- cloned downstream of the GST -white fusion to be co- 
expressed for White /Scarlet interaction tests. The cDNA sequence encoding 
the scarlet NBD was amplified by PCR using oligonucleotide primers designed 
to incorporate an EcoRl restriction site at the 5' end of the fragment, in addition 
to the UncE pregenic sequence15 upstream of the start codon, and a Notl 
restriction site at the 3' end. The scarlet NBD fragment was amplified 
successfully by PCR as shown in Fig. 4. This fragment was cloned into the 
EcoRl /Notl restriction site of the multiple cloning site of p2GEX,wNBD and the 
resulting plasmid was named p2GEX,wNBD, stNBD. 
6.2.1.e Mutagenesis of the Walker motif A of the white NBD 
Site directed mutagenesis of the Walker motif A of the white NBD was carried 
out in order to obtain mutant protein which would act as a negative control for 
structure -function analysis. The amino acids targeted for mutagenesis were 
Gly135Lys136 which are 100% conserved in the Walker A motif of ABC 
transporters and other ATP and GTP binding proteins and form part of the 
phosphate binding loop (P -loop) described in the introductory Chapter 1, 
15 uncE gene of E.coli encodes the c subunit of ATPsynthase and the uncE pregenic sequence 
contains a ribosome binding site and results in high expression in E. co /i (Solomon et al, 1989). 
Fig. 4 Plasmid construct p2GEX,wNBD,stNBD 
This plasmid vector p2GEX, wNBD,stNBD was designed for co- expression of the 
following proteins: 
1. GST -wNBD fusion protein 
2. Unfused GST 
3. stNBD 
A. Physical map of the p2GEX,wNBD,stNBD plasmid. 
B. Amplified PCR product representing cDNA encoding the NBD of Scarlet. 
Plasmid DNA harbouring the scarlet cDNA was used as template. 
C. Agarose gel electrophoresis analysis of an EcoRl /Not! restriction digest of 
p2GEX,wNBD,stNBD after successful sub -cloning of stNBD amplified by 
PCR. The stNBD insert (1,300 bp) and the vector DNA (7,430) are 
labelled). 
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Section 1.5.2a. Mutations of this motif have been shown to completely knock- 
out function of a number of ABC transporters (Cox et al, 1989; Ewart et al, 1994; 
Mimura et al, 1991) and reduce ATP binding and hydrolysis activity (Mimura et 
al, 1991). In this work, Gly135Lys136 were mutated to Leu135Gln136 which is a 
non -conservative mutation expected to alter the structure in the vicinity of the P- 
loop and thereby substantially reduce ATP binding activity. Mutagenesis of this 
site has been performed previously and the mutant white gene was transformed 
into w° flies carrying a large deletion in the endogenous white gene (Ewart et al, 
1994). The mutant white gene carrying the Leut35Gln135 substitutions failed to 
restore eye pigmentation in the transformants which showed that the mutant 
White protein was unable to support the function of either White /Scarlet, or 
White /Brown transporters (Ewart et al, 1994). The oligonucleotide used for the 
introduction of these substitutions at the DNA level, were designed to introduce 
a unique Pstl site for selection of successful mutants by restriction mapping. 
Site directed mutagenesis was performed using the Kunkel method described in 
Chapter 2, Section 22.10. The mutagenic oligonucleotide 91 -122 (sequence 
provided in Chapter 2, Section 2.14) was used and annealed to uracil- containing 
single stranded template DNA which was then passaged through E. coli strain 
XL1 Blue which destroys the non -mutant template DNA while replicating the 
mutant strand. Purified plasmid was then prepared from transformant colonies 
and screened for the presence of the introduced Pstl restriction site (see Fig. 5). 
DNA sequence analysis of plasmids showing the correct restriction pattern and 
harbouring the Pstl site introduced by mutagenesis was used to confirm the 
presence of the mutation (data not shown). 
Table 1 provides a summary of the pGEX based plasmid constructs used to 
express wNBD in E. coif for affinity purification. 
135K'36 of the White NBD Fig. 5 Site directed mutagenesis of G 
The mutation G135K136 LQ within the Walker A motif introduces a Pstl restriction 
site. The Kunkel method of mutagenesis was performed (described Chapter 2) 
using single stranded DNA template prepared using the E. coli plasmid vector 
pBSK- . When mutagenesis was complete, wNBD was sub -cloned into p2GEX and 
named p2GEX,wNBDmut 1. 
A. Plasmid map of the plasmid construct pBSK ",wNBDmut1 showing predicted 
fragments which would result from a Pstl /Notl double digest. 
B. Pstl /Notl double digest showing the successful introduction of the Pstl 
restriction site (lane 1). Lane 2 is pBSK -,wNBD prior to mutagenisis which 
results in a single DNA band of around 4,200 bp. 
C. Plasmid map of plasmid p2GEX,wNBDmut 1 showing predicted fragments 
which would result from a Pstl /Notl double digest. 
D. Pstl/Notl double digest showing correct restriction pattern (labelled) as 
predicted in C (lane 1). Lane 2 is p2GEX,wNBD prior to mutagenesis which 
results in the bands 4380, 2145 and 900 bp. 
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Table 1 Plasmid constructs for over -expression of wNBD in E. coli for 
subsequent affinity purification and functional analysis 
Plasmid name Use 
pGEX4T1,wNBD 
"p2GEX,wNBD 
Over -express GST -wNBD fusion protein for affinity 
purification using glutathione -agarose 
chromatography. 
No unfused GST monomer. 
Co over -expression of unfused GST and GST -wNBD 
to improve yield of fusion protein obtained by affinity 
purification. 
*p2GEX,wNBDshs Introduction of a second affinity tag (6 -his) for 
secondary purification using Ni -NTA affinity resin. 
"p2GEX,wNBD,stNBD Co- expression of GST -wNBD fusion protein and 
unfused stNBD for co- purification /interaction analysis. 
"p2GEX,wNBDmut1 The site directed mutation G135K136 LQ was 
introduced into the Walker A motif to test ATP binding 
function of wild -type and mutant wNBD partially 
purified by glutathione- agarose chromatography. 
"All p2GEX constructs produce GST monomer in addition to the GST -fusion 
protein. 
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6.2.2 Expression and partial purification of the white NBD 
6.2.2.a Expression of GST,wNBD fusion protein in E. coli 
The plasmid p2GEX,wNBD was transformed into E. coli strain AN3700 and 
expression of the GST,wNBD was analysed by SDS PAGE and Western blot 
detection over a time course. Fig. 6A shows the detection of the fusion protein 
from whole cell samples, and its increase in quantity over a time period 
between 0 and 3 hours after inducing expression from the pTac promoter by 
the addition of IPTG. A low level of fusion protein was detected at time 0 
indicating that the pTac promoter element is not completely repressed by the 
Laq I4 represser. This low level of fusion protein did not inhibit growth since 
high cell densities were obtained prior to induction. After induction rapid cell 
growth halted due to the over -expression of the heterologous protein. 
6.2.2.b Cell fractionation of cells expressing GST -wNBD fusion protein 
In order to determine the sub -cellular localisation of the expressed GST -wNBD 
fusion protein, cells were fractionated by differential centrifugation (described in 
Chapter 2, Section 2.6.5a). Fig. 6B is an SDS PAGE and Western blot analysis 
of the cell fractions obtained from the cytoplasm, crude membranes and cell 
debris16. It can be seen from the SDS PAGE and Western analysis shown in 
Fig_ 6A and B that most of the fusion protein was found in the insoluble cell 
debris fraction and also in the membrane fraction, and essentially no fusion 
protein was detected in the soluble, cytosolic fraction. This result gave a strong 
indication that most of the fusion protein was insoluble and that some was 
associating with the cell membrane. The following sections describe efforts to 
optimise some of the conditions necessary in order to solubilise the GST -wNBD 
from the membrane and cell debris fractions. 
16 Cell debris is the term given to cellular material which can be separated from the soluble and 
membrane fractions by low speed centrifugation (10,000 rpm). This includes insoluble proteins 
and other insoluble cell components such as the cell wall. 
Fig. 6 Expression of GST -wNBD fusion protein and its detection in 
different cell fractions of E. coli 
1L of E. coli strain AN3701, p2GEX,wNBD was grown to late log phase and 
induced with 0.1 mM IPTG for 3 hrs. 
A. 50 pl samples of cell culture were taken at the times (mins) indicated and 
mixed with 2 x SDS PAGE sample buffer, and analysed by SDS PAGE 
(Coomassie stained) and Western blotting using anti -wNT antibody. 
B. Cell fractions were separated by differential centrifugation (described 
Chapter 2, Section 2.6.5). Each fraction was resuspended to give a final 
volume equal to the starting volume when the cells were lysed, so that the 
levels of protein in each fraction could be directly compared. Samples were 
then analysed by SDS PAGE and Western Blotting. 
Abbreviations: Smash, lysed whole cells; CD, cell debris: cyto, cytoplasm; 
mem, crude membrane fraction. 
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6.2.2.c Partial purification of GST -wNBD fusion protein by glutathione 
agarose chromatography 
Cell fractionation experiments described above showed that a large proportion 
( -70 %) of the GST -wNBD fusion protein was found in the insoluble cell debris 
fraction, however some ( -30 %) was detected in the membrane fraction. First 
attempts to purify GST -wNBD involved the solubilisation of the membrane 
fraction using the non -denaturing detergents TX -100, and CHAPS, followed by 
affinity chromatography using glutathione -agarose (described in Chapter 2, 
2.9). Fig. 7 shows the partial purification of GST -wNBD, where Fig. 7A, lane 1 
shows detergent solubilised fusion protein which has bound to the glutathione- 
agarose beads, while lanes 2 to 5 shows removal of the fusion protein from the 
glutathione agarose by addition of reduced glutathione. Fig. 7B shows the 
resulting change in molecular weight after cleavage of the fusion protein by the 
addition of thrombin, from around 72 kDa, to around 47 kDa, which is the 
predicted molecular weight of the White NBD. This result was encouraging as it 
showed that the wNBD can be partially purified using this technique, from small 
scale cultures (1 L) at a level which is easily detectible by Coomassie Blue on 
an SDS PAGE gel. The following sections summarise work performed In an 
attempt to optimise the conditions required to obtain the highest yield, 
solubilisation and level of purification of the wNBD. 
6.2.2.d Optimisation of yield, solubilisation and purification of the 
White NDB 
A number of parameters were altered in order to compare different conditions 
with the view of increasing the final yield of partially purified wNBD, This work 
is summarised in Table 2 and the results are described below. 
Comparison of yields of soluble partially purified GST -wNDB fusion 
protein using single and double GST expression vectors 
As mentioned earlier in the introduction to this chapter, the p2GEX vector was 
thought to be superior to pGEX4T1 in that the presence of an unfused GST 
Fig. 7 Expression of GST -wNBD fusion protein in E. coli, and partial 
purification by glutathione -agarose affinity chromatography 
1L of E. coli strain AN3701, p2GEX,wNBD was grown at 30 °C in LB, Glucose, 
Amp, Tet medium and induced with 0.1 mM IPTG at late log phase and grown 
for a further 3 hrs. Cells were harvested, lysed and GST -wNBD fusion protein 
partially purified from the solubilised membrane cell fraction (with 0.1% TX -100) 
by glutathione -agarose chromatography using 0.2 ml of beads. Samples for 
SDS PAGE were diluted 10:1 in SDS PAGE sample buffer. Samples of 
glutathione agarose were a 50% slurry. The fusion protein was eluted with 1 ml 
samples of reduced glutathione. 
A. SDS PAGE and Western blot analysis of the partial purification of 
GST -wNBD fusion protein 
Lane 
1. Protein bound to glutathione- agarose. 
2. 1st eluent with 100 mM reduced glutathione 
3. 2' eluent with 100 mM reduced glutathione 
4. 3`d eluent with 100 mM reduced glutathione 
5. 4th eluent with 100 mM reduced glutathione 
B. SDS PAGE and Western blot analysis of cleavage by thrombin of the 
GST -wNBD fusion protein 
Thrombin was added (5 units /2m1) and incubated overnight at 4 °C prior to 
analysis by SDS PAGE. 
Lane 
1. GST -wNBD fusion protein prior to addition of thrombin. 
2. Post thrombin cleavage. 
A 
B 
98 - 
64 - 
50 - 
36 - 
30 - 
16 - 
6- 
1 2 3 4 5 
97 - -- 
66 - 
45 - 
SDS PAGE 
-1 2 
31 - 
21 - 
41- 
98 - 
64 - 
50 - 
36 - 
30 - 
16 - 
6- 
97 - 
-4--GST-wNBD 66 - 
-4- wNBD 
WIMP 40.f f CST 
SDS PAGE 
45 - 
31 - 
21 - 
1 2 3 4 5 
Western 
1 2 
Western 
GST -wNBD 
GST -wNBD 
.4- wNBD 
Table 2 Summary of conditions tested for optimisation 
of expression, solubilisation and purification of GST- 
wNBD heterologously expressed in E. coli 
This table provides a summary of the comparisons made between 
different E. coli strains, growth temperatures and solubilisation 
conditions. Shown are comparative levels of fusion protein 
present in different cell fractions. Abbreviations: VH, very high; 
H, high; VL, very low; L, low; M, medium. 
a,e 
.`' a-o a \a oJ ..pt o` a ot,5 ;.o `5 Ga po- G ,ca 
. 
Background Strain 
XL1 Blue Good VH H VL VH M 
AN3700 (rpoH ") Good VH H VL M M 
AN3701 (rpoH-)(pESL) Good VH H VL M H 
Growth temperature 
Growth 37° Induce 42° VL VH L VL H 
Growth 30° Induce 37° L VH L VL H 
Growth 30° Induce 37° Good VH H VL M 
MgCl2, ATP (5 mM) Good Lower 
Poly -histidine- Ni -NTA L Low 
Dye -ligand 
Chromatography 
Solubilisation 
Conditions 
VL 
% fusion protein solubilised 
Membrane Cell Debris 
1% CHAPS 20% 10% 
4% CHAPS, 0.4M NaCI 40% 15% 
0.1% TX -100 20% 10% 
0.1% TX -100, 0.4M NaCI 40% 15% 
DOC, 0.4M Nacl ND 20% 
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enables dimerization between free and fused GST resulting in greater solubility 
of the fusion protein. To test that this was in fact the case with respect to the 
GST -wNBD fusion protein, a comparison was made of the levels of soluble 
GST -wNBD fusion which could be partially purified. This comparison is shown 
in Fig. 8 where it can be seen that a higher yield of partially purified, soluble 
GST -wNBD was obtained using the p2GEX,wNBD vector. As a consequence of 
this result, the p2GEX vector was used for the rest of the work described here. 
Protease deficient background strains 
The over -expression of a heterologous protein in E. coli causes substantial 
metabolic stress and the level of mis- folded proteins can cause a `stress 
response' to be mounted. The rpoH gene encodes a sigma factor involved in 
regulating expression of many of the proteases and chaperones involved in the 
stress response, resulting in proteolytic degradation of misfolded proteins. The 
rpohf negative E. coli strain AN3700 (described in Section 2.13) was shown to 
result in a lower level of proteolytic degradation in comparison to a non -protease 
deficient strain XL1 Blue (Table 2) and was therefore the strain used for the work 
described here. 
The effect of altering growth and induction temperatures on proteolysis and 
expression levels was also tested. Levels of soluble fusion protein which could 
be partially purified by glutathione -agarose chromatography under the same 
solubilisation conditions were compared. The following experiments were 
performed: 
Growth at 37 °C, induction at 42 °C 
Growth at 30 °C, induction at 37 °C 
Growth at 30 °C, induction at 30 °C 
The results of these experiments are shown in Fig. 9. It can be seen from 
Fig. 9A and B, that induction at 42 °C resulted in no detectible fusion protein 
bound to the glutathione -agarose beads. In addition induction at 42 °C resulted 
in a decreased level of fusion protein expressed overall as judged by the lower 
Fig. 8 Effect on yield of GST -wNBD fusion protein in 
the presence of an unfused GST 
1L of E coli AN3700, p2GEX,wNBD and pGEX41T,wNBD 
respectively were grown to late log phase and induced with 0.1 
mM IPTG for 2 hrs. Fusion protein was partially purified from 
sofubílised membrane fraction (0.1% TX -100), (as described in 
the experimental procedures). Shown is an SDS PAGE analysis 
of proteins from samples of glutathione -agarose beads with 
bound fusion protein (50% slurry of beads). The positions of 
GST -wNBD, groEL and GST are shown at their respective 
molecular weights. 
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Fig. 9 Effect of growth and induction temperature on degradation and 
yield of GST -wNBD fusion protein 
1L of E. coli strain AN3700, p2GEX, wNBD was grown to late log phase and 
induced with 0.1 mM IPTG for 2 hrs. Fusion protein was partially purified from 
the solubilised membrane fraction using 0.1% TX -100 (described in Chapter 2, 
Section 2.9) using 0.2 ml glutathione -agarose beads. Proteins bound to 
glutathione -agarose beads were separated by SDS PAGE on a 12% 
polyacrylamide gel using a 50% bead slurry diluted in 2 x SDS PAGE sample 
buffer. The cell debris fraction was also analysed in A. 
A. Comparison of the effect of induction temperatures of 37 °C or 42 °C after 
growth at 37 °C on levels of partially purified fusion protein. The protein 
band representing GST -wNBD is highlighted with an arrow. 
B. Western blot analysis of A using anti -wNT antibody. 
C. Comparison of the effect of induction temperatures of 30 °C or 37 °C after 
growth at 30 °C on levels fo partially purified fusion protein. The protein 
band representing GST -wNBD is highlighted with an arrow. 
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level found in the cell debris. Induction at 37 °C resulted in an easily detectible 
level of fusion protein, in addition to some degradation products detected by 
Western blot. A higher level of fusion protein was seen in the cell debris 
fraction at 37 °C induction temperature, in comparison to 42 °C. SDS PAGE 
analysis of yield of fusion protein at the induction temperatures at 30 °C and 
37 °C respectively (Fig. 9C) clearly shows that a much higher level of fusion 
protein was obtained at induction at the lower temperature. 
Co- expression of molecular chaperones GroESL 
In Section 6.2.2b above it was shown that although high levels of GST -wNDB 
were expressed in E. coli, that most of this protein was found in the insoluble 
cell fraction associated with aggregated proteins or inclusion bodies. This is a 
common problem with heterologous expression in E, coli (Goeddel, 1990) and 
in order to attempt to overcome this problem, molecular chaperones GroESL 
were co- expressed with the GST -wNBD fusion protein. GroESL is part of the 
E. coli Hsp60 family of proteins expressed during the stress -response. GroESL 
forms a protein folding machine which binds to unfolded polypeptides and can 
potentiate correct folding (reviewed in (Braig et al, 1994; Georgopoulos, 1993)). 
The use of the molecular chaperones GroESL have been previously shown to 
help the folding and solubility of heterologously expressed proteins in E. coli 
(Goloubinoff et al, 1989; Lee and Olins, 1992). 
Yields of soluble fusion protein were compared between strain AN3701 
harbouring the plasmid pESL which expresses the GroES and GroEL subunits 
of GroESL, and the same strain without pESL (AN3700) (a description of these 
strains is provided in Chapter 2, Section 2.13). It can be seen from Fig. 10 that 
there was no visible difference between the levels of partially purified fusion 
protein. It was also noted that a large amount of a 60 kDa contaminant co- 
purified with the fusion protein which was shown by N- terminal sequence 
analysis" to be groEL (data not shown). The pathway for chaperone -facilitated 
17 N- terminal sequence analysis was performed by the Biomolecular Resource Facility of the 
AN U. 
Fig. 10 Effect of levels of contaminating groEL protein 
in a strain over -expressing groESL proteins 
1L of E. coli strains AN3700, and ÁN3701 (harbouring the 
plasmid pESL for overexpression of GroESL) both harbouring the 
plasmid pGEX4T1wNBD, were grown to late log phase and 
induced with 0.1 mM IPTG for 2 hrs. Fusion protein was 
partially purified from solubilised membrane fraction (0.1% 
TX -100), (as described in the experimental procedures). Shown 
is an SDS PAGE analysis of proteins from samples of 
glutathione- agarose beads with bound fusion protein (50% 
slurry of beads). The positions of GST -wNBD and groEL are 
shown at their respective molecular weights. 
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folding of proteins requires firstly that the groES subunit binds to the groEL 
subunit complex and secondly, ATP hydrolysis brings about the release of the 
folded protein. It was thought that ATP may be a limiting factor in the groESL 
folding pathway due to the high levels of the recombinant fusion protein being 
produced in the cell, in addition to the over -expression of groES and groEL. 
The effect of the addition of Mg' and ATP (5 mM) during solubilisation and 
affinity purification, on the presence of the 60 kDa contaminant, was tested and 
it can be seen from Fig. 11 that the presence of MgCIZ and ATP reduced this 
contamination substantially but not completely. As a consequence of these 
results, the strain ÁN3700 which does not harbour the pESL plasmid, was 
routinely used for further studies. However, even with this strain, the 60 Kd 
GroEL contaminant persisted due to endogenous GroESL and the inclusion of 
Mg2'ATP was often employed to reduce this contamination. However, due to 
the unknown effect of this practice on later ATP binding and hydrolysis studies, 
this procedure was usually omitted and other methods were trialed in attempt to 
further purify wNBD. 
Detergent solubilisation of GST -wNBD fusion protein from membrane and 
cell debris cell fractions 
Three different non -denaturing detergents (TX -100, CHAPS and deoxycholate) 
were tested for their ability to solubilise GST -wNBD fusion protein under 
different concentrations of NaCI, from the membrane and cell debris fractions. 
The results of numerous trials are summarised in Table 2. All three detergents 
were capable of solubilising GST -wNBD from both membrane and cell debris 
fractions to some degree, and yield of solubilised fusion protein was increased 
in the presence of 0.4 M NaCI. It was noted that deoxycholate solubilised a 
much higher level of fusion protein from the cell debris fraction, compared to 
TX -100 and CHAPS. However activity tests showed that wNBD partially 
purified from cell debris using deoxycholate was inactive (data not shown). 
The levels of solubilisation achieved using CHAPS and TX -100 were not visibly 
different. As a consequence of these studies TX -100 (0.1%), and 0.4 M NaCI 
were used for solubilisation and subsequent purification. TX -100 is very cheap 
Fig. 11 Effect of ATP, MgCl2 on the level of groEL protein 
1L of E. coli AN3701, p2GEX, wNBD was grown to late log phase and 
induced with 0.1 mM IPTG for 2 hrs. Fusion protein was partially purified in 
the presence or absence of 5 mM MgCl2 and 5 mM ATP, from solubilised 
membrane fraction (0.1% TX -100), (as described in the experimental 
procedures). Shown is an SDS PAGE analysis of proteins from samples of 
glutathione- agarose beads with bound fusion protein (50% slurry of beads). 
The positions of GST -wNBD, groEL and GST are shown at their respective 
molecular weights. 
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in comparison to CHAPS and does not interfere with subsequent 8- azido -ATP- 
affinity labelling (unlike CHAPS) (Koronakis et al, 1993) which is described in 
Section 6.2.3. 
Additional affinity- purification utilising the six -his affinity tag, dye- ligand 
chromatography and HPLC cation exchange 
The additional unfused GST expressed using the p2GEX,wNBD construct was 
shown to have a beneficial effect on the yield of soluble partially pure fusion 
protein (see Fig. 8), however it also resulted in high levels of contaminating 
GST. In order to remove GST -wNBD from the affinity resin, high levels of 
reduced glutathione were used (100 mM), which eluted most of the fusion 
protein, in addition to excessive quantities of free GST. Some of the unfused 
GST could be removed from partially pure wNBD preparations by removing the 
reduced glutathione by buffer exchange or dialysis followed by addition of a 
small amount of reduced glutathione beads which were then removed by 
centrifugation. However an unacceptable level of GST persisted. Attempts to 
elute wNBD alone, after thrombin digestion were unsuccessful due to the 
wNBD binding strongly to the affinity resin for reasons not understood. A 
number of different conditions (high salt, low salt and reducing agents), were 
trialed in an attempt to remove wNBD from the glutathione beads, however 
these were unsuccessful (data not shown). Additional affinity purification steps 
were therefore trialed in an attempt to increase the level of purity of the wNBD. 
The construct p2GEX,wNBD6h1 (see Section 6.2.1c) was used to express GST- 
wNBD6h1s introducing an additional affinity tag to the N- terminus of the wNBD for 
purification using Ni -NTA resin (described in Chapter 2, Section 2.9). Fig. 12 
shows an additional affinity purification step involving binding wNBD6,, to Ni- 
NTA affinity resin. The wNBD6h1 protein bound to the affinity resin (Fig. 12 lane 
2), and was removed from the resin with the addition of imidazole (lanes 1, 3, 4, 
5). This purification trial was performed using DOC for the solubilisation of cell 
debris material prior to the knowledge that material purified using this detergent 
(or possibly due to its derivation from the cell debris) was inactive (data not 
Fig. 12 Further purification of wNBD by Ni -NTA affinity purification 
5L of E. coli AN3701, p2GEX,wNBD,, was grown to late log phase and 
induced with 0.1 mM IPTG for 2 hrs. Fusion protein was partially purified from 
solubilised membrane fraction usng 0.25% DOC, 0.4 M NaCI, and using 0.2 ml 
glutathione -agarose beads. Fusion protein was eluted with 100 mM reduced 
glutathione, and digested with thrombin prior to passing through a Ni -NTA 
column containing 0.2 ml of resin. Partially purified wNBD,, was eluted in 1 ml 
fractions from the resin with increasing levels of imidazole as indicated. 
SDS PAGE and Western analysis of fractions obtained from Ni -NTA purification 
of wNBD5h15 
Lane 
1 First eluent (10 mM imidazole) 
2 Proteins bound to Ni -NTA resin prior to eluting with imidazole 
3 Second eluent (50 mM imidazole) 
4 Third eluent (100 mM imidazole) 
5 Fourth eluent (200 mM imidazole) 
6 Fifth eluent (500 mM imidazole) 
7 Sixth eluent (1 M imidazole) 
8 Seventh eluent (1.3 M imidazole) 
9 Proteins remaining bound to the resin 
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shown). This purification result using the detergent deoxycholate (DOC) was 
encouraging, however, the yield of wNBD was much lower when TX -100 or 
CHAPS were tested for solubilisation. When these detergents were used, most 
of the wNBD remained bound to the resin (data not shown). Efforts to elute 
wNBD6hs using high levels of imidazole, NaCI and reducing agents were 
unsuccessful. 
Dye -ligand chromatography utilising Cibacron Blue and Reactive Red resins 
have previously been reported to be useful in the purification of many proteins 
containing a nucleotide binding fold (Thompson et al, 1975) and has been used 
in the purification of bacterial NBDs (Higgins et al, 1985; Walter et al, 1992). 
Fig. 13 illustrates the attempted further purification of wNBD using Reactive 
Red and Cibacron Blue resins. It can be seen from comparing Fig. 13A lanes 1 
and 2 which represent samples before and after addition to the resin that the 
wNBD protein bound to the affinity resin of both Cibacron Blue and Reactive 
Red (Fig. 13C, lane 4), and that a large proportion of contaminating proteins 
were removed and found In the flow through (Fig. 13A lane 2, Fig. 13C, lane 3). 
However attempts to elute wNBD using Mg -ATP, increasing levels of NaCI, as 
well as high levels of reducing agent, were unsuccessful (shown in Fig. 13B) 
and most of the wNBD remained bound to the affinity resin (Fig. 13A, lane 7; B, 
lane 6; C, lane 11). 
Cation exchange high performance liquid chromatography 
Cation exchange high performance liquid chromatography (HPLC) (described in 
Chapter 2, Section 2.9.4) was utilised in an attempt to further purify the partially 
purified wNBD. For this technique CHAPS was the detergent of choice for the 
solubilisation of wNBD from membrane fractions because TX -100 was 
unsuitable due its high optical absorbance reading at 278 nm which interferes 
with protein detection. The iso- electric point predicted from sequence analysis 
of wNDB is Pi 8.95, which is substantially different to the iso -electric points of 
both GST (Pi 6.09) and GroEL (Pi 4.65) which are the major contaminants. A 
strong cation exchange column (Biorad) was chosen in an attempt to separate 
Fig. 13 Reactive Red and Cibacron Blue affinity purification trials 
1L of E. coli strain AN3701, p2GEX,wNBD was grown at 30 °C in LB, Glucose, 
Amp, Tet medium and induced with 0.1 mM IPTG at late log phase. Cells were 
harvested, lysed and GST -wNBD fusion protein partially purified from the 
solubilised membrane cell fraction by glutathione -agarose chromatography 
(Chapter 2, Section 2.9). After digesting the GST -wNBD fusion protein with 
thrombin, samples were added to either 0.2 ml of Reactive Red or Cibacron 
Blue resin, as indicated, and attempts to elute wNBD from the dye -resin under 
different conditions of salt are shown. The figures illustrate SDS PAGE 
(Coomassie stained except where indicated) and Western blot analysis (using 
anti -wNT antibody). 
A. Cibacron Blue 
Lane 
1 Sample prior to adding to Cibacron Blue 
2 Unbound fraction 
3 First eluent, 10 mM MgC12, ATP 
4 Second eluent, 20 mM MgCl2, ATP 
5 Third eluent, 50 mM MgC12, ATP 
6 Fourth eluent, 50 mM MgCl2, ATP, 10 mM (i- mercapto- ethanol 
7 Protein remaining bound to resin 
B. Cibacron Blue, high salt during elution 
Lane 
1 Sample prior to adding to Cibacron Blue 
2 Unbound fraction 
3 First eluent, 10 mM MgCl2, ATP, 100 mM NaCI 
4 Second eluent, 10 mM MgC12, ATP, 200 mM NaCI 
5 Third eluent, 10 mM MgC12, ATP, 400 mM NaCI 
6 Fourth eluent, 10 mM MgC12, ATP, 500 mM NaCI 
8 Protein remaining bound to resin 
C. Reactive Red 
SDS PAGE Gel is silver stained 
Lane 
1 Sample prior to thrombin digestion 
2 Sample post thrombin digestion 
3 Unbound fraction 
4 Protein bound to resin 
5 First eluent, 0,4 M NaCI, 20 mM MgC12, ATP 
6 Second eluent, 0.5 M NaCI, 20 mM MgC12, ATP 
7 Third eluent, 0.6 M NaCI, 20 mM MgC12, ATP 
8 Fourth eluent, 0.7 M NaCI, 20 mM MgC12, ATP 
9 Fifth eluent, 0.8 M NaCI, 20 mM MgC12, ATP 
10 Sixth eluent, 1.0 M NaCI, 20 mM MgCl2, ATP 
11 Protein remaining bound to resin 
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the wNBD from both of these contaminants as well as other minor 
contaminants. In theory the wNBD should bind to the column at pH 7 (as it is 
predicted to have a net positive charge at pH 7 and the column has a negative 
charge to bind cations), while GroEL and GST should elute without binding to 
the column. Unfortunately the cation exchange attempt was unsuccessful 
(data not shown). Most of the wNBD was seen in the fractions which did not 
bind to the column which included GST and groEL contaminants suggesting a 
complex between groEL and wNBD. 
6.2.2.e Summary of attempted purification of wNBD 
From the results described above it was concluded that heterologously 
expressed GST -wNBD could be partially purified under non -denaturing 
conditions from solubilised membrane and cell debris E.coli fractions. Further 
affinity purification steps subsequent to glutathione -agarose chromatography 
were largely unsuccessful due to non -specific binding of wNBD to the resins 
used for further affinity purification. High levels of salt did not elute bound 
proteins suggesting that the interaction of wNBD to affinity resins was not due 
to ionic interactions but possibly hydrophobic interactions. 
Although the aim of the work presented here was to purify the wNBD to 
homogeneity, time constraints prevented further time being devoted to this 
cause, and focus was turned to the determination of the biological activity of the 
wNBD which was partially purified using glutathione -agarose chromatography. 
The final purification protocol is illustrated in the flow chart in Fig. 14. 
6.2.3 ATP binding and hydrolysis studies of partially 
purified wNBD 
In order to detect ATP binding and /or hydrolysis activity of the partially purified 
wNBD obtained through the work described above, the following three methods 
were used: 
Fig. 14 Final protocol of the partial purification of 
wN BD 
This figure summarises the purification wNBD after E. coli 
expression using strain AN3700, p2GEX,wNBD grown to late log 
phase at 30 °C in LB medium (plus glucose and antibiotics). Cells 
were induced with 0.1 mM IPTG for 2 -3 hrs (30 °C). Cells were 
harvested by centrifugation at 4 °C and lysed by french press. 
Partial purification of wNBD was achieved as follows: 
Separate membrane fraction by differential centriguation 
10,000 g centrifugation 
Pellet Supernatant (cell debris) (cytoplasm 
and membranes) 
50,000 g centrifugation 
Pellet 
(membranes) 
Supernat ant 
(cyt oplasm) 
Soiubilisat ion of GST -wNBD 
Gently resuspend 50 mM Tris, 20% 
glycerol, 0.1% TX -100, 0.4 M NaCI, 
protease inhibitors. Incubate 4 °C o/n 
with constant gentle stirring 
50,000 g centrifugation 
Supernatant /Ly 
(solubilised proteins) Pellet 
(insoluble material) 
Glut at hione -agarose chromat rography 
Add glutathione-agarose beads, incubate 2 hrs at 4 °C 
Wash beads with solubilisation buffer 
Elute GST -wNBD fusion protein with 100 mM reduced glutathione 
Add thrombin and incubate 4 °C o/n and desalt to remove reduced 
glut at h lone 
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1. Detection of ATP hydrolysis activity in non -denaturing gels 
This technique was used both to separate proteins by polyacrylamide gel 
electrophoresis, followed by staining for ATP hydrolysis by detection of a 
lead phosphate precipitate concurrent with ATP hydrolysis (Weinbaum and 
Markman, 1966). This technique was found to detect low levels of ATP 
hydrolysis activity of proteins which could not be detected using standard 
colorimetric methods (data not shown). 
2. Photo -affinity labelling using 8- azidoATP[a32P] 
This technique, utilising azido- derivatised nucleotides, has been used 
successfully to show ATP binding of many ATP binding proteins and ABC 
transporters (Campbell et al, 1990; Dayan et al, 1996; Haley, 1977; Hobson 
et al, 1984; Sankaran et al, 1997; Walter et al, 1992). This method is very 
sensitive and involves photo -labelling of partially purified proteins, followed 
by separation of the proteins and autoradiography. This enables 
separation of non -labelled proteins from labelled proteins according to their 
approximate molecular weight, allowing identification of whether or not the 
protein of interest binds the photolabel. 
3. Detection of [32P]ATP binding to immobilised GST -wNDB fusion 
protein 
This technique was developed during this project and Involves the 
incubation of radiolabelled ATP with GST -wNBD immobilised to 
glutathione -agarose, followed by a number of washing and filtration steps 
and determination of the level of radiolabelled ATP remaining with the 
sample. 
6.2.3.a Detection of ATP hydrolysis activity of wNBD in non- denaturing 
gels 
A number of colorimetric ATP hydrolysis assays were tested in order to detect 
ATP hydrolysis activity of the wNBD expressed and purified as described 
above. However due to the presence of contaminating proteins with ATPase 
activity these methods were unsuccessful (data not shown). In order to try and 
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overcome this problem, non -denaturing PAGE was used to separate the 
proteins contained in the partially purified preparations of wNBD and the gel 
was stained for ATPase activity which was detected by a lead- phosphate 
precipitate (see Chapter 2, Section 2.6.9). Positive staining for ATPase activity 
was detected in samples of partially purified wNBD, and these bands aligned 
with immuno- reactive bands analysed by Western blot (see Fig. 15). However 
ATP hydrolysis activity was detected both in the wild type lane, and also the 
lane containing the Walker A mutation. It was subsequently shown in Sections 
6.2.3b and 6.2.3c that this mutation should substantially decrease ATP binding 
activity. The presence of ATP hydrolysis activity is therefore unexpected in the 
mutant lane and was thought to be due to contaminating groEL protein which is 
known to have ATP hydrolysis activity. Therefore, it is not possible from these 
results to conclude whether wNBD has ATPase activity. 
6.2.3.b 8- AzidoATPr2P] photo -affinity labelling of wNBD 
Partially purified wNBD protein samples were irradiated at 254 nm in the 
presence of 8- AzidoATP[3ZP], plus, and minus non -radioactive Mg' ATP for 
either 45 seconds or 90 seconds (see Chapter 2, Section 2.6.8). The proteins 
were then TCA precipitated and separated by SDS PAGE. Fig. 16A is an 
autoradiograph of the Coomassie stained gel and it can be seen that a band 
corresponding to the wNBD was strongly labelled (Fig. 16A lane3). 
Interestingly, the GST -wNBD fusion protein (i.e. sample prior to thrombin 
digestion - lane 1) was only weakly labelled compared to the liberated wNBD18. 
This experiment was repeated in order to determine the effect of the Walker A 
mutation GIy135Lys136 -> Leu'35GIn136which is harboured by wNDBmut1 
(Section 6.2.1e). Fig. 16B is an autoradiograph and corresponding Coomassie 
stained gel of proteins separated by SDS PAGE after photo -affinity labelling as 
described above. A comparison of Lanes 2 (wild -type) and lane 3 (muti ) 
'e The weak labelling of the GST -wNBD fusion protein is difficult to see in the reproduction of the 
autoradiograph shown in Fig. 16A, however was clearly identifiable in the original. 
Fig. 15 Detection of ATPase activity by non - 
denat uring PAGE 
Protein samples containing partially purified GST -wNBD 
fusion protein and fusion protein digested with thrombin (Tn) 
were separated by non -denaturing PAGE (see experimental 
procedures). Gels were then either stained for ATPase 
activity, stained with Coomassie blue, or analysed by Western 
blotting using anti -White (wNT) antibody. The gels shown 
below show a comparison between wild type and mutant 
(G135 K136 - LQ) forms of wNBD 
Fusion Tn digest Fusion Tn digest Fusion Tn digest 
Activity gel 
I I I 
,(\\'` 
ftimis aims 
Co orn ass ¡e anti -White 
Western 
Fig. 16 Azido -ATP photo -crosslinking to wNBD 
GST -wNBD fusion protein was in expressed E coli and partially purified from 
solubilised membrane fraction (0.1% TX -100) by glutathione- agarose 
chromatography. Fusion protein was eluted with 100 mM reduced glutathione 
and a sample of eluted fusion protein was digested with thrombin resulting in 
unfused wNBD. Protein samples were desalted using a PD -10 column 
(Pharmacia) prior to the photo- crosslinking experiment. 50 µl samples 
containing either GST -wNBD or wNBD were irradiated with UV light (254 nm) in 
the presence of [a32 -P] -Azido -ATP as described in Chapter 2, Section 2.6.8. 
The proteins were TCA precipitated prior to separating by SDS PAGE followed 
by autoradiography of the dried gel. 
A. Photocrosslinking (a32 -P] -Azido -ATP to the wNBD 
Samples used in this experiment were partially purified from a large scale 
(40 L) E.coli culture. 
Lane 
1. GST -wNBD fusion protein 
2. wNBD + 1 mM non -radioactive ATP 
3. wNBD 
B. Comparison of photocrosslinking to wild -type and mutant forms of 
wNBD 
Samples used in this experiment were partially purified from a 20 L E.coli 
culture. 
Lane 
1. Wild -type wNBD + non -radioactive azido -ATP (1 mM) 
2. Wild -type wNBD 
3. wNBD mut 1 
A. SDS PAGE analysis Autoradiograph 
1 2 3 
B. 
1 2 3 
SDS PAGE analysis Autoradiograph 
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reveals that there is a labelled band corresponding to the predicted molecular 
weight of the wNBD which is present in the wild -type lane (lane 2), but only a 
weakly labelled band is visible in the mutant lane (lane 3). This is good 
evidence that the Gfy135Lys' Leu735GIn136 mutation has greatly reduced the 
binding of ATP to the wNBD. Note that the presence of non -radioactive azido- 
ATP completely inhibits radiolabelling (Fig. 16B, lane 1). 
6.2.3.c Comparison of ATP binding activity of immobilised GST -wNBD 
and GST- wNBDmut 1 fusion protein 
A second method for detecting ATP binding activity was used to compare wild - 
type and mutant forms of the GST -wNBD fusion protein. Radiolabelled 
[32P]aATP was added to fusion protein immobilised on glutathione- agarose, 
which was subsequently washed by filtration and the level of radioactivity 
remaining with the immobilised fusion protein sample was determined by liquid 
scintillation. The bar graph in Fig. 17A shows that more radiolabelled 
[32P]aATP remained bound to the sample containing the wild -type GST -wNBD 
fusion protein than the GST- wNDBmut1 fusion protein. This radiolabelling is 
inhibited by the addition of 5 mM ATP illustrating the specificity of the binding. 
The control sample containing GST immobilised to glutathione -agarose bound 
only a low level of radiofabel indicating that the radiolabelling observed in the 
wild -type GST -wNBD sample was due to the wNBD protein rather than GST or 
other contaminating proteins. This result provides evidence that the wNBD 
binds ATP and that the mutation Gly135Lys'36 - Leu'35GIn136, decreases this 
activity at least three fold. 
A further experiment was performed to test the ATP binding activity of fusion 
protein samples with high and low levels of groEL contamination. Wild -type 
GST -wNBD was partially purified as described above, from two different strains: 
1) harbouring the pESL plasmid which over -expresses groES and groEL 
(strain AN3701); and 
Fig. 17 ATP binding activity of immobilised GST -wNBD fusion protein 
The GST fusion proteins were partially purified by glutathione -agarose 
chromatography (Chapter 2, Section 2.9) however were not eluted from the 
affinity beads but remained immobilised to the glutathione -agarose. 
Radiolabelled ATP ([32P]ccATP) was added to samples of the immobilised fusion 
protein for 30 seconds (and pre- incubated with non -radioactive ATP where 
indicated), prior to washing by filtration and subsequent scintillation counting 
(described in Chapter 2, Section 2.6.7). The samples labelled 'control' were 
samples of immobilised GST (no wNBD present) which was prepared in the 
same manner as the immobilised GST -wNBD, however using the plasmid 
vector pGEX4T1. GST was purified from the cell lysate under the same buffer 
conditions used in purification of GST -wNBD. 
A. Bar graph comparing radiolabelled ATP binding activity of wild type GST- 
wNBD and GST- wNBDmutl which harbours the mutation G135Ki36 to LQ. 
The same amount of immobilised fusion protein were used for both the wild 
type and mutant experiments. 
B. SDS PAGE analysis ( Coomassie stained) of samples used in experiment 
shown in A. 
C. Bar graph comparing ATP binding activity of GST -wNBD fusion protein 
samples either containing a high or low level of groEL contamination 
(indicated by + pESL, or -pESL respectively) in order to rule out the 
possibility that the ATP binding observed in A was due to this contaminant. 
D. SDS PAGE analysis (Coomassie stained) of samples used in experiment 
shown in C. 
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2) the same strain as above but without pESL (AN3700). 
The presence of the plasmid pESL results in a large amount of the 60 kDa (see 
Fig. 17D) contaminant which was identified by sequence analysis to be groEL 
protein. 
Fig. 17C illustrates the differences in the level of radiolabelled ATP remaining 
bound to the fusion protein samples partially purified from either ÁN3701 and 
AN3700 and the effect cm ATP binding in the presence of competitive non- 
radioactive ATP. It can be seen that the presence of contaminating groEL 
does not result in an increase in ATP binding activity. 
6.2.4 Co- purification of wNBD and stNBD 
In order to investigate whether the White and Scarlet NBDs physically interact, 
these two proteins were co- expressed in E. coli using the plasmid construct 
p2GEX,wNBD, stNBD (see Section 6.2.1d), in which the stNBD is expressed on 
its own i.e. not fused to GST. The aim of this experiment was to determine 
whether the wNBD and stNBD interact (e.g. form a dimer), and if this interaction 
is relatively strong, then the stNBD should co- purify with the GST -wNBD fusion 
protein. 
The GST -wNBD fusion protein was partially purified by glutathione -agarose 
affinity purification and the co- purification of the stNBD was detected by 
Western blot analysis. Fig. 18 shows the detection of both the wNBD and 
stNBD proteins during the purification procedure. It can be seen from the 
Western blot shown in Fig. 18B, that stNBD is present in: the glutathione- 
agarose bead sample (Fig. 18B lane 4); the first eluent with reduced glutathione 
(lane 5); the glutathione -agarose bead fraction with proteins which remain 
bound (lane 11). This result indicates that the stNBD protein co- purifies with 
the GST -wNBD_ However due to the possibility that the stNBD may interact 
non -specifically with the glutathione -agarose beads, a further control 
Fig. 18 Co- expression and co- purification of GST -wNBD fusion protein 
and stNBD 
1L of E coil AN3700, p2GEX,wNBD. stNBD was grown to late log phase and 
induced with 0.1 mM IPTG for 2 hrs. Fusion protein was partially purified from 
solubilised membrane fraction (0.1% TX -100) using 0.2 ml glutathione -agarose 
beads and analysed by SDS PAGE and Western blot. 
A. Detection of wNBD by SDS PAGE and Western blot. 
Lane 
1. Supernatant and membrane fractions. 
2. Cell debris. 
3. Proteins which did not bind to the glutathione agarose 
4. Proteins bound to glutathione -agarose beads 
5. First eluent (100 mM reduced glutathione) digested with thrombin 
6. Second eluent (100 mM reduced glutathione) 
7. Third eluent (100 mM reduced glutathione) 
8. Fourth eluent (100 mM reduced glutathione) 
9. Fifth eluent (100 mM reduced glutathione) 
10. Protein remaining bound to glutathione -agarose. 
B. Detection of stNBD by SDS PAGE and Western blot 
Lane 
1. Supernatant and membrane fractions. 
2. Cell debris. 
3. Proteins which did not bind to the glutathione agarose 
4. Proteins bound to glutathione -agarose beads 
5. First eluent (100 mM reduced glutathione) digested with thrombin 
6. Second eluent (100 mM reduced glutathione) 
7. Third eluent (100 mM reduced glutathione) 
8. Fourth eluent (100 mM reduced glutathione) 
9. Fifth eluent (100 mM reduced glutathione) 
10. Protein remaining bound to glutathione- agarose. 
11 No Scarlet NBD control. 
12. Sample containing wNBD but no stNBD 
13. Background strain, no wNBD or stNBD 
98 - 
64 - 
50 - 
36 - 
30 - 
98 
98 - 
64 - 
50 - 
36 - 
30 - 
64 - 
50 - 
36 - 
30 - 
16 - 
98 - 
64 - 
50 - 
36 - 
30 - 
1 2 3 4 5 6 7 8 9 10 
SDS PAGE 
1 2 3 4 5 6 7 8 910 
anti -wNT Western 
1 2 3 4 5 6 7 8 910 1112 13 
SDS PAGE 
1 2 3 4 5 6 7 8 9 1 0 1 1 1 2 1 3 
anti -stNT Western 
145 
experiment is required in which stNBD protein can be tested for non -specific 
binding. 
In an attempt to do the control experiment to test for non -specific binding of 
stNBD to the glutathione -agarose beads, the stNBD was sub -cloned and 
expressed as a GST fusion protein (data not shown), however the resultant 
protein detected by Western blot was a much lower apparent molecular weight 
than predicted (data not shown) which is suggestive of proteolytic degradation. 
It can be seen from the Western blot in Fig. 18B lane 1 that there are two anti - 
stNT immuno- reactive bands, one with a molecular weight much higher than 
that predicted ( -70 kDa) and another at around the predicted molecular weight 
predicted from sequence analysis ( -45 kDa). It is possible that co- expression of 
GST -wNBD and stNBD protects the stNBD from proteolytic degradation, and 
also results in a strong interaction which is not interrupted by SDS PAGE 
resulting in the high apparent molecular weight. Since a number of such issues 
remain unanswered at this stage, the observation that stNBD co- purifies with 
GST -wNBD should be considered as preliminary evidence only. However, this 
is an encouraging result worth pursuing further. 
6.2.5 Interaction analysis of the White NBD and an intracellular loop 
The work described in this section is a preliminary investigation into possible 
interactions which may occur between the wNBD and a predicted intracellular 
loop between putative TM helices 2 and 3 (see Fig. 1). 
lAsys Biosensor technology was used for this investigation and the basic 
principles of this technique are illustrated in Fig. 19. This system has the 
sensitivity to detect weak inter -molecular interactions and has many advantages 
over the yeast two -hybrid interaction analysis system in that it is quantitative and 
provides a large amount of flexibility with respect to solution conditions. In 
addition, different protein concentrations can be tested and direct comparisons 
can be made with respect to the level of protein interaction between different 
controls and mutants. 
Fig. 19 lAsys Biosensor - general principles 
The components of the lAsys Biosensor are illustrated in this Figure. The 
cuvette carboxy methyl dextran (CMD) surface is designed to acts as a resonant 
mirror comprised of a thin, monomode waveguide which is highly sensitive to 
changes in the surface refractive index. The optical components of the 
instrument are suitably arranged so that a sharp peak of intensity is seen at a 
discreet angle of interest and this is extremely sensitive to the surface binding 
reactions which are subsequently detected by the instrument. A typical surface 
binding event is illustrated in B, where the binding event is revealed as an 
increase in arc seconds (i.e. changes in the angle of reflectance) over time. The 
graph shown in B illustrates a text book profile of a molecule binding to an 
immobilised ligand at the cuvette surface, followed by dissociation and 
regeneration of the cuvette by washing. This figure was taken from an lAsys 
publication entitled "How lAsys Works ". 
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The interaction analysis experiments performed herein were aimed at 
investigating the possible interaction between a TM loop region of White and 
the nucleotide binding domain of White (see Fig. 1). If such an interaction can 
be demonstrated this may provide information with respect to the mechanism 
by which conformational changes are transduced from the NBD to the TM 
domain. 
The synthetic peptide representing the intracellular loop was immobilised onto 
the carboxy methyl dextran (CMD) cuvette surface (described in Chapter 2, 
Section 2.10). Solutions containing the wNBD were added to the cuvette and 
any protein -peptide interactions which occurred at the cuvette surface resulting 
in a large change in molecular weight19 are detected using the resonant mirror 
device of the lAsys biosensor. 
Fig. 20A illustrates the lAsys biosensor output obtained when partially purified 
wNBD was added to the cuvette with immobilised loop peptide. The curve 
shown in Fig. 20A is typical of a specific binding event. The major contaminant 
of this partially purified wNBD preparation was GST (Fig. 20C, lane 1), so a 
control reaction containing a high level GST protein but no wNDB was 
performed. The output illustrated in Fig. 20B was observed, which is typical of 
non -specific binding and is visibly different from the binding curve observed 
when wNBD is present (Fig. 20A). 
Comparison of binding rate constants of wNBD to w' and wET87 mutant 
loop peptides 
To test the hypothesis that the wET87 mutant causes decreased function of the 
White /Scarlet transporter in flies due to changes in the interaction between the 
wNBD and the TM loop, a synthetic peptide representing this loop harbouring 
the mutation identified in the wET8' allele (see Chapter 3) was immobilised onto 
Fig. 20 wNBD interacts with peptide corresponding to the loop between 
TM 2 and 3 of the White protein 
The graphs shown in this figure illustrate binding profiles obtained using the 
lAsys biosensor machine where binding of wNBD and GST was tested 
respectively, to an immobilised peptide representing the loop between TM 
helices 2 and 3 of the White protein. Samples of wNBD used in these 
experiments was partially purified using the E. coli expression, and glutathione- 
agarose affinity purification system described in Section 6.2.2e. The control 
sample containing no wNBD but a high level of GST was obtained by 
expression of GST in E. coli using the plasmid p2GEX4T1 (Chapter 2, Section 
0) and affinity purification using glutathione -agarose chromatography from cell 
lysates under the same detergent and buffer conditions used for purification of 
the wNBD. 
A. Graph of binding response recorded when partially purified wNBD was 
added to an lAsys cuvette containing immobilised wild type loop peptide. 
B. Graph of binding response when GST was added to an lAsys cuvette 
containing immobilised wild type loop peptide. 
C. SDS PAGE and Western blot analysis of samples used in binding 
experiments. 
Lane 
1 Partially purified wNBD (diluted 10:1 in SDS PAGE sample buffer) 
2 GST control (diluted 10:1 in SDS PAGE sample buffer) 
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the cuvette CMD surface matrix. Fig. 21A illustrates the differences in binding 
curves observed when wNBD was added to either immobilised wild -type and 
mutant loop peptides. The Fastfit program supplied with the lAsys machine 
(described in Chapter 2, Section 2.10) was used to calculate the binding rates 
and showed that wNBD bound approximately at a rate four times that of the 
rate of binding of wNBD to the mutant loop peptide. This result was 
investigated further by performing a series of binding experiments at four 
different wNBD concentrations. Each individual binding experiment was 
performed using the same sample of wNBD which was added to the cell 
containing either immobilised wild -type loop peptide, or mutant loop peptide 
respectively. Rate constants were calculated at each concentration using the 
Fastfit program. Fig. 21B illustrates the individual rate constants obtained at 
each concentration of wNBD plotted against concentration (arbitrary units20) 
and a the line of best fit was calculated by Fastfit. The gradient of the line fitted 
to these individual rates (k0,) is representative of the association rate constant. 
Fig 21B illustrates that the slope representing the rate constant of wNBD 
binding to the wild -type loop (4.9 x 10') is 10 fold higher than that calculated for 
the rate constant of wNBD binding to the mutant loop peptide (3.8 x 10-0). This 
result indicates that the amino acid change G1y509 to Asp has substantially 
decreased the rate of wNBD binding to this peptide. 
6.3 Discussion 
The results presented in this chapter described work directed towards the 
development of a model system with which to study structure -function 
relationships of the nucleotide binding domain of the White protein. It was 
shown that the White NBD can be expressed in E. coli and subsequently 
partially purified from solubilised E. coli membranes. The partially purified 
19 The 23 residue immobilised peptide has a very low molecular weight in comparison to the 
wNBD resulting in a large increase in molecular weight if a binding event occurs which should be 
easily detected by the lAsys Biosensor. 
20 The concentration of wNBD in the samples used for these experiments was not determined. 
Samples of wNBD were diluted in sample buffer by 90 %, 80 %, 50% and an undiluted sample 
was also tested. 
Fig. 21 Comparison of association rate constants of wNBD binding to 
wild -type and mutant loop peptides 
The lAsys biosensor machine was used to detect differences in binding of 
wNBD to the wild -type loop peptide, and a mutant loop peptide containing a 
ti mutation identified in WET8 (G509D). Samples of wNBD used in these 
experiments were partially purified using the E. coli expression, and glutathione- 
agarose affinity purification system described in Section 6.2.2e. 
A. Comparison of binding curves obtained from the lAsys biosensor machine 
when the identical samples of wNBD was added to an lAsys cuvette with 
immobilised wild -type peptide and mutant peptide respectively. 
B. This graph shows plots of the first apparent association rate constants for 
four concentrations of wNBD for both the wild -type loop and the mutant 
loop peptide. Identical samples of wNBD were added to the cuvette with 
immobilised wild type and mutant peptide. The gradient of the fitted line 
(calculated by the Fastfit program) is the theoretical association rate 
constant. 
C. Sequences of amino -terminally biotinylated peptides (biotin not shown) 
immobilised via avidin to the CMD surface of the lAsys cuvette. Equivalent 
amounts of each the wild type and mutant loop peptides respectively were 
immobilised to separate wells (as described in Chapter 2, Section 2.10.1) 
of an lAsys 2 well cuvette. Nevertheless, minor differences in levels of 
immobilised peptide would alter individual ko values, however the overall 
binding rate constant represented by the line of best fit would not alter 
appreciably. 
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wNBD was shown to have ATP binding activity, as well as being able to interact 
with an intracellular loop predicted to form an interface between the NBD and 
TM domains. 
The difficulties faced during the purification of the wNBD involved a number of 
factors including: 
insolubility (90% of GST -wNBD was found in the insoluble cell fraction); 
co- purification of GST and GroEL proteins; 
inability to remove GST -wNBD or wNBD from affinity resins suggesting 
the protein was precipitating on the resins. 
Despite the abovementioned difficulties, sufficient wNBD was solubilised and 
partially purified from the E. coli membrane fraction to show that the domain 
has ATP binding activity as predicted from its sequence conservation with ABC 
transporters. In addition, two lines of evidence: 
(i) [32P]azido -ATP photocrosslinking; and 
(ii) immobilised GST -wNBD [32P]aATP binding experiments; 
showed that ATP binding activity was reduced by the G135K'36 LQ mutant. 
In the experiments described in Section 6.2.3c it was observed that the 
presence of a high level of groEL protein did not result in additional retention of 
[32P]ATP on the glutathione -agarose beads - even though the experiments in 
Section 6.2.3b clearly showed that groEL was crosslinked to [32P]azido -ATP. 
This apparent discrepancy may be due to groEL's ATP hydrolysis activity, 
whereby ATP does not remain bound to the protein, but is removed easily once 
it is hydrolysed, by the washing steps. On the other hand, the GST -wNBD may 
have ATP binding activity, but if ATP hydrolysis activity is absent, ATP may 
remain tightly bound to the protein. Although effort was devoted to determining 
whether this domain had ATP hydrolysis activity, this was not shown 
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conclusively. The ATP hydrolysis activity observed in activity stained gels 
may reflect the hydrolysis activity of groEL. Although a number of procaryotic 
NBDs purified in this way have been shown to hydrolyse ATP, these systems 
are different to the D. metanogaster transporters in that the two NBDs of the 
transporter are identical (e.g. HisP, HlyB) and there is evidence that they 
interact and function as dimers (Koronakis et al, 1993; Nikaido et al, 1997). In 
particular, positive cooperativity has been demonstrated for the maltose 
transporter of E. coil indicating that the two NBDs interact (Davidson et al, 
1996). In eucaryotic systems there is also an increasing body of evidence 
suggesting the NBDs interact and function cooperatively. A model has been 
postulated for the P- glycoprotein system, which predicts that the two NBDs 
interact in alternating cycles of ATP binding and hydrolysis, and that loss of 
function of one NBD results in loss of function of the other NBD (Azzaria et al, 
1989; Loo and Clarke, 1995a; Senior et al, 1995; Urbatsch et al, 1995a). 
Although it has been reported that purified CFTR NBD -1 has ATP hydrolysis 
activity (Ko and Pedersen, 1995), the CFTR second NBD -2 does not hydrolyse 
ATP when expressed and purified in isolation (Randak et al, 1995). It is 
possible that the White NBD may not dimerize and interact appropriately as a 
homodimer but instead may require either the Scarlet or Brown NBD to exhibit 
ATP hydrolysis activity. This would be an interesting issue to pursue using the 
model system developed here. 
The insolubility problems experienced in this work suggests that the wNBD is 
not the soluble protein domain predicted from sequence analysis. The finding 
that some of the GST -wNBD fusion protein was associating with the membrane 
fraction of the cell suggests the wNBD harbours protein determinants enabling 
membrane interactions. The interaction of the NBD of other ABC transporters 
with membranes has been described previously, and has subsequently been 
shown to be functionally important (Gruis and Price, 1997; Kerppola et al, 1991; 
Ko et al, 1997). As mentioned earlier in the introduction to this chapter, NBD -1 
of CFTR interacts with lipid bilayers to such an extent as to allow formation of 
an ion channel (Arispe et al, 1992). Membrane association characteristics 
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have also been reported for the NBD component of the S. typhimurium histidine 
transporter (HisP) which was shown to be tightly membrane bound despite its 
hydrophilic sequence (Baichwal et al, 1993; Kerppola et al, 1991) and has been 
described as being intermediate between a peripheral and integral membrane 
protein (Kerppola et al, 1991). 
Intracellular loop regions of the transmembrane domains of ABC transporters 
have previously been implicated to be an important functional link between the 
NBDs and transmembrane domains. The interaction analysis described in 
Section 6.2.5 represents the early stages of development of a model system 
which may be used to pursue this important issue. The results obtained so far, 
indicate that the White NBD interacts with the loop 2 -3 peptide (see Fig. 1), and 
that the mutation present in this loop encoded by the WT87 eye -colour mutant 
reduces this binding. The w'' mutation (GIy509 to Asp) introduces an acidic 
residue adjacent to Lys5'0 (which would neutralise the positive charge of this 
residue) and flies homozygous for this mutation have very low levels of 
pigments (2% drosopterins, 0% xanthommatin) (described in Chapter 3, 
Section 3.2.1). The decreased binding observed, as analysed by the lAsys 
Biosensor, is consistent with current models of a number of ABC transporters, 
based on genetic and mutational analysis that NBDs and specific loops of the 
TM domain interact (Cotten et al, 1996; Kerppola and Ames, 1992; Mourez et 
al, 1997; Saurin et al, 1994a; Seibert et al, 1997; Shani et al, 1996). In 
addition, the results reported herein are also consistent with the observed 
phenotypic effect of the wET87 mutation and indicates that the positive charge of 
Lys510 is important in the interaction between the loop 2 -3 peptide and the White 
NBD. 
The importance of the intracellular loop region harbouring the EAA motif of 
procaryotes and the EAA -like motif of eucaryotes was discussed earlier (see 
Chapter 3). In the bacterial maltose transporter, it has been shown that 
particular mutations in this motif result in the nucleotide binding domain (MaIK) 
failing to assemble with the transmembrane domains (MaIF and MaIG) (Mourez 
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et al, 1997). Two of these mutations affect charged residues, one involves the 
replacement of the conserved glutamic acid with a hydrophobic amino acid; and 
the other with the introduction of an aspartic acid residue at a position normally 
held by an alanine (Mourez et al, 1997). This indicates the importance of charge 
in the interaction between MalK and the EAA motif, which is consistent with the 
introduction of the charged aspartic acid residue found in WET87. Also of interest 
are MaIK suppressor mutations which compensate for mutations within the EAA 
motif (Mourez et al, 1997). According to sequence alignment information and 
inferences from the recent crystal structure of HisP (Hung et al, 1998) these 
mutations occur within regions which could potentially be important for 
transmission of signals from Arm I (site of ATP binding /hydrolysis) to Arm II 
(region which interacts with the TM domain), or which may alter slightly the 
structure of the helical domain in Arm I! (see Fig. 22). It is noteworthy that 
signal- independent mutants (mutations which release HisP from the regulatory 
control of HisQ /HisM and result in constitutive ATPase activity in the absence of 
HisJ) occur in similar positions to two MalF suppressor mutants. These HisP 
mutations occur within a loop which connects a5 with 09 (see Fig. 22) which is 
close to the ABC signature sequence. These studies therefore strongly suggest 
that arm II and the EAA motif are involved both with protein -protein interactions 
and with signal transduction between the NBDs and TM domains. 
Future directions 
This system can be applied to the expression and partial purification of the 
Scarlet and Brown NBDs in order to investigate predicted interactions between 
the NBDs of White /Scarlet, and White /Brown and to characterise the ATP 
binding and hydrolysis activity which is predicted from such interactions. 
The results obtained from the lAsys experiments analysing the interaction 
between the intracellular loop and the wNBD indicate that this is a feasible and 
potentially very powerful technique for analysis of protein -peptide interactions. 
This system allows analysis of interaction under different conditions which 
Fig. 22 Crystal structure of the nucleotide binding domain of HisP 
The crystal structure of HisP dimer (Hung et al, 1998) shows that the HisP 
monomer is roughly "L" shaped with two arms as indicated in this figure. Arm II 
is predicted to be the region of HisP which interacts with the membrane bound 
domains. Mutant data (discussed in the text) of HisP and other ABC 
transporters suggests that the loop connection between 13-9 and a -5 is 
important for the structure -function of arm Il with respect to interactions with the 
membrane domain and loop regions of this domain. 
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would enable the effects on interactions in the presence or absence of ATP to 
be determined. In addition, analysis of mutant wNBDs with an aim of identifying 
the region which interacts with the loop peptide could be pursued. This 
system could also be used to further characterise the interaction of the wNBD 
and stNBD for which co- purification provides the first preliminary biochemical 
evidence that these domains interact. The tethering of either the White or 
Scarlet NBD to the matrix surface would allow the analysis the interaction 
between the domains. An interaction study such as the one suggested here 
has not been reported for any ABC transporter. 
CHAPTER 7 
IMMUNO -LOCALISATION OF WHITE AND 
SCARLET PROTEINS IN Drosophila EYE TISSUE 
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7. IMMUNO- LOCALISATION OF WHITE AND SCARLET 
PROTEINS IN DROSOPHILA EYE TISSUE 
7.1 Introduction 
The aim of the work described in this chapter is to determine the localisation of 
White and Scarlet protein within the compound eye of D. melanogaster. 
Biochemical analysis of mutant tissues as discussed in Chapter 1, Section 1.6.2 
imply a plasma membrane location of White and Scarlet, where the heterodimeric 
complex transports tryptophan into the cell. However direct evidence is lacking, 
and such information is fundamental to the understanding of the biology of the 
xanthommatin biosynthetic pathway and the major question addressed in this 
chapter is whether the proteins localise to the plasma membrane of pigment cells, 
or a subcellular membrane, such as the pigment granule membrane. 
The localisation studies described in this chapter were performed using 
transmission electron microscopy, and in order to provide a perspective of the 
cellular structure of the compound eye an overview is provided below. 
Ultra- structure of the compound eye of D. melanogaster 
The structure of the compound eye of D. melanogaster has been studied 
previously by electron microscopy (Cagan and Ready, 1989; Carlson and Chi, 
1979; Shoup, 1966) and is illustrated diagrammatically in Fig. 1. An overall view of 
the whole Drosophila eye is shown in the scanning electron micrograph in Fig. 2. 
The peripheral retina of the compound eye is made up of a repetitive array of 
ommatidia or facets and a diagrammatic structure of a single ommatidia is 
illustrated in Fig. 3. Each ommatidium is a stereotyped assembly of 14 cells 
including 8 photoreceptor cells, 4 cone cells and 2 primary pigment cells. 
Fig. 1 Components of the dipteran compound eye 
This figure was taken from (Summers et al, 1982). There are two major 
components which make up the dipteran compound eye. The first component, 
the peripheral retina (PR) is made up primarily of non -nervous tissue and 
includes many hundred ommatidia. The peripheral retina receives optical 
information (e.g. light, movement, contrast) and electrically transmits this 
information to the second component of the retina which is made up mainly of 
nerve fibres and is collectively termed the optic neuropile masses. This 
component of the retina integrates information received from the peripheral 
retina and transmits it to the protocerebrum of the brain for analysis (Bullock and 
Horridge, 1965; Laughlin, 1975). The peripheral retina and the optic neuropile 
masses are separated by a basal lamina. 
Abbreviations: PR peripheral retina; IC, intermediate chiasma; M, medulla; 
lamina (L); medulla (M); the optic lobe (OL). 
Fig. 2 Surface structure of the D. melanogaster compound eye 
This scanning electron micrograph was taken from (Renfranz and Benzer, 
1989) and shows the wild -type adult eye made up of around 800 ommatidia or 
facets. Bristle processes which intervene between each facet and which 
perform a mechano- sensory function can be seen. Bar = 50 µm. 

Fig. 3 The structure of the ommatidium of the adult retina of 
D. melanogaster 
This figure was reproduced from (Cagan and Ready, 1989). 
A schematic longitudinal view of a single ommatidium, drawn to scale. 
B. Five micrometers below the lens. The secondary and tertiary pigment cells 
and bristles, which form the hexagonal lattice, are the most apical cells. At 
this level, the lattice surrounds the pseudocone. 
C. Twelve micrometers below the lens. The anterior and posterior cone cells 
are separated by the equatorial and polar cones. They are enwrapped by 
two primary pigment cells and the surrounding hexagonal lattice of the 
secondary and tertiary pigment cells. 
D. Twenty to eighty micrometers below the lens. Seven photoreceptors can 
be seen. They are surrounded by the hexagonal lattice. The cone cells are 
thin threads, and the primary pigment cells do not extend to this depth. 
E. Eighty to one hundred fifteen micrometers below the lens. Photoreceptor 
R8 is visible at this depth, its rhabdomere replacing R7's in the center. 
F. One hundred twenty micrometers below the lens. The feet of the 
secondary and tertiary pigment cells widen into the filamentous fenestrated 
membrane. At the centre, the cone cells have enlarged into pigment - 
containing sacs; the anterior and posterior cone cells contact each other 
(compare with C). 
Abbreviations: 1° pig. cell, primary pigment cell; 2° pig. cell, secondary pigment 
cell; 3° pig. cell, tertiary pigment cell; ac, anterior cone cell; eqc, equatorial cone 
cell; pc, posterior cone cell; plc, polar cone cell. Anterior is to the right." (Cagan 
and Ready, 1989) 
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Secondary pigment cells are shared between neighbouring ommatidia. The bristle 
process has a mechanosensory function and projects out from the pigment cell 
lattice. The photoreceptor cells possess a unique microvillar arrangement of the 
plasma membrane forming a structure called the rhabdomere and is the 
photosensitive component of the cell and harbours the visual pigment rhodopsin 
(Carlson and Chi, 1979; Eakin, 1972). The primary pigment cells surround the 
pseudocone and cone cells of the ommatidium. The secondary pigment cells 
surround both the primary pigment cells and photoreceptor cells. The primary 
pigment cells harbour pigment granules containing xanthommatin (known as Type 
I pigment granules (Shoup, 1966), while the secondary pigment granules harbour 
both xanthommatin Type I granules and drosopterin containing granules (called 
Type Il pigment granules (Shoup, 1966)). 
Fig. 4 is a low magnification transmission electron micrograph montage illustrating 
the structure of the Drosophila eye tissue section which provides an overall view 
of the sections studied in this work. Ultra- structural components are illustrated at 
higher magnification in Fig. 5. In the longitudinal section (Fig. 5A) the cornea, 
psuedocone and photoreceptor cells ( retinula cells) can be easily seen, in addition 
to the primary and secondary pigment cells which harbour pigment granules. 
While some of the retinula cells are cut longitudinally, most are cut tangentially or 
in cross -section and the rhabdomeres appear as bundles of seven circles. This 
cross sectional appearance of the rhabdomeres is shown in (Fig. 5B) where the 7 
rhabdomeres can be seen surrounded by secondary pigment cells. The pigment 
granules within the secondary pigment cells are clearly seen at this magnification. 
Fig. 5C is a low magnification electron micrograph of a section of the peripheral 
retina showing the repetitive array of ommatidia in both cross section and 
longitudinal section, and provides a perspective of the higher magnification view 
shown in Fig. 5B. 
Fig. 4 Cross section of the Drosophila compound eye viewed by 
transmission electron microscopy 
This figure was produced during the course of the work described herein and is 
a montage of many low magnification (1,000 x) transmission electron 
micrographs taken of a section of eye tissue from the wild -type Canton -S strain 
of D. melanogaster. The tissue was prepared for transmission electron 
microscopy (TEM) by Cathy Gillespie (EM unit, JCSMR, ANU) as described in 
Chapter 2, Section 2.12.1, This montage provides an overall perspective of the 
compound eye and some of the structures are labelled as follows: 
C, cornea; PR, peripheral retina; BM, basement or fenestrated membrane; NS, 
neural sheath. 

Fig. 5 Transmission electron microscopy analysis of the ultrastructure of 
the compound eye of D. melanogaster 
Thin sections of adult eyes were prepared for TEM as described in Chapter 2, 
Section 2.12. 
A. Longitudinal section of the anteria portion of the peripheral retina. The 
primary pigment cells can be distinguished from secondary pigment cells by 
the darker staining of the cytoplasm of the primary pigment cells which are 
adjacent the psuedocone. The cellular components are labelled as follows: 
C, cornea; PC, pseudocone; RC, retinula cells; R, rhabdomere; P, primary 
pigment cells; S, secondary pigment cells; B, bristle. 
Magnification 3,000, Bar = 6.5 µm. 
B. Cross section showing a set of seven rhabdomeres within their respective 
retinula cells of an ommatidium and the surrounding pigment cells which 
harbour pigment granules. 
RC, retinula cell; R, rhabdomere; S, secondary pigment cell; pg pigment 
granule. 
Magnification 105,000 x, bar = 2 µm 
C. Lower magnification view of B, showing the repetitive array of ommatidia 
which make up the peripheral retina. The retinula cells of ommatidia can be 
seen both in cross section (lower half of the page) as well as longitudinal 
section (top of figure). 
Magnification 1,500 x, bar = 13 pm. 
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7.2 Results 
The preparation of D. melanogaster eye tissue for electron microscopy studies 
described herein (described in Chapter 2, Section 2.12.1) 0.e. fixation, 
dehydration, embeding in resin and sectioning) was performed by Cathy Gillespie 
(EM Unit, JCSMR, ANU). 
7.2.1 Immuno- Localisation of the White protein to pigment granules 
The preparation of eye tissue and immuno -gold labelling for transmission electron 
microscopy was performed as described in Chapter 2, Section 2.12. Immuno- 
gold labelling using purified anti -White antibody raised against a predicted 
extracellular loop of the White protein (described in Chapter 4) was observed 
strongly associating with pigment granules of both the primary (Fig. 6A) and 
secondary pigment cells (Fig. 6B and C) as well as to the small pigment granules 
within retinula cells (Fig. 6E and F). Some of the pigment granules in the primary 
pigment cells (Fig. 6A) appear electron lucent (or pale but not transparent) which 
is consistent with previously reported findings in newly emerged flies (Stark and 
Sapp, 1988). Newly emerged flies were selected for this work as the cuticle 
covering the eye hardens with age making it increasingly difficult to obtain cleanly 
cut sections. It has been shown by freeze fracture and platinum replicas that 
these granules are membrane bounded, although the membrane is usually difficult 
to see in micrographs of sectioned material (Stark and Sapp, 1988). Difficulty in 
preservation of pigment granules of eclosed flies for electron microscopy analysis 
has been noted previously and attributed to their increased solubility in alcohol 
and water (Cagan and Ready, 1989; Forrest, 1957; Shoup, 1966; Stark and Sapp, 
1988). This problem was partially overcome in this work by reducing the level of 
alcohol during the dehydration process, resulting in increased preservation of 
intact pigment granules. Also shown in Fig. 6F and G are immuno -labelled 
pigment granules at the posterior region of secondary pigment cells close to the 
basement or fenestrated membrane of the secondary pigment cell, as well as 
pigment granules of the sub -retinal cells which lie beneath the fenestrated 
Fig. 6 Immuno -labelling of White protein at pigment granules of primary, 
secondary pigment cells, retinula cells and sub -retinal cells 
Thin sections of adult eyes were ìmmuno- labelled using the procedure 
described in the experimental procedures Section 2.12. The anti -White 
antibody (raised against the wECL peptide, Section 2.11.1) was used for the 
primary antibody incubation, followed by a secondary anti -rabbit 10nm colloidal 
gold conjugated antibody which are visualised as very electron dense (black) 
particles easily seen at a magnification of 17,000 x. 
A. Longitudinal section of the peripheral retina where a large amount of gold 
label is seen associated with intact pigment granules within a primary 
pigment cell. The primary pigment cell can be identified due to its darker 
appearance compared to the neighbouring secondary pigment cell, as 
well as its proximity to the cornea. P, primary pigment cell; PG, pigment 
granule; C, cornea; S secondary pigment cell. 
Magnification 22,500x, bar = 0.8 µm. 
B. Longitudinal section of the peripheral retina, where gold label is seen 
associated with pigment granules within a secondary pigment cell. 
PG, pigment granule; S, secondary pigment cell. Magnification 22,500x , 
bar = 0.8 µm. 
C. A lower magnification view showing the general area seen in B. PG, 
pigment granule; S, secondary pigment cell; R, rhabdomere. 
Magnification, 13,500 x, bar = 1.5 µm. 
D. Gold label can be seen associating with small pigment granules within a 
retinula cell. R, rhabdomere; PG, pigment granule. Magnification, 60,000 
x, bar = 
E. Lower magnification where the area shown in C. is boxed. 
PG, pigment granule; R, rhabdomere; D, desmosome; RC, retinula cell. 
Magnification 12,000 x, bar = 1.6 p.m. 
F. Immuno -labelling of pigment granules of both secondary pigment cells 
near the basement or fenestrated membrane of the secondary pigment 
cell, in addition to pigment granules of the sub -retinal cells below the 
basement membrane. S, secondary pigment cell; PG, pigment granule; 
BM, basement membrane; SR, sub -retinal cell. 
Magnification 255,000 x, bar = 0.8 p.m. 
G. Lower magnification view where the area shown in F is boxed. 
Magnification 6,000 x, bar = 3 µm. 
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membrane. Although there is some background gold labelling, it is highly 
concentrated at the pigment granule. Labelling of the pigment cell plasma 
membranes was not observed. 
7.2.2 Immuno -gold localisation of Scarlet protein to pigment granules 
Immuno -localisation of the Scarlet protein was carried out as described for the 
localisation of the White protein, using purified anti -Scarlet antibody which was 
raised against a peptide representative of the amino -terminus of the Scarlet 
protein (see Chapter 4). Fig. 7 shows transmission electron micrographs of eye 
sections immuno -gold labelled using anti -Scarlet antibody. Again, labelling is 
concentrated on pigment granules within both primary pigment cells (Fig.7A and 
B) and secondary pigment cells (Fig. 7C and D), in addition to the small pigment 
granules of retinula cells (Fig. 7E and F). Pigment granules of sub -retinal cells 
were also immuno -labelled (Fig. 7G and H). Labelling of the pigment cell plasma 
membranes was not observed. 
Control experiments were performed where the secondary gold- conjugated 
antibody alone was tested for non -specific labelling. Tissue sections cut from the 
same blocks as used for staining with anti -White and anti -Scarlet antibodies, were 
stained as described in Section 2.12 with the omission of the primary antibody 
incubation. Electron micrographs shown in Fig. 8 show that there is no gold 
labelling around pigment granules in primary (Fig. 8A and B) or secondary 
pigment cells (Fig. 8C) which provides good evidence that gold labelling of 
pigment granules described above is not due to non- specific labelling by the 
secondary antibody, but is due to specific labelling of the White and Scarlet 
proteins by anti -White and anti -Scarlet antibodies respectively. 
In order to further rule out the possibility that the antibody labelling observed at 
pigment granules using either anti -White or anti -Scarlet was non -specific, eye 
tissue sections using material from the strain harbouring the mutation w118 was 
Fig. 7 Immuno- labelling of Scarlet protein at pigment granules of primary 
and secondary pigment cells, retinula cells, and sub -retinal cells. 
Thin sections of adult eyes were immuno -labelled using the procedure 
described in the Section 2.12. Anti -Scarlet, antibody (raised against the stNT 
peptide, Section 2.11.1) was used for the primary antibody incubation, followed 
by a secondary anti -rabbit 10nm colloidal gold conjugated antibody which are 
visualised as very electron dense particles easily seen at a magnification of 
17,000 x. 
A. Longitudinal section of the peripheral retina where gold label is seen 
associated with pigment granule membranes within a primary pigment 
cell. The primary pigment cell can be identified due to its darker 
appearance compared to the neighbouring secondary pigment cell, as 
well as its proximity to the cornea. P, primary pigment cell; PG, pigment 
granule; S secondary pigment cell. Magnification 22,500 x, bar = 0.8 um. 
B. A lower magnification view of the area shown in A (boxed). PG, pigment 
granule; S, secondary pigment cell; C, cornea. 
Magnification, (10,500 x), bar = 2 um. 
C. Cross section of the peripheral retina where gold label is seen associated 
with pigment granules within a secondary pigment cell. PG, pigment 
granule; S secondary pigment cell, R, rhabdomere. 
Magnification 22,500 x , bar = 0.8 um. 
D. A lower magnification view of the area shown in C (boxed). PG, pigment 
granule; R, rhabdomere; S, secondary pigment cell. 
Magnification, (13,500 x). Bar = 1.5 pm. 
E. Gold label can be seen associating with small pigment granules within a 
retinula cell_ PG, pigment granule; R, rhabdomere. 
Magnification 60,000 x, bar = 0.3 um. 
F. Lower magnification where the area shown in C. is boxed. 
PG, pigment granule; RC, retinula cell. 
Magnification 7,500 x, bar = 2.6 um. 
G. Immuno -labelling of pigment granules of both secondary pigment cells 
near the basement or fenestrated membrane of the secondary pigment 
cell, in addition to pigment granules of the sub -retinal cells below the 
basement membrane. S, secondary pigment cell; PG, pigment granule; 
BM, basement membrane; SR, sub -retinal cell. 
Magnification 255,000 x, bar = 0.8 um. 
H. Lower magnification view where the area shown in F is boxed. 
Magnification 3,750 x, bar = 5 um. 
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Fig. 8 Secondary antibody control immuno -labelling of pigment cells 
Thin sections of adult eyes were immuno -labelled using the procedure 
described Chapter 2, Section 2.12, however primary antibody incubation was 
omitted followed by incubation with the secondary anti -rabbit lOnm colloidal 
gold conjugated antibody. 
A. Longitudinal section of the peripheral retina where no gold labelling can be 
seen associating with pigment granules of the primary pigment cells. 
Primary pigment cells can be identified as staining darker than the 
adjacent secondary pigment cells. Labelling is also absent from pigment 
granules within secondary pigment cells. S, secondary pigment cell; P, 
primary pigment cell; PG, pigment granule. Magnification 22,500 x, bar = 
0.8 µm. 
B. Lower magnification micrograph illustrating the general area shown in A 
(boxed). C, cornea; P, primary pigment cell; S, secondary pigment cell. 
Magnification 6,000 x, bar = 3 µm. 
C. Cross section of the peripheral retina showing the absence of gold - 
labelling associated with pigment granules of secondary pigment cells. R 
rhabdomere; S, secondary pigment cell; PG, pigment granules. 
Magnification, 22,500 x, bar = 0.8 pm. 
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used as a negative control. The mutation associated with w178 is due to a deletion 
of the 5' region of white including all of exon I (Kurkulos et al, 1991; Levis et al, 
1985) resulting in loss of function and a white -eyed phenotype. Ultrastructure of 
white -eyed mutants have been described previously (Schraermeyer and Dohms, 
1993; Shoup, 1966; Stark and Sapp, 1988). These mutants lack pigment 
granules, however in their place are numerous electron dense granules of varying 
morphology, which are peculiar to the loss of function of the white gene product 
and were named type IV granules (Shoup, 1966). These type IV granules were 
observed in secondary pigment cells in the w1"8 tissue, as shown in Fig. 9. No 
immuno -labelling was observed by anti- White, or anti -Scarlet antibodies 
respectively at type IV granules or any other cellular location in primary (Fig. 9A 
and B) or secondary pigment cells (Fig. 9C and D). This result provides strong 
evidence that the labelling observed in wild -type tissue was specific for White and 
Scarlet protein. The absence of Scarlet immuno -labelling suggests that Scarlet 
protein is not stably incorporated into pigment granule membranes (or type IV 
granules) in the absence of the White protein. 
7.3 Discussion 
The immuno- electron microscopy localisation studies described in this report 
provide the first experimental evidence that both White and Scarlet proteins co- 
localise to the membrane of pigment granules of primary and secondary pigment 
cells as well as pigment granules of retinula cells of the D. melanogaster 
compound eye. No evidence of plasma membrane localisation was observed, 
suggesting that White and Scarlet are not located in the pigment cell plasma 
membrane. Therefore, these findings do not support the traditional model for the 
involvement of these proteins in pigmentation (see Chapter 1, Section 1.6.2). 
Instead they suggest the model depicted in Fig. 10 for the involvement of White 
and Scarlet in the xanthommatin biosynthetic pathway. Entry of tryptophan into the 
pigment cells is not facilitated by the White /Scarlet transporter, but is presumably 
mediated by another transporter localised in the plasma membrane. 
Fig. 9 Immuno -labelling with anti -White and anti -Scarlet antibodies 
respectively of eye tissue from a white mutant (w118) 
Tissue was prepared eyes of adult w118 flies and immuno -labelled in the same 
way as for wild -type. Results of immuno -labelling with both anti -White and 
anti -Scarlet antibodies respectively were the same and TEMs shown here are 
representative of both immuno- labelling experiments. 
A. Longitudinal section of the peripheral retina showing the absence of gold - 
labelling associated with electron dense type IV granules within primary 
pigment cells; these granules are peculiar to the white loss of function 
mutants, as described in the text. PC, psuedocone; S, secondary pigment 
cell; P, primary pigment cell; T, type IV granule. Magnification, 22,500 x, 
bar = 0.8 pm. 
B. A lower magnification view showing the general area seen in A (boxed). 
C, cornea; PC, psuedocone; S, secondary pigment cell; P, primary 
pigment cell; T, type IV granule. Magnification, (4,500 x). Bar = 4.5 pm. 
C. Cross section of the peripheral retina showing the absence of gold - 
labelling associated with electron dense type IV granules within 
secondary pigment cells. S, secondary pigment cell; T, type IV granule. 
Magnification, 22,500 x, bar = 0,8 pm. 
D. A lower magnification view showing the general area seen in C (boxed). 
RC, retinula cell; S, secondary pigment cell; T, type IV granule; 
R, rhabdomere. Magnification, (4,500 x). Bar = 4.5 pm. 

Fig. 10 Model of the involvement of White and Scarlet proteins in the 
biosynthetic pathway of xanthommatin 
The steps involved in the biosynthesis of xanthommatin within pigment cells of 
the compound eye, from its precursor tryptophan are outlined here (reviewed in 
(Summers et al, 1982)) and illustrates how the White and Scarlet proteins fit 
into this pathway. Enzymes involved at different steps of the pathway are 
boxed and are shown at their respective sub -cellular locations. Our results 
show that the White and Scarlet proteins are not located in the plasma 
membrane but are located in the membrane surrounding the pigment granules. 
The predicted orientation of the White /Scarlet transporter is also indicated 
where the nucleotide binding domains are exposed on the cytoplasmic face of 
the pigment granule membrane. Putative sites of glycosylation (evidence for 
which is presented in Chapter 5, Section b) are shown as asterisks. 
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Instead, the White /Scarlet transporter is located in the membrane of the pigment 
granules and is probably involved in the transport of 3- hydroxykynurenine. The 
results reported here raise new and interesting issues regarding the fundamental 
role of White and Scarlet in the xanthommatin production pathway, as discussed 
below. 
Substrate specificity 
To date, the substrate specificity of the White /Scarlet transporter has not been 
definitively characterised. The work of Sullivan et al (Sullivan et al, 1980; Sullivan 
and Sullivan, 1975) provided strong evidence that tryptophan, and kynurenine 
were candidate substrates due to the reduced ability of explanted developing eyes 
or larval malpighian tubules from the null mutants w° or st° to take up these 
compounds, in comparison to wild -type W tissues. It was also shown that these 
mutants excreted high levels of kynurenine and 3- hydroxykynurenine (Howells et 
al, 1977) indicating a defect in storage of these tryptophan metabolites. 
Pigment cells possess the enzymatic machinery to catalyse the conversion of 
intra- cellular tryptophan to kynurenine by tryptophan oxygenase, as well as the 
conversion of kynurenine to 3- hydroxykynurenine by kynurenine hydroxylase (see 
Fig. 10) (reviewed in (Summers et al, 1982)). Pigment deposition within the 
pigment granules requires the oxidation of 3- hydroxykynurenine involving both 
autocatalysis, as well as an enzyme mediated reaction by phenoxazinone 
synthase to form the pigment xanthommatin (Wiley and Forrest, 1981). The 
localisation of White and Scarlet to the pigment granule membrane is therefore 
highly suggestive that the White /Scarlet transport complex provides the import 
machinery for 3- hydroxykynurenine into the pigment granule (see Fig. 10). It is 
also consistent with Sullivan's uptake observations in null mutants if it is assumed 
that tryptophan and kynurenine enter the cells of the eyes or malphigian tubules, 
are converted to 3- hydroxykynurenine which is then imported into the granules. 
The observation reported herein for the compound eye may also apply to sub- 
160 
cellular compartments of malpighian tubules. Although wild -type malpighian 
tubules do not contain pigment granules, fluorescent sub -cellular granules have 
been implicated to be a site for storage of xanthommatin precursors, and these 
fluorescent granules are absent in null mutants of white and in the double 
brown /scarlet mutant (Yagi and Ogawa, 1996). 
Another important observation made by Sullivan's group, with respect to white and 
scarlet mutants, was that although the tissues of the null mutants w° and st° 
showed reduced tryptophan uptake, tryptophan was nevertheless available for 
protein synthesis (Sullivan et al, 1980). In addition there are no known mutations 
of white which are lethal - lethality would be expected from a defect that prevented 
transport of an essential amino acid into cells - suggesting that tryptophan is 
transported into cells by another transport mechanism. Evidence for this has 
been provided by experiments showing that uptake of tryptophan by the w' 
system of wild -type malpighian tubules was inhibited by the analogue 5- methyl- 
tryptophan, however, incorporation of radioactive tryptophan into protein in 
malpighian tubules from wild -type as well as the null mutant w° occurred at the 
same rates and was not affected by 5- methyl -tryptophan (Sullivan et al, 1980). It 
was concluded that ` Malpighian tubules have a transport system that enables 
entry of tryptophan into a cellular pool and that this cellular pool is initially 
independent of the tryptophan pool used for protein synthesis' (Sullivan et al, 
1980). If this proposal also applies to the pigment cells of the compound eye, the 
immuno- localisation studies reported herein are consistent with this hypothesis. It 
is probable that tryptophan is imported into pigment cells via amino acid 
transporters such as those described in other eucaryotic cells (Castagna et al, 
1997; McGivan and Pastor -Anglada, 1994; Shotwell and Oxender, 1983). This 
may be a system of uptake which is common to most cell types and provide a 
means for uptake of tryptophan necessary for protein synthesis. However in 
pigment cells, deposition of xanthommatin within pigment granules would cause a 
metabolic sink for 3- hydroxykynurenine, thereby dictating a higher rate of uptake 
of xanthommatin precursors in these cells. In this respect, uptake of 3- 
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similar to the uptake of tyrosine by melanosomes in mammalian melanocytes 
(Potterf et al, 1996). 
The xanthommatin pathway has been recognised as a major pathway for the 
removal of free tryptophan (Linzen, 1974). The glutarate pathway - the pathway 
which removes tryptophan in mammalian cells - is absent in insects (Linien, 1974). 
The expression of the white gene (and presumably also scarlet) is largely restricted 
to tissues which are associated with storage of tryptophan metabolites or 
pigmentation (Fjose et al, 1984; Summers et al, 1982). It has been reported that 
30% of the total tryptophan content of early pupae is channelled into pigment (Ryall 
and Howells, 1974). During metamorphosis large amounts of tryptophan are 
released from the fat body and it is thought that expression of white and scarlet in 
the pigment cells of the developing eye enables these cells to take up tryptophan, 
kynurenine and 3- hydroxykynurenine at much higher rates than is required for 
protein synthesis (Howells and Ryall, 1975; Howells et al, 1977). 
Orientation in the membrane 
There are two possible orientations for the White and Scarlet proteins in the 
pigment cell membrane: either the nucleotide binding domains are located in the 
cytoplasm, or within the lumen of the pigment granule. Unfortunately from the 
immuno -labelling described here, it is impossible to distinguish the sidedness of 
the labelling. This issue might best be addressed using a double labelling 
technique where epitopes on opposite sides would be labelled with different sized 
gold particles. The molecular weights of White and Scarlet proteins extracted from 
fly heads and analysed by SDS PAGE and Western blotting, suggests that these 
proteins may be glycosylated in vivo (described in Chapter 5 Section b). Possible 
N- linked glycosylation signals are present within a large loop between putative 
transmembrane helices 5 and 6 of both White and Scarlet. This loop is predicted 
to be on the opposite side of the membrane to the nucleotide binding domains 
(Ewart et al, 1994). If White and Scarlet are N- glycosylated in the golgi 
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and endoplasmic reticulum as suggested by Western analysis - where sugar 
groups are added to the luminal side of the golgi -ER membrane - then the loop 
between transmembrane helix 5 and 6 would be located in the lumen of the 
pigment granule, (and the nucleotide binding domains in the cytoplasm) giving the 
orientation for the transporter shown in Fig. 10. 
Protein targeting of White and Scarlet 
It has recently been reported that the protein targeting machinery involved in 
biogenesis of the eye pigment granules, is similar to pathways involved in protein 
sorting to melanosomes and lysosomes (reviewed in (Lloyd et al, 1998)). The 
recent cloning and sequencing of the Drosophila eye- colour gene garnet, reveals 
that the product of this gene shows strong sequence homology to a subunit of the 
human AP -3 complex (Ooi et al, 1997; Simpson et al, 1997), which is involved in 
protein trafficking to lysosomes as well as specialised endosomal -lysosomal 
organelles (Simpson et al, 1997). The garnet gene product is necessary for 
biogenesis of eye pigment granules in Drosophila and it has been postulated that 
the Garnet protein is involved in the protein sorting events leading to the granules 
(Ooi et al, 1997; Simpson et al, 1997). It was suggested that Garnet -containing 
coat complex may be involved in targeting pigment biosynthetic enzymes and 
pigment precursor transporters to the pigment granule membrane (Ooi et al, 1997; 
Simpson et al, 1997). 
The relationships between the protein sorting machinery of pigment granules, 
melanosomes and lysosomes leads to the possibility that membrane proteins 
targeted to these organelles harbour similar sorting signals. It has been noted that 
some lysosomal and melanosomal membrane proteins harbour similar di- leucine 
motifs, which are recognised by AP -3 (Honing et al, 1998; Lloyd et al, 1998; 
Odorizzi et al, 1998). Inspection of the amino -terminal region of White, Brown and 
Scarlet from Drosophila and White homologs of other species reveals a putative di- 
leucine motif similar to those reported in membrane proteins of melanosomes, 
lysosomes and the yeast vacuole (reviewed in (Lloyd et al, 1998)) and this is 
163 
melanosomes, lysosomes and the yeast vacuole (reviewed in (Lloyd et al, 
1998)) and this is illustrated in Fig. 11. The White homologs which occur in 
other insect species are related in function to the D. melanogaster White protein 
(Zwiebel et al, 1995). The function of the White homologs identified in humans 
(which shares 33% identity (56% similarity)) (Chen et al, 1996; Croop et al, 
1997) and mouse (which shared 34% identity with D. melanogaster White) 
(Croop et al, 1997; Savary et al, 1996), are unknown. However the mammalian 
homologs of white have been shown to be highly expressed in brain and other 
tissues, and it has been postulated that the gene product may perform a role in 
the tryptophan --3 serotonin biosynthetic pathway (Croop et al, 1997). It is 
tempting to speculate on the possible location of human White to synaptic 
vesicles involved in serotonin storage in nerve cells. 
It is interesting to note that the amino acid region containing the di- leucine in 
White is not conserved in Scarlet and Brown (not shown), however there is a 
sequence further upstream resembling a di- leucine motif in these proteins (see 
Fig. 11). The observation that no Scarlet labelling was detected in the w178 
tissue, even though the wild -type scarlet gene is present, raises the possibility 
that the White subunit interacts with AP -3 and this interaction is required for the 
assembly of the Scarlet, and also possibly the Brown subunit. 
7.4 Summary 
The localisation studies described in this chapter has provided new insights into 
the role of the White and Scarlet proteins in the eye pigmentation. The 
localisation to the pigment granule membrane rather than the plasma membrane 
provides fundamental new information with respect substrate specificity, now 
proposed to be 3- hydroxykynurenine rather than tryptophan, in addition to the 
likely orientation of the transporter in the membrane and to the direction in which 
substrate molecules move, relation to the transporter during transport. 
Fig. 11 Alignment of putative pigment granule targeting signals of White 
of D. melanogaster and related proteins 
A sequence alignment (ClustalW) - performed as described in Section 2.6.10 - 
reveals a conserved region near the first predicted transmembrane spanning 
region, which is similar to di- leucine -based signal sequences identified and 
experimentally characterised in a number of membrane proteins targeted to 
melanosomes, and lysosomes respectively (Odorizzi et al, 1998). The putative 
di- leucine -based sequences are boxed, and conserved acidic residues located 
upstream of the di- leucine are shown in bold face. The positions of the N- or C- 
termini and transmembrane domains (TMDs) are indicated. Protein sequences 
were obtained from the Swiss Prot data base. 
Abbreviations and Swiss Prot accession numbers are as follows: 
dWhite, D. melanogaster White, P10090; Lc, Lucilla cuprina (Australian sheep 
blowfly), Q05360; Cc, Ceratitis capitata (Mediterranean fruit fly), 017320; Ag, 
Anopheles gambiae (African malaria mosquito), Q27256; hWhite, human White 
homolog P45844; mWhite, mouse White homolog Q64343; dBrown, 
D. melanogaster Brown, P12428; dScarlet, D. melanogaster Scarlet, P45843. 
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How are White and Scarlet targeted to the pigment granule? The 
characterisation of the role of the dileucine signal sequence in targeting the White 
protein would be a good starting point for investigation of this question. In addition, 
this system could potentially be used as a new model system for the study of 
protein targeting by the AP -3 adaptor proteins. 
What is the substrate of the White /Scarlet transporter? The results 
discussed in this Chapter have led to the proposal that the White /Scarlet 
transporter is specific for 3- hydroxykynurenine, however, definitive biochemical 
evidence is required in order to confirm this hypothesis. The insect cell expression 
system described in Chapter 5 could prove very useful in investigating this 
proposal. 
What is the orientation of the White /Scarlet transporter in the membrane of 
the pigment granule? Further studies are required in order to establish the 
orientation of White /Scarlet in the membrane. Although the SDS PAGE analysis 
of White Scarlet suggests it may be glycosylated, further evidence is required to 
confirm this possibility. 
Do White and Scarlet localise to an intracellular organelle in other tissues 
expressing these proteins? Further investigation into the location of White /Scarlet 
in malpighian tubules, testes sheath, ocelli, and the larval pharangeal apparatus 
would contribute further to the understanding of the functional role White and 
Scarlet in these tissues. 
CHAPTER 8 
FINAL DISCUSSION 
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8. FINAL DISCUSSION 
This final chapter will briefly compare and contrast the aims of the research 
described in this thesis at its outset, with the experimental systems which were 
developed in order to achieve these aims. A summary of the experimental 
results and how they contribute to the understanding of the White /Scarlet and 
White /Brown ABC transporters will be provided. Potential courses of action to 
extend the achievements described here will also be discussed. 
The major aim of this thesis was to develop a number of experimental systems 
with which to investigate the structure, function and biology of the pigment 
precursor ABC transporters of D. melanogaster. Methods for the in vivo 
localisation, heterologous expression, isolation and characterisation of White 
and Scarlet proteins were investigated (summarised in Fig. 1). An important 
goal of setting up the heterologous expression systems was to facilitate the use 
of site directed mutagenesis of White and Scarlet in order to determine 
specifically the effects of certain mutations on various measurable functions 
such as ATP binding and hydrolysis, substrate transport and inter -subunit 
interactions. In addition, sequence analysis of white alleles from partially 
pigmented flies was used to identify a number of specific point mutations 
responsible for the mutant phenotypes (Ewart et al, 1994). This approach has 
been used previously by the group to identify residues important for functional 
interactions between the White and Brown subunits (Ewart et al, 1994; Ewart 
and Howells, 1998). 
A summary of the results obtained from each of the experimental systems 
developed herein is provided below. The contribution these results make to the 
understanding of the White /Scarlet and White /Brown transporters, as well as 
the field of ABC transporters is discussed. 
il 
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Localisation of White and Scarlet in the compound eye of D. melanogaster 
The findings presented in Chapter 7 described the localisation of White and 
Scarlet proteins to the membranes of the sub -cellular organelles known as 
pigment granules. This finding is significant in that it provides the first definitive 
evidence for the localisation of White and Scarlet, which provides new insights 
into the role of these proteins in the transport of xanthommatin precursors. 
Previous models based on biochemical data, predicted a plasma membrane 
localisation of White /Scarlet, thereby situating the transporter in an ideal 
position for tissue specific transport of high levels of tryptophan into those cells 
involved in pigmentation or storage of tryptophan metabolites. However, the 
finding that White /Scarlet complex is located at the pigment granule membrane 
suggests a new model, such that the transporter functions as an importer of 3- 
hydroxykynurenine into the pigment granule. The absence of White and 
Scarlet at the plasma membrane implies the use of another transporter for entry 
of tryptophan into the cells (see Fig. 2). 
Another implication of the new model involves the direction of transport of 
substrate with respect to the transporter orientation. A plasma membrane 
localisation would logically locate the NBDs on the cytoplasmic side of the 
plasma membrane and hence, extracellular substrate would first interact with 
extracellular loops and be transported inwards. However, the location of White 
and Scarlet at the intracellular membrane of the pigment granule in combination 
with evidence of glycosylation, indicates the direction of transport of substrate 
with respect to the transporter is reversed and therefore initial substrate binding 
sites would reside at locations exposed to the cytoplasm. If the orientation 
predicted herein is correct, the transporter would function as an ATP -driven 
efflux pump, hydrolysing ATP in the cytoplasm and linking this to the removal of 
its substrate from the cytoplasm, similar to the way the drug -efflux pump P- 
glycoprotein functions. 
Fig. 2 Comparison of the previous and new model for the location and 
transport function of the White /Scarlet transporter. 
A. This figure is a simple cartoon illustrating the previously published model 
for White /Scarlet. In this model White /Scarlet was located in the plasma 
membrane where it functioned in the uptake of tryptophan into pigment 
cells of the eye and cells of the malpighian tubules. 
B. This figure is a simple cartoon illustration of the new model based on the 
findings presented in Chapter 7, In this model the White /Scarlet 
transporter is located in the membrane of pigment granules within pigment 
cells of the eye and transports 3- hydroxykynurenine into the pigment 
granule for subsequent conversion into xanthommatin. Asterisks indicate 
potential glycosylation sites on intra- granular loops which connect 
transmembrane helices 5 and 6 of both White and Scarlet. 
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The localisation of White and Scarlet to the pigment granule membrane 
suggests that the Brown protein is similarly located within the membrane of 
drosopterin containing granules. If this assumption is correct, the White /Brown 
complex is predicted to transport drosopterin precursor towards the end of the 
biosynthesis pathway rather than the previously predicted substrate guanine. 
Guanine is the primary precursor to a number of related pigments called the 
pteridines which includes the pigment drosopterin. The drosopterin biosynthetic 
pathway is not as well understood as the xanthommatin pathway however 
studies of two of the late precursors to drosopterin (pyruvoyl -H4- pterin and PDA) 
(shown in Fig. 3) have shown that they require a highly reductive environment 
(Wiederrecht and Brown, 1984). This environment may be provided inside the 
drosopterin pigment granule and the precursor previous to those precursors 
requiring a special redox environment environment i.e. díhydropneopterin 
triphosphate, is a potential candidate substrate for the White /Brown complex. 
Dihydropneopterin triphosphate is chemically different - being larger carrying 
more charge - to the predicted substrate of the White /Scarlet transporter (3- 
hydroxykynurenine) which may account for the different sensitivities of the 
White /Brown and White /Scarlet complexes to mutations in the White TM 
domain. A proteoliposome transport system whereby the White /Brown complex 
are correctly assembled and orientated, could be used to test these predictions. 
The finding that White and Scarlet are located in the membrane of an 
intracellular organelle coupled with the recent discovery that the eye -colour gene 
garnet encodes a subunit of a specialised protein trafficking complex (AP -3) 
essential for pigment granule biogenesis, is consistent with the role of the AP -3 
adaptor complexes21 in other systems. AP -3 adaptor complexes are strongly 
associated with membrane protein trafficking to the specialised intracellular 
organelles including melanosomes, lysosomes and pigment granules (Lloyd et 
al, 1998). AP -3 adaptor complexes have been shown to bind to dí- leucine 
signal sequences of the target protein, and sequence analysis revealed a 
putative di- leucine based sorting signal (Section 7.3) which is highly conserved 
2' AP -3 adaptor complexes associate with clathrin coats and play an important role in targeting 
membrane proteins to intracellular specialised organelles (Lloyd et ai, 1998). 
Fig. 3 Drosopterin biosynthetic pathway 
This figure is derived from (Summers et al, 1982; and 
Wiederrecht and Brown, 1984) and shows the chemical 
structures of precursors to drosopterin and possible sub -cellular 
locations of the precursors. 
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not only in insect homologs of White, but also the mammalian homologs. 
Construction of transgenic flies with mutations in the putative di- leucine motif 
could be used to investigate the role of these residues on the sub -cellular 
location of White and Scarlet which could be assayed by immuno -EM 
localisation. 
Implications for the roles of mammalian homologs of Drosophila White 
Two mammalian homologs of Drosophila white gene have been cloned recently 
(Chen et al, 1996; Croop et al, 1997; Savary et al, 1996), however the functional 
significance of these proteins has not yet been determined. It is tempting to 
speculate on the analogy of the model presented here, and the role of White in 
mammalian systems. Studies of the human and mouse white genes have 
shown that the genes are highly expressed in several tissues including brain, 
spleen, lung and placenta (Croop et al, 1997). In addition, the human white 
gene has been mapped to a chromosomal region close to loci for bipolar 
affective disorder and a recessive form of deafness (Croop et al, 1997). The 
role of Drosophila White in transport of tryptophan metabolites prompted the 
proposal that mammalian homologs of White may perform a similar function in 
the context of the tryptophan serotonin metabolic pathway of the nervous 
system (Croop et al, 1997). If the observations reported herein are applicable to 
the sub -cellular location of mammalian White in nerve cells, then mammalian 
White may perform a role in the import of serotonin or one of its precursors into 
synaptic vesicles. It is interesting to note that a neuron specific AP -3 homolog 
(ß -NAP) (Newman et al, 1995) has been shown to be involved in apical sorting 
of vesicles from the neuron cell body toward the axon terminus. The possible 
co- localisation of mammalian White and R -NAP to these vesicles, would be an 
interesting issue to pursue. 
The extent of homology between mammalian and Drosophila White proteins 
(26-34% identical and an additional 20 -25% conserved amino -acid residues) 
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(Croop et al, 1997) presents the exciting possibility that information gained from 
the study of the related Drosophila proteins may contribute to the 
understanding of fundamental neurological processes which occur in the 
mammalian nervous system. 
It is interesting to note that over -expression of White in Drosophila was reported 
to cause male -male courtship in Drosophila suggesting that White plays a role 
in the nervous system (Zhang and Odenwald, 1995). Although this effect 
might be explained by an imbalance of tryptophan metabolites which may alter 
brain function, further investigation into the possible expression and localisation 
of White in brain tissue would be worthwhile pursuing. Northern analysis and in 
situ hybridisation analysis has been reported indicating expression is mainly 
restricted to tissues known to be involved in pigmentation, however expression 
was also found in a group of cells associated with the larval photoreceptor 
organ (Fjose et al, 1984). A thorough immuno -EM study of this tissue and other 
nervous tissue is required in order to investigate the localisation of White in 
these tissues. 
Heterologous expression of White and Scarlet in insect cells 
The main aim of this work was to provide a system whereby White and Scarlet 
would be co- expressed and subsequently assemble as a biologically active 
transporter in the plasma membrane, allowing transport function to be 
characterised by uptake assays. The results presented in Chapter 5 showed 
that high levels of expression of White and Scarlet protein could be achieved 
using the Baculovirus- mediated approach, and that some of this protein was 
located in the plasma membrane. At the time this work was performed, 
tryptophan was a strong candidate substrate for the White /Scarlet transporter 
based on previous biochemical uptake studies (Howells et al, 1977; Sullivan et 
al, 1980; Sullivan and Sullivan, 1975). However uptake assays using 
[3H]tryptophan provided no evidence of a novel tryptophan transporter in the 
insect cell plasma membrane. The lack of tryptophan transport function may be 
due to a number of factors including assembly failure, or the presence of a 
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native transport activity which masks any small amount of uptake activity which 
might be due to the White /Scarlet complex. However the immuno -localisation 
studies described in Chapter 7 suggest that the assumption made at the 
commencement of this work (that White /Scarlet transported tryptophan at the 
plasma membrane) was incorrect. In addition, the location and orientation of 
the White /Scarlet complex as described above not only indicates that the 
substrate is not tryptophan, but also indicates that even if White /Scarlet did 
assemble in the Sf9 cell plasma membrane with retention of its function, it 
would act as an efflux pump or exporter, rather than an importer of substrate. 
These concepts are highly significant with respect to the design of further 
experimental work with this system. 
A major problem encountered in the insect cell expression system was that a 
large amount of the White and Scarlet protein was not assembling in the 
membrane, instead, was found intracellularly and was associated with the 
insoluble fraction of the cell. Intracellular immuno -localisation studies 
performed by confocal microscopy - using the anti -White antibody specific for 
the N- terminus of White - indicated punctate labelling reminiscent of localisation 
to an intracellular organeflar membrane. This observation was consistent with 
the immune -EM localisation studies where White and Scarlet locate to the 
pigment granule membrane. Nevertheless it was evident that much of the 
protein was not assembling in a cell membrane possibly due to the specialised 
nature of the sorting requirements of White and Scarlet which are not fulfilled in 
the Sf9 insect cell line. The over -expression of these polytopic membrane 
proteins late in viral infection was also deemed to be a contributing factor to the 
insolubility of White and Scarlet. 
Further experimentation is required in order to find an approach which will 
enable White /Scarlet to assemble efficiently within a membrane bilayer 
whereby a transport assay could be performed. Two feasible approaches were 
described: 
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i) utilising an earlier promoter element to drive expression, in addition to the 
use of a cell line which stably expresses an additional molecular 
chaperone; and 
ii) solubilisation of White and Scarlet and subsequent reconstitution of the 
proteins into proteoliposomes. 
If approach (i) enabled efficient membrane assembly of White /Scarlet complex, 
the membranes enriched with these proteins could be isolated by percoll 
gradient or differential centrifugation and the membrane vesicles obtained 
could be used for uptake assays. Approach (ii) is also feasible since the 
technique of reconstituting membrane proteins into proteolipisomes has been 
shown to be successful for a number of complex membrane transport or 
channel proteins. In this system, high levels of White and Scarlet protein 
would be obtained by Baculovirus- mediated expression as described herein, 
and subsequent solubilisation of the White /Scarlet enriched cell fraction, and 
reconstitution into lipid vesicles would provide a means of producing vesicles 
where a proportion of White /Scarlet would be correctly orientated to enable 
uptake of labelled substrate into proteolipisomes to be assayed. 
This system is well worth pursuing, in that if successful, it could provide the 
basis for a potentially very powerful model system for studying the structure and 
function of the White /Scarlet transporter. Such a system could be used to test 
the proposal that White /Scarlet forms a transporter for 3- hydroxykynurenine, 
and to allow the kinetics of such transport to be determined, as well as a 
system for studying the effects of site directed mutations such as those 
identified in partially pigmented white mutants described in Chapter 3. 
Expression of the nucleotide binding domain of White in E. coli 
The findings presented in Chapter 6 showed that the White NBD could be 
expressed at relatively high levels in E. coli, as a C- terminal fusion to the 
enzyme GST. Some of this protein was located in the E. coli membrane 
fraction and was subsequently partially purified and shown to bind ATP as 
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predicted by the published model (Swart et al, 1994). Introduction of a mutation 
within the highly conserved Walker A motif of the wNBD, substantially reduced 
the ATP binding function, This functional data provided good evidence that the 
heterologous expression and purification system developed herein resulted in 
correctly folded wNBD. 
The finding that separately expressed White and Scarlet NBDs in this system 
(Chapter 6, Section 6.2.4) co- purified is the first preliminary experimental 
evidence for possible protein -protein interactions between these two domains. 
This finding provides a basis for experimentation in order to characterise this 
interaction, in addition to investigating the consequences of those interactions 
on the functional activity of the protein. For example, does the wNBD -stNBD 
have ATP hydrolysis activity'?; and how might the interaction affect ATP binding 
affinity? The results of co- expression of GST -wNBD and stNBD, indicated that 
the NBDs form a complex and that the formation of this complex had a 
stabilising effect on the Scarlet NBD which was degraded to a large extent when 
expressed as a GST fusion protein without the presence of the wNBD. 
Protein -peptide interaction analysis of the nucleotide binding domain of 
White and an intra- helical loop 
The experiments described in Chapter 6, Section 6.2.5 tested the hypothesis 
that the wNBD interacted with the TM domain via the loop between putative TM 
a helices 2 and 3. Experiments using an lAsys biosensor, showed that the 
wNBD binds to a synthetic equivalent of this peptide and that this binding was 
greatly decreased by a single amino acid change in the peptide representative 
of the w5T87 mutation (G509D) described in Chapter 3. These findings provide 
the first direct evidence that the NBD of White binds to this loop and thereby 
represents an important starting point for further experiments to investigate the 
link between the NDB and conformational changes in the TM domain important 
for the mechanism of transport. Future issues that may be addressed using the 
lAsys system include: 
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i) do conformational changes in the NBD brought about by ATP binding 
affect the binding affinity between the NBD and the peptide ?; 
ii) the effects of other mutations in the wNBD - the mutation G135K136 LQ 
which was shown to substantially reduce ATP binding activity by wNBD; 
does this affect binding between the NBD and the loop peptide ?. In 
addition, the mutations identified in the white alleles w101 and vif" 
described in Chapter 3 should be tested. Both are predicted to be 
located in regions of the wNBD important for conformational signal 
transduction between the NBD and TM domain. Information about the 
effects of these mutations on binding could potentially be highly 
informative with respect to the roles of the ABC signature motif (G243S: 
w101) as well as the highly conserved histidine residue (H298N: w°'); 
iii) the effect of the presence of both the wNBD and stNBD; 
iv) the use of site directed mutagenesis to locate the region of the wNBD 
which interacts with the loop peptide, and also the residues in the loop 
peptide critical for binding; and 
v) analysis of interactions of analogous loops linking TM helices of the 
Scarlet and Brown TM domains. 
Such studies could provide a wealth of information with respect to this 
fundamental aspect of ABC transporter function which to date, has been 
addressed in an indirect way through mutant and reversion analysis (Mourez et 
al, 1997; Shyamala et al, 1991). 
Genetic analysis of partially pigmented white mutants 
In Chapter 3 sequences were determined for five white alleles which produce 
partial loss of eye pigmentation phenotype. Most of these turn out to have point 
mutations in the white gene, altering single amino acid residues in critical 
regions of structure. This study has added further weight to a previous 
proposal that TM helix 5 of White is essential for substrate specificity for 
drosopterin precursors. The new data has allowed development of a more 
detailed (somewhat speculative) model of the transport pore, involving TMs 5 
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and 6 of both White and Brown, and the roles of residues predicted to line the 
pore. This is described below. 
Figure 4A illustrates the potential interactions of TM 5 and 6 of Brown with TM 6 
of White brought about by a salt bridge between Asp570 of TM5 of Brown or 
Asp646 of TM 6 of Brown alternating with Arg672 of TM 6 of White. These 
residues all lie within a similar plane of the predicted a- helices around the TM 
helix mid -point, and this is shown in the net diagrams in Fig 5. The cause of 
these conformational changes could be brought about in part by the proline 
residue in TM 5 of Brown which is predicted to be on the other side of the a- 
helix to Asp570. The two prolines in TM 5 of White would very likely also perform 
an important structure /function role in the regulation of the structural changes 
required for the opening and closing of the transport route. Proline has been 
found to occur in TM domains of transport proteins with a much higher 
frequency than in TM domains of non -transport proteins (Brandi and Deber, 
1986), even though proline is the least likely amino acid to occur in an a- helix22 
(Chou and Fasman, 1978). This gave rise to the notion that functional 
membrane -buried proline residues are selectively included in transport proteins 
(Brandi and Deber, 1986). It was postulated that "... the cis -trans isomerization 
of an Xaa -Pro peptide bond (Xaa = unspecified amino acid) buried within the 
membrane - and the resulting redirection of the protein chain - is proposed to 
provide the reversible conformational change requisite for regulation 
(opening /closing) of a transport channel." (Brandi and Deber, 1986). The 
importance of proline residues has been shown in a number of ABC 
transporters ((Sheppard et al, 1996; Webb et al, 1992). In particular, in the 
phosphate transport system (Pst) double mutations P123L, P183L as well as 
P123A, P183A, resulted in the transporter being locked into an `open" 
configuration, highlighting a functional role in gating (Webb et al, 1992). 
Also shown in Fig. 4A are putative TM helices 3 of White and 2 of Brown. 
These two helices are the only other TM helices (other than TMs 5 and 6 of 
Fig. 4 Putative model of the gating mechanism for transport of 
drosopterin precursors 
A. This figure illustrates diagrammatically the possible conformational 
changes which may occur in order to open and close the transport 
channel specific for guanine. The closed conformation results when TM 6 
of White and TM 6 of Brown interact by way of electrostatic interaction 
between R672 of White and D646 of Brown. The open conformation results 
when this charge pair between TM 6 of White and Brown breaks and 
reforms with D570 of TM 5 of Brown. The relative position of the proline 
residues are indicated and may act as "hinge" regions contributing to the 
gating of the pore. The dashed ellipses give an indication of the change in 
diameter of the pore in the open and closed conformations. TM 3 of 
White and TM 2 of Brown are also shown and may play an important role 
in transmission of conformational changes of the pore region via signals 
transduced from the NBD -> loop 2 -+ TM. Both TM 2 and 3 of Brown 
and White harbour glutamic acid residues which may play a role in 
structure and function of the pore by either attractive forces with R672 of 
White TM 6 or repulsive forces with other negatively charged residues in 
the helices proposed to line the pore. For example E461 of TM2 of Brown 
is appropriately positioned to interact with R672 and may play a role in 
breaking of the salt bridge between R672 and D646 by the introduction of a 
second negative residue. 
B. A simplified cartoon illustration which takes into account the localisation 
data obtained in Chapter 7, where it was shown that White and Scarlet are 
located in the pigment granule membrane and that the NBDs are located 
in the cytoplasm. It is assumed that the Brown subunit is similarly 
orientated within the membrane of drosopterin containing granules. This 
figure illustrates that the major restriction of the transport route in the 
closed state is located near the intra- granular face of the membrane. This 
illustration also takes into account information gained from the crystal 
structure of HisP (Hung et al, 1998) illustrating the interactions between 
the two NBDs of White and Scarlet and the interaction of arm Il with the 
loop between TMs 2 and 3 thought to play an important role in transducing 
conformational changes between the NBDs and the TM domains. This 
figure was adapted from (Welsh et al, 1998). 
A 
G54F _G578 
Triple 
proline 
a F 672 
64 6 
WTM6 
Closed 
.$GuTM5 W TM3 
W loop 2 
Co nformationa I 
changes at NBD 
B Inside pigment granule 
Bw TM2 
TM) 
Open 
Dro so pt er in 
w loop 2 
Co nfo rmational 
changes at NBD 
Pigment cell cytop lasm Drosopterin precursor 
Fig. 5 Helical net diagram of residues in the putative transmembrane 
helices 5 and 6 of both the White and Brown subunits. 
In the helical net diagrams the intracellular end is at the bottom. The x -axis 
represents the position on the circumference of the helix. Residues that align 
vertically are on the same face of the helix. This figure illustrates that R672 (TM 
6 White), D570 (TM 5 Brown), 0646 (TM 6 Brown) and E461 (TM2 Brown) are at 
positions on the helix appropriate for electrostatic interactions proposed in the 
text and illustrated in Fig. 2. 
Fig. 5 Helical net diagrams of residues in the putative transmembrane 
helices 5 and 6 of both the White and Brown subunits 
In these helical net diagrams the intra- cellular end is at the bottom. The x- 
axis represents the position on the circumference of the helix. Residues that 
align vertically are on the same face of the helix. This figure illustrates that 
R672 (TM 6 White), D570 (TM5 Brown), D646 (TM 6 Brown) and E461 (TM 
2 Brown) are at positions on the helix appropriate for electrostatic 
interactions proposed in the text and illustrated in Fig. 2. 
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both White and Brown) which contain charged residues. Both TM 2 and TM 3 
of Brown and White respectively are linked to the loop 2 region of the TM 
domain, proposed to form an interface between the NBD and TM region as 
discussed above. Thus, these helices are predicted to be affected by 
conformational signals from the NBD. Although there is no evidence of these 
helices involvement in the transport mechanism, it is predicted that they play a 
role in the conformational changes proposed in Fig. 4A. TM 2 of Brown 
harbours a glutamic acid residue (E461) in a similar plane to R672 of White TM 
6 and D570 of Brown TM 5 (see Fig. 4). It is possible that E461 of TM 2 of 
Brown, appropriately placed by conformational changes transduced by the 
NBD, may provide the driving force for the changed position of the salt bridge 
which opens and closes the pore. 
It is interesting to note the homology of amino acid sequence at the 
extracellular ends of both TM 5 of Brown and TM 5 of White, both harbouring 
GGF[I /L]L. It is possible that the glycines at these positions, when positioned 
appropriately, also contribute to the widening of the pore when facing inwards 
with respect to the pore, and the substitution of Gly for a larger residue (as is 
the case in bwT50 G578D, w°' G589E and w°O2 G588S) may cause a partial 
blockage, or slowing of the transport of substrate. However, this interpretation 
is not consistent with the w mutation which has the lowest levels of 
drosopterins. In this mutant a large Phe is substituted for glycine, which could 
be imagined to cause the pore to be wider than usual. It may be that the loop 
which follows TM 5 of White and which connects to TM 6 also plays an 
important structure /function role which is abrogated by the F590G substitution 
of wsa`. Alternatively F590 may play an important physical /chemical role in 
substrate binding through hydrophobic interactions between the aromatic rings. 
The predicted model discussed above could he tested using a transgenic fly 
system, as well as the proteoliposome model system to assay transport directly, 
once the system has been established. The importance of the charged 
22 This is based on analysis of a- helices of soluble proteins. 
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residues predicted to form structurally and functionally important salt bridges 
could be investigated by mutagenesis in addition to the substitution of residues 
of specific sizes which could be used to study the effects on transport at each 
end of the proposed pore illustrated in Fig. 4. For example, it is predicted that 
substitutions for alanine may have little effect at the putative wide end of the 
pore, while having an increasingly significant effect towards the region of the 
pore predicted to form a constriction of the pore when in the closed state. If this 
model is correct, it may be possible to engineer a permanently open transporter 
by appropriate mutagenesis of the proline residues and other residues 
proposed to perform a role in closing the pore, analogous to mutagenic studies 
performed on the Pst phosphate transport system of E. coli (Webb et al, 1992). 
Although insights into regions of the White /Brown complex important for 
transport of drosopterin precursors have been discussed, little is known with 
respect to residues within the TM regions of White /Scarlet important for the 
transport of xanthommatin precursors. Mutagenesis utilizing the model 
systems mentioned above could be used to investigate this issue. 
Conclusion 
This thesis has described efforts towards the development of a variety of 
experimental model systems to investigate various aspects of structure and 
function of both the transmembrane domains and nucleotide binding domains 
of the Drosophila ABC transporters involved in eye pigmentation. While further 
work is required to perfect these systems, results have been obtained which 
contribute to the overall understanding of structure and function of the White, 
Brown and Scarlet proteins and their roles in the eye pigmentation pathway of 
Drosophila. In addition, information gained through this study is inherently 
relevant to the ABC transporter superfamily as a whole. 

178 
APPENDIX 1 
Protein and cDNA sequence of Drosophila melanogster white 
The genomic white was sequenced by (O'Hare et al, 1984) and the intron -exon 
junctions were deduced with only minor modifications being required when a 
cDNA clone was subsequently isolated (Pepling and Mount 1990). The cDNA 
(bases are numbered) and protein sequence is shown here. Motifs 
characteristic of ABC transporters are highlighted in bold; positions of mutations 
identified from mutant white alleles which result in partial decreases in eye 
colouration described in Chapter 3 are shown above the DNA sequence; 
putative transmembrane domains predicted from hydropathy analysis are 
shown in bold and underlined. 
10 20 30 40 50 
ATG GGC CAA GAG GAT CAG GAG CTA TTA ATT CGC GGA GGC AGC AAA CAC CCA TCT 
TAC CCG GTT CTC CTA GTC CTC GAT AAT TAA GCG CCT CCG TCG TTT GTG GGT AGA 
Met Gly Gln Glu Asp Gln Glu Leu Leu Ile Arg Gly Gly Ser Lys His Pro Ser> 
60 70 80 90 100 
GCC GAG CAT CTG AAC AAT GGT GAC AGC GGA GCG GCT TCG CAG AGC TGC ATT AAC 
CGG CTC GTA GAC TTG TTA CCA CTG TCG OCT CGC CGA AGC GTC TCG ACG TAA TTG 
Ala Glu His Leu Asn Asn Gly Asp Ser Gly Ala Ala Ser Gln Ser Cys Ile Asn> 
110 120 130 140 150 160 
CAG GGC TTC GGG CAG GCC AAA AAC TAC GGC ACG CTC CTG CCA CCC AGT CCG CCG 
GTC CCG AAG CCC GTC CGG TTT TTG ATG CCG TGC GAG GAC GGT GGG TCA GGC GGC 
Gln Gly Phe Gly Gln Ala Lys Asn Tyr Gly Thr Leu Leu Pro Pro Ser Pro Pro> 
170 180 190 200 210 
GAG GAC TCC GGT TCA GGG AGC GGC CAA CTA GCC GAG AAC CTC ACC TAT GCC TGG 
CTC CTG AGG CCA AGT CCC TCG CCG GTT GAT CGG CTC TTG GAG TGG ATA CGG ACC 
Glu Asp Ser Gly Ser Gly Ser Gly Gln Leu Ala Glu Asn Leu Thr Tyr Ala Trp> 
220 230 240 250 260 270 
CAC AAT ATG GAC ATC TTT GGG GCG GTC AAT CAG CCG GGC TCC GGA TGG COG CAG 
GTG TTA TAC CTG TAG AAA CCC CGC CAG TPA GTC GGC CCG AGG CCT ACC GCC GTC 
His Asn Met Asp Ile Phe Gly Ala Val Asn Gln Pro Gly Ser Gly Trp Arg Gln> 
280 290 300 310 320 
CTG GTC AAC CGG ACA CGC GGA CTA TTC TGC AAC GAG CGA CAC ATA CCG GCG CCC 
GAC CAG TTG GCC TGT GCG CCT GAT AAG ACG TTG CTC GCT GTG TAT GGC CGC GGG 
Leu Val Asn Arg Thr Arg Gly Leu Phe Cys Asn Glu Arg His Ile Pro Ala Pro> 
330 340 350 360 370 
AGG AAA CAT TTG CTC AAG AAC GTT TGC GGC GTG GCC TAT CCG GGC GAA CTT TTG 
TCC TTT GTA AAC GAG TTC TTG CAA ACG CCG CAC CGG ATA GGC CCG CTT GAA AAC 
Arg Lys His Leu Leu Lys Asn Val Cys Gly Val Ala Tyr Pro Gly Glu Leu Leu> 
380 390 400 410 420 430 
GCC GTG ATG GGC AGT TCC GGT GCC GGA AAG ACG ACC CTG CTG AAT GCC CTT GCC 
CGG CAC TAC CCG TCA AGG CCA CGG CCT TTC TGC TGG GAC GAC TTA CGG GAA CGG 
Ala Val Met Gly Ser Ser Gly Ala Gly Lys Thr Thr Leu Leu Asn Ala Leu Ala> 
Walker A 
440 450 
TTT CGA TCG CCG CAG GGC ATC CAA 
AAA GCT AGC GGC GTC CCG TAG GTT 
Phe Arg Ser Pro Gln Gly Ile Gin 
490 500 510 
GGC CAA CCT GTG GAC GCC AAG GAG 
CCG GTT GGA CAC CTG CGG TTC CTC 
Gly Gln Pro Val Asp Ala Lys Glu 
550 560 
GAT GAC CTC TIT ATC GGC TCC CTA 
CTA CTG GAG AAA TAG CCG AGG GAT 
Asp Asp Leu Phe Ile Gly Ser Leu 
600 
ATG GTG CGG ATG 
TAC CAC GCC TAC 
Met Val Arg Met 
650 
CAG GTG ATC 
GTC CAC TAG 
Gln Val Ile 
660 
CAG 
GTC 
Gln 
460 
GTA TCG 
CAT AGC 
Val Ser 
ATG CAP 
TAC GTC 
Met Gln 
570 
ACG GCC 
TGC CGG 
Thr Ala 
610 620 
CCA CGA CAT CTG ACC TAT 
GGT GCT GTA GAC TGG ATA 
Pro Arg His Leu Thr Tyr 
670 
GAG CTT TCG CTC 
CTC GAA AGC GAG 
Glu Leu Ser Leu 
710 720 
CCC GGC AGG GTG AAA GGT CTG TCC 
GGG CCG TCC CAC TTT CCA GAC AGG 
Pro Gly Arg Val Lys Gly Leu Ser 
760 770 
TCC GAG GCA CTA ACC GAT CCG 
AGG CTC CGT GAT TGG CTA GGC 
Ser Glu Ala Leu Thr Asp Pro 
470 
CCA TCC GGG 
GGT AGG CCC 
Pro Ser Gly 
520 
GCC AGG TGC 
CGG TCC ACG 
Ala Arg Cys 
480 
ATG CGA CTG CTC AAT 
TAC GCT GAC GAG TTA 
Met Arg Leu Leu Asn> 
530 540 
GCC TAT GTC CAG CAG 
CGG ATA CAG GTC GTC 
Ala Tyr Val Gln Gln> 
580 590 
AGG GAA CAC CTG ATT TTC CAG GCC 
TCC CTT GTG GAC TAA AAG GTC CGG 
Arg Glu His Leu Ile Phe Gln Ala> 
630 
CGG CAG CGA 
GCC GTC GCT 
Arg Gln Arg 
680 
AGC AAA TGT CAG CAC 
TCG TTT ACA GTC GTG 
Ser Lys Cys Gln His 
wies 740 
GGC GGA GAA AGG AAG 
CCG CCT CTT TCC TTC 
Gly Gly Glu Arg Lys 
ABC Signature 
640 
GTG GCC CGC GTG GAT 
CAC CGG GCG CAC CTA 
Val Ala Arg Val Asp> 
690 700 
ACG ATC ATC GGT GTG 
TGC TAG TAG CCA CAC 
Thr Ile Ile Gly Val> 
750 
CGT CTG GCA TTC GCC 
GCA GAC CGT AAG CGG 
Arg Leu Ala Phe Ala> 
780 790 800 810 
CCG CTT CTG ATC TGC GAT GAG CCC ACC TCC GGA 
GGC GAA GAC TAG ACG CTA CTC GGG TGG AGG CCT 
Pro Leu Leu Ile Cys Asp Glu Pro Thr Ser Gly> 
Walker B 
840 850 860 
GTC CAG GTG CTG AAG AAG CTG TCG CAG 
CAG GTC CAC GAC TTC TTC GAC AGC GTC 
Val Gln Val Leu Lys Lys Leu Ser Gln> 
820 830 
CTG GAC TCA TTT ACC GCC CAC AGC GTC 
GAC CTG AGT AAA TGG CGG GTG TCG CAG 
Leu Asp Ser Phe Thr Ala His Ser Val 
870 
AAG GGC AAG 
TTC CCG TTC 
Lys Gly Lys 
920 
CTC TTT GAC 
GAG AAA CTG 
Leu Phe Asp 
880 
ACC GTC ATC CTG 
TGG CAG TAG GAC 
Thr Val Ile Leu 
890 - 900 
ACC ATT CAT CAG CCG TCT 
TGG TAA GTA GTC GGC AGA 
Thr Ile His Gln Pro Ser 
930 940 950 
AAG ATC CTT CTG ATG GCC GAG GGC AGG GTA 
TTC TAG GAA GAC TAC CGG CTC CCG TCC CAT 
Lys Ile Leu Leu Met Ala Glu Gly Arg Val 
980 990 100 
CCC AGC GAA GCC GTC GAC TTC TTT TCC 
GGG TCG CTT CGG CAG CTG AAG AAA AGG 
Pro Ser Glu Ala Val Asp Phe Phe Ser 
1030 1040 1050 
TAC AAT CCG GCG GAC TTT TAC GTA CAG 
ATG TTA GGC CGC CTG AAA ATG CAT GTC 
Tyr Asn Pro Ala Asp Phe Tyr Val Gln 
1090 1100 
ATC GAG TCC CGT GAT CGG ATC 
TAG CTC AGG GCA CTA GCC TAG 
Ile Glu Ser Arg Asp Arg Ile 
1140 1150 
GTA GCC CGG GAT ATG GAG CAG 
CAT COG GCC CTA TAC CTC GTC 
Val Ala Arg Asp Met Glu Gln 
0 1010 
TAC GTG GGT GCC 
ATG CAC CCA CGG 
Tyr Val Gly Ala 
1 
GCC AAG 
OGG TTC 
Ala Lys 
1160 
TTG TTG 
AAC AAC 
Leu Leu 
1060 
GTG TTG GCC 
CAC AAC CGG 
Val Leu Ala 
GTT 
CAA 
Val 
110 112 
ATA TGC GAO AAT 
TAT ACG CTG TTA 
Ile Cys Asp Asn 
1170 
GCC ACC AAA AAT 
CGG TGG TTT TTA 
Ala Thr Lys Asn 
910 
TCC GAG CTG 
AGG CTC GAC 
Ser Glu Leu 
TTT GAG 
AAA CTC 
Phe Glu> 
960 970 
GCT TTC TTG GGC ACT 
CGA AAG AAC CCG TGA 
Ala Phe Leu Gly Thr> 
1020 
CAG TGT CCT ACC AAC 
GTC ACA GGA TGG TTG 
Gln Cys Pro Thr Asn> 
1070 1080 
GTG CCC GGA CGG GAG 
CAC GGG CCT GCC CTC 
Val Pro Gly Arg Glu> 
0 1130 
TTT GCC ATT AGC AAA 
AAA CGG TAA TCG TIT 
Phe Ala Ile Ser Lys> 
1180 
TTG GAG AAG CCA CTG 
AAC CTC TTC GGT GAC 
Leu Glu Lys Pro Leu> 
179 
1190 1200 1210 
GAG CAG CCG GAG AAT GGG TAC ACC 
CTC GTC GGC CTC TTA CCC ATG TGG 
Glu Gln Pro Glu Asn Gly Tyr Thr 
1250 1260 
GCG GTC CTG TGG CGA TCC TGG CTG 
CGC CAG GAC ACC GCT AGG ACC GAC 
Ala Val Leu Trp Arg Ser Trp Leu 
1300 1310 
GTG CGA CTT ATT CAG ACA 
CAC GCT GAA TAA GTC TGT 
Val Arg Leu Ile Gln Thr 
1220 1230 1240 
TAC AAG GCC ACC TGG TTC ATG CAG TTC CGG 
ATG TTC CGG TGG ACC AAG TAC GTC AAG GCC 
Tyr Lys Ala Thr Trp Phe Met Gln Phe Arg> 
1270 1280 
TCG GTG CTC AAG GAA 
AGC CAC GAG TTC CTT 
Ser Val Leu Lys Glu 
1320 
ACG ATG GTT GCC 
TGC TAC CAA CGG 
Thr Met Val Ala 
TM 1 
1290 
CCA CTC CTC GTA AAA 
GGT GAG GAG CAT TTT 
Pro Leu Leu Val Lys> 
1330 1340 1350 
ATC TTG ATT GGC CTC ATC TTT TOG 
TAG AAC TAA CCG GAG TAG AAA AAC 
Ile Leu Ile Gly Leu Ile Phe Leu> 
1360 1370 1380 1390 1400 
GGC CAA CAA CTC ACG CAA GTG GGC GTG ATG AAT ATC AAC GGA GCC ATC TTC CTC 
CCG GTT GTT GAG TGC GTT CAC CCG CAC TAC TTA TAG TTG CCT CGG TAG AAG GAG 
Glv Gln Gln Leu Thr Gln Val Gly Val Met Asn Ile Asn Gly Ala Ile Phe Leu> 
1410 1420 1430 1440 
TTC CTG ACC AAC ATG ACC TTT CAA AAC GTC TTT GCC ACG 
AAG GAC TGG TTG TAC TGG AAA GTT TTG CAG AAA CGG TGC 
Phe Leu Thr Asn Met Thr Phe Gln Asn Val Phe Ala Thr 
1450 
ATA AAT GTG TTC ACC 
TAT TTA CAC AAG TGG 
Ile Asn Val Phe Thr> 
TM 2 
1460 1470 1480 1490 1500 1510 
TCA GAG CTG CCA GTT TTT ATG AGG GAG GCC CGA AGT CGA CTT TAT CGC TGT GAC 
AGT CTC GAC GGT CAA AAA TAC TCC CTC CGG GCT TCA GCT GAA ATA GCG ACA CTG 
Ser Glu Leu Pro Val Phe Met Arg Glu Ala Arg Ser Arg Leu Tyr Arg Cys Asp> 
1520 
ACA TAC TIT CTG 
TGT ATG AAA GAC 
Thr Tyr Phe Leu 
1540 1550 1560 
GGC AAA ACG ATT GCC GAA TTG CCG CTT TTT CTC ACA GTG CCA 
CCG TTT TGC TAA CGG CTT AAC GGC GAA AAA GAG TGT CAC GGT 
Gly Lys Thr Ile Ala Glu Leu Pro Leu Phe Leu Thr Val Pro> 
TM 3 
1570 1580 1590 1600 
CTG GTC TTC ACG GCG ATT GCC TAT CCG ATG ATC GGA CTG 
GAO CAG AAG TGC CGC TAA CGG ATA GGC TAC TAG CCT GAC 
Leu Val Phe Thr Ala Ile Ala Tyr Pro Met Ile Gly Leu 
1610 1620 
CGG GCC GGA GTG CTG 
GCC CGG CCT CAC GAO 
Arg Ala Gly Val Leu> 
1630 1640 1650 1660 1670 
CAC TTC TTC AAC TGC CTG GCG COG GTC ACT CTG GTG GCC AAT GTG TCA ACG TCC 
GTG AAG AAG TTG ACG GAC CGC GAC CAG TGA GAC CAC CGG TTA CAC AGT TGC AGG 
His Phe Phe Aso Cvs Leu Ala Leu Val Thr Leu Val Ala Asn Val Ser Thr Ser> 
TM 4 
1680 1690 1700 1710 1720 
TTC GGA TAT CTA ATA TCC TGC GCC AGC TCC TCG ACC TCG ATG GCG CTG TCT GTG 
AAG CCT ATA GAT TAT AGG ACG CGG TCG AGG AGC TGG AGC TAC CGC GAC AGA CAC 
Phe Gly Tyr Leu Ile Ser Cys Ala Ser Ser Ser Thr Ser Met Ala Leu Ser Val> 
1730 1740 eT" 1750 
GGT CCG CCG &I"P ATC ATA CCA TTC 
CCA GGC GGC CAA TAG TAT GGT AAG 
Glv Pro Pro Val Ile Ile Pro Phe 
TM 5 
1790 1800 
GGC TCG GTG CCA GTA TAC CTC AAA 
CCG AGC CAC GGT CAT ATG GAG TTT 
Gly Ser Val Pro Val Tyr Leu Lys 
1840 1850 1860 
GCC AAC GAG GGT CTG CTG ATT AAC 
CGG TTG CTC CCA GAC GAC TAA TTG 
Ala Asn Glu Gly Leu Leu Ile Asn 
1760 P2 sae 
CTG CTC TTT GGC GGC TTC TTC TTG 
GAC GAG AAA CCG CCG AAG AAG AAC 
Leu Leu Phe Gly Gly Phe Phe Leu 
1810 1820 1830 
TGG TTG TCG TAC CTC TCA TGG TTC 
ACC AAC AGC ATG GAG AGT ACC AAG 
Trp Leu Ser Tyr Leu Ser Trp Phe 
1780 
AAC TCG 
TTG AGC 
Asn Ser> 
CGT TAC 
GCA ATG 
Arg Tyr> 
1870 1880 1890 
CAA TGG GCG GAC GTG GAG CCG GGC GAA ATT 
GTT ACC CGC CTG CAC CTC GGC CCG CTT TAA 
Gln Trp Ala Asp Val Glu Pro Gly Glu Ile> 
180 
181 
1900 1910 1920 1930 1940 
AGC TGC ACA TCG TCG AAC ACC ACG TGC CCC AGT TCG GGC AAG GTC ATC CTG GAG 
TOG ACG TGT AGC AGC TTG TGG TGC ACG GGG TCA AGC CCG TTC CAG TAG GAC CTC 
Ser Cys Thr Ser Ser Asn Thr Thr Cys Pro Ser Ser Gly Lys Val Ile Leu Glu> 
1950 1960 1970 1980 1990 
ACG CTT AAC TTC TCC GCC GCC GAT CTG CCG CTG GAC TAC GTG GGT CTG GCC ATT 
TGC GAA TTG AAG AGG CGG CGG CTA GAC GGC GAC CTG ATG CAC CCA GAC CGG TAA 
Thr Leu Asn Phe Ser Ala Ala Asp Leu Pro Leu Asp Tyr Val Gly Leu Ala Ile> 
2000 2010 2020 2030 2040 2050 
CTC ATC GTG AGC TTC CGG GTG CTC GCA TAT CTG GCT CTA AGA CTT CGG GCC CGA 
GAG TAG CAC TCG AAG GCC CAC GAG CGT ATA GAC CGA GAT TCT GAA GCC CGG GCT 
Leu Ile Val Ser Phe Arv Val Leu Ala Tyr Leu Ala Leu Arg Leu Arg Ala Arg> 
TM 6 
2060 
CGC AAG GAG TAG 
GCG TTC CTC ATC 
Arg Lys Glu * ** > 
182 
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